data_2ax5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ax5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 120.799 0.333 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -151.5 132.55 14.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.13 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.36 120.29 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.38 102.09 13.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -99.47 142.12 15.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -118.07 102.49 9.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.06 131.7 34.56 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 mp -139.3 175.83 9.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.237 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 -85.96 1.35 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.625 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.15 28.1 1.55 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.869 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.93 -46.3 4.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.08 -26.35 66.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.367 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.75 80.42 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.827 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.455 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 4.3 mt -77.03 -40.5 30.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -63.74 -30.78 71.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.02 46.55 0.22 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.69 34.71 25.03 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.12 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.75 97.77 8.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.71 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -31.16 70.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.9 128.39 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.917 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.69 138.63 37.92 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 142.23 27.58 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.8 mm -121.39 148.13 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.32 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 126.3 31.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 142.22 50.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.48 102.07 4.52 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -149.37 -69.33 0.21 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.489 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.66 -178.25 5.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.013 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.6 -57.98 0.67 Allowed Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.378 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.88 61.78 3.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.388 2.059 . . . . 0.0 112.724 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.58 116.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.8 p -84.84 160.1 20.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.898 0.38 . . . . 0.0 110.957 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -58.15 -34.14 48.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.62 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.25 62.0 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.965 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -42.69 71.35 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.746 0.308 . . . . 0.0 110.303 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.0 -52.39 58.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.254 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.4 mt -57.96 -39.6 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.256 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.93 -44.29 91.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.733 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -38.16 76.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 32.2 mm -68.68 -28.97 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.2 t -96.02 -6.53 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 p -99.33 -77.52 0.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.199 -0.313 . . . . 0.0 111.728 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -84.55 -44.02 13.96 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.475 0.179 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.442 ' HB2' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -56.31 -52.31 65.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.219 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.2 mt -122.4 141.53 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.566 0.222 . . . . 0.0 111.075 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.15 74.05 0.77 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.134 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -165.94 139.07 3.44 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.444 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.95 70.57 5.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.59 2.193 . . . . 0.0 111.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -171.86 -44.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.799 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.68 -41.88 11.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.97 -35.3 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -55.55 -38.44 69.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.36 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.53 -30.87 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.598 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -79.52 -57.47 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.024 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 mm -106.18 135.66 43.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -124.87 97.16 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.982 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.64 66.27 1.28 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.09 28.62 9.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.799 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 m -147.19 122.57 10.32 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.358 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.12 152.48 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 111.158 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.3 116.63 60.59 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -52.68 119.33 5.8 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.85 -27.15 3.22 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.776 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 mt -72.51 125.31 31.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 mp -86.17 148.56 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.327 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 m -149.71 100.69 2.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 46.7 mt -91.6 114.87 27.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.3 pt -103.52 110.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.765 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 60.19 45.63 11.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.701 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.34 28.64 17.02 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 167.6 20.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.264 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.87 144.33 33.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 111.242 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -63.31 -50.61 69.38 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.976 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -24.59 67.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.25 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -50.03 63.76 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.018 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.15 -72.2 0.34 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.74 36.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.962 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 56.71 -83.98 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 111.808 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -101.86 3.54 39.35 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -91.56 31.09 1.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.696 0.284 . . . . 0.0 111.482 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -123.45 109.2 13.54 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.5 mm -65.73 137.28 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.782 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 mt -63.06 174.19 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.069 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -167.64 101.06 0.49 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -47.06 119.88 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.706 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.32 20.29 8.34 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.146 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.93 162.84 13.4 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.745 0.307 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.54 95.18 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.0 mm -90.84 149.75 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -133.97 137.96 45.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.297 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -124.83 142.58 51.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.18 166.9 24.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.697 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 t -145.58 120.15 9.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 121.168 0.508 . . . . 0.0 110.6 179.567 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -81.67 126.09 31.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.85 141.99 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.267 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.65 102.93 14.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.0 m -108.03 154.09 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.294 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -123.0 152.38 40.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.85 125.02 21.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 111.184 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 93' ' ' THR . 3.8 mm? -130.26 172.26 12.0 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.493 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -97.99 1.69 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.711 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.74 -29.57 2.84 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.107 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.88 -38.39 72.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.831 0.315 . . . . 0.0 111.288 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -60.87 -38.2 84.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.09 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.94 78.85 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.624 0.249 . . . . 0.0 111.358 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 33.1 mt -71.67 -34.21 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.41 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.47 -34.14 63.05 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.84 45.77 0.15 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.447 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.35 35.92 26.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.888 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.52 13.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.974 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.57 -49.89 2.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.983 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -118.99 134.75 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.307 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -123.46 149.7 44.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.47 119.43 29.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.911 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mm -126.07 148.29 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 23.7 pttt -130.07 113.55 14.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.412 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.66 132.12 38.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.794 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -115.49 91.56 3.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.722 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -156.09 -50.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.972 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -161.04 -174.67 4.49 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -59.08 0.36 Allowed Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.91 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.84 58.97 6.23 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.432 2.088 . . . . 0.0 112.631 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.21 125.4 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.612 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.5 p -72.93 155.47 39.84 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.984 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 p -57.39 -33.32 43.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.53 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' HA3' ' HE2' ' A' ' 80' ' ' LYS . . . -57.99 -28.45 60.92 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.769 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.41 -38.76 68.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.701 0.286 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -48.27 73.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.128 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 mt -63.07 -42.84 98.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.285 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.142 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -60.46 -44.28 96.04 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mt -70.04 -31.33 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.5 t -90.66 -4.27 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 t -81.87 -78.79 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.45 -0.156 . . . . 0.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -99.88 -33.74 10.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.525 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -44.29 91.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.136 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.3 mt -131.64 100.57 4.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.091 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.24 55.08 1.41 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -144.74 122.17 6.44 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.344 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.52 77.56 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.911 2.408 . . . . 0.0 112.027 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -162.26 -54.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.11 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.411 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -91.42 -38.32 12.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.696 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.96 -36.24 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -54.84 -36.23 64.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.626 0.251 . . . . 0.0 110.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 mt -82.5 -33.88 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.326 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -80.07 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mm -91.89 137.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.616 0.246 . . . . 0.0 111.286 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.26 147.23 41.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.898 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.73 39.38 1.64 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.37 0.418 . . . . 0.0 111.58 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.04 43.02 18.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.57 165.2 35.06 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.25 154.2 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -75.04 134.42 74.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.123 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.9 84.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.449 2.099 . . . . 0.0 111.459 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.53 -32.34 0.44 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.671 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mm -60.86 127.71 20.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.17 145.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -151.57 131.67 13.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.685 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -125.61 117.93 24.61 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.318 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 pt -90.96 106.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.17 50.21 6.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.05 32.25 20.95 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 175.86 9.21 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.586 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.71 158.96 26.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.465 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -56.22 3.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -25.39 63.26 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.665 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 tt -53.36 -32.5 49.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.521 0.201 . . . . 0.0 111.358 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.73 -54.84 2.23 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.782 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 106.12 0.2 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.699 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -50.27 -57.63 7.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.483 0.141 . . . . 0.0 110.99 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE2' ' HA3' ' A' ' 35' ' ' GLY . 43.4 tttm -110.83 -26.66 9.23 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.222 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.92 57.35 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -139.88 110.64 6.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.049 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.2 130.76 28.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.624 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.4 mt -64.78 175.05 1.59 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.42 102.08 0.72 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.274 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -48.67 114.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.4 26.07 5.54 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.43 164.05 12.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.706 0.288 . . . . 0.0 111.087 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.4 mm -104.39 133.53 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.6 mt -140.84 147.52 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 t -132.2 149.55 52.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.301 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -138.52 86.26 2.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.426 ' CG2' ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -93.36 175.76 6.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.487 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -155.34 82.18 1.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.616 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 121.196 0.522 . . . . 0.0 110.653 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -96.94 101.62 13.24 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.6 127.38 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.26 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -96.79 108.46 21.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.075 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.62 146.35 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -122.52 129.75 52.31 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 97.3 m-85 -109.94 130.12 55.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.61 165.82 26.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.74 -21.2 40.37 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.649 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.01 -26.21 1.6 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.95 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.4 mt -54.48 -37.75 65.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.75 0.275 . . . . 0.0 111.667 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -56.78 -31.34 64.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.226 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.67 78.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 23.2 mt -80.37 -35.21 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.283 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.38 -75.19 0.1 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.1 37.84 0.17 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.704 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt 52.01 34.29 13.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.447 0.299 . . . . 0.0 111.508 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -125.29 122.52 37.11 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.732 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -50.36 72.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.727 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.67 138.22 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.124 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.61 156.09 49.32 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.63 146.74 47.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.39 146.9 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -134.1 119.77 19.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.148 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -110.11 131.96 54.59 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.091 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.34 98.49 5.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.49 -49.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.055 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -161.31 -176.55 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.11 -58.56 0.41 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.68 56.5 4.08 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.547 2.164 . . . . 0.0 112.749 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.84 126.33 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 p -78.67 151.17 32.37 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.24 -32.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.672 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -27.13 57.33 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.724 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -41.57 68.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.734 0.302 . . . . 0.0 110.385 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.6 -52.22 60.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.189 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.1 mm -62.37 -38.82 82.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.39 -46.0 90.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.039 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.406 ' HB2' ' HE1' ' A' ' 26' ' ' MET . 1.4 t60 -57.85 -42.22 84.03 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.045 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.7 mt -65.64 -31.76 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.792 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.45 -2.9 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.901 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -74.83 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.462 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -95.7 -42.73 8.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.294 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -42.77 76.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.48 ' CG2' HG21 ' A' ' 52' ' ' VAL . 35.0 mt -131.73 131.56 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -162.24 74.96 0.44 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.018 0.437 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.03 121.03 1.42 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.611 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.67 79.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.44 2.093 . . . . 0.0 112.046 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -172.88 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.7 p30 -87.4 -41.79 13.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.602 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.48 HG21 ' CG2' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -77.63 -35.52 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 t -53.83 -31.56 49.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.333 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.4 mt -90.6 -44.53 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.501 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -72.86 -53.75 10.6 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.477 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 56' ' ' ILE . 37.8 mm -99.87 114.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.305 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -162.97 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.542 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -64.43 86.93 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.899 0.381 . . . . 0.0 111.046 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 60.38 43.55 13.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.93 176.5 3.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.07 149.82 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.713 0.292 . . . . 0.0 110.799 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.11 148.89 35.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.79 159.06 47.42 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.633 2.222 . . . . 0.0 112.275 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.26 -23.66 35.19 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.798 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.8 mm -83.25 102.62 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.0 124.19 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.198 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.6 m -120.18 141.25 50.07 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.4 mt -135.95 115.06 12.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.289 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.2 mt -97.71 105.2 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.638 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 57.63 52.5 8.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 59.61 32.79 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.216 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.32 169.31 18.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.417 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.92 171.52 15.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.847 0.356 . . . . 0.0 111.093 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -100.98 -48.19 4.52 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.993 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -27.04 58.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.99 -27.63 53.67 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.269 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -120.96 -50.9 2.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.406 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.11 93.22 0.1 Allowed Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.726 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -43.5 73.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -124.58 -40.21 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.81 56.52 1.54 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.944 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.19 108.25 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.807 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.86 128.17 20.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.46 175.07 1.46 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.88 100.96 0.66 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.481 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -48.02 115.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.858 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.17 6.58 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.691 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.49 169.16 9.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.744 0.307 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.43 128.07 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.7 mt -136.24 145.66 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.842 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -128.65 155.55 44.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.748 0.309 . . . . 0.0 111.348 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.429 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 41.8 m-85 -143.6 82.2 1.72 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 m -86.75 140.82 29.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.126 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 t -102.61 103.24 13.52 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.355 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.675 0.274 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -97.94 140.49 32.21 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.432 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.476 ' CG2' HD23 ' A' ' 37' ' ' LEU . 35.7 m -136.01 146.11 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 113.33 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 8' ' ' PHE . 31.2 m -115.78 151.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.479 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -122.11 110.12 15.37 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' A' ' 6' ' ' VAL . 79.3 m-85 -91.21 138.28 31.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mp -141.84 163.37 33.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.8 -107.87 3.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.402 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 26.73 5.25 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.047 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.421 HD22 ' CE1' ' A' ' 55' ' ' PHE . 1.9 mp -96.38 -41.79 8.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.89 0.345 . . . . 0.0 110.983 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.29 -28.95 65.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.357 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.05 78.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.727 0.299 . . . . 0.0 111.047 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 24.7 mt -79.78 -43.75 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.509 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.6 m-85 -58.61 -70.4 0.15 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.455 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.7 44.08 0.07 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.395 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.59 32.96 18.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.505 0.322 . . . . 0.0 111.402 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -119.38 113.76 21.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.389 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -58.8 -62.56 1.78 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -94.87 143.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.153 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -129.06 161.29 30.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -145.31 133.41 21.49 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.437 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.1 pt -147.2 178.76 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.326 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 132.09 15.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.38 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.25 108.07 19.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.475 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -91.93 48.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -45.06 6.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.985 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -166.7 -178.24 4.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.32 -59.13 0.3 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.773 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.8 58.93 6.66 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.363 2.042 . . . . 0.0 112.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.01 149.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.1 p -98.86 161.6 13.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 p -60.74 -39.85 83.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.711 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.8 -30.51 69.54 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.945 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -40.44 86.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.769 0.319 . . . . 0.0 110.314 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.476 HD23 ' CG2' ' A' ' 4' ' ' VAL . 2.6 tm? -56.64 -44.9 81.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.128 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.89 -45.26 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.38 -37.97 82.45 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -60.07 -43.71 95.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.6 mt -64.63 -30.21 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.153 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.8 t -95.99 -2.46 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -95.33 -64.59 1.05 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.3 p -98.03 -46.98 5.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.722 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -56.8 17.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.458 ' CG2' HG21 ' A' ' 52' ' ' VAL . 19.4 mt -115.61 149.08 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -173.87 72.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -163.76 133.46 3.11 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.148 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.98 65.52 3.32 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.441 2.094 . . . . 0.0 111.823 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -158.85 -49.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.028 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.422 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -89.52 -42.51 11.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.456 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -72.9 -36.28 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.223 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.7 -28.69 15.67 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.42 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -89.28 -34.41 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.428 ' CD1' HG13 ' A' ' 65' ' ' ILE . 51.2 t80 -86.95 -57.63 2.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.515 0.198 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.53 139.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -148.86 129.6 14.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.96 42.98 15.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 59.2 38.99 23.34 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.51 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.9 t -166.91 162.31 15.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.908 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.0 148.88 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -78.48 147.7 72.3 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.057 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.22 75.69 2.8 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 111.842 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.03 -45.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.541 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.428 HG13 ' CD1' ' A' ' 55' ' ' PHE . 28.5 mm -67.17 137.21 25.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.857 0.36 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.4 mt -110.73 132.41 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -126.32 138.64 53.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.5 mt -125.48 109.87 13.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.463 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 7.2 mt -86.73 105.74 15.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.8 t30 56.92 45.9 20.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 61.68 41.87 11.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.177 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.76 156.82 43.85 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.578 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 129.63 34.64 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.949 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -57.65 -35.32 70.38 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.645 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.13 -1.94 58.26 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -16.08 59.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -137.31 -58.53 0.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.507 0.194 . . . . 0.0 111.26 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.92 112.57 0.53 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.673 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -49.61 -71.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.537 0.208 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -107.65 -28.23 9.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.931 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.71 -31.37 37.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.226 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.463 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 38.2 t80 -48.26 118.95 2.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 110.838 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.17 141.25 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.74 178.23 0.47 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.955 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -162.74 99.71 1.0 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.824 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -43.5 105.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.828 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.13 5.4 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.035 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.83 170.19 8.31 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.714 0.292 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.3 123.27 68.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.402 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.24 107.39 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.774 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -81.72 157.99 24.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 111.597 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -146.82 82.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.45 164.13 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.11 132.94 50.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.277 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.638 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -105.53 125.1 50.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.09 110.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.271 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 112.98 20.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.526 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 7.2 m -113.35 139.79 36.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.336 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.7 115.46 29.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -96.46 124.03 40.31 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.405 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 mp -125.47 159.69 31.33 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.299 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.37 -109.26 3.57 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.414 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.08 35.49 2.84 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.589 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 mt -104.15 -43.13 5.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.637 0.218 . . . . 0.0 111.178 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -59.38 -28.47 66.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.33 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.23 78.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.77 0.319 . . . . 0.0 111.032 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 41.9 mt -73.96 -37.99 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.219 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -69.65 -70.44 0.28 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.74 44.72 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 56.1 33.54 22.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.621 0.248 . . . . 0.0 111.401 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 129.1 51.55 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.603 0.24 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -83.44 -64.13 1.22 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.5 t -79.65 105.87 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.2 173.7 6.22 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.61 136.26 47.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.309 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 37' ' ' LEU . 17.6 mm -117.87 152.11 19.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -150.0 99.52 2.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.127 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -73.52 -53.77 9.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.049 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.59 76.13 0.32 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -136.67 -67.57 0.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.335 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -140.97 -175.73 4.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.72 -59.59 0.43 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.086 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.37 60.37 6.39 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.469 2.112 . . . . 0.0 112.598 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.7 t -77.8 142.27 14.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 155.24 18.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -57.74 -35.88 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.803 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.63 -27.74 66.71 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.978 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' HB3' ' HE1' ' A' ' 26' ' ' MET . 0.5 OUTLIER -73.25 -39.13 65.69 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.431 HD13 HG21 ' A' ' 24' ' ' ILE . 1.3 tm? -54.97 -51.43 66.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.382 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.7 -43.15 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.18 -43.66 78.64 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 55.4 t60 -59.63 -46.52 88.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.31 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.48 -31.59 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.891 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.7 t -97.4 -4.13 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -92.7 -68.81 0.78 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.28 -41.48 7.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.614 0.245 . . . . 0.0 111.351 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -39.78 69.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.1 mt -131.65 129.79 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.664 0.269 . . . . 0.0 111.047 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -143.91 51.41 1.32 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -142.92 121.52 7.37 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.32 74.41 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.99 2.46 . . . . 0.0 112.238 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.63 -58.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.364 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.487 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.8 p30 -79.9 -36.49 36.38 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.706 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.77 -35.33 7.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.945 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -54.23 -36.24 63.31 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.121 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.2 -37.93 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.219 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -67.11 -39.93 86.77 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.006 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.31 116.22 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -115.01 130.89 57.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.64 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 58.81 43.78 17.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.966 0.413 . . . . 0.0 110.464 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.39 33.31 22.18 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.489 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.61 149.66 26.87 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.911 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.62 151.58 10.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.061 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -93.1 130.25 36.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.999 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.42 118.66 5.3 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.79 2.327 . . . . 0.0 112.325 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.94 -37.88 0.93 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.555 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 mt -74.11 127.89 36.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.69 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.8 mm -103.04 127.54 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.059 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -121.92 134.8 54.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.235 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.58 98.54 7.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.446 HG23 ' CD1' ' A' ' 82' ' ' TYR . 24.1 mt -81.13 102.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 57.63 48.4 14.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.628 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 62.13 32.26 17.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.289 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -128.58 162.97 26.04 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.227 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.49 134.64 36.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -57.48 -53.37 58.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.888 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.44 -36.54 83.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.306 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 tt -56.4 -52.48 64.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.597 0.237 . . . . 0.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.56 -35.73 81.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 34.08 0.8 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.185 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.76 -78.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.628 0.371 . . . . 0.0 111.432 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -109.2 16.73 22.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 47.52 1.25 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.993 0.425 . . . . 0.0 110.786 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.446 ' CD1' HG23 ' A' ' 69' ' ' ILE . 24.1 t80 -144.23 138.23 27.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mp -92.91 129.96 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -59.75 173.78 0.54 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.0 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.65 100.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.029 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -43.07 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.907 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.53 26.96 5.43 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.482 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.4 174.76 6.86 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.64 0.257 . . . . 0.0 111.086 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.2 mm -119.46 130.43 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.481 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 43.3 mt -133.39 153.17 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.385 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -127.55 156.45 42.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.05 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -143.88 105.76 4.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.229 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -109.6 142.19 41.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.032 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.3 t -116.63 97.56 6.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.567 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 -179.701 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -111.02 139.68 46.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.88 136.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.541 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.25 115.54 27.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.362 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 2.9 m -113.27 143.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.461 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.35 154.95 20.54 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -142.82 111.75 6.46 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -123.32 145.41 48.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.012 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.25 -111.16 3.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.524 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.87 28.43 6.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.929 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.17 -48.75 4.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.81 0.305 . . . . 0.0 110.767 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.74 -27.0 68.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.621 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.78 -34.19 76.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.647 0.261 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.4 mt -74.91 -37.4 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.227 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.63 -61.33 1.83 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.33 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.62 46.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.503 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp 57.35 33.87 23.91 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -112.24 103.93 12.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.713 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mtt-85 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.604 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 p -97.85 130.32 46.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.88 0.371 . . . . 0.0 111.003 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -128.61 164.67 22.37 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.259 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -128.68 133.48 48.22 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.305 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' CD1' HG12 ' A' ' 41' ' ' ILE . 22.6 mm -117.19 145.96 22.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.23 89.72 3.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.1 148.56 51.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.175 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -123.59 101.76 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.386 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -166.29 -53.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -174.07 -166.59 0.3 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.78 -59.53 0.33 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 59.26 5.83 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.486 2.124 . . . . 0.0 112.548 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.66 131.24 34.23 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -66.69 146.38 54.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 p -54.62 -33.37 27.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.473 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.57 59.17 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.043 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -39.88 61.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 110.3 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -55.85 -56.57 19.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.304 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 pt -59.12 -35.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.623 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -63.27 -43.86 96.75 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.662 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -58.07 -39.55 78.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.431 HG12 ' CD1' ' A' ' 24' ' ' ILE . 16.5 mt -68.6 -30.23 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.038 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.8 t -97.01 -6.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.1 t -100.72 -64.33 1.05 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 m -87.77 -51.27 5.95 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.38 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -51.9 67.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.405 HG23 HG22 ' A' ' 52' ' ' VAL . 26.1 mt -116.2 143.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-O 120.759 0.314 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -162.56 41.22 0.12 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.587 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 50' ' ' ASN . 5.4 t30 -134.03 118.54 14.2 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.708 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.37 75.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.908 2.405 . . . . 0.0 112.711 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ASN . 9.5 m-20 -165.72 -61.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.354 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -79.84 -33.25 40.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.33 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 46' ' ' ILE . 1.4 t -93.83 -41.15 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.636 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -35.49 68.49 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.197 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.6 mt -89.0 -33.97 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.33 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.495 0.188 . . . . 0.0 111.004 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.4 mt -131.84 141.8 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.446 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.18 -170.27 3.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -63.16 93.04 0.06 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.956 0.407 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 56.09 43.65 26.6 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.88 128.63 1.69 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -71.97 153.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.293 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -88.48 139.48 29.92 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.016 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.21 125.1 17.95 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.811 2.341 . . . . 0.0 112.389 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.15 -46.97 1.02 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.866 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.43 112.92 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.45 146.77 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.561 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 91' ' ' SER . 2.0 m -141.52 138.19 32.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.633 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -145.87 128.05 15.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.058 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.6 mt -90.33 90.27 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.434 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.01 65.88 1.34 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.955 0.407 . . . . 0.0 111.253 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.2 24.29 14.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.595 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 m -130.17 164.6 24.12 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.317 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.404 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -79.71 165.87 22.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.898 0.38 . . . . 0.0 111.474 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -94.22 -41.14 9.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.796 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.24 -27.48 35.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.618 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.404 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -54.69 -27.45 40.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.466 ' HG3' ' CD1' ' A' ' 82' ' ' TYR . 1.4 pt-20 -128.41 27.33 5.59 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.68 102.75 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.743 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -54.14 -34.36 60.16 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -122.18 -40.51 2.49 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.448 0.166 . . . . 0.0 110.626 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -55.16 -29.19 57.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.369 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.466 ' CD1' ' HG3' ' A' ' 77' ' ' GLU . 72.3 t80 -55.13 118.91 4.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.22 139.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.565 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 37' ' ' LEU . 22.9 mt -64.07 175.25 1.28 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.942 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -167.11 100.84 0.53 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.595 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -44.35 114.31 0.66 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.99 18.98 6.58 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.017 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.17 177.54 4.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.746 0.273 . . . . 0.0 110.961 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.474 HG23 HD11 ' A' ' 89' ' ' ILE . 27.4 mt -128.12 150.32 33.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.962 0.41 . . . . 0.0 111.71 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 5.3 mp -142.55 100.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.11 142.99 34.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.695 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' A' ' 90' ' ' ILE . 12.1 m-85 -136.23 82.9 1.97 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.349 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -94.02 150.05 20.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.675 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 m -133.98 99.31 4.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.59 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.464 0.226 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.927 -179.921 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 120.643 0.259 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -141.95 114.28 8.27 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -117.75 132.76 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.113 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -106.41 105.26 15.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.725 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 15.3 m -105.53 144.37 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.371 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -107.32 135.56 48.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -119.01 115.42 24.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.746 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.5 132.53 54.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.088 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 -109.27 1.82 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.386 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.03 -23.84 5.97 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.242 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -48.24 74.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.994 0.397 . . . . 0.0 111.468 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -57.9 -36.01 71.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.129 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.424 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 7.5 mt -75.19 -39.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.363 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -67.38 -75.09 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.321 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.21 41.71 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.602 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.35 34.4 20.61 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.705 0.288 . . . . 0.0 111.159 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -110.16 117.5 33.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.721 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -28.98 69.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.67 142.28 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -122.73 170.35 10.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -135.24 121.71 20.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.1 143.93 24.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.065 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.96 91.79 2.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.449 ' HE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.3 156.73 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.052 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.92 113.91 7.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 111.586 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.68 -48.28 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.94 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -156.13 -177.7 6.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.26 -59.83 0.37 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.984 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.09 58.28 6.51 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.534 2.156 . . . . 0.0 112.409 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -75.14 121.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.657 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.6 p -68.75 153.47 43.73 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.876 0.369 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.68 -31.95 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.579 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.08 -28.04 57.99 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.33 -38.07 71.7 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.776 0.322 . . . . 0.0 110.324 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -47.1 79.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.054 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.39 -41.88 91.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.449 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -39.68 87.3 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.449 ' HB2' ' HE2' ' A' ' 26' ' ' MET . 47.5 t60 -63.12 -46.1 88.9 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -61.24 -31.41 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.16 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.1 t -97.57 -3.36 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.4 t -93.43 -74.87 0.51 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.388 -0.195 . . . . 0.0 111.494 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -96.58 -39.99 9.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.556 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.8 tpt -57.1 -38.56 73.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.024 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.531 ' CG2' HG23 ' A' ' 52' ' ' VAL . 15.0 mt -137.62 136.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.693 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -159.81 71.72 0.49 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.813 0.34 . . . . 0.0 111.365 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.5 t30 -162.88 134.64 3.9 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.38 64.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.21 1.94 . . . . 0.0 111.702 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.73 -45.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.424 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -91.24 -41.92 10.7 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.641 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG23 ' CG2' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -72.01 -34.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.29 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.29 -30.67 12.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.5 -65.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.466 0.174 . . . . 0.0 111.371 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.05 -36.53 84.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.324 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD13 HG22 ' A' ' 56' ' ' ILE . 29.6 mm -125.37 93.84 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.89 119.22 38.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.57 64.65 1.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p30 43.23 33.81 0.62 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.247 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -157.36 149.07 22.2 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.661 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.07 152.91 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -79.73 115.68 55.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.631 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.76 101.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.649 2.233 . . . . 0.0 111.959 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.05 -30.64 0.6 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.584 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mt -64.22 136.42 26.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.819 0.343 . . . . 0.0 110.836 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.3 mt -103.82 144.79 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.413 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -143.63 140.93 30.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.7 mt -141.04 121.13 13.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.264 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.2 mt -93.7 102.76 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.53 55.42 3.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t0 57.01 31.89 20.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.206 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -136.25 166.6 23.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.77 149.23 31.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 111.467 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -69.05 -54.1 16.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.73 -7.77 55.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.042 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -31.45 64.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.597 0.237 . . . . 0.0 111.366 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.26 -52.06 1.52 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.96 109.15 0.35 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.926 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.46 -48.9 77.96 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.847 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -121.19 -42.82 2.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.865 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.76 -24.54 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.948 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -52.84 119.79 5.02 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.883 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -75.56 132.59 32.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.17 174.99 1.78 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.726 0.298 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -169.6 101.85 0.33 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.421 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -44.05 115.43 0.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 119.17 3.95 12.7 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.984 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.94 164.25 23.66 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.082 0.441 . . . . 0.0 111.155 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mm -123.05 93.22 2.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 41.6 mt -91.83 152.1 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.12 146.62 50.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.228 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -138.32 94.75 2.9 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.54 132.91 45.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.04 96.56 5.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.223 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.129 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -104.41 131.88 51.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 37' ' ' LEU . 19.9 m -133.26 147.48 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -103.66 100.64 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 m -106.01 151.88 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.2 159.09 32.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -130.17 143.13 50.61 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.395 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.65 171.02 14.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.503 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.67 -111.42 3.28 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.353 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.84 27.44 5.42 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.829 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.4 mt -90.36 -51.52 5.38 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.763 0.281 . . . . 0.0 110.863 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.0 -27.06 61.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.519 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.28 80.56 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.729 0.3 . . . . 0.0 111.18 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -78.62 -43.21 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.82 -69.2 0.24 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.367 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.01 42.33 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.778 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 57.5 6.33 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 111.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -143.81 119.42 10.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.0 mtm-85 -72.52 -72.02 0.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.59 138.76 19.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 111.362 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -145.55 143.81 30.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -108.57 125.42 51.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.59 145.61 19.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.56 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.61 95.56 4.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.234 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.428 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -62.78 -64.51 0.9 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.636 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 58.66 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.851 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.6 -45.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.089 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -150.6 -179.85 7.58 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.89 -58.67 0.41 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.756 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.0 57.76 6.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.481 2.121 . . . . 0.0 112.602 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.5 116.21 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.495 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.8 p -75.01 156.13 36.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.65 -31.88 40.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.396 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.86 -25.59 59.37 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.932 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.36 -39.49 59.2 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 110.282 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -54.82 -55.41 30.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.417 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 pt -61.07 -36.0 69.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.625 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -39.47 94.27 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.764 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.428 ' CD2' ' HA ' ' A' ' 26' ' ' MET . 18.4 t-80 -61.22 -40.09 92.7 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.0 mt -67.86 -30.88 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.551 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.6 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.811 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.3 p -100.21 -60.83 1.45 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -100.22 -50.99 3.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -42.39 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.273 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 mt -130.87 129.63 63.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.88 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 64.87 1.15 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.786 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.24 131.14 6.86 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.93 74.41 2.35 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.617 2.211 . . . . 0.0 112.196 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -168.17 -47.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.53 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.85 -38.96 10.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.852 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -82.97 -37.44 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.409 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -53.24 -42.62 66.6 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.663 0.268 . . . . 0.0 111.098 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.01 -34.15 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.583 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.03 -48.59 62.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.674 0.273 . . . . 0.0 110.649 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 mm -124.56 124.02 67.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.993 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -163.24 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.481 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.97 84.94 0.08 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 40.29 12.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.57 126.32 1.07 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.57 153.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.2 143.26 52.18 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.94 125.61 11.71 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.523 2.149 . . . . 0.0 112.084 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.54 -35.16 2.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.597 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 mt -73.29 114.51 12.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.706 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.1 mt -96.31 149.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.057 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.506 ' CG2' ' CE3' ' A' ' 74' ' ' TRP . 9.3 t -143.73 128.26 18.04 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.861 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.8 mt -108.53 126.98 53.53 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 pt -106.31 109.2 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.099 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.32 44.74 21.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.2 41.62 16.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.0 167.67 21.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 125.32 29.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CE3' ' CG2' ' A' ' 67' ' ' THR . 0.3 OUTLIER -59.16 -26.83 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.732 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -97.66 -1.34 43.86 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -32.37 72.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.482 0.182 . . . . 0.0 111.423 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 -68.63 0.66 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.22 110.15 0.54 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.033 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -72.68 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.115 0.166 . . . . 0.0 111.287 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.05 -31.03 16.44 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.555 0.217 . . . . 0.0 110.749 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -28.18 28.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.487 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -57.39 113.67 1.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.7 mm -77.62 141.53 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.8 mt -62.93 173.65 1.3 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.59 101.32 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -43.65 110.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.764 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.39 26.84 4.98 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.874 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.26 168.74 9.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.476 HD12 HG21 ' A' ' 89' ' ' ILE . 26.6 mm -117.32 129.57 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.612 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.51 101.84 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.61 152.0 28.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -134.23 93.15 3.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 p -95.97 162.31 13.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 t -151.72 102.01 2.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.3 p . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.415 -179.541 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 120.698 0.285 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -132.08 110.43 10.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.1 m -117.44 135.0 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.304 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -104.55 99.18 8.86 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 26.2 m -93.31 144.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -116.61 103.06 10.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -88.74 119.54 29.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.762 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mp -126.0 161.88 26.54 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.6 -104.65 2.94 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.338 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.8 -12.82 8.3 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.397 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -44.13 96.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.246 0.523 . . . . 0.0 111.294 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.89 -32.88 71.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.085 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.9 69.45 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.534 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.429 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 30.1 mt -74.43 -47.41 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.412 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -60.42 -61.15 2.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.357 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.63 0.02 OUTLIER Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.588 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp 59.09 65.01 1.27 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 111.97 8.57 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -34.05 77.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.002 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.8 122.99 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.49 174.73 5.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.066 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -137.94 129.14 27.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.067 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.42 140.3 46.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.78 86.41 2.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 128.84 37.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.842 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -112.01 82.53 1.64 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.595 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.3 -66.33 0.7 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -148.28 -173.33 4.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -87.71 -54.42 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.975 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.2 Cg_exo -78.47 53.96 4.8 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.872 2.381 . . . . 0.0 112.621 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.6 t -80.08 129.78 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.709 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -81.99 156.6 24.6 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 110.743 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.69 -37.7 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.748 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.02 59.19 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.413 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.91 -41.02 75.24 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.709 0.29 . . . . 0.0 110.385 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -54.34 43.5 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.89 -35.27 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.455 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -46.0 90.93 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.173 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.36 -40.62 87.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.649 0.262 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.2 mt -64.32 -33.22 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.713 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.76 -6.37 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.846 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.3 -74.95 0.44 Allowed 'General case' 0 N--CA 1.462 0.167 0 O-C-N 122.384 -0.197 . . . . 0.0 111.444 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.5 m -99.19 -41.5 7.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.45 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.46 -38.31 63.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.118 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.4 mt -133.42 103.59 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.726 0.298 . . . . 0.0 110.957 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.23 71.22 1.19 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.07 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.2 130.16 2.79 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.185 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.48 75.18 2.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.599 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -168.5 -44.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.857 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.429 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -92.67 -38.71 11.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.663 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.17 -36.06 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -54.75 -39.07 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 111.029 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.9 mt -76.03 -35.04 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.167 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -72.48 -52.94 13.6 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.669 0.271 . . . . 0.0 110.912 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 mt -118.0 110.12 29.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.5 130.46 55.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 59.4 40.95 20.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.04 29.61 19.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.46 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 144.78 32.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.44 153.96 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.277 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -88.66 146.1 36.49 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.71 88.73 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.623 2.215 . . . . 0.0 111.957 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.12 -34.76 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.773 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.6 mm -68.33 119.53 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 111.083 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.4 mt -96.72 147.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.428 HG22 ' CE2' ' A' ' 92' ' ' PHE . 64.2 p -136.83 112.61 9.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.5 mt -105.27 108.17 19.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.754 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.2 mt -89.3 100.87 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 t30 58.81 53.2 5.97 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.29 32.93 20.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.235 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 154.14 49.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 129.07 34.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.653 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -54.58 -33.24 59.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.648 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.17 -32.47 38.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.923 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.75 -30.99 64.14 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.44 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -121.38 26.26 8.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.534 0.207 . . . . 0.0 111.432 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.29 -101.54 0.64 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.838 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.8 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.575 0.35 . . . . 0.0 110.509 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -109.94 -25.15 10.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.219 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -53.48 -25.71 17.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.666 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -52.75 115.56 1.88 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.678 0.275 . . . . 0.0 110.718 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.77 142.04 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -63.22 174.94 1.04 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.936 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -160.53 97.33 1.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.784 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -45.85 110.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.83 26.18 4.83 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.678 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.85 176.57 5.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.649 0.262 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.445 HD12 HG23 ' A' ' 89' ' ' ILE . 19.8 mt -123.3 152.69 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.554 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 5.2 mp -141.5 153.12 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.72 139.39 48.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.428 ' CE2' HG22 ' A' ' 67' ' ' THR . 30.2 m-85 -127.99 91.07 3.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 162.13 14.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -155.22 103.9 2.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.005 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 CA--C 1.533 0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -83.91 110.11 18.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.5 m -117.06 138.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.434 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.95 116.74 33.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 t -109.82 144.98 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.402 ' HB3' HD12 ' A' ' 9' ' ' LEU . 3.7 mt-10 -127.49 101.27 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.92 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -87.7 123.89 33.0 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.826 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 7' ' ' GLU . 4.9 mp -143.6 167.81 21.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.07 -20.73 38.16 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.509 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.36 -34.85 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.746 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -37.24 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.65 0.225 . . . . 0.0 111.577 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.83 -36.7 72.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.56 0.219 . . . . 0.0 111.017 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.91 68.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.479 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.2 mt -73.56 -42.09 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.203 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -68.94 -71.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.36 41.58 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.57 44.81 27.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.65 -31.6 15.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.302 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 72.63 -67.44 0.26 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.853 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p -117.72 124.15 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 152.73 46.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.284 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -112.2 145.22 40.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.9 mt -138.29 148.57 24.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 108.27 8.05 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.95 159.08 32.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.81 93.36 3.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.106 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -162.54 -67.91 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.243 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.28 -175.63 5.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -58.44 0.46 Allowed Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.37 59.22 6.01 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.485 2.123 . . . . 0.0 112.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.15 142.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.83 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.02 151.39 25.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -55.5 -32.34 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.681 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.84 -25.96 64.57 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.063 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.29 75.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.738 0.304 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -47.84 84.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.312 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.2 mm -59.81 -38.52 76.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.406 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.36 -41.89 97.81 Favored 'General case' 0 C--N 1.335 -0.032 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -60.22 -38.32 83.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.022 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.0 mt -67.83 -31.8 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 t -98.12 -2.9 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -94.46 -75.79 0.5 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -91.6 -45.19 8.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.658 0.265 . . . . 0.0 111.293 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.2 ttt -54.57 -44.34 72.88 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 mt -131.94 145.66 34.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.703 0.287 . . . . 0.0 111.237 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 47.28 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.84 126.28 13.27 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.073 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.41 77.03 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.938 2.425 . . . . 0.0 112.23 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -170.83 -58.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.411 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -82.42 -36.9 26.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 t -93.92 -35.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.873 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 t -53.75 -38.67 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.037 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -85.87 -34.37 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.083 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -67.48 -53.31 29.87 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.074 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.7 mm -104.77 131.1 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.916 0.388 . . . . 0.0 111.397 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -124.37 100.32 6.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.767 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 57.62 77.27 0.28 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.067 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 41.6 35.34 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -161.32 137.38 8.12 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.751 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.29 151.94 4.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.889 0.376 . . . . 0.0 111.391 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.87 140.52 46.96 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.89 118.1 4.75 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 112.31 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.05 -37.08 1.94 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.504 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.0 mm -74.5 139.5 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.966 0.412 . . . . 0.0 111.019 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.8 mt -105.4 145.29 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.971 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -139.86 84.51 1.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.654 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.05 124.41 28.71 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.332 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.3 mt -105.63 105.44 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.87 54.43 4.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.01 30.51 20.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.503 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 169.9 16.81 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.424 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.01 162.03 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -77.88 -44.2 27.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.228 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.25 -24.97 46.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.368 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -36.44 61.69 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.962 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.34 -32.15 10.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.835 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.83 -86.19 0.07 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.06 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.573 0.349 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -114.67 -27.1 7.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.45 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.79 -22.58 25.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -45.24 117.7 1.47 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.42 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -69.19 177.36 2.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.86 103.89 0.11 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.954 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -38.67 106.35 0.05 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.942 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.45 -8.88 5.9 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.741 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -80.06 164.33 23.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.166 0.483 . . . . 0.0 111.21 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.8 mm -125.0 117.33 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.12 142.48 22.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.034 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.7 m -121.68 139.46 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.317 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -119.57 79.98 1.51 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.93 172.68 11.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.924 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.45 118.17 9.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.103 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.045 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.753 0.311 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -130.68 126.66 37.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 ' CG1' HG12 ' A' ' 90' ' ' ILE . 17.9 t -128.75 138.31 54.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.47 103.28 15.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.2 t -92.63 143.47 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.937 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.34 105.92 9.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 110.896 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 96.4 m-85 -92.62 127.76 38.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.069 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mp -132.94 168.12 19.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.743 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.19 -109.46 3.45 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.299 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.79 24.69 7.86 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.014 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.0 mt -100.55 -37.1 8.94 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.939 0.37 . . . . 0.0 111.273 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.78 -17.31 62.94 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.33 -30.02 22.55 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 1.1 mt -93.55 -27.21 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.692 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.482 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 3.0 m-85 -69.84 -74.66 0.13 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.63 0.252 . . . . 0.0 111.203 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.27 0.1 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.807 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt 50.67 37.29 16.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.45 0.3 . . . . 0.0 111.731 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 102.96 3.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.736 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -66.9 -49.03 66.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.947 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.21 93.61 2.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.36 154.48 29.09 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.288 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -109.07 152.4 25.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.485 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 37' ' ' LEU . 22.1 mm -128.28 147.17 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.55 123.19 15.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.989 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.475 ' HE3' ' HB2' ' A' ' 40' ' ' HIS . 2.8 mmt -118.71 132.87 56.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.136 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.21 47.76 1.04 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.72 -164.73 1.02 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.778 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HG3' ' HD2' ' A' ' 31' ' ' PRO . 5.9 pt-20 -68.32 -171.27 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.021 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.15 -57.56 1.1 Allowed Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.36 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' HG3' ' A' ' 29' ' ' GLU . 65.1 Cg_endo -72.54 61.49 3.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.284 1.99 . . . . 0.0 113.067 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.15 125.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.598 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.74 152.23 35.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.806 0.336 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.65 -34.5 47.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.807 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.52 -27.95 59.04 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -40.85 75.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.649 0.261 . . . . 0.0 110.49 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 HG22 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.15 -50.23 71.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.089 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 38' ' ' ILE . 46.0 mt -58.91 -38.86 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.11 -42.24 85.28 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.475 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 2.9 t60 -62.04 -39.57 92.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.867 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.74 -32.13 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.794 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' CG1' HG13 ' A' ' 52' ' ' VAL . 32.2 t -96.46 -3.64 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.8 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.3 t -100.22 -62.68 1.21 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.556 0.217 . . . . 0.0 111.56 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 p -98.1 -50.2 4.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.515 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -38.0 69.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.482 HD11 ' CZ ' ' A' ' 16' ' ' PHE . 23.4 mt -136.25 145.26 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.988 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -171.23 72.88 0.05 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.926 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -165.48 126.2 1.32 Allowed Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.078 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.81 77.02 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.895 2.397 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.36 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -78.48 -42.14 30.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.187 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.43 HG23 ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -79.6 -36.46 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.164 179.546 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 -31.1 26.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.493 0.187 . . . . 0.0 111.345 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.0 mt -94.2 -30.81 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -85.67 -52.17 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.381 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.0 mm -103.74 145.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.174 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -118.48 61.83 0.78 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 57.97 84.78 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 58.12 38.67 26.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.646 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.4 t -170.1 118.99 0.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.65 151.94 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -76.44 147.62 79.19 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.44 128.08 14.93 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.773 2.315 . . . . 0.0 112.577 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.62 -25.86 6.42 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.945 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 mt -72.97 130.21 35.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 120.897 0.379 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.68 121.79 45.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.1 m -125.66 111.18 14.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.834 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 mt -108.1 140.59 41.06 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.5 mt -119.18 111.54 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.704 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 46.92 8.58 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.78 33.44 17.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.3 178.46 7.4 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.38 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -178.4 6.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.968 0.414 . . . . 0.0 111.325 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -104.45 -47.07 4.21 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.017 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.31 -30.2 30.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -26.68 62.2 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.533 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.7 -64.91 1.24 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.522 0.201 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.66 105.31 0.27 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.679 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -53.24 -65.74 0.51 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.409 0.147 . . . . 0.0 111.318 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -117.56 -39.52 3.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.25 -25.52 48.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.74 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -48.32 116.38 1.54 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.824 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mt -72.87 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.1 173.85 3.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.07 100.57 0.97 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.419 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -46.33 118.13 1.83 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.08 15.99 9.45 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.384 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.33 171.29 9.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mm -126.94 101.16 7.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.757 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.404 HG12 ' CG1' ' A' ' 4' ' ' VAL . 8.0 mm -98.28 142.62 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.87 138.46 53.39 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.31 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.478 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 59.7 m-85 -130.34 82.39 2.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.471 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.2 m -97.73 138.25 35.39 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 m -108.03 112.12 24.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 121.311 0.577 . . . . 0.0 110.458 179.835 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.75 0.309 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.0 117.18 29.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.5 t -115.66 134.73 57.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -103.06 104.68 14.87 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.71 155.96 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -119.15 154.2 33.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -136.29 104.75 5.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.82 121.0 25.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.957 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 46.56 0.45 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.833 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.63 -35.68 4.27 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.795 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.411 HD22 ' CE1' ' A' ' 55' ' ' PHE . 3.3 mt -54.95 -42.76 72.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.653 0.227 . . . . 0.0 111.415 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.23 -37.33 82.65 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.02 -33.58 75.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mt -79.77 -42.12 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.522 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.72 -73.8 0.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.392 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.55 40.38 0.07 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.758 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.3 mttm 54.51 59.71 3.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 111.26 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.29 113.04 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -61.42 -32.84 72.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 t -125.52 119.28 54.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -113.63 146.03 40.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.959 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -108.84 146.48 33.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.27 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.8 mm -128.57 146.61 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.679 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -128.2 87.38 2.59 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.302 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.416 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.87 135.83 45.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.534 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.77 90.29 2.96 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.44 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.71 -67.6 0.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.396 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.94 -171.59 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -59.18 0.5 Allowed Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.99 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.73 61.46 4.54 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.369 2.046 . . . . 0.0 112.547 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.6 t -73.85 131.14 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.6 p -97.8 161.16 13.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.628 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.76 -33.03 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.594 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.96 -27.38 62.1 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.044 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -41.37 71.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 -44.84 74.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.907 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 41' ' ' ILE . 24.4 mm -68.92 -33.34 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.788 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -50.33 36.13 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.7 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.416 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 26.0 t-80 -60.48 -48.07 83.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 38' ' ' ILE . 7.1 tt -62.72 -30.96 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.633 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.0 t -94.88 -11.24 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.9 m -100.99 -69.57 0.77 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 p -76.75 -56.91 4.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.52 -55.62 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.938 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.5 mt -109.93 129.43 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.437 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -149.03 59.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.028 0.442 . . . . 0.0 110.703 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -150.12 131.8 7.63 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.183 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.03 66.12 3.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.573 2.182 . . . . 0.0 112.327 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.11 -49.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.46 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.93 -39.08 15.04 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.679 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.57 -35.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.3 t -52.93 -36.19 59.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.642 0.258 . . . . 0.0 111.12 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.99 -34.19 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.391 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CE1' HD22 ' A' ' 12' ' ' LEU . 38.0 t80 -73.28 -52.71 12.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.325 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.452 HG23 HD13 ' A' ' 56' ' ' ILE . 32.3 mm -111.87 136.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -132.14 134.52 45.52 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.018 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.65 38.77 25.06 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.775 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 33.44 21.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.68 152.67 35.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.062 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.57 154.5 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.256 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -101.04 138.94 20.12 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.22 133.32 57.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.797 2.331 . . . . 0.0 112.426 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.35 -35.57 2.56 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.681 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.1 mt -83.37 111.84 20.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.962 0.411 . . . . 0.0 110.97 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.99 146.26 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 m -129.43 136.64 50.18 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.3 mt -130.04 113.78 14.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.003 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.47 109.53 25.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.34 49.05 9.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.637 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 58.54 31.7 21.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 m -135.06 170.56 15.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.385 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.68 172.0 14.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.417 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 23.0 p-90 -103.86 -33.99 8.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.953 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -88.24 -26.76 22.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.468 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mt -60.62 -21.66 62.93 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.32 -71.55 0.72 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.525 0.203 . . . . 0.0 111.114 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.1 108.8 0.4 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.654 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 16.4 mt-10 -54.92 -72.54 0.06 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.457 0.17 . . . . 0.0 111.074 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -104.39 -33.89 8.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.952 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.21 -23.75 23.85 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.453 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -56.38 106.13 0.26 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.81 141.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.7 mt -63.8 175.79 1.07 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.36 97.83 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -47.8 104.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.79 27.94 4.43 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.693 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.97 170.48 7.89 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.602 0.239 . . . . 0.0 111.014 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -118.31 130.35 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.15 150.64 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.064 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.03 146.83 50.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.388 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -133.02 82.11 1.98 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.723 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.05 141.61 28.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -119.89 97.34 5.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.429 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 CA--C 1.534 0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.022 -179.858 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.771 0.319 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -82.26 112.05 18.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.075 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 m -110.26 129.2 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.326 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 118.16 24.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -122.75 147.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.503 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -119.38 107.27 13.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.499 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -85.25 128.71 34.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -135.98 149.62 48.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.956 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.72 -102.28 1.96 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.508 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.58 26.46 3.66 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.015 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.72 -41.58 8.02 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.868 0.334 . . . . 0.0 110.828 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.54 -33.05 74.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.04 73.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 -44.95 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.35 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -65.02 -71.46 0.18 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.227 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.63 45.64 0.1 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.542 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 56.87 54.35 7.22 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 106.95 8.23 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.019 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -9.02 50.46 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.928 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.47 138.69 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.507 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.69 168.82 19.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -138.97 143.5 38.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 41' ' ' ILE . 2.9 mp -136.28 150.77 27.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.358 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.62 101.66 5.03 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.842 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.406 ' HG2' ' CG ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -77.67 124.45 27.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.742 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.15 68.68 9.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.93 -159.12 0.94 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.509 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -170.78 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.225 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -59.7 0.77 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.99 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.42 58.98 6.52 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.39 2.06 . . . . 0.0 112.733 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -72.6 132.23 33.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.8 p -73.91 149.26 41.56 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.64 -36.49 54.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.88 -27.79 59.81 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.64 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.93 -42.77 69.42 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.735 0.302 . . . . 0.0 110.424 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.5 -53.15 55.62 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 mt -61.01 -37.25 76.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.357 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -41.55 97.26 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.406 ' CG ' ' HG2' ' A' ' 26' ' ' MET . 1.3 t60 -62.16 -36.88 83.19 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 24' ' ' ILE . 33.1 mt -72.09 -27.65 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.296 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.8 t -94.53 -5.49 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.8 p -100.25 -72.41 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.1 p -87.32 -49.3 7.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.502 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.409 ' HB3' ' HA ' ' A' ' 41' ' ' ILE . 5.1 ttt -53.36 -54.74 32.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.0 mt -110.43 125.87 67.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.611 0.243 . . . . 0.0 110.829 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.46 74.69 1.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.188 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.78 119.93 0.42 Allowed Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.63 76.85 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.774 2.316 . . . . 0.0 112.067 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -166.14 -57.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.513 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -82.16 -36.13 27.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.758 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.43 -35.67 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.984 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 m -58.07 -34.35 70.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.38 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.0 mt -83.15 -39.12 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 111.0 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -68.44 -38.1 80.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.077 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 mt -132.08 129.55 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.288 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.0 122.79 48.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 55.25 52.72 11.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.76 26.61 11.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.72 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.71 125.64 22.67 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 110.66 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -56.81 151.7 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.499 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.16 143.57 34.92 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.069 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.67 123.81 9.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.654 2.236 . . . . 0.0 112.208 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.15 -37.38 1.16 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.627 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.78 130.07 34.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.0 mm -110.31 152.76 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.963 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 t -146.33 142.56 28.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.692 0.282 . . . . 0.0 111.254 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 mt -131.12 108.16 9.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.22 109.32 19.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.6 m120 58.67 43.34 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.96 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.59 30.62 18.73 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.023 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 163.99 25.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.59 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.91 117.2 20.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -50.53 -38.65 45.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.909 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.07 -43.87 94.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.655 0.264 . . . . 0.0 110.833 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.83 -26.14 65.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -111.02 30.43 6.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 111.192 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.66 96.22 0.53 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.487 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.58 -52.73 6.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.407 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -112.97 -36.45 5.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.67 56.61 2.28 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -119.08 114.98 23.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.859 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.19 119.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.63 176.35 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -167.01 101.12 0.54 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.356 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -45.73 122.29 3.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.89 25.21 9.88 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.2 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -100.99 169.51 8.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -113.87 104.95 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.79 100.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.15 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.089 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.62 103.22 5.57 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 159.48 15.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.593 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -142.22 110.47 6.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.779 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 110.803 179.825 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.654 0.264 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -105.07 89.78 3.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.36 150.07 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.582 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -111.32 110.65 21.22 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 t -104.86 144.98 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.36 101.4 7.61 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.74 128.81 36.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.034 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.39 118.45 13.45 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.302 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.06 -102.03 0.34 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.275 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.21 -33.39 3.2 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.961 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.91 -39.23 68.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.34 -37.8 75.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.055 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.45 68.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.997 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 45.5 mt -66.96 -34.07 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.263 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -71.89 -61.92 1.61 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.648 0.261 . . . . 0.0 111.301 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.58 48.0 0.01 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.318 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mttt 57.22 34.43 24.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 111.255 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.37 103.52 9.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.627 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -65.57 0.67 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.549 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -90.23 135.7 25.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.6 136.97 29.7 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.01 142.05 30.2 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.78 143.64 39.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.94 123.89 45.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.54 120.09 31.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -127.57 48.16 2.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -36.79 23.24 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.017 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -157.47 -178.74 7.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.472 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -85.62 -54.04 0.43 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.949 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 3.1 Cg_exo -79.53 53.8 4.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.949 2.433 . . . . 0.0 112.333 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.8 t -74.44 139.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.645 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.21 163.87 13.2 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.68 -40.44 51.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.995 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -56.93 -29.28 58.86 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.192 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.76 -42.55 73.71 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -53.37 40.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.091 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.469 HD13 ' HA2' ' A' ' 35' ' ' GLY . 2.3 mp -59.08 -38.78 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.405 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.6 -41.42 94.72 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -60.49 -39.89 89.34 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.674 0.273 . . . . 0.0 110.611 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mt -64.87 -32.19 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 t -96.39 -1.41 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.92 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -100.29 -72.73 0.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 t -87.97 -40.56 13.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.478 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -59.56 4.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.054 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.4 mt -117.53 148.43 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 120.706 0.289 . . . . 0.0 111.272 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -165.2 41.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.94 139.75 36.56 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.86 73.45 3.63 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.705 2.27 . . . . 0.0 112.463 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -169.38 -47.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.622 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.51 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -93.39 -35.9 12.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.22 -35.4 7.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -54.4 -33.22 58.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 54' ' ' ILE . 30.4 mt -84.51 -33.05 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.309 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -77.82 -35.57 51.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.03 133.26 69.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.393 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.1 -156.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.56 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.57 85.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.06 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.1 t0 60.7 40.75 15.95 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.163 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -178.57 138.92 0.17 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mt -65.78 142.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.55 155.85 48.19 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.35 146.33 68.59 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.7 2.267 . . . . 0.0 112.467 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.67 -42.54 1.46 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.578 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mp -73.1 122.44 25.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -94.68 131.45 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 74' ' ' TRP . 0.3 OUTLIER -122.33 114.56 20.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.7 mt -112.76 109.19 18.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.0 mt -88.16 98.58 7.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.55 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.1 m120 57.37 55.25 5.93 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.736 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 31.58 20.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.536 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.97 159.74 40.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.462 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.79 120.4 24.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.425 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -57.12 -30.68 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.639 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.05 -30.58 44.13 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.584 0.23 . . . . 0.0 111.129 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.55 -18.11 65.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.575 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -133.59 38.66 3.24 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 111.384 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.59 103.54 0.25 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.068 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -47.77 -61.88 1.73 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.101 0.16 . . . . 0.0 111.267 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.15 -28.78 11.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.19 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.76 -29.45 18.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.453 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -58.87 114.4 2.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.807 0.337 . . . . 0.0 110.605 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mp -76.82 144.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.46 171.69 3.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.203 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -171.04 104.25 0.23 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.471 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -46.11 115.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.995 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 20.06 6.67 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.779 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.05 169.98 8.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.779 0.324 . . . . 0.0 111.403 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 89' ' ' ILE . 15.3 mt -127.53 152.34 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.753 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.2 mm -135.5 150.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.222 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -130.11 138.92 50.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.019 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.85 90.76 2.95 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.019 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.19 104.24 16.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 80.98 1.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.761 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.675 0.274 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -155.85 96.03 1.7 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.74 153.85 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.448 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.34 107.77 15.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.581 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.91 155.41 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.379 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.88 152.64 43.76 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.222 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -128.92 114.12 16.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.352 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mp -128.66 108.39 10.45 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.701 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.8 -101.71 0.35 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.528 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.0 28.28 4.15 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.103 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.481 HD22 ' CE1' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -106.57 -45.34 4.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.737 0.269 . . . . 0.0 110.844 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.25 -33.57 71.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.08 86.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -72.01 -41.89 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -66.8 -71.59 0.19 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.62 43.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.626 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 54.7 34.51 21.79 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.545 0.338 . . . . 0.0 111.524 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.24 112.38 24.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -61.48 -67.05 0.44 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.905 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.3 t -90.83 117.89 34.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.986 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 148.32 38.19 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.052 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -115.84 137.67 51.88 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -134.37 139.84 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 123.4 21.55 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -38.29 54.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.576 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.08 43.48 26.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.92 0.39 . . . . 0.0 111.085 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.05 -74.13 0.62 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.72 -174.28 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -59.64 0.36 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.097 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.12 57.93 6.37 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.318 2.012 . . . . 0.0 112.573 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.85 118.9 21.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.458 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 p -66.21 147.01 53.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.37 -34.65 23.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.556 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.87 -26.77 58.44 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.117 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.5 -42.07 62.28 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.663 0.268 . . . . 0.0 110.615 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.04 -53.05 58.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.198 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.4 mt -62.36 -40.03 86.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.386 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.75 -42.71 99.32 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -58.94 -43.29 91.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.957 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.2 mt -64.52 -32.21 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.141 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.14 -3.51 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -92.92 -75.44 0.49 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.507 0.194 . . . . 0.0 111.357 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -94.62 -43.02 8.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.187 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -38.45 67.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.92 136.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.301 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -159.1 38.44 0.21 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 23.0 t30 -128.54 127.45 23.6 Favored Pre-proline 0 C--N 1.334 -0.088 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.866 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 24.9 Cg_exo -64.44 76.58 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.692 2.261 . . . . 0.0 112.254 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -168.25 -45.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.43 -31.54 12.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.135 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -102.57 -35.52 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.206 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -36.46 61.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.571 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.93 -22.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.481 ' CE1' HD22 ' A' ' 12' ' ' LEU . 46.4 t80 -77.25 -49.07 15.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.594 0.235 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.1 mm -106.5 150.28 9.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.07 85.12 2.2 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 57.06 67.25 1.01 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.401 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 76.28 -42.87 0.45 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.336 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -82.04 129.93 34.94 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.724 0.297 . . . . 0.0 110.985 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.48 153.38 6.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.348 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -82.66 135.95 45.61 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.174 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.18 106.54 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.65 2.234 . . . . 0.0 111.965 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.13 -35.52 0.24 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.75 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 mt -67.21 121.57 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.836 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -90.01 97.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.8 t -104.75 136.28 44.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.9 mt -126.1 118.53 25.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.6 mt -102.01 109.5 26.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.492 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.03 48.14 13.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.61 38.77 21.97 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.362 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.62 161.95 38.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.721 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.72 124.77 29.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.84 -33.59 64.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.506 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -80.11 -33.4 38.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.669 0.271 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.74 -24.87 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -103.52 -58.21 1.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.513 0.197 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.3 98.22 0.11 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.626 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -47.04 -56.81 5.83 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.127 0.171 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -117.34 -30.64 5.52 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.937 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.92 56.62 2.38 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.168 0.509 . . . . 0.0 110.977 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -137.65 112.52 8.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.76 127.87 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.31 177.7 1.06 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 110.741 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -163.45 100.03 0.93 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.143 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -49.07 108.91 0.21 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.03 26.31 5.55 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.16 176.15 5.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.662 0.268 . . . . 0.0 111.041 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -116.77 111.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.362 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.41 97.61 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.652 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.4 m -79.91 158.54 26.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.501 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -145.05 85.24 1.74 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.92 162.67 14.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.623 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.44 93.96 2.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.865 0.364 . . . . 0.0 110.823 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.918 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.661 0.267 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -112.93 93.16 4.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 m -93.3 144.16 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -116.37 97.31 5.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.665 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -92.79 146.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.98 97.65 6.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -87.23 117.92 26.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.3 mp -127.23 176.47 7.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.467 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.94 -112.22 3.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.354 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.81 23.17 12.03 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.784 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.27 -43.31 6.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.805 0.303 . . . . 0.0 111.212 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.12 -34.03 67.96 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.39 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -33.74 76.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.703 0.287 . . . . 0.0 111.097 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.7 mt -80.28 -41.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.326 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -61.96 -73.3 0.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.267 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.78 41.63 0.09 OUTLIER Glycine 0 C--N 1.335 0.472 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt 53.59 41.56 32.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.717 0.294 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -121.78 121.83 38.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -46.06 91.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.384 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.34 126.93 75.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.868 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.85 135.75 54.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.492 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.8 pttt -102.46 146.35 28.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.361 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD13 HG12 ' A' ' 41' ' ' ILE . 19.0 mm -132.22 147.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -121.52 98.14 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.774 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.18 139.55 32.18 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -138.16 81.51 1.86 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -120.62 -63.07 1.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -148.4 -175.51 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.797 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.26 -60.14 0.3 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.052 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.49 58.02 6.8 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.489 2.126 . . . . 0.0 112.297 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 84' ' ' LEU . 22.5 t -81.17 152.67 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.339 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -103.36 163.8 12.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.327 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.55 -34.46 51.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.028 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -27.71 62.61 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.11 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -71.36 -41.86 69.2 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.641 0.258 . . . . 0.0 110.42 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.96 -51.79 65.05 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.328 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mt -59.18 -39.67 79.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.336 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.25 -41.94 89.96 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -60.76 -45.02 95.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.204 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.44 HG12 HD13 ' A' ' 24' ' ' ILE . 28.2 mt -62.68 -28.41 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.395 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 t -100.52 -9.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -76.21 -75.62 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.58 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.3 m -100.33 -36.33 9.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.294 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.4 mmm -56.64 -53.49 57.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.431 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.6 mt -124.61 88.03 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 120.938 0.399 . . . . 0.0 111.082 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -104.2 51.17 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.48 116.54 6.47 Favored Pre-proline 0 N--CA 1.457 -0.105 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.67 -30.92 30.4 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.77 2.313 . . . . 0.0 112.739 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -55.96 -48.91 74.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.319 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.14 31.48 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.56 -49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 p -56.68 -27.54 59.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.474 0.178 . . . . 0.0 111.447 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.2 mt -84.04 -33.87 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.666 0.27 . . . . 0.0 110.625 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -74.34 -44.21 53.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.085 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 56' ' ' ILE . 42.1 mt -111.57 148.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.899 0.381 . . . . 0.0 111.38 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.15 -158.33 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.851 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.28 92.63 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.109 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t0 53.35 37.0 24.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.874 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.45 141.04 1.48 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.557 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -58.06 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.705 0.288 . . . . 0.0 111.334 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.99 120.2 58.91 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.72 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.57 101.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.676 2.251 . . . . 0.0 112.166 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.67 -42.65 0.63 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.694 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.6 mt -59.12 140.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -108.3 137.71 38.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.118 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.9 t -137.63 125.9 23.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.0 mt -108.66 111.09 22.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.54 111.73 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.615 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 58.85 47.5 12.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.96 34.1 23.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.963 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.1 m -140.88 161.7 37.21 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.89 150.79 30.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.377 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -62.44 -42.33 99.39 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.43 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -9.07 58.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -35.85 81.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.343 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.54 29.3 6.65 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 111.503 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.51 -102.72 0.83 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.442 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.72 -81.13 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 122.546 0.338 . . . . 0.0 110.303 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -104.82 -24.55 12.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.273 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -52.98 -25.48 12.19 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -45.15 107.7 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 110.489 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mt -68.26 138.41 22.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.421 HD11 HG11 ' A' ' 32' ' ' VAL . 18.4 mt -66.52 174.07 3.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -170.85 104.22 0.24 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.504 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -42.06 109.17 0.12 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.007 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.02 27.05 4.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.44 165.77 12.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.02 116.64 46.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.804 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.92 150.49 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' THR . 40.3 m -130.26 142.33 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.708 0.29 . . . . 0.0 111.413 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -130.99 95.27 3.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 156.86 16.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.084 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 t -153.92 79.94 1.14 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 179.67 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -157.64 94.23 1.34 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.884 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 m -105.19 135.38 43.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -89.23 115.56 26.82 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.709 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 7.7 t -110.4 148.48 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.244 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.29 99.18 6.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -84.55 133.45 34.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.443 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.64 152.13 45.16 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.35 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -101.53 2.76 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.222 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.75 -28.74 4.66 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mt -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.897 0.349 . . . . 0.0 111.734 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.04 -33.48 75.9 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.419 0.152 . . . . 0.0 111.12 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.75 80.87 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 51' ' ' ASP . 4.7 mt -81.69 -34.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.521 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.8 -73.22 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.58 0.228 . . . . 0.0 111.187 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.8 41.75 0.09 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.591 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 53.19 34.78 18.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.484 0.313 . . . . 0.0 111.705 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -121.61 123.55 42.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.613 0.244 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -26.87 68.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.598 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.46 135.27 58.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.838 0.352 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.16 142.23 28.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -85.42 142.22 29.41 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.991 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.1 mm -123.9 140.75 46.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.135 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.3 115.62 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 40' ' ' HIS . 15.1 ttt -88.98 -42.36 11.83 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.141 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 86.25 0.1 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -66.09 0.37 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.58 -169.26 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -86.83 -54.2 0.39 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.082 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 4.8 Cg_exo -74.08 55.86 3.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.834 2.356 . . . . 0.0 112.588 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.59 124.78 49.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.619 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.73 153.98 30.42 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.14 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -56.19 -33.66 37.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.71 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.5 -27.64 54.45 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.82 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -40.74 68.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.677 0.275 . . . . 0.0 110.496 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.88 -52.89 61.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.344 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.3 mt -60.17 -41.29 86.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.107 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -61.23 -40.01 92.39 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG3' ' A' ' 26' ' ' MET . 72.6 t60 -58.52 -46.72 86.18 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 45' ' ' MET . 17.9 mt -63.29 -30.01 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.279 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.5 t -97.15 -4.9 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.76 -73.92 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.3 m -87.34 -45.14 10.84 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.465 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -54.77 -51.67 64.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.042 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.411 ' CG2' HG22 ' A' ' 52' ' ' VAL . 7.6 mt -121.79 150.96 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.106 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -160.81 65.53 0.3 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.42 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 8.9 t30 -170.88 138.51 1.22 Allowed Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 120.601 0.239 . . . . 0.0 111.572 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.88 75.17 3.23 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.735 2.29 . . . . 0.0 112.6 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 48' ' ' ASN . 20.3 p-10 -166.13 -41.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.434 ' HB3' HG22 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -100.98 -37.31 8.69 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 46' ' ' ILE . 2.1 t -82.5 -34.45 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.412 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -50.88 -31.94 18.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.677 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.95 -46.31 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.755 0.312 . . . . 0.0 111.018 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -66.59 -47.87 71.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.335 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 mm -129.57 143.55 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.813 0.34 . . . . 0.0 111.294 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.5 127.89 26.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 58.33 45.43 16.98 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.449 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 53.99 33.5 17.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.374 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.4 m -150.53 145.66 26.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.915 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.87 152.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -92.64 137.73 24.12 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 99.59 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.582 2.188 . . . . 0.0 111.89 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.17 -35.28 0.44 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.558 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -66.27 134.48 29.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.43 118.62 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -121.5 92.09 3.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.945 0.402 . . . . 0.0 111.016 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.4 mt -101.23 122.0 42.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.207 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mt -100.66 107.73 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.02 52.64 6.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.33 30.64 19.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.117 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -133.28 164.99 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.77 177.6 8.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.921 0.391 . . . . 0.0 111.18 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -102.88 -39.94 6.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.92 -27.62 28.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.763 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.27 -30.6 51.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -115.69 -62.15 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.522 0.201 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.75 103.86 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.686 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -57.5 6.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.59 0.234 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -117.4 -44.3 2.77 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.1 -27.0 5.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.018 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -48.99 109.53 0.27 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.95 133.33 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.138 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -67.63 172.44 5.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.804 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.16 102.6 0.29 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.395 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -48.91 114.51 1.01 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.71 -9.56 6.81 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.814 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.04 157.23 26.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.045 0.422 . . . . 0.0 111.163 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 89' ' ' ILE . 1.5 mp -107.69 125.45 64.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.764 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 6.5 mt -125.99 141.89 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.27 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.57 142.21 47.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.76 90.98 3.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.794 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 95.52 5.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.874 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -88.04 89.4 7.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.707 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.02 0.438 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -87.63 117.19 26.27 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 m -114.98 139.5 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.94 105.88 16.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.655 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 m -98.68 146.13 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.329 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -126.0 98.43 5.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.64 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -82.95 142.48 31.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -146.04 172.45 13.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.213 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.75 -107.96 2.59 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.219 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.44 -6.04 13.76 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.664 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.72 -45.13 83.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.398 0.599 . . . . 0.0 111.284 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.56 -30.22 69.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.256 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.66 88.21 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.658 0.266 . . . . 0.0 111.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 11.0 mt -70.43 -40.14 77.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.44 -70.16 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.45 48.04 0.04 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.366 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt 56.77 33.81 23.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.382 0.273 . . . . 0.0 111.344 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -104.16 110.65 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.755 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.45 -62.39 1.49 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.45 144.14 20.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.808 0.337 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -180.0 6.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.9 141.79 25.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.2 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.406 HG13 HD11 ' A' ' 41' ' ' ILE . 20.0 mm -135.16 146.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.17 84.0 2.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.04 127.25 30.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.177 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.38 92.86 4.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.97 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -144.38 -66.04 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.43 -178.03 6.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.197 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.73 -59.78 0.35 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.002 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.94 58.78 6.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.558 2.172 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -92.38 132.86 35.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.2 p -75.37 153.02 37.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.859 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.14 -32.13 33.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.707 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -26.52 55.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.086 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.01 -45.71 69.84 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.584 0.231 . . . . 0.0 110.56 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -46.82 72.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.221 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.3 mt -58.13 -41.12 79.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.322 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -37.63 80.53 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.835 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.6 -40.48 97.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.866 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 24' ' ' ILE . 22.1 mm -65.75 -31.22 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.46 -2.9 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -99.54 -75.74 0.56 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -87.42 -48.07 8.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.359 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.17 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 mt -126.48 136.39 60.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.806 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -153.0 44.01 0.64 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -130.64 129.56 22.74 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.193 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.55 73.85 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.39 -52.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.575 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.3 p30 -83.91 -35.64 23.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.74 -35.67 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.946 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 t -58.43 -38.98 78.57 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.312 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.27 -36.86 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.316 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.06 -51.43 38.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.062 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.4 mm -111.71 125.35 69.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.134 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -114.5 122.77 47.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.766 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.11 45.14 21.3 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.73 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.29 32.33 21.58 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.362 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -143.89 147.87 34.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -61.58 152.32 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -93.64 148.44 35.42 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.92 122.16 9.26 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.752 2.301 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.47 -46.26 1.08 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.768 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.64 117.81 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.5 mm -80.55 147.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' SER . 7.4 t -147.49 99.86 3.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.19 143.11 32.41 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.1 mt -126.09 112.22 29.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.37 44.74 11.87 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.984 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.31 39.09 25.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -142.93 166.36 24.84 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.42 28.54 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.512 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.87 -36.01 46.99 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.906 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -39.54 32.02 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.406 0.146 . . . . 0.0 111.358 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -25.22 62.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -106.56 -35.75 6.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.238 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.4 98.53 0.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 2.9 tt0 -42.06 -69.61 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.258 0.223 . . . . 0.0 111.552 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -116.66 -36.81 3.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.971 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.77 -24.94 24.77 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.494 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -52.12 110.94 0.54 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.837 0.351 . . . . 0.0 110.728 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.0 mt -68.49 141.0 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.12 176.43 0.75 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.04 103.52 0.3 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.41 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -43.01 108.29 0.1 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.819 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 29.91 3.4 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.66 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.81 165.06 11.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.92 141.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.78 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.434 HG21 ' CE2' ' A' ' 92' ' ' PHE . 4.7 mp -138.43 90.12 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -81.41 132.73 35.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 90' ' ' ILE . 23.7 m-85 -118.95 110.09 16.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.34 100.94 8.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.0 t -92.4 88.05 6.25 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 CA--C 1.538 0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.911 -179.759 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.607 0.241 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.04 112.13 10.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.16 134.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 116.74 33.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.47 143.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.403 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -110.95 153.79 25.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -128.57 118.23 22.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.048 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.78 171.59 9.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.18 -103.14 1.54 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.436 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.05 27.27 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.948 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mt -87.64 -41.41 13.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.825 0.313 . . . . 0.0 110.896 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.2 -33.93 71.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.165 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.77 -31.99 73.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.229 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mt -74.3 -46.89 42.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.216 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -62.76 -65.58 0.67 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.319 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.48 46.74 0.03 OUTLIER Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.444 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.9 mttt 57.44 51.72 9.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -125.82 122.33 35.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.992 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -68.86 -64.31 0.89 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.93 137.32 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -126.93 156.67 41.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.059 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -123.89 132.2 53.7 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.69 144.07 25.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.338 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.45 108.31 10.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.428 ' HE1' ' HB2' ' A' ' 40' ' ' HIS . 0.3 OUTLIER -100.11 110.12 22.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.993 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -102.39 63.83 0.89 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 110.904 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -112.44 -44.98 3.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.012 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -169.95 -176.66 2.38 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -86.29 -51.93 0.46 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.5 Cg_exo -78.67 54.09 4.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.961 2.44 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.8 t -85.65 122.48 38.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.026 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -74.4 150.45 40.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.234 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -52.59 -30.77 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.583 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.56 -25.71 61.27 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.279 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.4 -43.48 73.37 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -47.06 77.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.775 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.68 -39.15 78.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.014 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.77 -41.07 94.76 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.829 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.428 ' HB2' ' HE1' ' A' ' 26' ' ' MET . 1.1 t60 -59.89 -41.87 92.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.807 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.9 mm -63.81 -33.18 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.047 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.2 t -98.06 -3.89 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 m -95.54 -75.22 0.53 Allowed 'General case' 0 C--O 1.232 0.183 0 O-C-N 122.382 -0.199 . . . . 0.0 111.463 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 t -93.15 -38.78 11.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.458 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -46.81 88.62 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.079 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.77 150.98 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.25 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -166.06 40.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.106 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -128.58 128.44 23.56 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.484 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.67 74.37 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.84 2.36 . . . . 0.0 112.191 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.07 -58.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.457 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.462 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.2 p30 -81.29 -34.56 31.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.758 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.78 -36.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.065 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.86 72.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.432 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.4 mt -86.63 -36.84 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.025 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.462 ' CD1' HD12 ' A' ' 65' ' ' ILE . 31.9 t80 -69.09 -37.04 78.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.088 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -127.3 130.13 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.795 0.331 . . . . 0.0 111.353 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.41 -158.32 0.6 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.591 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.55 85.99 0.11 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.895 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 60.75 46.75 8.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.39 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.39 175.94 2.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mt -97.07 153.4 3.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.832 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 125.31 79.04 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.85 105.33 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.62 2.213 . . . . 0.0 112.065 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 151.88 -31.25 0.9 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.557 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 55' ' ' PHE . 31.2 mt -70.38 127.59 32.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mt -100.77 134.69 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.958 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 91' ' ' SER . 1.5 m -138.24 143.81 40.28 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.234 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.3 mt -139.4 126.21 20.82 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.447 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.6 mt -100.73 102.35 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.0 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 59.99 59.75 2.33 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.304 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 57.83 26.02 12.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.58 173.27 11.04 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.036 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 2.3 m-20 -79.38 157.95 27.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -59.99 2.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.712 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.24 -37.42 77.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.185 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -60.36 -29.98 69.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.923 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -93.57 28.4 2.31 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.069 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.95 -6.55 82.73 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.59 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 67.85 -72.41 0.09 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.027 0.414 . . . . 0.0 111.021 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -116.78 -29.71 5.97 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.03 54.88 1.68 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.227 0.537 . . . . 0.0 110.922 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -124.58 113.62 18.31 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.615 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.6 mt -61.45 128.5 22.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.8 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.2 174.5 1.57 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.39 103.65 0.21 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -46.68 113.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.026 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 23.98 5.69 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.02 177.65 4.83 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.337 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 mm -121.74 132.23 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.1 mt -143.06 92.55 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.631 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 67' ' ' THR . 12.9 m -79.88 149.11 31.05 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.711 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -134.46 86.87 2.3 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.776 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 m -91.23 144.72 25.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.604 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -148.66 79.98 1.44 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.004 0.43 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.737 0.303 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -80.18 125.28 29.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.551 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.41 HG22 HD12 ' A' ' 37' ' ' LEU . 31.2 m -128.47 139.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.79 118.28 36.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.0 153.25 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.376 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 158.86 33.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' HB2' ' CB ' ' A' ' 12' ' ' LEU . 8.2 p90 -160.24 148.03 16.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -137.96 178.22 7.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.112 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.59 -109.97 3.04 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.83 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.19 -24.22 17.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.943 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.4 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 4.3 mm? -55.03 -46.41 75.29 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.721 0.261 . . . . 0.0 111.362 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.89 -30.73 71.07 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.0 -38.2 45.4 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.271 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 22.3 mt -75.63 -44.59 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.71 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.27 -69.78 0.19 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.521 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.74 46.85 0.03 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.452 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.74 44.89 22.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -121.3 -176.66 3.34 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 -56.44 0.56 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.91 117.67 45.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.31 153.57 28.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.21 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -124.47 119.08 28.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.41 ' HB ' ' CG2' ' A' ' 4' ' ' VAL . 3.9 mp -99.45 143.07 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -116.22 80.42 1.45 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.293 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.97 106.75 18.62 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -93.92 43.83 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.121 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -90.11 -162.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.07 -172.19 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.904 0.383 . . . . 0.0 111.365 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.457 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -83.47 -54.01 0.54 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.036 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.7 Cg_exo -78.66 50.22 3.35 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.858 2.372 . . . . 0.0 112.713 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 t -81.84 126.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 1.3 p -73.34 157.47 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.914 0.387 . . . . 0.0 111.2 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.54 -34.98 48.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.471 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.33 -28.33 54.79 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.875 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -68.91 -43.39 75.31 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.41 HD12 HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -53.04 -51.93 60.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mt -59.97 -36.84 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.171 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -63.75 -37.85 88.89 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.766 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -60.85 -39.64 89.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.627 0.251 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.8 mt -72.74 -25.76 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.09 -1.44 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -93.72 -77.87 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.381 -0.199 . . . . 0.0 111.234 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.29 -40.87 14.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -56.88 16.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.148 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.2 mt -116.24 123.01 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 120.629 0.252 . . . . 0.0 111.07 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.6 39.34 1.69 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.139 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -131.84 129.24 21.87 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.72 70.18 2.11 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.519 2.146 . . . . 0.0 112.044 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.9 -50.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.448 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.425 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.4 p30 -88.68 -36.88 15.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.947 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.08 -35.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.342 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 m -56.11 -32.1 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.447 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.2 mt -92.08 -32.03 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.56 0.219 . . . . 0.0 111.127 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -73.37 -37.4 66.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.01 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 56' ' ' ILE . 27.1 mt -127.93 150.32 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.17 -163.98 1.02 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.695 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.62 92.41 0.07 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.735 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.5 33.66 22.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.471 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.1 p -165.93 122.55 1.37 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.867 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.82 151.61 9.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -74.5 142.36 77.71 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.16 97.14 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.689 2.26 . . . . 0.0 112.203 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.9 -39.2 0.09 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.49 132.92 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.5 mt -108.18 93.49 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 91' ' ' SER . 3.5 t -93.61 138.66 31.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -125.03 122.27 36.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.54 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.24 101.65 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 60.25 59.9 2.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.356 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 58.29 24.56 11.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.582 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.38 178.85 6.15 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.173 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -80.02 -177.07 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 111.009 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.61 -39.8 6.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.94 -24.59 19.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.017 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -54.42 -29.76 50.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.22 -69.32 0.86 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.563 0.221 . . . . 0.0 111.167 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.71 106.81 0.3 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.434 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.11 -71.01 0.08 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.504 0.192 . . . . 0.0 111.067 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -107.83 -36.65 6.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.947 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.37 -29.15 22.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.783 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.53 121.25 4.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.677 0.275 . . . . 0.0 110.856 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.97 138.36 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.05 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -66.52 177.9 1.41 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.85 103.28 0.11 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.909 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -35.22 111.91 0.14 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.44 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.4 6.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.946 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -95.26 164.33 12.89 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.823 0.344 . . . . 0.0 111.082 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm -119.49 134.5 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.172 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.0 154.04 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.045 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 67' ' ' THR . 16.3 m -134.75 161.6 34.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.14 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CD1' ' HB ' ' A' ' 67' ' ' THR . 94.1 m-85 -150.39 79.98 1.35 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.38 130.56 34.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.54 101.18 8.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.074 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.628 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.39 167.94 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.799 0.333 . . . . 0.0 111.818 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -151.5 132.55 14.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.13 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.36 120.29 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.38 102.09 13.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -99.47 142.12 15.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -118.07 102.49 9.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.06 131.7 34.56 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.042 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 mp -139.3 175.83 9.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.237 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 -85.96 1.35 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.625 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.15 28.1 1.55 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.869 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.93 -46.3 4.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.08 -26.35 66.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.367 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.75 80.42 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.827 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.455 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 4.3 mt -77.03 -40.5 30.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -63.74 -30.78 71.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.02 46.55 0.22 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.69 34.71 25.03 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.12 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.75 97.77 8.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.71 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -31.16 70.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.9 128.39 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.917 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.69 138.63 37.92 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 142.23 27.58 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.8 mm -121.39 148.13 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.32 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 126.3 31.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 142.22 50.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.48 102.07 4.52 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -149.37 -69.33 0.21 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.489 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.66 -178.25 5.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.013 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.6 -57.98 0.67 Allowed Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.378 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.88 61.78 3.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.388 2.059 . . . . 0.0 112.724 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.58 116.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.8 p -84.84 160.1 20.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.898 0.38 . . . . 0.0 110.957 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -58.15 -34.14 48.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.62 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.25 62.0 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.965 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -42.69 71.35 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.746 0.308 . . . . 0.0 110.303 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.0 -52.39 58.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.254 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.4 mt -57.96 -39.6 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.256 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.93 -44.29 91.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.733 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -38.16 76.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 32.2 mm -68.68 -28.97 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.2 t -96.02 -6.53 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 p -99.33 -77.52 0.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.199 -0.313 . . . . 0.0 111.728 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -84.55 -44.02 13.96 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.475 0.179 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.442 ' HB2' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -56.31 -52.31 65.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.219 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.2 mt -122.4 141.53 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.566 0.222 . . . . 0.0 111.075 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.15 74.05 0.77 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.134 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -165.94 139.07 3.44 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.444 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.95 70.57 5.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.59 2.193 . . . . 0.0 111.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -171.86 -44.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.799 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.68 -41.88 11.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.97 -35.3 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -55.55 -38.44 69.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.36 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.53 -30.87 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.598 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -79.52 -57.47 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.024 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 mm -106.18 135.66 43.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -124.87 97.16 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.982 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.64 66.27 1.28 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.09 28.62 9.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.799 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 m -147.19 122.57 10.32 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.358 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.12 152.48 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 111.158 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.3 116.63 60.59 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -52.68 119.33 5.8 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.85 -27.15 3.22 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.776 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 mt -72.51 125.31 31.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 mp -86.17 148.56 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.327 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 m -149.71 100.69 2.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 46.7 mt -91.6 114.87 27.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.3 pt -103.52 110.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.765 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 60.19 45.63 11.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.701 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.34 28.64 17.02 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 167.6 20.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.264 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.87 144.33 33.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 111.242 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -63.31 -50.61 69.38 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.976 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -24.59 67.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.25 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -50.03 63.76 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.018 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.15 -72.2 0.34 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.74 36.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.962 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 56.71 -83.98 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 111.808 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -101.86 3.54 39.35 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -91.56 31.09 1.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.696 0.284 . . . . 0.0 111.482 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -123.45 109.2 13.54 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.5 mm -65.73 137.28 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.782 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 mt -63.06 174.19 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.069 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -167.64 101.06 0.49 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -47.06 119.88 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.706 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.32 20.29 8.34 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.146 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.93 162.84 13.4 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.745 0.307 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.54 95.18 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.0 mm -90.84 149.75 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -133.97 137.96 45.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.297 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -124.83 142.58 51.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.18 166.9 24.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.697 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 t -145.58 120.15 9.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.8 t -94.43 53.99 1.76 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.168 0.508 . . . . 0.0 110.6 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.3 126.3 15.43 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -143.48 109.94 5.45 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.604 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.02 110.19 0.06 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.288 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.443 -1.198 . . . . 0.0 112.589 179.666 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 22.6 m -99.4 100.34 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 111.671 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -81.67 126.09 31.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.85 141.99 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.267 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.65 102.93 14.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.0 m -108.03 154.09 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.294 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -123.0 152.38 40.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.85 125.02 21.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 111.184 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 93' ' ' THR . 3.8 mm? -130.26 172.26 12.0 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.493 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -97.99 1.69 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.711 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.74 -29.57 2.84 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.107 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.88 -38.39 72.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.831 0.315 . . . . 0.0 111.288 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -60.87 -38.2 84.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.09 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.94 78.85 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.624 0.249 . . . . 0.0 111.358 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 33.1 mt -71.67 -34.21 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.41 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.47 -34.14 63.05 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.84 45.77 0.15 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.447 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.35 35.92 26.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.888 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.52 13.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.974 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.57 -49.89 2.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.983 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -118.99 134.75 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.307 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -123.46 149.7 44.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.47 119.43 29.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.911 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mm -126.07 148.29 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 23.7 pttt -130.07 113.55 14.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.412 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.66 132.12 38.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.794 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -115.49 91.56 3.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.722 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -156.09 -50.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.972 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -161.04 -174.67 4.49 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -59.08 0.36 Allowed Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.91 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.84 58.97 6.23 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.432 2.088 . . . . 0.0 112.631 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.21 125.4 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.612 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.5 p -72.93 155.47 39.84 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.984 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 p -57.39 -33.32 43.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.53 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' HA3' ' HE2' ' A' ' 80' ' ' LYS . . . -57.99 -28.45 60.92 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.769 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.41 -38.76 68.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.701 0.286 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -48.27 73.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.128 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 mt -63.07 -42.84 98.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.285 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.142 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -60.46 -44.28 96.04 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mt -70.04 -31.33 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.5 t -90.66 -4.27 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 t -81.87 -78.79 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.45 -0.156 . . . . 0.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -99.88 -33.74 10.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.525 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -44.29 91.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.136 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.3 mt -131.64 100.57 4.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.091 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.24 55.08 1.41 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -144.74 122.17 6.44 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.344 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.52 77.56 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.911 2.408 . . . . 0.0 112.027 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -162.26 -54.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.11 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.411 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -91.42 -38.32 12.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.696 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.96 -36.24 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -54.84 -36.23 64.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.626 0.251 . . . . 0.0 110.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 mt -82.5 -33.88 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.326 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -80.07 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mm -91.89 137.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.616 0.246 . . . . 0.0 111.286 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.26 147.23 41.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.898 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.73 39.38 1.64 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.37 0.418 . . . . 0.0 111.58 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.04 43.02 18.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.57 165.2 35.06 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.25 154.2 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -75.04 134.42 74.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.123 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.9 84.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.449 2.099 . . . . 0.0 111.459 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.53 -32.34 0.44 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.671 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mm -60.86 127.71 20.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.17 145.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -151.57 131.67 13.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.685 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -125.61 117.93 24.61 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.318 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 pt -90.96 106.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.17 50.21 6.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.05 32.25 20.95 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 175.86 9.21 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.586 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.71 158.96 26.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.465 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -56.22 3.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -25.39 63.26 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.665 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 tt -53.36 -32.5 49.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.521 0.201 . . . . 0.0 111.358 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.73 -54.84 2.23 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.782 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 106.12 0.2 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.699 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -50.27 -57.63 7.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.483 0.141 . . . . 0.0 110.99 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE2' ' HA3' ' A' ' 35' ' ' GLY . 43.4 tttm -110.83 -26.66 9.23 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.222 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.92 57.35 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -139.88 110.64 6.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.049 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.2 130.76 28.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.624 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.4 mt -64.78 175.05 1.59 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.42 102.08 0.72 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.274 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -48.67 114.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.4 26.07 5.54 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.43 164.05 12.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.706 0.288 . . . . 0.0 111.087 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.4 mm -104.39 133.53 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.6 mt -140.84 147.52 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 t -132.2 149.55 52.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.301 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -138.52 86.26 2.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.426 ' CG2' ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -93.36 175.76 6.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.487 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -155.34 82.18 1.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.616 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t -136.07 82.06 1.92 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.196 0.522 . . . . 0.0 110.653 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -29.9 71.06 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.857 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.95 170.48 13.0 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.591 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.87 -176.86 42.65 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.944 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.562 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.2 122.42 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -96.94 101.62 13.24 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.6 127.38 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.26 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -96.79 108.46 21.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.075 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.62 146.35 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -122.52 129.75 52.31 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 97.3 m-85 -109.94 130.12 55.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.61 165.82 26.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.74 -21.2 40.37 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.649 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.01 -26.21 1.6 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.95 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.4 mt -54.48 -37.75 65.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.75 0.275 . . . . 0.0 111.667 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -56.78 -31.34 64.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.226 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.67 78.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 23.2 mt -80.37 -35.21 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.283 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.38 -75.19 0.1 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.1 37.84 0.17 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.704 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt 52.01 34.29 13.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.447 0.299 . . . . 0.0 111.508 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -125.29 122.52 37.11 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.732 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -50.36 72.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.727 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.67 138.22 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.124 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.61 156.09 49.32 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.63 146.74 47.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.39 146.9 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -134.1 119.77 19.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.148 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -110.11 131.96 54.59 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.091 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.34 98.49 5.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.49 -49.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.055 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -161.31 -176.55 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.11 -58.56 0.41 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.68 56.5 4.08 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.547 2.164 . . . . 0.0 112.749 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.84 126.33 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 p -78.67 151.17 32.37 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.24 -32.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.672 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -27.13 57.33 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.724 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -41.57 68.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.734 0.302 . . . . 0.0 110.385 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.6 -52.22 60.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.189 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.1 mm -62.37 -38.82 82.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.39 -46.0 90.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.039 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.406 ' HB2' ' HE1' ' A' ' 26' ' ' MET . 1.4 t60 -57.85 -42.22 84.03 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.045 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.7 mt -65.64 -31.76 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.792 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.45 -2.9 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.901 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -74.83 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.462 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -95.7 -42.73 8.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.294 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -42.77 76.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.48 ' CG2' HG21 ' A' ' 52' ' ' VAL . 35.0 mt -131.73 131.56 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -162.24 74.96 0.44 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.018 0.437 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.03 121.03 1.42 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.611 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.67 79.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.44 2.093 . . . . 0.0 112.046 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -172.88 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.7 p30 -87.4 -41.79 13.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.602 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.48 HG21 ' CG2' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -77.63 -35.52 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 t -53.83 -31.56 49.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.333 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.4 mt -90.6 -44.53 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.501 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -72.86 -53.75 10.6 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.477 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 56' ' ' ILE . 37.8 mm -99.87 114.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.305 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -162.97 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.542 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -64.43 86.93 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.899 0.381 . . . . 0.0 111.046 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 60.38 43.55 13.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.93 176.5 3.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.07 149.82 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.713 0.292 . . . . 0.0 110.799 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.11 148.89 35.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.79 159.06 47.42 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.633 2.222 . . . . 0.0 112.275 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.26 -23.66 35.19 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.798 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.8 mm -83.25 102.62 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.0 124.19 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.198 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.6 m -120.18 141.25 50.07 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.4 mt -135.95 115.06 12.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.289 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.2 mt -97.71 105.2 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.638 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 57.63 52.5 8.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 59.61 32.79 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.216 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.32 169.31 18.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.417 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.92 171.52 15.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.847 0.356 . . . . 0.0 111.093 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -100.98 -48.19 4.52 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.993 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -27.04 58.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.99 -27.63 53.67 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.269 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -120.96 -50.9 2.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.406 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.11 93.22 0.1 Allowed Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.726 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -43.5 73.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -124.58 -40.21 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.81 56.52 1.54 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.944 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.19 108.25 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.807 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.86 128.17 20.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.46 175.07 1.46 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.88 100.96 0.66 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.481 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -48.02 115.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.858 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.17 6.58 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.691 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.49 169.16 9.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.744 0.307 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.43 128.07 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.7 mt -136.24 145.66 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.842 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -128.65 155.55 44.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.748 0.309 . . . . 0.0 111.348 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.429 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 41.8 m-85 -143.6 82.2 1.72 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 m -86.75 140.82 29.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.126 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 t -102.61 103.24 13.52 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.71 88.4 1.69 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.355 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.99 133.0 53.91 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.225 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -134.42 131.17 37.85 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.011 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.64 -95.65 0.54 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.377 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.828 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.585 0.231 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.7 136.06 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.28 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -97.94 140.49 32.21 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.432 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.476 ' CG2' HD23 ' A' ' 37' ' ' LEU . 35.7 m -136.01 146.11 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 113.33 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 8' ' ' PHE . 31.2 m -115.78 151.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.479 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -122.11 110.12 15.37 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' A' ' 6' ' ' VAL . 79.3 m-85 -91.21 138.28 31.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mp -141.84 163.37 33.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.8 -107.87 3.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.402 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 26.73 5.25 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.047 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.421 HD22 ' CE1' ' A' ' 55' ' ' PHE . 1.9 mp -96.38 -41.79 8.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.89 0.345 . . . . 0.0 110.983 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.29 -28.95 65.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.357 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.05 78.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.727 0.299 . . . . 0.0 111.047 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 24.7 mt -79.78 -43.75 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.509 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.6 m-85 -58.61 -70.4 0.15 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.455 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.7 44.08 0.07 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.395 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.59 32.96 18.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.505 0.322 . . . . 0.0 111.402 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -119.38 113.76 21.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.389 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -58.8 -62.56 1.78 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -94.87 143.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.153 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -129.06 161.29 30.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -145.31 133.41 21.49 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.437 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.1 pt -147.2 178.76 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.326 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 132.09 15.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.38 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.25 108.07 19.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.475 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -91.93 48.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -45.06 6.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.985 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -166.7 -178.24 4.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.32 -59.13 0.3 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.773 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.8 58.93 6.66 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.363 2.042 . . . . 0.0 112.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.01 149.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.1 p -98.86 161.6 13.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 p -60.74 -39.85 83.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.711 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.8 -30.51 69.54 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.945 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -40.44 86.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.769 0.319 . . . . 0.0 110.314 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.476 HD23 ' CG2' ' A' ' 4' ' ' VAL . 2.6 tm? -56.64 -44.9 81.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.128 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.89 -45.26 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.38 -37.97 82.45 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -60.07 -43.71 95.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.6 mt -64.63 -30.21 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.153 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.8 t -95.99 -2.46 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -95.33 -64.59 1.05 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.3 p -98.03 -46.98 5.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.722 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -56.8 17.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.458 ' CG2' HG21 ' A' ' 52' ' ' VAL . 19.4 mt -115.61 149.08 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -173.87 72.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -163.76 133.46 3.11 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.148 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.98 65.52 3.32 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.441 2.094 . . . . 0.0 111.823 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -158.85 -49.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.028 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.422 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -89.52 -42.51 11.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.456 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -72.9 -36.28 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.223 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.7 -28.69 15.67 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.42 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -89.28 -34.41 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.428 ' CD1' HG13 ' A' ' 65' ' ' ILE . 51.2 t80 -86.95 -57.63 2.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.515 0.198 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.53 139.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -148.86 129.6 14.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.96 42.98 15.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 59.2 38.99 23.34 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.51 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.9 t -166.91 162.31 15.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.908 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.0 148.88 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -78.48 147.7 72.3 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.057 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.22 75.69 2.8 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 111.842 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.03 -45.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.541 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.428 HG13 ' CD1' ' A' ' 55' ' ' PHE . 28.5 mm -67.17 137.21 25.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.857 0.36 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.4 mt -110.73 132.41 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -126.32 138.64 53.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.5 mt -125.48 109.87 13.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.463 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 7.2 mt -86.73 105.74 15.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.8 t30 56.92 45.9 20.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 61.68 41.87 11.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.177 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.76 156.82 43.85 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.578 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 129.63 34.64 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.949 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -57.65 -35.32 70.38 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.645 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.13 -1.94 58.26 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -16.08 59.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -137.31 -58.53 0.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.507 0.194 . . . . 0.0 111.26 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.92 112.57 0.53 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.673 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -49.61 -71.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.537 0.208 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -107.65 -28.23 9.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.931 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.71 -31.37 37.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.226 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.463 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 38.2 t80 -48.26 118.95 2.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 110.838 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.17 141.25 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.74 178.23 0.47 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.955 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -162.74 99.71 1.0 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.824 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -43.5 105.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.828 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.13 5.4 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.035 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.83 170.19 8.31 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.714 0.292 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.3 123.27 68.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.402 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.24 107.39 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.774 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -81.72 157.99 24.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 111.597 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -146.82 82.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.45 164.13 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.11 132.94 50.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.277 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.19 -63.98 1.22 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.638 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -131.01 165.56 22.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.319 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 73.08 114.27 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.082 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.53 93.02 1.75 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.27 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.553 -1.137 . . . . 0.0 112.863 -179.873 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p -118.62 111.24 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 111.258 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -105.53 125.1 50.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.09 110.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.271 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 112.98 20.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.526 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 7.2 m -113.35 139.79 36.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.336 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.7 115.46 29.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -96.46 124.03 40.31 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.405 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 mp -125.47 159.69 31.33 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.299 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.37 -109.26 3.57 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.414 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.08 35.49 2.84 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.589 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 mt -104.15 -43.13 5.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.637 0.218 . . . . 0.0 111.178 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -59.38 -28.47 66.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.33 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.23 78.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.77 0.319 . . . . 0.0 111.032 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 41.9 mt -73.96 -37.99 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.219 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -69.65 -70.44 0.28 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.74 44.72 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 56.1 33.54 22.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.621 0.248 . . . . 0.0 111.401 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 129.1 51.55 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.603 0.24 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -83.44 -64.13 1.22 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.5 t -79.65 105.87 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -111.2 173.7 6.22 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.61 136.26 47.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.309 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 37' ' ' LEU . 17.6 mm -117.87 152.11 19.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -150.0 99.52 2.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.127 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -73.52 -53.77 9.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.049 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.59 76.13 0.32 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -136.67 -67.57 0.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.335 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -140.97 -175.73 4.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.72 -59.59 0.43 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.086 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.37 60.37 6.39 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.469 2.112 . . . . 0.0 112.598 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.7 t -77.8 142.27 14.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 155.24 18.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -57.74 -35.88 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.803 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.63 -27.74 66.71 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.978 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' HB3' ' HE1' ' A' ' 26' ' ' MET . 0.5 OUTLIER -73.25 -39.13 65.69 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.431 HD13 HG21 ' A' ' 24' ' ' ILE . 1.3 tm? -54.97 -51.43 66.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.382 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.7 -43.15 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.18 -43.66 78.64 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 55.4 t60 -59.63 -46.52 88.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.31 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.48 -31.59 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.891 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.7 t -97.4 -4.13 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -92.7 -68.81 0.78 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.28 -41.48 7.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.614 0.245 . . . . 0.0 111.351 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -39.78 69.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.1 mt -131.65 129.79 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.664 0.269 . . . . 0.0 111.047 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -143.91 51.41 1.32 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -142.92 121.52 7.37 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.32 74.41 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.99 2.46 . . . . 0.0 112.238 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.63 -58.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.364 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.487 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.8 p30 -79.9 -36.49 36.38 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.706 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.77 -35.33 7.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.945 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -54.23 -36.24 63.31 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.121 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.2 -37.93 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.219 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -67.11 -39.93 86.77 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.006 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.31 116.22 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -115.01 130.89 57.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.64 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 58.81 43.78 17.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.966 0.413 . . . . 0.0 110.464 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.39 33.31 22.18 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.489 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.61 149.66 26.87 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.911 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.62 151.58 10.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.061 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -93.1 130.25 36.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.999 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.42 118.66 5.3 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.79 2.327 . . . . 0.0 112.325 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.94 -37.88 0.93 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.555 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 mt -74.11 127.89 36.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.69 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.8 mm -103.04 127.54 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.059 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -121.92 134.8 54.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.235 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -110.58 98.54 7.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.446 HG23 ' CD1' ' A' ' 82' ' ' TYR . 24.1 mt -81.13 102.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 57.63 48.4 14.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.628 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 62.13 32.26 17.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.289 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -128.58 162.97 26.04 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.227 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.49 134.64 36.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -57.48 -53.37 58.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.888 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.44 -36.54 83.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.306 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 tt -56.4 -52.48 64.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.597 0.237 . . . . 0.0 110.575 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.56 -35.73 81.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 34.08 0.8 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.185 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.76 -78.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.628 0.371 . . . . 0.0 111.432 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -109.2 16.73 22.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 47.52 1.25 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.993 0.425 . . . . 0.0 110.786 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.446 ' CD1' HG23 ' A' ' 69' ' ' ILE . 24.1 t80 -144.23 138.23 27.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mp -92.91 129.96 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -59.75 173.78 0.54 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.0 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.65 100.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.029 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -43.07 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.907 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.53 26.96 5.43 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.482 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.4 174.76 6.86 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.64 0.257 . . . . 0.0 111.086 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.2 mm -119.46 130.43 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.481 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 43.3 mt -133.39 153.17 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.385 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -127.55 156.45 42.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.05 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -143.88 105.76 4.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.229 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -109.6 142.19 41.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.032 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.3 t -116.63 97.56 6.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.567 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 68.0 p -73.65 -66.9 0.64 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.49 102.19 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.9 m80 65.36 17.17 10.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.275 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.89 69.71 1.18 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.385 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.385 -1.231 . . . . 0.0 112.643 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 m -108.63 129.62 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -111.02 139.68 46.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.88 136.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.541 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.25 115.54 27.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.362 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 2.9 m -113.27 143.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.461 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.35 154.95 20.54 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -142.82 111.75 6.46 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -123.32 145.41 48.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.012 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.25 -111.16 3.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.524 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.87 28.43 6.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.929 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.17 -48.75 4.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.81 0.305 . . . . 0.0 110.767 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.74 -27.0 68.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.621 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.78 -34.19 76.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.647 0.261 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.4 mt -74.91 -37.4 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.227 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.63 -61.33 1.83 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.33 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.62 46.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.503 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp 57.35 33.87 23.91 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -112.24 103.93 12.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.713 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mtt-85 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.604 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 p -97.85 130.32 46.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.88 0.371 . . . . 0.0 111.003 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -128.61 164.67 22.37 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.259 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -128.68 133.48 48.22 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.305 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' CD1' HG12 ' A' ' 41' ' ' ILE . 22.6 mm -117.19 145.96 22.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.23 89.72 3.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.1 148.56 51.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.175 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -123.59 101.76 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.386 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -166.29 -53.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -174.07 -166.59 0.3 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.78 -59.53 0.33 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 59.26 5.83 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.486 2.124 . . . . 0.0 112.548 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.66 131.24 34.23 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -66.69 146.38 54.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 p -54.62 -33.37 27.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.473 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.57 59.17 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.043 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -39.88 61.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 110.3 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -55.85 -56.57 19.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.304 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 pt -59.12 -35.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.623 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -63.27 -43.86 96.75 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.662 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -58.07 -39.55 78.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.431 HG12 ' CD1' ' A' ' 24' ' ' ILE . 16.5 mt -68.6 -30.23 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.038 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.8 t -97.01 -6.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.1 t -100.72 -64.33 1.05 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 m -87.77 -51.27 5.95 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.38 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -51.9 67.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.405 HG23 HG22 ' A' ' 52' ' ' VAL . 26.1 mt -116.2 143.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-O 120.759 0.314 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -162.56 41.22 0.12 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.587 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 50' ' ' ASN . 5.4 t30 -134.03 118.54 14.2 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.708 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.37 75.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.908 2.405 . . . . 0.0 112.711 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ASN . 9.5 m-20 -165.72 -61.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.354 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -79.84 -33.25 40.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.33 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 46' ' ' ILE . 1.4 t -93.83 -41.15 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.636 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -35.49 68.49 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.197 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.6 mt -89.0 -33.97 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.33 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.495 0.188 . . . . 0.0 111.004 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.4 mt -131.84 141.8 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.446 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.18 -170.27 3.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -63.16 93.04 0.06 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.956 0.407 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 56.09 43.65 26.6 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.88 128.63 1.69 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -71.97 153.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.293 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -88.48 139.48 29.92 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.016 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.21 125.1 17.95 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.811 2.341 . . . . 0.0 112.389 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.15 -46.97 1.02 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.866 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.43 112.92 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.45 146.77 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.561 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 91' ' ' SER . 2.0 m -141.52 138.19 32.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.633 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -145.87 128.05 15.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.058 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.6 mt -90.33 90.27 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.434 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.01 65.88 1.34 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.955 0.407 . . . . 0.0 111.253 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.2 24.29 14.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.595 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 m -130.17 164.6 24.12 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.317 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.404 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -79.71 165.87 22.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.898 0.38 . . . . 0.0 111.474 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -94.22 -41.14 9.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.796 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.24 -27.48 35.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.618 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.404 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -54.69 -27.45 40.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.466 ' HG3' ' CD1' ' A' ' 82' ' ' TYR . 1.4 pt-20 -128.41 27.33 5.59 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.68 102.75 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.743 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -54.14 -34.36 60.16 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -122.18 -40.51 2.49 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.448 0.166 . . . . 0.0 110.626 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -55.16 -29.19 57.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.369 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.466 ' CD1' ' HG3' ' A' ' 77' ' ' GLU . 72.3 t80 -55.13 118.91 4.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.22 139.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.565 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 37' ' ' LEU . 22.9 mt -64.07 175.25 1.28 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.942 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -167.11 100.84 0.53 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.595 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -44.35 114.31 0.66 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.99 18.98 6.58 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.017 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.17 177.54 4.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.746 0.273 . . . . 0.0 110.961 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.474 HG23 HD11 ' A' ' 89' ' ' ILE . 27.4 mt -128.12 150.32 33.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.962 0.41 . . . . 0.0 111.71 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 5.3 mp -142.55 100.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.11 142.99 34.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.695 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG23 ' A' ' 90' ' ' ILE . 12.1 m-85 -136.23 82.9 1.97 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.349 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -94.02 150.05 20.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.675 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 m -133.98 99.31 4.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.59 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.3 p -78.14 -51.23 10.56 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 mp 65.43 -68.22 0.12 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.4 0.438 . . . . 0.0 111.656 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -77.1 119.99 21.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.751 0.31 . . . . 0.0 110.847 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -120.4 128.02 7.3 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.343 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.454 -179.787 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m -145.9 172.78 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.604 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -141.95 114.28 8.27 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -117.75 132.76 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.113 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -106.41 105.26 15.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.725 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 15.3 m -105.53 144.37 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.371 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -107.32 135.56 48.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -119.01 115.42 24.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.746 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.5 132.53 54.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.088 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 -109.27 1.82 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.386 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.03 -23.84 5.97 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.242 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -48.24 74.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.994 0.397 . . . . 0.0 111.468 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -57.9 -36.01 71.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.129 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.424 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 7.5 mt -75.19 -39.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.363 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -67.38 -75.09 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.321 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.21 41.71 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.602 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.35 34.4 20.61 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.705 0.288 . . . . 0.0 111.159 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -110.16 117.5 33.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.721 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -28.98 69.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.67 142.28 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -122.73 170.35 10.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -135.24 121.71 20.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.1 143.93 24.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.065 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.96 91.79 2.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.449 ' HE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.3 156.73 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.052 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.92 113.91 7.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 111.586 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.68 -48.28 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.94 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -156.13 -177.7 6.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.26 -59.83 0.37 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.984 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.09 58.28 6.51 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.534 2.156 . . . . 0.0 112.409 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -75.14 121.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.657 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.6 p -68.75 153.47 43.73 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.876 0.369 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.68 -31.95 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.579 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.08 -28.04 57.99 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.33 -38.07 71.7 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.776 0.322 . . . . 0.0 110.324 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -47.1 79.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.054 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.39 -41.88 91.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.449 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -39.68 87.3 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.449 ' HB2' ' HE2' ' A' ' 26' ' ' MET . 47.5 t60 -63.12 -46.1 88.9 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -61.24 -31.41 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.16 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.1 t -97.57 -3.36 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.4 t -93.43 -74.87 0.51 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.388 -0.195 . . . . 0.0 111.494 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -96.58 -39.99 9.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.556 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.8 tpt -57.1 -38.56 73.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.024 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.531 ' CG2' HG23 ' A' ' 52' ' ' VAL . 15.0 mt -137.62 136.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.693 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -159.81 71.72 0.49 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.813 0.34 . . . . 0.0 111.365 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.5 t30 -162.88 134.64 3.9 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.38 64.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.21 1.94 . . . . 0.0 111.702 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.73 -45.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -91.24 -41.92 10.7 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.641 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG23 ' CG2' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -72.01 -34.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.29 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.29 -30.67 12.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.5 -65.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.466 0.174 . . . . 0.0 111.371 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.05 -36.53 84.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.324 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD13 HG22 ' A' ' 56' ' ' ILE . 29.6 mm -125.37 93.84 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.89 119.22 38.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.57 64.65 1.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p30 43.23 33.81 0.62 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.247 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -157.36 149.07 22.2 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.661 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.07 152.91 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -79.73 115.68 55.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.631 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.76 101.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.649 2.233 . . . . 0.0 111.959 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.05 -30.64 0.6 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.584 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mt -64.22 136.42 26.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.819 0.343 . . . . 0.0 110.836 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.3 mt -103.82 144.79 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.413 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -143.63 140.93 30.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.7 mt -141.04 121.13 13.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.264 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.2 mt -93.7 102.76 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.53 55.42 3.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t0 57.01 31.89 20.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.206 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -136.25 166.6 23.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.77 149.23 31.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 111.467 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -69.05 -54.1 16.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.73 -7.77 55.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.042 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -31.45 64.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.597 0.237 . . . . 0.0 111.366 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.26 -52.06 1.52 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.96 109.15 0.35 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.926 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.46 -48.9 77.96 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.847 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -121.19 -42.82 2.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.865 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.76 -24.54 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.948 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -52.84 119.79 5.02 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.883 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -75.56 132.59 32.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.17 174.99 1.78 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.726 0.298 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -169.6 101.85 0.33 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.421 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -44.05 115.43 0.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 119.17 3.95 12.7 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.984 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.94 164.25 23.66 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.082 0.441 . . . . 0.0 111.155 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mm -123.05 93.22 2.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 41.6 mt -91.83 152.1 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.12 146.62 50.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.228 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -138.32 94.75 2.9 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.54 132.91 45.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.04 96.56 5.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.223 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.29 -28.14 66.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.129 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 mp -60.85 117.25 5.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.765 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -109.1 138.86 44.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.291 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.61 81.32 0.52 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.423 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.605 -179.87 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.62 0.248 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m -144.25 127.41 11.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.176 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -104.41 131.88 51.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 37' ' ' LEU . 19.9 m -133.26 147.48 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -103.66 100.64 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 m -106.01 151.88 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.2 159.09 32.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -130.17 143.13 50.61 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.395 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -140.65 171.02 14.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.503 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.67 -111.42 3.28 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.353 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.84 27.44 5.42 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.829 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.4 mt -90.36 -51.52 5.38 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.763 0.281 . . . . 0.0 110.863 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.0 -27.06 61.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.519 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.28 80.56 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.729 0.3 . . . . 0.0 111.18 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -78.62 -43.21 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.82 -69.2 0.24 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.367 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.01 42.33 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.778 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 57.5 6.33 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 111.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -143.81 119.42 10.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.0 mtm-85 -72.52 -72.02 0.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.59 138.76 19.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 111.362 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -145.55 143.81 30.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -108.57 125.42 51.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.59 145.61 19.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.56 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.61 95.56 4.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.234 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.428 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -62.78 -64.51 0.9 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.636 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 58.66 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.851 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.6 -45.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.089 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -150.6 -179.85 7.58 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.89 -58.67 0.41 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.756 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.0 57.76 6.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.481 2.121 . . . . 0.0 112.602 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.5 116.21 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.495 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.8 p -75.01 156.13 36.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.65 -31.88 40.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.396 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.86 -25.59 59.37 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.932 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.36 -39.49 59.2 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 110.282 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -54.82 -55.41 30.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.417 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 pt -61.07 -36.0 69.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.625 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -39.47 94.27 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.764 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.428 ' CD2' ' HA ' ' A' ' 26' ' ' MET . 18.4 t-80 -61.22 -40.09 92.7 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.0 mt -67.86 -30.88 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.551 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.6 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.811 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.3 p -100.21 -60.83 1.45 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -100.22 -50.99 3.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -42.39 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.273 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.9 mt -130.87 129.63 63.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.88 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 64.87 1.15 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.786 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.24 131.14 6.86 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.93 74.41 2.35 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.617 2.211 . . . . 0.0 112.196 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -168.17 -47.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.53 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.85 -38.96 10.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.852 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -82.97 -37.44 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.409 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -53.24 -42.62 66.6 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.663 0.268 . . . . 0.0 111.098 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.01 -34.15 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.583 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.03 -48.59 62.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.674 0.273 . . . . 0.0 110.649 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 mm -124.56 124.02 67.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.993 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -163.24 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.481 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.97 84.94 0.08 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 40.29 12.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.57 126.32 1.07 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.57 153.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.2 143.26 52.18 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.94 125.61 11.71 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.523 2.149 . . . . 0.0 112.084 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.54 -35.16 2.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.597 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 mt -73.29 114.51 12.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.706 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.1 mt -96.31 149.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.057 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.506 ' CG2' ' CE3' ' A' ' 74' ' ' TRP . 9.3 t -143.73 128.26 18.04 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.861 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.8 mt -108.53 126.98 53.53 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 pt -106.31 109.2 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.099 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.32 44.74 21.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.2 41.62 16.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.0 167.67 21.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 125.32 29.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CE3' ' CG2' ' A' ' 67' ' ' THR . 0.3 OUTLIER -59.16 -26.83 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.732 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -97.66 -1.34 43.86 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -32.37 72.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.482 0.182 . . . . 0.0 111.423 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 -68.63 0.66 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.22 110.15 0.54 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.033 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -72.68 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.115 0.166 . . . . 0.0 111.287 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.05 -31.03 16.44 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.555 0.217 . . . . 0.0 110.749 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -28.18 28.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.487 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -57.39 113.67 1.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.7 mm -77.62 141.53 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.8 mt -62.93 173.65 1.3 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.59 101.32 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -43.65 110.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.764 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.39 26.84 4.98 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.874 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.26 168.74 9.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.476 HD12 HG21 ' A' ' 89' ' ' ILE . 26.6 mm -117.32 129.57 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.612 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.51 101.84 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.61 152.0 28.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -134.23 93.15 3.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 p -95.97 162.31 13.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 t -151.72 102.01 2.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.3 p -123.16 -45.6 2.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.415 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 96' ' ' LEU . 2.0 tt 64.04 74.32 0.41 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.868 0.366 . . . . 0.0 111.449 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -164.11 40.47 0.09 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -120.69 -70.58 0.3 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.686 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.519 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.7 m -97.59 164.5 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.698 0.285 . . . . 0.0 111.516 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -132.08 110.43 10.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.1 m -117.44 135.0 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.304 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -104.55 99.18 8.86 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 26.2 m -93.31 144.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -116.61 103.06 10.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -88.74 119.54 29.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.762 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mp -126.0 161.88 26.54 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.6 -104.65 2.94 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.338 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.8 -12.82 8.3 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.397 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -44.13 96.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.246 0.523 . . . . 0.0 111.294 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.89 -32.88 71.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.085 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.9 69.45 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.534 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.429 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 30.1 mt -74.43 -47.41 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.412 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -60.42 -61.15 2.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.357 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.63 0.02 OUTLIER Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.588 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp 59.09 65.01 1.27 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 111.97 8.57 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -34.05 77.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.002 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.8 122.99 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.49 174.73 5.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.066 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -137.94 129.14 27.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.067 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.42 140.3 46.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.78 86.41 2.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 128.84 37.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.842 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -112.01 82.53 1.64 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.595 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.3 -66.33 0.7 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -148.28 -173.33 4.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -87.71 -54.42 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.975 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.2 Cg_exo -78.47 53.96 4.8 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.872 2.381 . . . . 0.0 112.621 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.6 t -80.08 129.78 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.709 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -81.99 156.6 24.6 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 110.743 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.69 -37.7 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.748 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.02 59.19 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.413 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.91 -41.02 75.24 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.709 0.29 . . . . 0.0 110.385 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -54.34 43.5 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.89 -35.27 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.455 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -46.0 90.93 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.173 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.36 -40.62 87.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.649 0.262 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.2 mt -64.32 -33.22 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.713 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.76 -6.37 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.846 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.3 -74.95 0.44 Allowed 'General case' 0 N--CA 1.462 0.167 0 O-C-N 122.384 -0.197 . . . . 0.0 111.444 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.5 m -99.19 -41.5 7.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.45 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.46 -38.31 63.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.118 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.4 mt -133.42 103.59 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.726 0.298 . . . . 0.0 110.957 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.23 71.22 1.19 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.07 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.2 130.16 2.79 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.185 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.48 75.18 2.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.599 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -168.5 -44.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.857 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -92.67 -38.71 11.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.663 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.17 -36.06 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -54.75 -39.07 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 111.029 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.9 mt -76.03 -35.04 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.167 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -72.48 -52.94 13.6 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.669 0.271 . . . . 0.0 110.912 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 mt -118.0 110.12 29.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.5 130.46 55.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 59.4 40.95 20.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.04 29.61 19.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.46 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 144.78 32.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.44 153.96 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.277 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -88.66 146.1 36.49 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.71 88.73 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.623 2.215 . . . . 0.0 111.957 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.12 -34.76 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.773 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.6 mm -68.33 119.53 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 111.083 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.4 mt -96.72 147.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.428 HG22 ' CE2' ' A' ' 92' ' ' PHE . 64.2 p -136.83 112.61 9.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.5 mt -105.27 108.17 19.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.754 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.2 mt -89.3 100.87 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 t30 58.81 53.2 5.97 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.29 32.93 20.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.235 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 154.14 49.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 129.07 34.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.653 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -54.58 -33.24 59.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.648 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.17 -32.47 38.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.923 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.75 -30.99 64.14 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.44 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -121.38 26.26 8.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.534 0.207 . . . . 0.0 111.432 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.29 -101.54 0.64 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.838 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.8 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.575 0.35 . . . . 0.0 110.509 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -109.94 -25.15 10.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.219 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -53.48 -25.71 17.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.666 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -52.75 115.56 1.88 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.678 0.275 . . . . 0.0 110.718 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.77 142.04 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -63.22 174.94 1.04 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.936 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -160.53 97.33 1.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.784 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -45.85 110.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.83 26.18 4.83 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.678 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.85 176.57 5.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.649 0.262 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.445 HD12 HG23 ' A' ' 89' ' ' ILE . 19.8 mt -123.3 152.69 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.554 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 5.2 mp -141.5 153.12 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.72 139.39 48.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.428 ' CE2' HG22 ' A' ' 67' ' ' THR . 30.2 m-85 -127.99 91.07 3.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 162.13 14.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -155.22 103.9 2.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.005 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -104.07 -82.57 0.5 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt 51.19 86.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.821 0.343 . . . . 0.0 111.553 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -127.67 40.89 3.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.134 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.27 177.06 14.68 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.778 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.571 -1.127 . . . . 0.0 112.804 179.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mmt . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 m -147.2 103.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -83.91 110.11 18.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.5 m -117.06 138.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.434 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.95 116.74 33.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.1 t -109.82 144.98 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.402 ' HB3' HD12 ' A' ' 9' ' ' LEU . 3.7 mt-10 -127.49 101.27 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.92 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -87.7 123.89 33.0 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.826 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 7' ' ' GLU . 4.9 mp -143.6 167.81 21.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.07 -20.73 38.16 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.509 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.36 -34.85 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.746 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -37.24 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.65 0.225 . . . . 0.0 111.577 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.83 -36.7 72.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.56 0.219 . . . . 0.0 111.017 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.91 68.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.479 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.2 mt -73.56 -42.09 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.203 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -68.94 -71.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.36 41.58 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.57 44.81 27.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.65 -31.6 15.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.302 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 72.63 -67.44 0.26 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.853 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p -117.72 124.15 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 152.73 46.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.284 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -112.2 145.22 40.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.9 mt -138.29 148.57 24.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 108.27 8.05 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.95 159.08 32.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.81 93.36 3.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.106 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -162.54 -67.91 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.243 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.28 -175.63 5.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -58.44 0.46 Allowed Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.37 59.22 6.01 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.485 2.123 . . . . 0.0 112.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.15 142.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.83 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.02 151.39 25.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -55.5 -32.34 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.681 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.84 -25.96 64.57 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.063 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.29 75.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.738 0.304 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -47.84 84.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.312 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.2 mm -59.81 -38.52 76.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.406 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.36 -41.89 97.81 Favored 'General case' 0 C--N 1.335 -0.032 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -60.22 -38.32 83.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.022 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.0 mt -67.83 -31.8 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 t -98.12 -2.9 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -94.46 -75.79 0.5 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -91.6 -45.19 8.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.658 0.265 . . . . 0.0 111.293 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.2 ttt -54.57 -44.34 72.88 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 mt -131.94 145.66 34.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.703 0.287 . . . . 0.0 111.237 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 47.28 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.84 126.28 13.27 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.073 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.41 77.03 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.938 2.425 . . . . 0.0 112.23 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -170.83 -58.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.411 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -82.42 -36.9 26.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 t -93.92 -35.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.873 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 t -53.75 -38.67 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.037 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -85.87 -34.37 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.083 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -67.48 -53.31 29.87 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.074 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.7 mm -104.77 131.1 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.916 0.388 . . . . 0.0 111.397 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -124.37 100.32 6.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.767 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 57.62 77.27 0.28 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.067 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 41.6 35.34 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -161.32 137.38 8.12 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.751 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.29 151.94 4.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.889 0.376 . . . . 0.0 111.391 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.87 140.52 46.96 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.89 118.1 4.75 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 112.31 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.05 -37.08 1.94 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.504 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.0 mm -74.5 139.5 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.966 0.412 . . . . 0.0 111.019 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.8 mt -105.4 145.29 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.971 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -139.86 84.51 1.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.654 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.05 124.41 28.71 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.332 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.3 mt -105.63 105.44 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.87 54.43 4.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.01 30.51 20.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.503 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 169.9 16.81 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.424 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.01 162.03 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -77.88 -44.2 27.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.228 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.25 -24.97 46.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.368 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -36.44 61.69 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.962 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.34 -32.15 10.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.835 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.83 -86.19 0.07 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.06 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.573 0.349 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -114.67 -27.1 7.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.45 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.79 -22.58 25.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -45.24 117.7 1.47 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.42 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -69.19 177.36 2.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.86 103.89 0.11 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.954 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -38.67 106.35 0.05 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.942 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.45 -8.88 5.9 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.741 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -80.06 164.33 23.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.166 0.483 . . . . 0.0 111.21 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.8 mm -125.0 117.33 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.12 142.48 22.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.034 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.7 m -121.68 139.46 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.317 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -119.57 79.98 1.51 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.93 172.68 11.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.924 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.45 118.17 9.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.103 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.2 39.64 1.18 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.045 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.19 -39.36 11.6 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.834 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -152.95 -45.65 0.1 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.576 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.3 -176.76 33.09 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.723 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.399 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.615 0.245 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.4 m -100.3 157.07 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.621 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -130.68 126.66 37.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 ' CG1' HG12 ' A' ' 90' ' ' ILE . 17.9 t -128.75 138.31 54.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.47 103.28 15.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.2 t -92.63 143.47 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.937 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.34 105.92 9.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 110.896 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 96.4 m-85 -92.62 127.76 38.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.069 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mp -132.94 168.12 19.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.743 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.19 -109.46 3.45 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.299 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.79 24.69 7.86 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.014 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.0 mt -100.55 -37.1 8.94 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.939 0.37 . . . . 0.0 111.273 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.78 -17.31 62.94 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.33 -30.02 22.55 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 1.1 mt -93.55 -27.21 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.692 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.482 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 3.0 m-85 -69.84 -74.66 0.13 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.63 0.252 . . . . 0.0 111.203 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.27 0.1 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.807 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt 50.67 37.29 16.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.45 0.3 . . . . 0.0 111.731 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 102.96 3.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.736 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -66.9 -49.03 66.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.947 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.21 93.61 2.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.36 154.48 29.09 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.288 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -109.07 152.4 25.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.485 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 37' ' ' LEU . 22.1 mm -128.28 147.17 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.55 123.19 15.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.989 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.475 ' HE3' ' HB2' ' A' ' 40' ' ' HIS . 2.8 mmt -118.71 132.87 56.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.136 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.21 47.76 1.04 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.72 -164.73 1.02 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.778 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HG3' ' HD2' ' A' ' 31' ' ' PRO . 5.9 pt-20 -68.32 -171.27 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.021 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.15 -57.56 1.1 Allowed Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.36 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' HG3' ' A' ' 29' ' ' GLU . 65.1 Cg_endo -72.54 61.49 3.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.284 1.99 . . . . 0.0 113.067 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.15 125.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.598 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.74 152.23 35.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.806 0.336 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.65 -34.5 47.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.807 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.52 -27.95 59.04 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -40.85 75.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.649 0.261 . . . . 0.0 110.49 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 HG22 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.15 -50.23 71.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.089 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 38' ' ' ILE . 46.0 mt -58.91 -38.86 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.11 -42.24 85.28 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.475 ' HB2' ' HE3' ' A' ' 26' ' ' MET . 2.9 t60 -62.04 -39.57 92.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.867 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.74 -32.13 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.794 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' CG1' HG13 ' A' ' 52' ' ' VAL . 32.2 t -96.46 -3.64 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.8 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.3 t -100.22 -62.68 1.21 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.556 0.217 . . . . 0.0 111.56 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 p -98.1 -50.2 4.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.515 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -38.0 69.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.482 HD11 ' CZ ' ' A' ' 16' ' ' PHE . 23.4 mt -136.25 145.26 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.988 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -171.23 72.88 0.05 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.926 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -165.48 126.2 1.32 Allowed Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.078 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.81 77.02 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.895 2.397 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.36 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -78.48 -42.14 30.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.187 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.43 HG23 ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -79.6 -36.46 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.164 179.546 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 -31.1 26.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.493 0.187 . . . . 0.0 111.345 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.0 mt -94.2 -30.81 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -85.67 -52.17 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.381 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.0 mm -103.74 145.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.174 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -118.48 61.83 0.78 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 57.97 84.78 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 58.12 38.67 26.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.646 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.4 t -170.1 118.99 0.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.65 151.94 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -76.44 147.62 79.19 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.44 128.08 14.93 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.773 2.315 . . . . 0.0 112.577 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.62 -25.86 6.42 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.945 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 mt -72.97 130.21 35.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 120.897 0.379 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.68 121.79 45.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.1 m -125.66 111.18 14.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.834 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 mt -108.1 140.59 41.06 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.5 mt -119.18 111.54 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.704 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 46.92 8.58 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.78 33.44 17.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.3 178.46 7.4 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.38 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -178.4 6.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.968 0.414 . . . . 0.0 111.325 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -104.45 -47.07 4.21 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.017 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.31 -30.2 30.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -26.68 62.2 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.533 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.7 -64.91 1.24 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.522 0.201 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.66 105.31 0.27 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.679 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -53.24 -65.74 0.51 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.409 0.147 . . . . 0.0 111.318 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -117.56 -39.52 3.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.25 -25.52 48.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.74 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -48.32 116.38 1.54 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.824 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mt -72.87 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.1 173.85 3.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.07 100.57 0.97 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.419 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -46.33 118.13 1.83 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.08 15.99 9.45 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.384 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.33 171.29 9.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mm -126.94 101.16 7.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.757 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.404 HG12 ' CG1' ' A' ' 4' ' ' VAL . 8.0 mm -98.28 142.62 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.87 138.46 53.39 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.31 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.478 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 59.7 m-85 -130.34 82.39 2.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.471 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.2 m -97.73 138.25 35.39 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 m -108.03 112.12 24.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t -118.13 72.5 0.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.311 0.577 . . . . 0.0 110.458 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.12 118.63 16.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.89 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -112.84 -42.99 3.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.014 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.33 97.63 1.27 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.353 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.651 -179.73 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.552 0.215 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 m -123.4 131.64 72.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.222 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.0 117.18 29.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.5 t -115.66 134.73 57.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -103.06 104.68 14.87 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.71 155.96 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -119.15 154.2 33.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -136.29 104.75 5.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.82 121.0 25.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.957 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 46.56 0.45 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.833 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.63 -35.68 4.27 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.795 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.411 HD22 ' CE1' ' A' ' 55' ' ' PHE . 3.3 mt -54.95 -42.76 72.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.653 0.227 . . . . 0.0 111.415 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.23 -37.33 82.65 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.02 -33.58 75.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mt -79.77 -42.12 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.522 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.72 -73.8 0.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.392 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.55 40.38 0.07 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.758 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.3 mttm 54.51 59.71 3.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 111.26 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.29 113.04 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -61.42 -32.84 72.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 t -125.52 119.28 54.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -113.63 146.03 40.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.959 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -108.84 146.48 33.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.27 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.8 mm -128.57 146.61 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.679 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -128.2 87.38 2.59 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.302 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.416 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.87 135.83 45.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.534 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.77 90.29 2.96 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.44 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.71 -67.6 0.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.396 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.94 -171.59 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -59.18 0.5 Allowed Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.99 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.73 61.46 4.54 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.369 2.046 . . . . 0.0 112.547 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.6 t -73.85 131.14 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.6 p -97.8 161.16 13.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.628 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.76 -33.03 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.594 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.96 -27.38 62.1 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.044 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -41.37 71.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 -44.84 74.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.907 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 41' ' ' ILE . 24.4 mm -68.92 -33.34 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.788 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -50.33 36.13 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.7 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.416 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 26.0 t-80 -60.48 -48.07 83.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 38' ' ' ILE . 7.1 tt -62.72 -30.96 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.633 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.0 t -94.88 -11.24 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.9 m -100.99 -69.57 0.77 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 p -76.75 -56.91 4.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.52 -55.62 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.938 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.5 mt -109.93 129.43 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.437 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -149.03 59.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.028 0.442 . . . . 0.0 110.703 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -150.12 131.8 7.63 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.183 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.03 66.12 3.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.573 2.182 . . . . 0.0 112.327 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.11 -49.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.46 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.93 -39.08 15.04 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.679 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.57 -35.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.121 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.3 t -52.93 -36.19 59.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.642 0.258 . . . . 0.0 111.12 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.99 -34.19 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.391 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CE1' HD22 ' A' ' 12' ' ' LEU . 38.0 t80 -73.28 -52.71 12.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.325 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.452 HG23 HD13 ' A' ' 56' ' ' ILE . 32.3 mm -111.87 136.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -132.14 134.52 45.52 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.018 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.65 38.77 25.06 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.775 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 33.44 21.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.68 152.67 35.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.062 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.57 154.5 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.256 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -101.04 138.94 20.12 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.22 133.32 57.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.797 2.331 . . . . 0.0 112.426 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.35 -35.57 2.56 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.681 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.1 mt -83.37 111.84 20.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.962 0.411 . . . . 0.0 110.97 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.99 146.26 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 m -129.43 136.64 50.18 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.3 mt -130.04 113.78 14.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.003 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.47 109.53 25.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.34 49.05 9.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.637 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 58.54 31.7 21.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 m -135.06 170.56 15.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.385 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.68 172.0 14.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.417 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 23.0 p-90 -103.86 -33.99 8.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.953 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -88.24 -26.76 22.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.468 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mt -60.62 -21.66 62.93 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.32 -71.55 0.72 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.525 0.203 . . . . 0.0 111.114 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.1 108.8 0.4 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.654 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 16.4 mt-10 -54.92 -72.54 0.06 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.457 0.17 . . . . 0.0 111.074 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -104.39 -33.89 8.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.952 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.21 -23.75 23.85 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.453 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -56.38 106.13 0.26 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.81 141.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.7 mt -63.8 175.79 1.07 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.36 97.83 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -47.8 104.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.79 27.94 4.43 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.693 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.97 170.48 7.89 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.602 0.239 . . . . 0.0 111.014 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -118.31 130.35 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.15 150.64 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.064 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.03 146.83 50.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.388 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -133.02 82.11 1.98 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.723 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.05 141.61 28.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -119.89 97.34 5.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.429 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p -87.73 52.83 2.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.022 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.27 28.98 0.29 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 62.56 178.46 0.14 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.75 0.309 . . . . 0.0 111.09 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.92 83.87 0.06 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.843 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.604 179.846 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtm . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.668 0.271 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.33 99.5 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.072 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -82.26 112.05 18.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.075 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 m -110.26 129.2 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.326 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 118.16 24.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -122.75 147.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.503 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -119.38 107.27 13.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.499 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -85.25 128.71 34.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -135.98 149.62 48.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.956 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.72 -102.28 1.96 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.508 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.58 26.46 3.66 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.015 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.72 -41.58 8.02 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.868 0.334 . . . . 0.0 110.828 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.54 -33.05 74.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.04 73.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 -44.95 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.35 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -65.02 -71.46 0.18 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.227 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.63 45.64 0.1 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.542 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 56.87 54.35 7.22 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 106.95 8.23 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.019 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -9.02 50.46 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.928 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.47 138.69 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.507 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.69 168.82 19.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -138.97 143.5 38.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 41' ' ' ILE . 2.9 mp -136.28 150.77 27.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.358 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.62 101.66 5.03 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.842 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.406 ' HG2' ' CG ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -77.67 124.45 27.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.742 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.15 68.68 9.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.93 -159.12 0.94 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.509 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -170.78 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.225 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -59.7 0.77 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.99 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.42 58.98 6.52 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.39 2.06 . . . . 0.0 112.733 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -72.6 132.23 33.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.8 p -73.91 149.26 41.56 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.64 -36.49 54.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.88 -27.79 59.81 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.64 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.93 -42.77 69.42 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.735 0.302 . . . . 0.0 110.424 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.5 -53.15 55.62 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 mt -61.01 -37.25 76.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.357 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -41.55 97.26 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.406 ' CG ' ' HG2' ' A' ' 26' ' ' MET . 1.3 t60 -62.16 -36.88 83.19 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 24' ' ' ILE . 33.1 mt -72.09 -27.65 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.296 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.8 t -94.53 -5.49 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.8 p -100.25 -72.41 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.1 p -87.32 -49.3 7.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.502 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.409 ' HB3' ' HA ' ' A' ' 41' ' ' ILE . 5.1 ttt -53.36 -54.74 32.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.0 mt -110.43 125.87 67.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.611 0.243 . . . . 0.0 110.829 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.46 74.69 1.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.188 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.78 119.93 0.42 Allowed Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.63 76.85 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.774 2.316 . . . . 0.0 112.067 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -166.14 -57.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.513 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -82.16 -36.13 27.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.758 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.43 -35.67 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.984 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 m -58.07 -34.35 70.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.38 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.0 mt -83.15 -39.12 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 111.0 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -68.44 -38.1 80.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.077 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 mt -132.08 129.55 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.288 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.0 122.79 48.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 55.25 52.72 11.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.76 26.61 11.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.72 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.71 125.64 22.67 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 110.66 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -56.81 151.7 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.499 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.16 143.57 34.92 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.069 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.67 123.81 9.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.654 2.236 . . . . 0.0 112.208 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.15 -37.38 1.16 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.627 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.78 130.07 34.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.0 mm -110.31 152.76 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.963 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 t -146.33 142.56 28.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.692 0.282 . . . . 0.0 111.254 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 mt -131.12 108.16 9.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.3 mt -88.22 109.32 19.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.6 m120 58.67 43.34 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.96 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.59 30.62 18.73 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.023 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 163.99 25.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.59 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.91 117.2 20.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -50.53 -38.65 45.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.909 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.07 -43.87 94.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.655 0.264 . . . . 0.0 110.833 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.83 -26.14 65.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -111.02 30.43 6.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 111.192 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.66 96.22 0.53 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.487 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.58 -52.73 6.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.407 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -112.97 -36.45 5.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.67 56.61 2.28 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -119.08 114.98 23.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.859 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.19 119.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.63 176.35 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -167.01 101.12 0.54 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.356 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -45.73 122.29 3.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.89 25.21 9.88 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.2 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -100.99 169.51 8.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -113.87 104.95 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.79 100.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.15 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.089 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.62 103.22 5.57 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 159.48 15.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.593 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -142.22 110.47 6.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.779 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.1 t -90.98 52.73 2.21 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 110.803 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.69 -55.8 2.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.688 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -100.05 -41.98 6.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.171 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 128.23 -66.7 0.56 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.508 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.49 179.842 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.867 0.365 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.86 128.3 19.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -105.07 89.78 3.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.36 150.07 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.582 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -111.32 110.65 21.22 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 t -104.86 144.98 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.36 101.4 7.61 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.74 128.81 36.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.034 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.39 118.45 13.45 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.302 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.06 -102.03 0.34 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.275 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.21 -33.39 3.2 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.961 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.91 -39.23 68.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.34 -37.8 75.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.055 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.45 68.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.997 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 45.5 mt -66.96 -34.07 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.263 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -71.89 -61.92 1.61 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.648 0.261 . . . . 0.0 111.301 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.58 48.0 0.01 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.318 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mttt 57.22 34.43 24.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 111.255 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.37 103.52 9.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.627 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -65.57 0.67 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.549 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -90.23 135.7 25.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.6 136.97 29.7 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.01 142.05 30.2 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 mt -132.78 143.64 39.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.94 123.89 45.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.54 120.09 31.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -127.57 48.16 2.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -36.79 23.24 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.017 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -157.47 -178.74 7.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.472 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -85.62 -54.04 0.43 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.949 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 3.1 Cg_exo -79.53 53.8 4.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.949 2.433 . . . . 0.0 112.333 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.8 t -74.44 139.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.645 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.21 163.87 13.2 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.68 -40.44 51.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.995 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -56.93 -29.28 58.86 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.192 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.76 -42.55 73.71 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -53.37 40.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.091 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.469 HD13 ' HA2' ' A' ' 35' ' ' GLY . 2.3 mp -59.08 -38.78 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.405 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.6 -41.42 94.72 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -60.49 -39.89 89.34 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.674 0.273 . . . . 0.0 110.611 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mt -64.87 -32.19 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 t -96.39 -1.41 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.92 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -100.29 -72.73 0.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 t -87.97 -40.56 13.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.478 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -59.56 4.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.054 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.4 mt -117.53 148.43 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 120.706 0.289 . . . . 0.0 111.272 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -165.2 41.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.94 139.75 36.56 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.86 73.45 3.63 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.705 2.27 . . . . 0.0 112.463 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -169.38 -47.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.622 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.51 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -93.39 -35.9 12.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.22 -35.4 7.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -54.4 -33.22 58.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 54' ' ' ILE . 30.4 mt -84.51 -33.05 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.309 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -77.82 -35.57 51.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.03 133.26 69.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.393 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.1 -156.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.56 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.57 85.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.06 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.1 t0 60.7 40.75 15.95 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.163 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -178.57 138.92 0.17 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mt -65.78 142.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.55 155.85 48.19 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.35 146.33 68.59 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.7 2.267 . . . . 0.0 112.467 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.67 -42.54 1.46 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.578 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mp -73.1 122.44 25.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -94.68 131.45 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 74' ' ' TRP . 0.3 OUTLIER -122.33 114.56 20.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.7 mt -112.76 109.19 18.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.0 mt -88.16 98.58 7.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.55 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.1 m120 57.37 55.25 5.93 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.736 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 31.58 20.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.536 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.97 159.74 40.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.462 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.79 120.4 24.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.425 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -57.12 -30.68 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.639 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.05 -30.58 44.13 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.584 0.23 . . . . 0.0 111.129 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.55 -18.11 65.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.575 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -133.59 38.66 3.24 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 111.384 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.59 103.54 0.25 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.068 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -47.77 -61.88 1.73 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.101 0.16 . . . . 0.0 111.267 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.15 -28.78 11.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.19 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.76 -29.45 18.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.453 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -58.87 114.4 2.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.807 0.337 . . . . 0.0 110.605 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mp -76.82 144.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.46 171.69 3.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.203 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -171.04 104.25 0.23 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.471 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -46.11 115.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.995 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 20.06 6.67 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.779 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.05 169.98 8.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.779 0.324 . . . . 0.0 111.403 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 89' ' ' ILE . 15.3 mt -127.53 152.34 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.753 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.2 mm -135.5 150.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.222 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -130.11 138.92 50.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.019 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.85 90.76 2.95 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.019 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.19 104.24 16.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 80.98 1.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.761 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 m -135.11 80.74 1.86 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.75 135.92 45.4 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.121 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -86.01 -45.17 11.7 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.982 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -171.21 -175.46 39.69 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.688 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.613 -1.104 . . . . 0.0 112.819 -179.765 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 m -142.53 165.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -155.85 96.03 1.7 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.74 153.85 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.448 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.34 107.77 15.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.581 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.91 155.41 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.379 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.88 152.64 43.76 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.222 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -128.92 114.12 16.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.352 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mp -128.66 108.39 10.45 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.701 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.8 -101.71 0.35 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.528 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.0 28.28 4.15 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.103 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.481 HD22 ' CE1' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -106.57 -45.34 4.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.737 0.269 . . . . 0.0 110.844 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.25 -33.57 71.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.08 86.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -72.01 -41.89 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -66.8 -71.59 0.19 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.62 43.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.626 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 54.7 34.51 21.79 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.545 0.338 . . . . 0.0 111.524 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.24 112.38 24.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -61.48 -67.05 0.44 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.905 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.3 t -90.83 117.89 34.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.986 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 148.32 38.19 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.052 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -115.84 137.67 51.88 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -134.37 139.84 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 123.4 21.55 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -38.29 54.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.576 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.08 43.48 26.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.92 0.39 . . . . 0.0 111.085 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.05 -74.13 0.62 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.72 -174.28 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -59.64 0.36 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.097 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.12 57.93 6.37 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.318 2.012 . . . . 0.0 112.573 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.85 118.9 21.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.458 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 p -66.21 147.01 53.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.37 -34.65 23.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.556 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.87 -26.77 58.44 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.117 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.5 -42.07 62.28 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.663 0.268 . . . . 0.0 110.615 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.04 -53.05 58.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.198 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.4 mt -62.36 -40.03 86.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.386 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.75 -42.71 99.32 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -58.94 -43.29 91.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.957 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.2 mt -64.52 -32.21 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.141 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.14 -3.51 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -92.92 -75.44 0.49 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.507 0.194 . . . . 0.0 111.357 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -94.62 -43.02 8.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.187 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -38.45 67.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.92 136.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.301 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -159.1 38.44 0.21 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 23.0 t30 -128.54 127.45 23.6 Favored Pre-proline 0 C--N 1.334 -0.088 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.866 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 24.9 Cg_exo -64.44 76.58 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.692 2.261 . . . . 0.0 112.254 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -168.25 -45.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.43 -31.54 12.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.135 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -102.57 -35.52 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.206 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -36.46 61.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.571 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 pp -94.93 -22.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.481 ' CE1' HD22 ' A' ' 12' ' ' LEU . 46.4 t80 -77.25 -49.07 15.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.594 0.235 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.1 mm -106.5 150.28 9.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.07 85.12 2.2 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 57.06 67.25 1.01 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.401 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 76.28 -42.87 0.45 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.336 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -82.04 129.93 34.94 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.724 0.297 . . . . 0.0 110.985 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.48 153.38 6.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.348 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -82.66 135.95 45.61 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.174 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.18 106.54 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.65 2.234 . . . . 0.0 111.965 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.13 -35.52 0.24 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.75 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 mt -67.21 121.57 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.836 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -90.01 97.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.8 t -104.75 136.28 44.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.9 mt -126.1 118.53 25.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.6 mt -102.01 109.5 26.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.492 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.03 48.14 13.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.61 38.77 21.97 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.362 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.62 161.95 38.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.721 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.72 124.77 29.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -55.84 -33.59 64.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.506 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -80.11 -33.4 38.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.669 0.271 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.74 -24.87 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -103.52 -58.21 1.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.513 0.197 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.3 98.22 0.11 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.626 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -47.04 -56.81 5.83 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.127 0.171 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -117.34 -30.64 5.52 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.937 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.92 56.62 2.38 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.168 0.509 . . . . 0.0 110.977 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -137.65 112.52 8.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.76 127.87 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.31 177.7 1.06 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 110.741 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -163.45 100.03 0.93 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.143 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -49.07 108.91 0.21 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.03 26.31 5.55 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.16 176.15 5.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.662 0.268 . . . . 0.0 111.041 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -116.77 111.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.362 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.41 97.61 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.652 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.4 m -79.91 158.54 26.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.501 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -145.05 85.24 1.74 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.92 162.67 14.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.623 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.44 93.96 2.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.865 0.364 . . . . 0.0 110.823 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.76 39.23 2.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.918 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.93 121.89 17.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.629 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.86 77.92 3.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.705 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.98 -116.88 2.66 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.654 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.446 -1.197 . . . . 0.0 112.489 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.84 142.31 38.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.661 0.267 . . . . 0.0 111.145 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -112.93 93.16 4.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 m -93.3 144.16 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -116.37 97.31 5.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.665 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -92.79 146.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.98 97.65 6.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -87.23 117.92 26.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.3 mp -127.23 176.47 7.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.467 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.94 -112.22 3.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.354 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.81 23.17 12.03 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.784 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.27 -43.31 6.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.805 0.303 . . . . 0.0 111.212 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.12 -34.03 67.96 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.39 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -33.74 76.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.703 0.287 . . . . 0.0 111.097 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.7 mt -80.28 -41.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.326 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -61.96 -73.3 0.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.267 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.78 41.63 0.09 OUTLIER Glycine 0 C--N 1.335 0.472 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt 53.59 41.56 32.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.717 0.294 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -121.78 121.83 38.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -46.06 91.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.384 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.34 126.93 75.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.868 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.85 135.75 54.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.492 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.8 pttt -102.46 146.35 28.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.361 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD13 HG12 ' A' ' 41' ' ' ILE . 19.0 mm -132.22 147.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -121.52 98.14 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.774 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.18 139.55 32.18 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -138.16 81.51 1.86 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -120.62 -63.07 1.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -148.4 -175.51 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.797 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.26 -60.14 0.3 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.052 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.49 58.02 6.8 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.489 2.126 . . . . 0.0 112.297 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 84' ' ' LEU . 22.5 t -81.17 152.67 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.339 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -103.36 163.8 12.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.327 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.55 -34.46 51.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.028 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -27.71 62.61 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.11 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -71.36 -41.86 69.2 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.641 0.258 . . . . 0.0 110.42 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.96 -51.79 65.05 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.328 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mt -59.18 -39.67 79.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.336 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.25 -41.94 89.96 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -60.76 -45.02 95.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.204 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.44 HG12 HD13 ' A' ' 24' ' ' ILE . 28.2 mt -62.68 -28.41 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.395 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 t -100.52 -9.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -76.21 -75.62 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.58 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.3 m -100.33 -36.33 9.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.294 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.4 mmm -56.64 -53.49 57.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.431 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.6 mt -124.61 88.03 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 120.938 0.399 . . . . 0.0 111.082 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -104.2 51.17 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.48 116.54 6.47 Favored Pre-proline 0 N--CA 1.457 -0.105 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.67 -30.92 30.4 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.77 2.313 . . . . 0.0 112.739 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -55.96 -48.91 74.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.319 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.14 31.48 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.56 -49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 p -56.68 -27.54 59.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.474 0.178 . . . . 0.0 111.447 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.2 mt -84.04 -33.87 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.666 0.27 . . . . 0.0 110.625 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -74.34 -44.21 53.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.085 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 56' ' ' ILE . 42.1 mt -111.57 148.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.899 0.381 . . . . 0.0 111.38 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.15 -158.33 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.851 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.28 92.63 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.109 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t0 53.35 37.0 24.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.874 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.45 141.04 1.48 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.557 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -58.06 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.705 0.288 . . . . 0.0 111.334 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.99 120.2 58.91 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.72 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.57 101.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.676 2.251 . . . . 0.0 112.166 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.67 -42.65 0.63 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.694 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.6 mt -59.12 140.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -108.3 137.71 38.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.118 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.9 t -137.63 125.9 23.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.0 mt -108.66 111.09 22.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.54 111.73 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.615 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 58.85 47.5 12.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.96 34.1 23.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.963 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.1 m -140.88 161.7 37.21 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.89 150.79 30.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.377 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -62.44 -42.33 99.39 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.43 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -9.07 58.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -35.85 81.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.343 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.54 29.3 6.65 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 111.503 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.51 -102.72 0.83 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.442 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.72 -81.13 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 122.546 0.338 . . . . 0.0 110.303 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -104.82 -24.55 12.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.273 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -52.98 -25.48 12.19 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -45.15 107.7 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 110.489 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mt -68.26 138.41 22.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.421 HD11 HG11 ' A' ' 32' ' ' VAL . 18.4 mt -66.52 174.07 3.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -170.85 104.22 0.24 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.504 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -42.06 109.17 0.12 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.007 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.02 27.05 4.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.44 165.77 12.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.02 116.64 46.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.804 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.92 150.49 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 67' ' ' THR . 40.3 m -130.26 142.33 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.708 0.29 . . . . 0.0 111.413 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -130.99 95.27 3.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 156.86 16.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.084 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 t -153.92 79.94 1.14 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p -69.59 -35.03 74.96 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.79 -25.21 67.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.745 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 75.86 122.79 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.587 0.355 . . . . 0.0 111.232 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.66 -58.4 12.36 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.887 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.516 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.716 0.293 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 m -138.46 168.76 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.2 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -157.64 94.23 1.34 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.884 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 m -105.19 135.38 43.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -89.23 115.56 26.82 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.709 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 7.7 t -110.4 148.48 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.244 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.29 99.18 6.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -84.55 133.45 34.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.443 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.64 152.13 45.16 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.35 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -101.53 2.76 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.222 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.75 -28.74 4.66 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mt -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.897 0.349 . . . . 0.0 111.734 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.04 -33.48 75.9 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.419 0.152 . . . . 0.0 111.12 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.75 80.87 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 51' ' ' ASP . 4.7 mt -81.69 -34.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.521 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.8 -73.22 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.58 0.228 . . . . 0.0 111.187 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.8 41.75 0.09 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.591 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 53.19 34.78 18.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.484 0.313 . . . . 0.0 111.705 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -121.61 123.55 42.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.613 0.244 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -26.87 68.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.598 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.46 135.27 58.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.838 0.352 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.16 142.23 28.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -85.42 142.22 29.41 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.991 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.1 mm -123.9 140.75 46.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.135 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.3 115.62 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 40' ' ' HIS . 15.1 ttt -88.98 -42.36 11.83 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.141 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 86.25 0.1 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -66.09 0.37 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.58 -169.26 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -86.83 -54.2 0.39 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.082 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 4.8 Cg_exo -74.08 55.86 3.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.834 2.356 . . . . 0.0 112.588 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.59 124.78 49.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.619 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.73 153.98 30.42 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.14 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -56.19 -33.66 37.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.71 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.5 -27.64 54.45 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.82 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -40.74 68.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.677 0.275 . . . . 0.0 110.496 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.88 -52.89 61.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.344 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.3 mt -60.17 -41.29 86.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.107 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -61.23 -40.01 92.39 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG3' ' A' ' 26' ' ' MET . 72.6 t60 -58.52 -46.72 86.18 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 45' ' ' MET . 17.9 mt -63.29 -30.01 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.279 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.5 t -97.15 -4.9 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.76 -73.92 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.3 m -87.34 -45.14 10.84 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.465 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -54.77 -51.67 64.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.042 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.411 ' CG2' HG22 ' A' ' 52' ' ' VAL . 7.6 mt -121.79 150.96 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.106 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -160.81 65.53 0.3 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.42 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 8.9 t30 -170.88 138.51 1.22 Allowed Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 120.601 0.239 . . . . 0.0 111.572 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.88 75.17 3.23 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.735 2.29 . . . . 0.0 112.6 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 48' ' ' ASN . 20.3 p-10 -166.13 -41.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.434 ' HB3' HG22 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -100.98 -37.31 8.69 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 46' ' ' ILE . 2.1 t -82.5 -34.45 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.412 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -50.88 -31.94 18.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.677 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.95 -46.31 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.755 0.312 . . . . 0.0 111.018 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -66.59 -47.87 71.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.335 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 mm -129.57 143.55 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.813 0.34 . . . . 0.0 111.294 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.5 127.89 26.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 58.33 45.43 16.98 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.449 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 53.99 33.5 17.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.374 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.4 m -150.53 145.66 26.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.915 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.87 152.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -92.64 137.73 24.12 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 99.59 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.582 2.188 . . . . 0.0 111.89 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.17 -35.28 0.44 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.558 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -66.27 134.48 29.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.43 118.62 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 t -121.5 92.09 3.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.945 0.402 . . . . 0.0 111.016 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.4 mt -101.23 122.0 42.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.207 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mt -100.66 107.73 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.02 52.64 6.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.33 30.64 19.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.117 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -133.28 164.99 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.77 177.6 8.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.921 0.391 . . . . 0.0 111.18 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -102.88 -39.94 6.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.92 -27.62 28.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.763 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.27 -30.6 51.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -115.69 -62.15 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.522 0.201 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.75 103.86 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.686 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -57.5 6.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.59 0.234 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -117.4 -44.3 2.77 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.1 -27.0 5.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.018 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -48.99 109.53 0.27 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.95 133.33 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.138 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -67.63 172.44 5.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.804 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.16 102.6 0.29 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.395 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -48.91 114.51 1.01 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.71 -9.56 6.81 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.814 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.04 157.23 26.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.045 0.422 . . . . 0.0 111.163 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 89' ' ' ILE . 1.5 mp -107.69 125.45 64.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.764 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 6.5 mt -125.99 141.89 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.27 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.57 142.21 47.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.76 90.98 3.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.794 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 95.52 5.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.874 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -88.04 89.4 7.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.52 -83.56 0.62 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.707 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 176.67 -49.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.58 0.229 . . . . 0.0 110.858 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.28 -69.44 0.19 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.24 -86.77 0.4 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.123 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.688 -179.895 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.522 0.201 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.69 108.96 19.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.02 0.438 . . . . 0.0 111.227 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -87.63 117.19 26.27 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 m -114.98 139.5 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.94 105.88 16.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.655 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 m -98.68 146.13 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.329 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -126.0 98.43 5.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.64 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -82.95 142.48 31.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -146.04 172.45 13.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.213 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.75 -107.96 2.59 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.219 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.44 -6.04 13.76 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.664 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.72 -45.13 83.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.398 0.599 . . . . 0.0 111.284 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.56 -30.22 69.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.256 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.66 88.21 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.658 0.266 . . . . 0.0 111.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 11.0 mt -70.43 -40.14 77.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.44 -70.16 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.45 48.04 0.04 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.366 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt 56.77 33.81 23.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.382 0.273 . . . . 0.0 111.344 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -104.16 110.65 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.755 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.45 -62.39 1.49 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.45 144.14 20.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.808 0.337 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -180.0 6.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.9 141.79 25.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.2 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.406 HG13 HD11 ' A' ' 41' ' ' ILE . 20.0 mm -135.16 146.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.17 84.0 2.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.04 127.25 30.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.177 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.38 92.86 4.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.97 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -144.38 -66.04 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.43 -178.03 6.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.197 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.73 -59.78 0.35 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.002 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.94 58.78 6.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.558 2.172 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -92.38 132.86 35.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.2 p -75.37 153.02 37.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.859 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.14 -32.13 33.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.707 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -26.52 55.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.086 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.01 -45.71 69.84 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.584 0.231 . . . . 0.0 110.56 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -46.82 72.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.221 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.3 mt -58.13 -41.12 79.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.322 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -37.63 80.53 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.835 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.6 -40.48 97.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.866 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 24' ' ' ILE . 22.1 mm -65.75 -31.22 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.46 -2.9 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -99.54 -75.74 0.56 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -87.42 -48.07 8.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.359 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.17 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 mt -126.48 136.39 60.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.806 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -153.0 44.01 0.64 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -130.64 129.56 22.74 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.193 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.55 73.85 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.39 -52.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.575 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.3 p30 -83.91 -35.64 23.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.74 -35.67 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.946 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 t -58.43 -38.98 78.57 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.312 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.27 -36.86 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.316 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.06 -51.43 38.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.062 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.4 mm -111.71 125.35 69.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.134 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -114.5 122.77 47.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.766 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.11 45.14 21.3 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.73 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.29 32.33 21.58 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.362 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -143.89 147.87 34.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -61.58 152.32 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -93.64 148.44 35.42 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.92 122.16 9.26 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.752 2.301 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.47 -46.26 1.08 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.768 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.64 117.81 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.5 mm -80.55 147.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' SER . 7.4 t -147.49 99.86 3.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.19 143.11 32.41 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.1 mt -126.09 112.22 29.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.37 44.74 11.87 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.984 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.31 39.09 25.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -142.93 166.36 24.84 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.42 28.54 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.512 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.87 -36.01 46.99 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.906 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -39.54 32.02 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.406 0.146 . . . . 0.0 111.358 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -25.22 62.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -106.56 -35.75 6.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.238 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.4 98.53 0.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 2.9 tt0 -42.06 -69.61 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.258 0.223 . . . . 0.0 111.552 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -116.66 -36.81 3.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.971 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.77 -24.94 24.77 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.494 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -52.12 110.94 0.54 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.837 0.351 . . . . 0.0 110.728 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.0 mt -68.49 141.0 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.12 176.43 0.75 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.04 103.52 0.3 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.41 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -43.01 108.29 0.1 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.819 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 29.91 3.4 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.66 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.81 165.06 11.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.92 141.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.78 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.434 HG21 ' CE2' ' A' ' 92' ' ' PHE . 4.7 mp -138.43 90.12 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -81.41 132.73 35.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 90' ' ' ILE . 23.7 m-85 -118.95 110.09 16.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.34 100.94 8.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.0 t -92.4 88.05 6.25 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m -119.35 -1.78 10.72 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.911 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 97' ' ' HIS . 13.5 mt 65.74 103.18 0.04 OUTLIER 'General case' 0 C--N 1.344 0.367 0 C-N-CA 122.447 0.299 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 24.4 m80 67.45 160.12 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.14 35.24 1.07 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.2 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.43 -1.205 . . . . 0.0 112.444 179.718 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mtp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.6 0.238 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.9 m -135.51 163.16 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.04 112.13 10.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.16 134.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 116.74 33.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.47 143.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.403 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -110.95 153.79 25.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -128.57 118.23 22.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.048 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.78 171.59 9.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.18 -103.14 1.54 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.436 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.05 27.27 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.948 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mt -87.64 -41.41 13.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.825 0.313 . . . . 0.0 110.896 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.2 -33.93 71.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.165 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.77 -31.99 73.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.229 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mt -74.3 -46.89 42.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.216 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -62.76 -65.58 0.67 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.319 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.48 46.74 0.03 OUTLIER Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.444 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.9 mttt 57.44 51.72 9.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -125.82 122.33 35.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.992 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -68.86 -64.31 0.89 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.93 137.32 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -126.93 156.67 41.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.059 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -123.89 132.2 53.7 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.3 mm -116.69 144.07 25.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.338 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.45 108.31 10.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.428 ' HE1' ' HB2' ' A' ' 40' ' ' HIS . 0.3 OUTLIER -100.11 110.12 22.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.993 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -102.39 63.83 0.89 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 110.904 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -112.44 -44.98 3.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.012 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -169.95 -176.66 2.38 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -86.29 -51.93 0.46 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.5 Cg_exo -78.67 54.09 4.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.961 2.44 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.8 t -85.65 122.48 38.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.026 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -74.4 150.45 40.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.234 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -52.59 -30.77 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.583 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.56 -25.71 61.27 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.279 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.4 -43.48 73.37 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -47.06 77.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.775 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.68 -39.15 78.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.014 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.77 -41.07 94.76 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.829 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.428 ' HB2' ' HE1' ' A' ' 26' ' ' MET . 1.1 t60 -59.89 -41.87 92.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.807 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.9 mm -63.81 -33.18 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.047 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.2 t -98.06 -3.89 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 m -95.54 -75.22 0.53 Allowed 'General case' 0 C--O 1.232 0.183 0 O-C-N 122.382 -0.199 . . . . 0.0 111.463 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 t -93.15 -38.78 11.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.458 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -46.81 88.62 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.079 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.77 150.98 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.25 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -166.06 40.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.106 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -128.58 128.44 23.56 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.484 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.67 74.37 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.84 2.36 . . . . 0.0 112.191 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.07 -58.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.457 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.462 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.2 p30 -81.29 -34.56 31.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.758 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.78 -36.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.065 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.86 72.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.432 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.4 mt -86.63 -36.84 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.025 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.462 ' CD1' HD12 ' A' ' 65' ' ' ILE . 31.9 t80 -69.09 -37.04 78.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.088 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -127.3 130.13 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.795 0.331 . . . . 0.0 111.353 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.41 -158.32 0.6 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.591 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.55 85.99 0.11 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.895 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 60.75 46.75 8.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.39 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.39 175.94 2.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mt -97.07 153.4 3.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.832 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 125.31 79.04 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.85 105.33 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.62 2.213 . . . . 0.0 112.065 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 151.88 -31.25 0.9 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.557 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 55' ' ' PHE . 31.2 mt -70.38 127.59 32.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mt -100.77 134.69 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.958 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 91' ' ' SER . 1.5 m -138.24 143.81 40.28 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.234 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.3 mt -139.4 126.21 20.82 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.447 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.6 mt -100.73 102.35 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.0 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 59.99 59.75 2.33 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.304 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 57.83 26.02 12.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.58 173.27 11.04 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.036 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 2.3 m-20 -79.38 157.95 27.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -59.99 2.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.712 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.24 -37.42 77.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.185 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -60.36 -29.98 69.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.923 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -93.57 28.4 2.31 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.069 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.95 -6.55 82.73 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.59 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 67.85 -72.41 0.09 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.027 0.414 . . . . 0.0 111.021 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -116.78 -29.71 5.97 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.03 54.88 1.68 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.227 0.537 . . . . 0.0 110.922 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -124.58 113.62 18.31 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.615 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.6 mt -61.45 128.5 22.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.8 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.2 174.5 1.57 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.858 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.39 103.65 0.21 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -46.68 113.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.026 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 23.98 5.69 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.02 177.65 4.83 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.337 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 mm -121.74 132.23 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.1 mt -143.06 92.55 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.631 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 67' ' ' THR . 12.9 m -79.88 149.11 31.05 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.711 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -134.46 86.87 2.3 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.776 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 m -91.23 144.72 25.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.604 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -148.66 79.98 1.44 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.004 0.43 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.44 -54.81 4.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.201 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.0 28.65 17.98 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.27 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -175.23 -63.59 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.24 166.64 46.32 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.812 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.482 -1.177 . . . . 0.0 112.522 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' HG3' ' HB3' ' A' ' 27' ' ' ASP . 1.8 mtp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.593 0.235 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.9 102.2 13.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -80.18 125.28 29.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.551 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG22 HD12 ' A' ' 37' ' ' LEU . 31.2 m -128.47 139.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.79 118.28 36.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.0 153.25 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.376 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 158.86 33.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' HB2' ' CB ' ' A' ' 12' ' ' LEU . 8.2 p90 -160.24 148.03 16.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -137.96 178.22 7.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.112 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.59 -109.97 3.04 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.83 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.19 -24.22 17.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.943 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.4 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 4.3 mm? -55.03 -46.41 75.29 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.721 0.261 . . . . 0.0 111.362 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.89 -30.73 71.07 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.0 -38.2 45.4 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.271 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 22.3 mt -75.63 -44.59 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.71 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.27 -69.78 0.19 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.521 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.74 46.85 0.03 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.452 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.74 44.89 22.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -121.3 -176.66 3.34 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 -56.44 0.56 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 t -99.91 117.67 45.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.31 153.57 28.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.21 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -124.47 119.08 28.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' HB ' ' CG2' ' A' ' 4' ' ' VAL . 3.9 mp -99.45 143.07 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -116.22 80.42 1.45 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.293 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.97 106.75 18.62 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 2.5 p30 -93.92 43.83 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -90.11 -162.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.07 -172.19 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.904 0.383 . . . . 0.0 111.365 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.457 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -83.47 -54.01 0.54 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.036 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.7 Cg_exo -78.66 50.22 3.35 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.858 2.372 . . . . 0.0 112.713 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 t -81.84 126.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 1.3 p -73.34 157.47 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.914 0.387 . . . . 0.0 111.2 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.54 -34.98 48.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.471 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.33 -28.33 54.79 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.875 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -68.91 -43.39 75.31 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD12 HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -53.04 -51.93 60.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.6 mt -59.97 -36.84 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.171 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -63.75 -37.85 88.89 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.766 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -60.85 -39.64 89.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.627 0.251 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.8 mt -72.74 -25.76 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.09 -1.44 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -93.72 -77.87 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.381 -0.199 . . . . 0.0 111.234 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.29 -40.87 14.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -56.88 16.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.148 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.2 mt -116.24 123.01 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 120.629 0.252 . . . . 0.0 111.07 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.6 39.34 1.69 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.139 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -131.84 129.24 21.87 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.72 70.18 2.11 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.519 2.146 . . . . 0.0 112.044 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.9 -50.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.448 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.425 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.4 p30 -88.68 -36.88 15.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.947 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.08 -35.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.342 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 m -56.11 -32.1 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.447 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.2 mt -92.08 -32.03 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.56 0.219 . . . . 0.0 111.127 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -73.37 -37.4 66.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.01 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 56' ' ' ILE . 27.1 mt -127.93 150.32 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.17 -163.98 1.02 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.695 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.62 92.41 0.07 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.735 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.5 33.66 22.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.471 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.1 p -165.93 122.55 1.37 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.867 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.82 151.61 9.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -74.5 142.36 77.71 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.16 97.14 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.689 2.26 . . . . 0.0 112.203 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.9 -39.2 0.09 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.49 132.92 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.5 mt -108.18 93.49 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 91' ' ' SER . 3.5 t -93.61 138.66 31.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -125.03 122.27 36.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.54 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.24 101.65 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 60.25 59.9 2.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.356 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 58.29 24.56 11.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.582 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.38 178.85 6.15 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.173 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -80.02 -177.07 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 111.009 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.61 -39.8 6.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.94 -24.59 19.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.017 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -54.42 -29.76 50.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.22 -69.32 0.86 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.563 0.221 . . . . 0.0 111.167 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.71 106.81 0.3 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.434 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.11 -71.01 0.08 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.504 0.192 . . . . 0.0 111.067 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -107.83 -36.65 6.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.947 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.37 -29.15 22.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.783 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.53 121.25 4.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.677 0.275 . . . . 0.0 110.856 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.97 138.36 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.05 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -66.52 177.9 1.41 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.85 103.28 0.11 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.909 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -35.22 111.91 0.14 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.44 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.4 6.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.946 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -95.26 164.33 12.89 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.823 0.344 . . . . 0.0 111.082 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm -119.49 134.5 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.172 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.0 154.04 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.045 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 67' ' ' THR . 16.3 m -134.75 161.6 34.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.14 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CD1' ' HB ' ' A' ' 67' ' ' THR . 94.1 m-85 -150.39 79.98 1.35 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.38 130.56 34.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.54 101.18 8.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.074 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.24 -43.63 14.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.628 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.86 139.51 30.46 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.2 m80 61.3 32.36 19.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.213 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.34 -77.94 1.25 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.359 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.604 179.759 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 120.799 0.333 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -151.5 132.55 14.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.13 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.36 120.29 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.38 102.09 13.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -99.47 142.12 15.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HG3' HG23 ' A' ' 21' ' ' VAL . 1.2 mt-10 -118.07 102.49 9.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.64 ' C ' HD12 ' A' ' 9' ' ' LEU . 88.2 m-85 -88.06 131.7 34.56 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 8' ' ' PHE . 6.8 mp -139.3 175.83 9.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.237 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 -85.96 1.35 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.625 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.15 28.1 1.55 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.869 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.777 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -105.93 -46.3 4.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.08 -26.35 66.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.367 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.75 80.42 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.827 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 4.3 mt -77.03 -40.5 30.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -63.74 -30.78 71.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.02 46.55 0.22 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.69 34.71 25.03 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.12 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.75 97.77 8.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.71 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -31.16 70.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 7' ' ' GLU . 8.0 p -139.9 128.39 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.917 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.69 138.63 37.92 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 142.23 27.58 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.539 HG13 HD11 ' A' ' 41' ' ' ILE . 25.8 mm -121.39 148.13 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.32 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 126.3 31.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 142.22 50.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.48 102.07 4.52 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -149.37 -69.33 0.21 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.489 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.66 -178.25 5.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.013 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.6 -57.98 0.67 Allowed Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.378 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.88 61.78 3.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.388 2.059 . . . . 0.0 112.724 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.509 ' CG1' HD12 ' A' ' 84' ' ' LEU . 21.4 t -77.58 116.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.561 HG22 HD13 ' A' ' 83' ' ' ILE . 56.8 p -84.84 160.1 20.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.898 0.38 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -58.15 -34.14 48.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.62 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.25 62.0 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.965 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -42.69 71.35 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.746 0.308 . . . . 0.0 110.303 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 84' ' ' LEU . 1.9 tm? -53.0 -52.39 58.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.254 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.4 mt -57.96 -39.6 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.256 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.93 -44.29 91.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.733 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -38.16 76.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.539 HD11 HG13 ' A' ' 24' ' ' ILE . 32.2 mm -68.68 -28.97 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.57 HG13 ' CG2' ' A' ' 52' ' ' VAL . 32.2 t -96.02 -6.53 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 p -99.33 -77.52 0.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.199 -0.313 . . . . 0.0 111.728 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -84.55 -44.02 13.96 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.475 0.179 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.48 ' HB2' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -56.31 -52.31 65.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.219 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.783 ' CG2' HG23 ' A' ' 52' ' ' VAL . 16.2 mt -122.4 141.53 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.566 0.222 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.15 74.05 0.77 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.134 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -165.94 139.07 3.44 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.444 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.95 70.57 5.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.59 2.193 . . . . 0.0 111.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -171.86 -44.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.799 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.472 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.68 -41.88 11.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.783 HG23 ' CG2' ' A' ' 46' ' ' ILE . 1.9 t -85.97 -35.3 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -55.55 -38.44 69.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.36 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.53 -30.87 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.598 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.777 ' CE1' HD21 ' A' ' 12' ' ' LEU . 14.5 t80 -79.52 -57.47 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.546 HG13 HG21 ' A' ' 42' ' ' VAL . 31.6 mm -106.18 135.66 43.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -124.87 97.16 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.982 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.64 66.27 1.28 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.09 28.62 9.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.799 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 m -147.19 122.57 10.32 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.358 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.12 152.48 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 111.158 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.3 116.63 60.59 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -52.68 119.33 5.8 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.85 -27.15 3.22 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.776 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 mt -72.51 125.31 31.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 mp -86.17 148.56 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.327 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.408 HG23 ' CE1' ' A' ' 92' ' ' PHE . 6.2 m -149.71 100.69 2.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 46.7 mt -91.6 114.87 27.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 HD12 ' A' ' 90' ' ' ILE . 10.3 pt -103.52 110.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.765 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 60.19 45.63 11.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.701 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.34 28.64 17.02 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 167.6 20.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.264 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.87 144.33 33.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 111.242 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -63.31 -50.61 69.38 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.976 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -24.59 67.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.25 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -50.03 63.76 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.018 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.15 -72.2 0.34 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.74 36.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.962 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 56.71 -83.98 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 111.808 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -101.86 3.54 39.35 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -91.56 31.09 1.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.696 0.284 . . . . 0.0 111.482 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -123.45 109.2 13.54 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.561 HD13 HG22 ' A' ' 33' ' ' THR . 42.5 mm -65.73 137.28 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.782 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 37' ' ' LEU . 21.6 mt -63.06 174.19 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -167.64 101.06 0.49 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -47.06 119.88 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.706 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.32 20.29 8.34 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.146 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.93 162.84 13.4 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.745 0.307 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.54 95.18 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.577 HD12 HG22 ' A' ' 69' ' ' ILE . 25.0 mm -90.84 149.75 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -133.97 137.96 45.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.297 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' HB3' HD13 ' A' ' 12' ' ' LEU . 9.8 m-85 -124.83 142.58 51.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -145.18 166.9 24.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.697 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 t -145.58 120.15 9.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 121.168 0.508 . . . . 0.0 110.6 179.567 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 2' ' ' VAL . 22.6 m . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -81.67 126.09 31.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.418 HG21 ' HG ' ' A' ' 37' ' ' LEU . 13.9 m -118.85 141.99 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.65 102.93 14.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 90' ' ' ILE . 26.0 m -108.03 154.09 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.294 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -123.0 152.38 40.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.686 ' C ' HD22 ' A' ' 9' ' ' LEU . 83.6 m-85 -137.85 125.02 21.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.686 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.8 mm? -130.26 172.26 12.0 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.493 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -97.99 1.69 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.711 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.74 -29.57 2.84 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.107 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.746 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -56.88 -38.39 72.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.831 0.315 . . . . 0.0 111.288 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -60.87 -38.2 84.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.09 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.94 78.85 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.624 0.249 . . . . 0.0 111.358 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 33.1 mt -71.67 -34.21 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.41 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.47 -34.14 63.05 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.84 45.77 0.15 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.447 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.35 35.92 26.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.888 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.52 13.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.974 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.57 -49.89 2.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.983 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.547 HG11 ' HE2' ' A' ' 5' ' ' LYS . 19.0 t -118.99 134.75 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.307 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -123.46 149.7 44.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.47 119.43 29.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.911 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mm -126.07 148.29 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 23.7 pttt -130.07 113.55 14.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.412 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.66 132.12 38.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.794 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -115.49 91.56 3.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.722 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -156.09 -50.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.972 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' HG22 ' A' ' 32' ' ' VAL . 1.8 pt-20 -161.04 -174.67 4.49 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -59.08 0.36 Allowed Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.91 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.84 58.97 6.23 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.432 2.088 . . . . 0.0 112.631 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 29' ' ' GLU . 41.2 t -80.21 125.4 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.612 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.5 p -72.93 155.47 39.84 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.984 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 79' ' ' GLU . 11.6 p -57.39 -33.32 43.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.53 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 38' ' ' ILE . . . -57.99 -28.45 60.92 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.769 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.41 -38.76 68.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.701 0.286 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.531 HD23 ' CD1' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -54.98 -48.27 73.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 42' ' ' VAL . 5.6 mt -63.07 -42.84 98.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.285 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.142 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -60.46 -44.28 96.04 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.575 HG23 ' SD ' ' A' ' 45' ' ' MET . 20.2 mt -70.04 -31.33 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.805 HG13 HG21 ' A' ' 52' ' ' VAL . 36.5 t -90.66 -4.27 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 t -81.87 -78.79 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.45 -0.156 . . . . 0.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -99.88 -33.74 10.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.525 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.575 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -58.87 -44.29 91.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.136 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.701 HG21 HG23 ' A' ' 52' ' ' VAL . 23.3 mt -131.64 100.57 4.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.091 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.24 55.08 1.41 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 1.1 t-20 -144.74 122.17 6.44 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.344 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 26.6 Cg_exo -63.52 77.56 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.911 2.408 . . . . 0.0 112.027 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -162.26 -54.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.11 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.426 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -91.42 -38.32 12.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.696 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.805 HG21 HG13 ' A' ' 42' ' ' VAL . 2.1 t -86.96 -36.24 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.122 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -54.84 -36.23 64.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.626 0.251 . . . . 0.0 110.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 mt -82.5 -33.88 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.326 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.746 ' CE1' HD21 ' A' ' 12' ' ' LEU . 29.3 t80 -80.07 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 42' ' ' VAL . 28.1 mm -91.89 137.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.616 0.246 . . . . 0.0 111.286 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.26 147.23 41.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.898 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.73 39.38 1.64 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.37 0.418 . . . . 0.0 111.58 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.04 43.02 18.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.57 165.2 35.06 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.419 HD13 ' HZ3' ' A' ' 74' ' ' TRP . 2.2 mp -70.25 154.2 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 61' ' ' ILE . 1.8 ttp85 -75.04 134.42 74.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.123 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.9 84.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.449 2.099 . . . . 0.0 111.459 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.53 -32.34 0.44 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.671 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 55' ' ' PHE . 32.1 mm -60.86 127.71 20.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.17 145.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' SER . 6.0 m -151.57 131.67 13.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.685 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -125.61 117.93 24.61 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.318 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.522 HG23 ' CD1' ' A' ' 74' ' ' TRP . 7.1 pt -90.96 106.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.17 50.21 6.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.05 32.25 20.95 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 175.86 9.21 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.586 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.71 158.96 26.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.465 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.522 ' CD1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -85.14 -56.22 3.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -25.39 63.26 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.665 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 tt -53.36 -32.5 49.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.521 0.201 . . . . 0.0 111.358 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.73 -54.84 2.23 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.782 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 106.12 0.2 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.699 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' O ' HG11 ' A' ' 34' ' ' VAL . 5.8 mt-10 -50.27 -57.63 7.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.483 0.141 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE2' ' HA3' ' A' ' 35' ' ' GLY . 43.4 tttm -110.83 -26.66 9.23 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.222 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.92 57.35 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -139.88 110.64 6.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.049 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.2 130.76 28.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.624 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.531 ' CD1' HD23 ' A' ' 37' ' ' LEU . 17.4 mt -64.78 175.05 1.59 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.848 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.42 102.08 0.72 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.274 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -48.67 114.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.4 26.07 5.54 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.43 164.05 12.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.706 0.288 . . . . 0.0 111.087 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.4 mm -104.39 133.53 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.664 ' HB ' HG12 ' A' ' 6' ' ' VAL . 35.6 mt -140.84 147.52 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 13.4 t -132.2 149.55 52.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.301 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -138.52 86.26 2.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -93.36 175.76 6.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.487 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -155.34 82.18 1.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.616 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 121.196 0.522 . . . . 0.0 110.653 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -96.94 101.62 13.24 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.6 127.38 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.26 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -96.79 108.46 21.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.075 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.856 HG12 ' HB ' ' A' ' 90' ' ' ILE . 27.3 m -114.62 146.35 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -122.52 129.75 52.31 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 97.3 m-85 -109.94 130.12 55.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.61 165.82 26.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.74 -21.2 40.37 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.649 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.01 -26.21 1.6 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.95 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 65' ' ' ILE . 9.4 mt -54.48 -37.75 65.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.75 0.275 . . . . 0.0 111.667 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -56.78 -31.34 64.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.226 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.67 78.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 23.2 mt -80.37 -35.21 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.283 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.38 -75.19 0.1 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.1 37.84 0.17 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.704 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt 52.01 34.29 13.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.447 0.299 . . . . 0.0 111.508 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -125.29 122.52 37.11 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.732 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -50.36 72.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.727 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.67 138.22 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.124 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.61 156.09 49.32 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.63 146.74 47.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.486 HD13 HD11 ' A' ' 37' ' ' LEU . 3.8 mp -134.39 146.9 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -134.1 119.77 19.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.148 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.11 131.96 54.59 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.091 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.34 98.49 5.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.49 -49.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.055 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -161.31 -176.55 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.11 -58.56 0.41 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.68 56.5 4.08 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.547 2.164 . . . . 0.0 112.749 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.84 126.33 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 p -78.67 151.17 32.37 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.24 -32.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.672 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -27.13 57.33 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.724 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -41.57 68.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.734 0.302 . . . . 0.0 110.385 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.566 ' CD1' HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -53.6 -52.22 60.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.189 179.02 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.478 ' HA ' HD12 ' A' ' 41' ' ' ILE . 34.1 mm -62.37 -38.82 82.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.39 -46.0 90.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.039 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -57.85 -42.22 84.03 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.045 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 37' ' ' LEU . 14.7 mt -65.64 -31.76 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.792 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.861 HG13 HG11 ' A' ' 52' ' ' VAL . 43.8 t -92.45 -2.9 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.901 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -74.83 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.462 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -95.7 -42.73 8.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.294 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -42.77 76.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.631 ' CG2' HG22 ' A' ' 52' ' ' VAL . 35.0 mt -131.73 131.56 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -162.24 74.96 0.44 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.018 0.437 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.03 121.03 1.42 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.611 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.67 79.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.44 2.093 . . . . 0.0 112.046 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -172.88 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.529 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.7 p30 -87.4 -41.79 13.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.602 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.861 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -77.63 -35.52 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 t -53.83 -31.56 49.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.333 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.4 mt -90.6 -44.53 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.501 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.654 ' CD1' HD21 ' A' ' 12' ' ' LEU . 35.2 t80 -72.86 -53.75 10.6 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.477 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.656 ' HB ' HG12 ' A' ' 52' ' ' VAL . 37.8 mm -99.87 114.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.305 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -71.85 -162.97 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.542 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -64.43 86.93 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.899 0.381 . . . . 0.0 111.046 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 60.38 43.55 13.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.93 176.5 3.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.07 149.82 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.713 0.292 . . . . 0.0 110.799 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HG2' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -96.11 148.89 35.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.79 159.06 47.42 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.633 2.222 . . . . 0.0 112.275 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.26 -23.66 35.19 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.798 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.691 HD12 HD11 ' A' ' 12' ' ' LEU . 33.8 mm -83.25 102.62 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.0 124.19 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.198 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 91' ' ' SER . 8.6 m -120.18 141.25 50.07 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.4 mt -135.95 115.06 12.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.289 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.2 mt -97.71 105.2 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.638 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 57.63 52.5 8.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 59.61 32.79 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.216 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.32 169.31 18.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.417 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.92 171.52 15.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.847 0.356 . . . . 0.0 111.093 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -100.98 -48.19 4.52 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.993 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -27.04 58.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.99 -27.63 53.67 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.269 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -120.96 -50.9 2.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.406 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.11 93.22 0.1 Allowed Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.726 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -43.5 73.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -124.58 -40.21 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.81 56.52 1.54 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.944 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.19 108.25 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.807 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.86 128.17 20.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.46 175.07 1.46 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.88 100.96 0.66 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.481 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -48.02 115.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.858 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.17 6.58 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.691 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.49 169.16 9.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.744 0.307 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.43 128.07 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.856 ' HB ' HG12 ' A' ' 6' ' ' VAL . 32.7 mt -136.24 145.66 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.842 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 67' ' ' THR . 0.7 OUTLIER -128.65 155.55 44.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.748 0.309 . . . . 0.0 111.348 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 41.8 m-85 -143.6 82.2 1.72 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 m -86.75 140.82 29.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.126 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 t -102.61 103.24 13.52 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.355 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.675 0.274 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -97.94 140.49 32.21 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.432 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.934 HG21 HD21 ' A' ' 37' ' ' LEU . 35.7 m -136.01 146.11 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 113.33 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.886 HG12 ' HB ' ' A' ' 90' ' ' ILE . 31.2 m -115.78 151.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.479 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.7 tt0 -122.11 110.12 15.37 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HD1' HD22 ' A' ' 12' ' ' LEU . 79.3 m-85 -91.21 138.28 31.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.725 ' HB2' HG23 ' A' ' 93' ' ' THR . 3.9 mp -141.84 163.37 33.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.8 -107.87 3.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.402 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 26.73 5.25 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.047 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 65' ' ' ILE . 1.9 mp -96.38 -41.79 8.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.89 0.345 . . . . 0.0 110.983 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.29 -28.95 65.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.357 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.05 78.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.727 0.299 . . . . 0.0 111.047 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 24.7 mt -79.78 -43.75 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.509 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.6 m-85 -58.61 -70.4 0.15 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.455 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.7 44.08 0.07 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.395 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.59 32.96 18.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.505 0.322 . . . . 0.0 111.402 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -119.38 113.76 21.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.389 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -58.8 -62.56 1.78 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 14.9 p -94.87 143.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.153 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -129.06 161.29 30.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -145.31 133.41 21.49 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 4' ' ' VAL . 2.1 pt -147.2 178.76 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.326 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 132.09 15.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.38 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.25 108.07 19.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.475 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -91.93 48.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -45.06 6.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.985 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' A' ' 32' ' ' VAL . 10.1 pt-20 -166.7 -178.24 4.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.32 -59.13 0.3 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.773 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.8 58.93 6.66 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.363 2.042 . . . . 0.0 112.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.492 ' HB ' HD12 ' A' ' 84' ' ' LEU . 17.9 t -77.01 149.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.1 p -98.86 161.6 13.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' HD21 ' A' ' 84' ' ' LEU . 10.5 p -60.74 -39.85 83.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.711 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.8 -30.51 69.54 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.945 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -40.44 86.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.769 0.319 . . . . 0.0 110.314 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.934 HD21 HG21 ' A' ' 4' ' ' VAL . 2.6 tm? -56.64 -44.9 81.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.128 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.465 ' HA ' HD12 ' A' ' 41' ' ' ILE . 35.8 mm -59.89 -45.26 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.38 -37.97 82.45 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -60.07 -43.71 95.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.488 HG23 ' SD ' ' A' ' 45' ' ' MET . 14.6 mt -64.63 -30.21 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.153 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.739 HG21 HG13 ' A' ' 56' ' ' ILE . 28.8 t -95.99 -2.46 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -95.33 -64.59 1.05 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.3 p -98.03 -46.98 5.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.722 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.488 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -57.58 -56.8 17.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 52' ' ' VAL . 19.4 mt -115.61 149.08 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -173.87 72.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -163.76 133.46 3.11 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.148 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.98 65.52 3.32 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.441 2.094 . . . . 0.0 111.823 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -158.85 -49.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.028 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -89.52 -42.51 11.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.456 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.692 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -72.9 -36.28 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.223 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.7 -28.69 15.67 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.42 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -89.28 -34.41 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.722 ' HE1' HG21 ' A' ' 65' ' ' ILE . 51.2 t80 -86.95 -57.63 2.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.515 0.198 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.739 HG13 HG21 ' A' ' 42' ' ' VAL . 35.8 mm -98.53 139.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -148.86 129.6 14.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.96 42.98 15.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 59.2 38.99 23.34 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.51 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.9 t -166.91 162.31 15.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.908 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.0 148.88 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -78.48 147.7 72.3 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.057 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.22 75.69 2.8 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 111.842 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.03 -45.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.541 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.722 HG21 ' HE1' ' A' ' 55' ' ' PHE . 28.5 mm -67.17 137.21 25.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.857 0.36 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.4 mt -110.73 132.41 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -126.32 138.64 53.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.5 mt -125.48 109.87 13.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 74' ' ' TRP . 7.2 mt -86.73 105.74 15.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.8 t30 56.92 45.9 20.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 61.68 41.87 11.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.177 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.76 156.82 43.85 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.578 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -79.98 129.63 34.64 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.949 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.482 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.5 p-90 -57.65 -35.32 70.38 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.645 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.13 -1.94 58.26 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.636 HD12 ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -76.88 -16.08 59.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -137.31 -58.53 0.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.507 0.194 . . . . 0.0 111.26 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.92 112.57 0.53 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.673 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -49.61 -71.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.537 0.208 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -107.65 -28.23 9.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.931 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.71 -31.37 37.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.226 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.435 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 38.2 t80 -48.26 118.95 2.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 110.838 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.17 141.25 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD12 ' HB ' ' A' ' 32' ' ' VAL . 19.2 mt -62.74 178.23 0.47 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.955 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -162.74 99.71 1.0 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.824 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -43.5 105.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.828 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.13 5.4 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.035 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.83 170.19 8.31 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.714 0.292 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.3 123.27 68.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.402 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.886 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.8 mp -126.24 107.39 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.774 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -81.72 157.99 24.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 111.597 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -146.82 82.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -91.45 164.13 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.11 132.94 50.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.277 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.638 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 86' ' ' ASP . 10.6 p . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -105.53 125.1 50.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 90' ' ' ILE . 38.9 t -125.09 110.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.271 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 112.98 20.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.526 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.76 HG12 ' HB ' ' A' ' 90' ' ' ILE . 7.2 m -113.35 139.79 36.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.336 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.7 115.46 29.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.54 ' C ' HD12 ' A' ' 9' ' ' LEU . 82.2 m-85 -96.46 124.03 40.31 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.405 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.54 HD12 ' C ' ' A' ' 8' ' ' PHE . 11.0 mp -125.47 159.69 31.33 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.299 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.37 -109.26 3.57 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.414 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.08 35.49 2.84 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.589 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 mt -104.15 -43.13 5.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.637 0.218 . . . . 0.0 111.178 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -59.38 -28.47 66.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.33 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.23 78.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.77 0.319 . . . . 0.0 111.032 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 41.9 mt -73.96 -37.99 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.219 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -69.65 -70.44 0.28 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.74 44.72 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 56.1 33.54 22.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.621 0.248 . . . . 0.0 111.401 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 129.1 51.55 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.603 0.24 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -83.44 -64.13 1.22 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.5 t -79.65 105.87 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -111.2 173.7 6.22 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.61 136.26 47.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.309 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 37' ' ' LEU . 17.6 mm -117.87 152.11 19.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -150.0 99.52 2.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.127 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -73.52 -53.77 9.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.049 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.59 76.13 0.32 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -136.67 -67.57 0.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.335 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -140.97 -175.73 4.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.72 -59.59 0.43 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.086 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.37 60.37 6.39 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.469 2.112 . . . . 0.0 112.598 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.661 ' CG1' HD12 ' A' ' 84' ' ' LEU . 26.7 t -77.8 142.27 14.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 155.24 18.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -57.74 -35.88 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.803 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.63 -27.74 66.71 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.978 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -39.13 65.69 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.551 ' HB2' HD11 ' A' ' 84' ' ' LEU . 1.3 tm? -54.97 -51.43 66.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.382 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.7 -43.15 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.18 -43.66 78.64 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.432 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 55.4 t60 -59.63 -46.52 88.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.31 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.48 -31.59 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.891 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.706 HG13 ' CG2' ' A' ' 52' ' ' VAL . 36.7 t -97.4 -4.13 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -92.7 -68.81 0.78 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.28 -41.48 7.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.614 0.245 . . . . 0.0 111.351 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -39.78 69.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.826 HG21 HG23 ' A' ' 52' ' ' VAL . 44.1 mt -131.65 129.79 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.664 0.269 . . . . 0.0 111.047 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -143.91 51.41 1.32 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -142.92 121.52 7.37 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.32 74.41 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.99 2.46 . . . . 0.0 112.238 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.63 -58.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.364 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.8 p30 -79.9 -36.49 36.38 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.706 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -88.77 -35.33 7.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.945 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -54.23 -36.24 63.31 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.121 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.2 -37.93 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.219 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -67.11 -39.93 86.77 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.006 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.31 116.22 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -115.01 130.89 57.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.64 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 58.81 43.78 17.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.966 0.413 . . . . 0.0 110.464 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.39 33.31 22.18 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.489 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.61 149.66 26.87 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.911 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.62 151.58 10.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.061 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.8 ttt180 -93.1 130.25 36.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.999 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 50.9 Cg_exo -54.42 118.66 5.3 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.79 2.327 . . . . 0.0 112.325 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.94 -37.88 0.93 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.555 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 mt -74.11 127.89 36.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.69 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.8 mm -103.04 127.54 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.059 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -121.92 134.8 54.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.235 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 72' ' ' THR . 2.4 mm? -110.58 98.54 7.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.681 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.665 HD11 ' CD1' ' A' ' 74' ' ' TRP . 24.1 mt -81.13 102.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 57.63 48.4 14.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.628 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 62.13 32.26 17.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.289 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.685 ' O ' HD13 ' A' ' 68' ' ' LEU . 1.3 m -128.58 162.97 26.04 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.49 134.64 36.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.665 ' CD1' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -57.48 -53.37 58.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.888 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.44 -36.54 83.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.306 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 76' ' ' LEU . 5.1 tt -56.4 -52.48 64.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.597 0.237 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.56 -35.73 81.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 34.08 0.8 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.185 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.76 -78.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.628 0.371 . . . . 0.0 111.432 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -109.2 16.73 22.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 47.52 1.25 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.993 0.425 . . . . 0.0 110.786 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 69' ' ' ILE . 24.1 t80 -144.23 138.23 27.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.421 HD12 ' H ' ' A' ' 83' ' ' ILE . 4.3 mp -92.91 129.96 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.661 HD12 ' CG1' ' A' ' 32' ' ' VAL . 18.7 mt -59.75 173.78 0.54 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.0 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.65 100.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.029 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.634 ' HA ' HG23 ' A' ' 2' ' ' VAL . 12.7 p-10 -43.07 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.53 26.96 5.43 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.482 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.584 ' OD1' HG13 ' A' ' 4' ' ' VAL . 3.3 p30 -95.4 174.76 6.86 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.64 0.257 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.2 mm -119.46 130.43 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.481 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.76 ' HB ' HG12 ' A' ' 6' ' ' VAL . 43.3 mt -133.39 153.17 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.385 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -127.55 156.45 42.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.05 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -143.88 105.76 4.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.229 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -109.6 142.19 41.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.032 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.3 t -116.63 97.56 6.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.567 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 -179.701 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -111.02 139.68 46.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.572 HG21 ' HG ' ' A' ' 37' ' ' LEU . 9.7 m -140.88 136.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.541 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.25 115.54 27.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.362 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.663 HG12 ' HB ' ' A' ' 90' ' ' ILE . 2.9 m -113.27 143.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.461 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.35 154.95 20.54 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.527 ' HD1' HD13 ' A' ' 12' ' ' LEU . 52.9 m-85 -142.82 111.75 6.46 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.4 mm? -123.32 145.41 48.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.012 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.25 -111.16 3.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.524 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.87 28.43 6.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.929 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.683 HD21 ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -100.17 -48.75 4.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.81 0.305 . . . . 0.0 110.767 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.74 -27.0 68.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.621 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.78 -34.19 76.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.647 0.261 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 51' ' ' ASP . 19.4 mt -74.91 -37.4 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.63 -61.33 1.83 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.33 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.62 46.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.503 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp 57.35 33.87 23.91 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -112.24 103.93 12.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.713 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mtt-85 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.604 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 p -97.85 130.32 46.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.88 0.371 . . . . 0.0 111.003 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -128.61 164.67 22.37 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.259 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -128.68 133.48 48.22 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.305 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HB ' HD11 ' A' ' 37' ' ' LEU . 22.6 mm -117.19 145.96 22.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.23 89.72 3.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.1 148.56 51.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.175 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -123.59 101.76 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.386 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -166.29 -53.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -174.07 -166.59 0.3 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.78 -59.53 0.33 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 59.26 5.83 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.486 2.124 . . . . 0.0 112.548 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.66 131.24 34.23 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -66.69 146.38 54.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.492 HG21 ' HE1' ' A' ' 74' ' ' TRP . 13.9 p -54.62 -33.37 27.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.473 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.57 59.17 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.043 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -39.88 61.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 110.3 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.572 ' HG ' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -55.85 -56.57 19.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.304 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 41' ' ' ILE . 12.9 pt -59.12 -35.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.623 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -63.27 -43.86 96.75 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.662 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -58.07 -39.55 78.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 38' ' ' ILE . 16.5 mt -68.6 -30.23 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.038 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.698 HG13 HG21 ' A' ' 52' ' ' VAL . 29.8 t -97.01 -6.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.1 t -100.72 -64.33 1.05 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 m -87.77 -51.27 5.95 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.38 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -51.9 67.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.869 HG21 HG23 ' A' ' 52' ' ' VAL . 26.1 mt -116.2 143.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-O 120.759 0.314 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -162.56 41.22 0.12 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.587 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 50' ' ' ASN . 5.4 t30 -134.03 118.54 14.2 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.708 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.37 75.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.908 2.405 . . . . 0.0 112.711 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ASN . 9.5 m-20 -165.72 -61.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.354 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB2' HG22 ' A' ' 15' ' ' ILE . 29.8 p-10 -79.84 -33.25 40.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.33 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.869 HG23 HG21 ' A' ' 46' ' ' ILE . 1.4 t -93.83 -41.15 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.636 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -35.49 68.49 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.197 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.6 mt -89.0 -33.97 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.33 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 12' ' ' LEU . 19.3 t80 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.495 0.188 . . . . 0.0 111.004 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 42' ' ' VAL . 17.4 mt -131.84 141.8 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.446 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.18 -170.27 3.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -63.16 93.04 0.06 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.956 0.407 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 56.09 43.65 26.6 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.88 128.63 1.69 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.432 ' HA ' HG23 ' A' ' 56' ' ' ILE . 2.1 mp -71.97 153.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.293 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' N ' HG22 ' A' ' 61' ' ' ILE . 8.6 mtp-105 -88.48 139.48 29.92 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.016 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.21 125.1 17.95 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.811 2.341 . . . . 0.0 112.389 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.15 -46.97 1.02 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.866 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.43 112.92 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.45 146.77 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.561 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' SER . 2.0 m -141.52 138.19 32.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.633 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -145.87 128.05 15.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.058 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.642 HD11 ' HD1' ' A' ' 74' ' ' TRP . 21.6 mt -90.33 90.27 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.434 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.01 65.88 1.34 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.955 0.407 . . . . 0.0 111.253 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.2 24.29 14.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.595 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 m -130.17 164.6 24.12 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.317 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -79.71 165.87 22.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.898 0.38 . . . . 0.0 111.474 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.642 ' HD1' HD11 ' A' ' 69' ' ' ILE . 4.6 t90 -94.22 -41.14 9.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.796 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.24 -27.48 35.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.618 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -54.69 -27.45 40.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG3' ' CD1' ' A' ' 82' ' ' TYR . 1.4 pt-20 -128.41 27.33 5.59 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.68 102.75 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.743 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -54.14 -34.36 60.16 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -122.18 -40.51 2.49 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.448 0.166 . . . . 0.0 110.626 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -55.16 -29.19 57.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.369 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 77' ' ' GLU . 72.3 t80 -55.13 118.91 4.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.22 139.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.565 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.5 ' CD1' HD23 ' A' ' 37' ' ' LEU . 22.9 mt -64.07 175.25 1.28 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.942 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -167.11 100.84 0.53 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.595 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -44.35 114.31 0.66 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.99 18.98 6.58 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.017 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.17 177.54 4.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.746 0.273 . . . . 0.0 110.961 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 90' ' ' ILE . 27.4 mt -128.12 150.32 33.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.962 0.41 . . . . 0.0 111.71 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' HB ' HG12 ' A' ' 6' ' ' VAL . 5.3 mp -142.55 100.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.11 142.99 34.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.695 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -136.23 82.9 1.97 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 9' ' ' LEU . 4.2 m -94.02 150.05 20.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.675 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.594 ' OG ' HD12 ' A' ' 12' ' ' LEU . 20.4 m -133.98 99.31 4.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.59 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.464 0.226 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.927 -179.921 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 120.643 0.259 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -141.95 114.28 8.27 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 37' ' ' LEU . 15.0 m -117.75 132.76 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -106.41 105.26 15.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.725 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.708 HG12 ' HB ' ' A' ' 90' ' ' ILE . 15.3 m -105.53 144.37 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.371 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -107.32 135.56 48.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.542 ' C ' HD22 ' A' ' 9' ' ' LEU . 60.7 m-85 -119.01 115.42 24.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.746 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.542 HD22 ' C ' ' A' ' 8' ' ' PHE . 4.5 mm? -122.5 132.53 54.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.088 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 -109.27 1.82 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.386 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.03 -23.84 5.97 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.242 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.717 HD21 ' CD1' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -55.46 -48.24 74.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.994 0.397 . . . . 0.0 111.468 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -57.9 -36.01 71.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.129 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 12' ' ' LEU . 7.5 mt -75.19 -39.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.363 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.5 m-85 -67.38 -75.09 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.321 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.21 41.71 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.602 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.35 34.4 20.61 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.705 0.288 . . . . 0.0 111.159 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -110.16 117.5 33.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.721 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -28.98 69.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.67 142.28 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -122.73 170.35 10.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -135.24 121.71 20.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -116.1 143.93 24.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.065 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.96 91.79 2.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.442 ' HE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.3 156.73 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.052 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.92 113.91 7.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 111.586 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.68 -48.28 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.94 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -156.13 -177.7 6.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.26 -59.83 0.37 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.984 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.09 58.28 6.51 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.534 2.156 . . . . 0.0 112.409 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -75.14 121.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.657 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.6 p -68.75 153.47 43.73 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.876 0.369 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 ' HE1' ' A' ' 74' ' ' TRP . 9.1 p -57.68 -31.95 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.579 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.08 -28.04 57.99 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.33 -38.07 71.7 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.776 0.322 . . . . 0.0 110.324 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -56.28 -47.1 79.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.054 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.691 HD11 ' CH2' ' A' ' 74' ' ' TRP . 49.7 mt -61.39 -41.88 91.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.449 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -39.68 87.3 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.442 ' HB2' ' HE2' ' A' ' 26' ' ' MET . 22.2 t-80 -63.12 -46.1 88.9 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 45' ' ' MET . 57.2 mt -61.24 -31.41 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.825 HG13 HG11 ' A' ' 52' ' ' VAL . 42.1 t -97.57 -3.36 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.4 t -93.43 -74.87 0.51 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.388 -0.195 . . . . 0.0 111.494 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -96.58 -39.99 9.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.556 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.8 tpt -57.1 -38.56 73.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.024 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.717 HG22 HG22 ' A' ' 52' ' ' VAL . 15.0 mt -137.62 136.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.693 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -159.81 71.72 0.49 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.813 0.34 . . . . 0.0 111.365 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.5 t30 -162.88 134.64 3.9 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.38 64.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.21 1.94 . . . . 0.0 111.702 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.73 -45.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -91.24 -41.92 10.7 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.641 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.825 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -72.01 -34.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.29 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.29 -30.67 12.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.5 -65.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.466 0.174 . . . . 0.0 111.371 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.717 ' CD1' HD21 ' A' ' 12' ' ' LEU . 41.0 t80 -64.05 -36.53 84.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.324 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 52' ' ' VAL . 29.6 mm -125.37 93.84 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.89 119.22 38.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.57 64.65 1.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p30 43.23 33.81 0.62 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.247 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -157.36 149.07 22.2 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.661 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.519 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.2 mp -65.07 152.91 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -79.73 115.68 55.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.631 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.76 101.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.649 2.233 . . . . 0.0 111.959 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.05 -30.64 0.6 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.584 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.622 HD13 ' CD1' ' A' ' 55' ' ' PHE . 49.1 mt -64.22 136.42 26.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.819 0.343 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.3 mt -103.82 144.79 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.413 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 91' ' ' SER . 25.1 m -143.63 140.93 30.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.7 mt -141.04 121.13 13.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.264 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.726 HD11 ' CD1' ' A' ' 74' ' ' TRP . 35.2 mt -93.7 102.76 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.53 55.42 3.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t0 57.01 31.89 20.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.206 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -136.25 166.6 23.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -79.77 149.23 31.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 111.467 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.726 ' CD1' HD11 ' A' ' 69' ' ' ILE . 1.6 t90 -69.05 -54.1 16.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.73 -7.77 55.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.042 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 ' HB2' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -56.65 -31.45 64.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.597 0.237 . . . . 0.0 111.366 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.26 -52.06 1.52 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.96 109.15 0.35 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.926 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.46 -48.9 77.96 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.847 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -121.19 -42.82 2.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.865 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.76 -24.54 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.948 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -52.84 119.79 5.02 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.883 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -75.56 132.59 32.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.17 174.99 1.78 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.726 0.298 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -169.6 101.85 0.33 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.421 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -44.05 115.43 0.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 119.17 3.95 12.7 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.984 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.94 164.25 23.66 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.082 0.441 . . . . 0.0 111.155 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mm -123.05 93.22 2.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.708 ' HB ' HG12 ' A' ' 6' ' ' VAL . 41.6 mt -91.83 152.1 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 67' ' ' THR . 0.9 OUTLIER -128.12 146.62 50.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.228 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -138.32 94.75 2.9 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.54 132.91 45.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.04 96.56 5.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.223 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.129 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -104.41 131.88 51.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 37' ' ' LEU . 19.9 m -133.26 147.48 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 21' ' ' VAL . 3.2 tttp -103.66 100.64 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.727 HG12 ' HB ' ' A' ' 90' ' ' ILE . 7.5 m -106.01 151.88 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.543 ' OE1' HD11 ' A' ' 9' ' ' LEU . 7.7 pt-20 -125.2 159.09 32.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.182 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' C ' HD12 ' A' ' 9' ' ' LEU . 99.5 m-85 -130.17 143.13 50.61 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.395 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 93' ' ' THR . 4.2 mp -140.65 171.02 14.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.503 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.67 -111.42 3.28 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.353 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.84 27.44 5.42 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.829 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.49 HD11 HG23 ' A' ' 65' ' ' ILE . 15.4 mt -90.36 -51.52 5.38 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.763 0.281 . . . . 0.0 110.863 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.0 -27.06 61.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.519 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.28 80.56 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.729 0.3 . . . . 0.0 111.18 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.609 HD13 HD11 ' A' ' 54' ' ' ILE . 40.8 mt -78.62 -43.21 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.82 -69.2 0.24 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.367 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.01 42.33 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.778 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 57.5 6.33 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 111.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -143.81 119.42 10.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 14.0 mtm-85 -72.52 -72.02 0.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.407 HG11 ' HE3' ' A' ' 5' ' ' LYS . 21.8 t -78.59 138.76 19.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -145.55 143.81 30.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -108.57 125.42 51.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.59 145.61 19.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.56 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.61 95.56 4.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.234 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.415 ' HG3' ' HB3' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -62.78 -64.51 0.9 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.636 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 58.66 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.851 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.6 -45.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.089 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -150.6 -179.85 7.58 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.89 -58.67 0.41 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.756 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.0 57.76 6.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.481 2.121 . . . . 0.0 112.602 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.5 116.21 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.495 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.492 HG22 HD13 ' A' ' 83' ' ' ILE . 70.8 p -75.01 156.13 36.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.65 -31.88 40.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.396 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.86 -25.59 59.37 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.932 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB3' ' HG3' ' A' ' 26' ' ' MET . 1.0 OUTLIER -75.36 -39.49 59.2 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 110.282 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -54.82 -55.41 30.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.417 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.809 ' HA ' HD12 ' A' ' 41' ' ' ILE . 11.9 pt -61.07 -36.0 69.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.625 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -39.47 94.27 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.764 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -61.22 -40.09 92.7 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 38' ' ' ILE . 5.0 mt -67.86 -30.88 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.551 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.68 HG21 HG13 ' A' ' 56' ' ' ILE . 47.7 t -92.6 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.811 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.3 p -100.21 -60.83 1.45 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -100.22 -50.99 3.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -42.39 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.273 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.674 ' CG2' HG23 ' A' ' 52' ' ' VAL . 7.9 mt -130.87 129.63 63.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 64.87 1.15 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.786 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.24 131.14 6.86 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.93 74.41 2.35 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.617 2.211 . . . . 0.0 112.196 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -168.17 -47.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.53 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.85 -38.96 10.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.852 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.674 HG23 ' CG2' ' A' ' 46' ' ' ILE . 1.9 t -82.97 -37.44 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.409 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -53.24 -42.62 66.6 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.663 0.268 . . . . 0.0 111.098 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.609 HD11 HD13 ' A' ' 15' ' ' ILE . 1.2 pt -80.01 -34.15 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.583 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.03 -48.59 62.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.674 0.273 . . . . 0.0 110.649 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.68 HG13 HG21 ' A' ' 42' ' ' VAL . 28.2 mm -124.56 124.02 67.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -163.24 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.481 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.97 84.94 0.08 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 40.29 12.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.57 126.32 1.07 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.57 153.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.2 143.26 52.18 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.94 125.61 11.71 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.523 2.149 . . . . 0.0 112.084 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.54 -35.16 2.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.597 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 12' ' ' LEU . 9.2 mt -73.29 114.51 12.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.706 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.1 mt -96.31 149.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.057 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.514 HG22 ' CE3' ' A' ' 74' ' ' TRP . 9.3 t -143.73 128.26 18.04 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.861 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.8 mt -108.53 126.98 53.53 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 pt -106.31 109.2 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.099 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.32 44.74 21.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.2 41.62 16.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.0 167.67 21.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 125.32 29.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.514 ' CE3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -59.16 -26.83 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.732 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -97.66 -1.34 43.86 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -61.73 -32.37 72.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.482 0.182 . . . . 0.0 111.423 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 -68.63 0.66 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.22 110.15 0.54 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.033 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -72.68 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.115 0.166 . . . . 0.0 111.287 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.05 -31.03 16.44 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.555 0.217 . . . . 0.0 110.749 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -28.18 28.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.487 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -57.39 113.67 1.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 33' ' ' THR . 31.7 mm -77.62 141.53 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.462 ' CD1' HD23 ' A' ' 37' ' ' LEU . 31.8 mt -62.93 173.65 1.3 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.59 101.32 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -43.65 110.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.764 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.39 26.84 4.98 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.874 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.26 168.74 9.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -117.32 129.57 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.612 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.727 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.8 mp -135.51 101.84 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.61 152.0 28.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -134.23 93.15 3.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 9' ' ' LEU . 14.4 p -95.97 162.31 13.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 t -151.72 102.01 2.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.3 p . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.415 -179.541 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 86' ' ' ASP . 18.7 m . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 120.698 0.285 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -132.08 110.43 10.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 24' ' ' ILE . 13.1 m -117.44 135.0 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.304 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -104.55 99.18 8.86 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.622 HG12 ' HB ' ' A' ' 90' ' ' ILE . 26.2 m -93.31 144.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -116.61 103.06 10.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 9' ' ' LEU . 66.1 m-85 -88.74 119.54 29.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.762 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 8' ' ' PHE . 11.2 mp -126.0 161.88 26.54 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.6 -104.65 2.94 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.338 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.8 -12.82 8.3 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.397 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD21 ' CE2' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -62.83 -44.13 96.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.246 0.523 . . . . 0.0 111.294 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.89 -32.88 71.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.085 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.9 69.45 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.534 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 30.1 mt -74.43 -47.41 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.412 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -60.42 -61.15 2.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.357 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.63 0.02 OUTLIER Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.588 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp 59.09 65.01 1.27 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 111.97 8.57 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -34.05 77.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.002 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.8 122.99 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.49 174.73 5.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.066 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -137.94 129.14 27.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.067 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 4' ' ' VAL . 3.6 mp -122.42 140.3 46.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.78 86.41 2.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 128.84 37.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.842 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -112.01 82.53 1.64 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.595 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.3 -66.33 0.7 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -148.28 -173.33 4.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -87.71 -54.42 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.975 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.2 Cg_exo -78.47 53.96 4.8 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.872 2.381 . . . . 0.0 112.621 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 36' ' ' ASP . 17.6 t -80.08 129.78 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.709 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -81.99 156.6 24.6 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 110.743 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.653 ' O ' HD12 ' A' ' 38' ' ' ILE . 9.1 p -53.69 -37.7 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.748 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.02 59.19 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.413 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HB2' HG12 ' A' ' 32' ' ' VAL . 64.9 m-20 -69.91 -41.02 75.24 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.709 0.29 . . . . 0.0 110.385 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 HD13 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -54.81 -54.34 43.5 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.754 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.6 mp -61.89 -35.27 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.455 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -46.0 90.93 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.173 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.36 -40.62 87.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.649 0.262 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 38' ' ' ILE . 14.2 mt -64.32 -33.22 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.713 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.693 HG13 ' CG2' ' A' ' 52' ' ' VAL . 40.9 t -90.76 -6.37 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.846 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.3 -74.95 0.44 Allowed 'General case' 0 N--CA 1.462 0.167 0 O-C-N 122.384 -0.197 . . . . 0.0 111.444 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.5 m -99.19 -41.5 7.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.45 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.526 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -53.46 -38.31 63.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.118 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 52' ' ' VAL . 21.4 mt -133.42 103.59 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.726 0.298 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.23 71.22 1.19 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.07 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.2 130.16 2.79 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.185 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.48 75.18 2.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.599 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -168.5 -44.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.857 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -92.67 -38.71 11.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.663 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.748 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -89.17 -36.06 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -54.75 -39.07 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 111.029 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.9 mt -76.03 -35.04 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.167 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.725 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 6.7 t80 -72.48 -52.94 13.6 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.669 0.271 . . . . 0.0 110.912 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.607 HD12 HG11 ' A' ' 42' ' ' VAL . 30.6 mt -118.0 110.12 29.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.5 130.46 55.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 59.4 40.95 20.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.04 29.61 19.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.46 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 144.78 32.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 62' ' ' ARG . 2.1 mp -65.44 153.96 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.0 mtt180 -88.66 146.1 36.49 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.71 88.73 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.623 2.215 . . . . 0.0 111.957 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.12 -34.76 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.773 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.725 HG21 ' CZ ' ' A' ' 55' ' ' PHE . 28.6 mm -68.33 119.53 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.4 mt -96.72 147.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.557 HG22 ' CE2' ' A' ' 92' ' ' PHE . 64.2 p -136.83 112.61 9.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.5 mt -105.27 108.17 19.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.754 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.549 HG21 ' CE1' ' A' ' 82' ' ' TYR . 21.2 mt -89.3 100.87 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.747 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 t30 58.81 53.2 5.97 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.29 32.93 20.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.235 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 154.14 49.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 129.07 34.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.653 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -54.58 -33.24 59.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.648 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.17 -32.47 38.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.923 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.75 -30.99 64.14 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.44 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -121.38 26.26 8.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.534 0.207 . . . . 0.0 111.432 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.29 -101.54 0.64 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.838 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.8 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.575 0.35 . . . . 0.0 110.509 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -109.94 -25.15 10.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.219 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -53.48 -25.71 17.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.666 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CE1' HG21 ' A' ' 69' ' ' ILE . 48.5 t80 -52.75 115.56 1.88 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.678 0.275 . . . . 0.0 110.718 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.77 142.04 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -63.22 174.94 1.04 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.936 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -160.53 97.33 1.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.784 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.465 ' HB2' HG12 ' A' ' 2' ' ' VAL . 41.1 t0 -45.85 110.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.83 26.18 4.83 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.678 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.85 176.57 5.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.649 0.262 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 90' ' ' ILE . 19.8 mt -123.3 152.69 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.554 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.622 ' HB ' HG12 ' A' ' 6' ' ' VAL . 5.2 mp -141.5 153.12 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.72 139.39 48.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.557 ' CE2' HG22 ' A' ' 67' ' ' THR . 30.2 m-85 -127.99 91.07 3.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 162.13 14.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -155.22 103.9 2.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.005 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 CA--C 1.533 0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 2' ' ' VAL . 11.3 m . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -83.91 110.11 18.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 37' ' ' LEU . 12.5 m -117.06 138.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.95 116.74 33.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 21' ' ' VAL . 18.1 t -109.82 144.98 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HB3' HD11 ' A' ' 9' ' ' LEU . 3.7 mt-10 -127.49 101.27 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.92 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -87.7 123.89 33.0 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.826 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 7' ' ' GLU . 4.9 mp -143.6 167.81 21.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.07 -20.73 38.16 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.509 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.36 -34.85 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.746 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -37.24 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.65 0.225 . . . . 0.0 111.577 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.83 -36.7 72.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.56 0.219 . . . . 0.0 111.017 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.91 68.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.479 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 35.2 mt -73.56 -42.09 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -68.94 -71.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.36 41.58 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.57 44.81 27.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.65 -31.6 15.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.302 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 72.63 -67.44 0.26 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.853 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 6' ' ' VAL . 8.3 p -117.72 124.15 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 152.73 46.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.284 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -112.2 145.22 40.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 37' ' ' LEU . 29.9 mt -138.29 148.57 24.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 108.27 8.05 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.95 159.08 32.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.81 93.36 3.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.106 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -162.54 -67.91 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.243 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.28 -175.63 5.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -58.44 0.46 Allowed Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.37 59.22 6.01 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.485 2.123 . . . . 0.0 112.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.15 142.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.83 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.02 151.39 25.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 80' ' ' LYS . 11.4 p -55.5 -32.34 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.681 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' HE3' ' A' ' 80' ' ' LYS . . . -60.84 -25.96 64.57 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.063 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.29 75.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.738 0.304 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.793 HD21 HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -60.35 -47.84 84.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.312 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.565 ' HA ' HD12 ' A' ' 41' ' ' ILE . 34.2 mm -59.81 -38.52 76.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.406 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.36 -41.89 97.81 Favored 'General case' 0 C--N 1.335 -0.032 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -60.22 -38.32 83.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.022 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 38' ' ' ILE . 20.0 mt -67.83 -31.8 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.502 HG13 HG21 ' A' ' 52' ' ' VAL . 22.5 t -98.12 -2.9 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -94.46 -75.79 0.5 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -91.6 -45.19 8.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.658 0.265 . . . . 0.0 111.293 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.2 ttt -54.57 -44.34 72.88 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.816 HG21 HG23 ' A' ' 52' ' ' VAL . 17.5 mt -131.94 145.66 34.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.703 0.287 . . . . 0.0 111.237 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 47.28 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -138.84 126.28 13.27 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.073 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 32.2 Cg_exo -62.41 77.03 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.938 2.425 . . . . 0.0 112.23 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -170.83 -58.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.411 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.4 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.6 p30 -82.42 -36.9 26.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.816 HG23 HG21 ' A' ' 46' ' ' ILE . 1.7 t -93.92 -35.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 t -53.75 -38.67 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.037 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -85.87 -34.37 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.083 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.64 ' HE1' HG21 ' A' ' 65' ' ' ILE . 15.9 t80 -67.48 -53.31 29.87 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 HG21 ' A' ' 42' ' ' VAL . 28.7 mm -104.77 131.1 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.916 0.388 . . . . 0.0 111.397 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -124.37 100.32 6.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.767 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 57.62 77.27 0.28 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.067 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 41.6 35.34 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -161.32 137.38 8.12 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.751 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.29 151.94 4.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.889 0.376 . . . . 0.0 111.391 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -81.87 140.52 46.96 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 52.4 Cg_exo -54.89 118.1 4.75 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 112.31 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.05 -37.08 1.94 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.504 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.64 HG21 ' HE1' ' A' ' 55' ' ' PHE . 28.0 mm -74.5 139.5 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.966 0.412 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.709 HD11 HG23 ' A' ' 95' ' ' THR . 77.8 mt -105.4 145.29 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.971 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -139.86 84.51 1.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.654 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.05 124.41 28.71 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.332 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 74' ' ' TRP . 17.3 mt -105.63 105.44 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.87 54.43 4.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.01 30.51 20.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.503 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 169.9 16.81 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.424 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -82.01 162.03 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.477 ' HA ' HD12 ' A' ' 69' ' ' ILE . 45.1 p90 -77.88 -44.2 27.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.228 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.25 -24.97 46.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.368 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -53.49 -36.44 61.69 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.962 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.34 -32.15 10.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.835 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.83 -86.19 0.07 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.06 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.573 0.349 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' VAL . 2.6 ttmp? -114.67 -27.1 7.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.45 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.79 -22.58 25.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -45.24 117.7 1.47 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.42 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -69.19 177.36 2.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.86 103.89 0.11 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.954 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -38.67 106.35 0.05 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.942 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.45 -8.88 5.9 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.741 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -80.06 164.33 23.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.166 0.483 . . . . 0.0 111.21 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.8 mm -125.0 117.33 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.12 142.48 22.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.034 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.7 m -121.68 139.46 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.317 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -119.57 79.98 1.51 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -83.93 172.68 11.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.45 118.17 9.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.103 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.709 HG23 HD11 ' A' ' 66' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.045 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 86' ' ' ASP . 29.4 m . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.753 0.311 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -130.68 126.66 37.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 90' ' ' ILE . 17.9 t -128.75 138.31 54.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.47 103.28 15.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.2 t -92.63 143.47 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.937 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.34 105.92 9.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 110.896 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 9' ' ' LEU . 96.4 m-85 -92.62 127.76 38.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.069 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 8' ' ' PHE . 6.7 mp -132.94 168.12 19.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.743 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.19 -109.46 3.45 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.299 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.79 24.69 7.86 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.014 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 55' ' ' PHE . 13.0 mt -100.55 -37.1 8.94 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.939 0.37 . . . . 0.0 111.273 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.78 -17.31 62.94 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.33 -30.02 22.55 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 1.1 mt -93.55 -27.21 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.692 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.699 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 3.0 m-85 -69.84 -74.66 0.13 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.63 0.252 . . . . 0.0 111.203 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.27 0.1 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.807 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt 50.67 37.29 16.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.45 0.3 . . . . 0.0 111.731 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 102.96 3.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.736 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.552 ' HG3' HG23 ' A' ' 21' ' ' VAL . 23.7 ptt180 -66.9 -49.03 66.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.947 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.552 HG23 ' HG3' ' A' ' 20' ' ' ARG . 24.6 t -81.21 93.61 2.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.36 154.48 29.09 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.288 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 24' ' ' ILE . 8.8 mtmp? -109.07 152.4 25.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.485 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.585 HG13 HD11 ' A' ' 37' ' ' LEU . 22.1 mm -128.28 147.17 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.55 123.19 15.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.989 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 mmt -118.71 132.87 56.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.136 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.21 47.76 1.04 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.72 -164.73 1.02 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.778 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HG3' ' HD2' ' A' ' 31' ' ' PRO . 5.9 pt-20 -68.32 -171.27 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.021 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.15 -57.56 1.1 Allowed Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.36 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' ' HG3' ' A' ' 29' ' ' GLU . 65.1 Cg_endo -72.54 61.49 3.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.284 1.99 . . . . 0.0 113.067 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.15 125.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.598 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.74 152.23 35.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.806 0.336 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.65 -34.5 47.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.807 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.52 -27.95 59.04 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -40.85 75.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.649 0.261 . . . . 0.0 110.49 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.585 HD11 HG13 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.15 -50.23 71.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.089 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -58.91 -38.86 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.11 -42.24 85.28 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -62.04 -39.57 92.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.867 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' MET . 42.7 mt -62.74 -32.13 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.794 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.863 HG13 HG11 ' A' ' 52' ' ' VAL . 32.2 t -96.46 -3.64 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.8 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.3 t -100.22 -62.68 1.21 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.556 0.217 . . . . 0.0 111.56 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 p -98.1 -50.2 4.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.515 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -55.74 -38.0 69.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.169 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.699 HD11 ' CZ ' ' A' ' 16' ' ' PHE . 23.4 mt -136.25 145.26 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.988 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -171.23 72.88 0.05 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.926 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -165.48 126.2 1.32 Allowed Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.078 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.81 77.02 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.895 2.397 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.36 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -78.48 -42.14 30.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.187 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.863 HG11 HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.6 -36.46 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.164 179.546 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 -31.1 26.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.493 0.187 . . . . 0.0 111.345 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.0 mt -94.2 -30.81 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 65' ' ' ILE . 51.9 t80 -85.67 -52.17 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.381 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.534 ' HB ' HG12 ' A' ' 52' ' ' VAL . 43.0 mm -103.74 145.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.174 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -118.48 61.83 0.78 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 57.97 84.78 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 58.12 38.67 26.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.646 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.4 t -170.1 118.99 0.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.7 HG22 HD12 ' A' ' 65' ' ' ILE . 2.2 mp -63.65 151.94 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -76.44 147.62 79.19 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.44 128.08 14.93 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.773 2.315 . . . . 0.0 112.577 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.62 -25.86 6.42 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.945 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 61' ' ' ILE . 20.0 mt -72.97 130.21 35.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 120.897 0.379 . . . . 0.0 110.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.68 121.79 45.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' SER . 91.1 m -125.66 111.18 14.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.834 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 mt -108.1 140.59 41.06 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.679 HG23 ' CD1' ' A' ' 90' ' ' ILE . 20.5 mt -119.18 111.54 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.704 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 46.92 8.58 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.78 33.44 17.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -141.3 178.46 7.4 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.38 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -80.18 -178.4 6.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.968 0.414 . . . . 0.0 111.325 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -104.45 -47.07 4.21 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.017 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.31 -30.2 30.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -26.68 62.2 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.533 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.7 -64.91 1.24 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.522 0.201 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.66 105.31 0.27 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.679 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -53.24 -65.74 0.51 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.409 0.147 . . . . 0.0 111.318 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -117.56 -39.52 3.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.25 -25.52 48.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.74 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' CE2' HG21 ' A' ' 69' ' ' ILE . 75.9 t80 -48.32 116.38 1.54 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.824 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mt -72.87 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.1 173.85 3.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.07 100.57 0.97 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.419 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' HB3' HG12 ' A' ' 2' ' ' VAL . 9.4 p-10 -46.33 118.13 1.83 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.08 15.99 9.45 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.384 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.33 171.29 9.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mm -126.94 101.16 7.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.757 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.679 ' CD1' HG23 ' A' ' 69' ' ' ILE . 8.0 mm -98.28 142.62 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -119.87 138.46 53.39 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.31 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.497 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 59.7 m-85 -130.34 82.39 2.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.471 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 9' ' ' LEU . 16.2 m -97.73 138.25 35.39 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 m -108.03 112.12 24.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 121.311 0.577 . . . . 0.0 110.458 179.835 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.75 0.309 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.0 117.18 29.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.714 ' CG1' HD13 ' A' ' 90' ' ' ILE . 18.5 t -115.66 134.73 57.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -103.06 104.68 14.87 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 90' ' ' ILE . 3.5 m -111.71 155.96 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.525 ' HG2' HG22 ' A' ' 21' ' ' VAL . 18.9 mt-10 -119.15 154.2 33.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.684 ' C ' HD22 ' A' ' 9' ' ' LEU . 42.4 m-85 -136.29 104.75 5.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.684 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.6 mm? -129.82 121.0 25.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.957 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 46.56 0.45 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.833 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.63 -35.68 4.27 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.795 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.838 HD21 ' CE1' ' A' ' 55' ' ' PHE . 3.3 mt -54.95 -42.76 72.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.653 0.227 . . . . 0.0 111.415 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.23 -37.33 82.65 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.02 -33.58 75.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mt -79.77 -42.12 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.522 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 41' ' ' ILE . 3.4 m-85 -63.72 -73.8 0.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.392 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.55 40.38 0.07 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.758 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.3 mttm 54.51 59.71 3.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 111.26 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.29 113.04 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -61.42 -32.84 72.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 7' ' ' GLU . 21.1 t -125.52 119.28 54.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -113.63 146.03 40.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.959 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.447 ' O ' HD13 ' A' ' 24' ' ' ILE . 5.2 mtpm? -108.84 146.48 33.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.27 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.939 HD11 HD12 ' A' ' 41' ' ' ILE . 17.8 mm -128.57 146.61 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.679 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -128.2 87.38 2.59 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.302 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.87 135.83 45.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.534 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.77 90.29 2.96 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.44 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.71 -67.6 0.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.396 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.94 -171.59 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -59.18 0.5 Allowed Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.99 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.73 61.46 4.54 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.369 2.046 . . . . 0.0 112.547 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.5 ' CG1' HD12 ' A' ' 84' ' ' LEU . 23.6 t -73.85 131.14 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.6 p -97.8 161.16 13.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.628 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.76 -33.03 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.594 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.96 -27.38 62.1 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.044 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -41.37 71.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.692 HD21 ' HB ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -54.82 -44.84 74.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.907 178.682 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.609 HD11 ' HZ ' ' A' ' 92' ' ' PHE . 24.4 mm -68.92 -33.34 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.788 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -50.33 36.13 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.7 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 15.8 t60 -60.48 -48.07 83.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.939 HD12 HD11 ' A' ' 24' ' ' ILE . 7.1 tt -62.72 -30.96 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.633 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.674 HG13 ' CG2' ' A' ' 52' ' ' VAL . 89.0 t -94.88 -11.24 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.9 m -100.99 -69.57 0.77 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 p -76.75 -56.91 4.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.52 -55.62 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.938 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.821 HG21 HG23 ' A' ' 52' ' ' VAL . 41.5 mt -109.93 129.43 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -149.03 59.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.028 0.442 . . . . 0.0 110.703 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -150.12 131.8 7.63 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.183 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 60.7 Cg_endo -72.03 66.12 3.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.573 2.182 . . . . 0.0 112.327 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.11 -49.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.46 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.93 -39.08 15.04 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.679 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.821 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -93.57 -35.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.121 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.4 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 13.3 t -52.93 -36.19 59.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.642 0.258 . . . . 0.0 111.12 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.99 -34.19 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.391 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.838 ' CE1' HD21 ' A' ' 12' ' ' LEU . 38.0 t80 -73.28 -52.71 12.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.325 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.571 HG13 HG21 ' A' ' 42' ' ' VAL . 32.3 mm -111.87 136.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -132.14 134.52 45.52 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.018 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.65 38.77 25.06 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.775 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 33.44 21.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.68 152.67 35.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.062 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 62' ' ' ARG . 2.1 mp -65.57 154.5 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.256 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 61' ' ' ILE . 2.7 mtt-85 -101.04 138.94 20.12 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 51.9 Cg_exo -55.22 133.32 57.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.797 2.331 . . . . 0.0 112.426 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.35 -35.57 2.56 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.681 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.52 HD13 ' CE1' ' A' ' 55' ' ' PHE . 3.1 mt -83.37 111.84 20.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.962 0.411 . . . . 0.0 110.97 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.99 146.26 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 m -129.43 136.64 50.18 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.3 mt -130.04 113.78 14.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.003 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.47 109.53 25.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.34 49.05 9.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.637 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 58.54 31.7 21.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 73' ' ' ASP . 1.5 m -135.06 170.56 15.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.385 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.63 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -79.68 172.0 14.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.262 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.424 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 23.0 p-90 -103.86 -33.99 8.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.953 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -88.24 -26.76 22.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.468 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 73' ' ' ASP . 6.1 mt -60.62 -21.66 62.93 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.32 -71.55 0.72 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.525 0.203 . . . . 0.0 111.114 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.1 108.8 0.4 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.654 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 16.4 mt-10 -54.92 -72.54 0.06 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.457 0.17 . . . . 0.0 111.074 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -104.39 -33.89 8.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.952 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.21 -23.75 23.85 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.453 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -56.38 106.13 0.26 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.81 141.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.5 HD12 ' CG1' ' A' ' 32' ' ' VAL . 17.7 mt -63.8 175.79 1.07 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.36 97.83 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -47.8 104.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.79 27.94 4.43 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.693 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.97 170.48 7.89 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.602 0.239 . . . . 0.0 111.014 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -118.31 130.35 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.714 HD13 ' CG1' ' A' ' 4' ' ' VAL . 5.2 mp -136.15 150.64 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.064 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.03 146.83 50.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.388 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.609 ' HZ ' HD11 ' A' ' 38' ' ' ILE . 18.1 m-85 -133.02 82.11 1.98 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.723 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.05 141.61 28.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -119.89 97.34 5.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.429 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 CA--C 1.534 0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.022 -179.858 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.771 0.319 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -82.26 112.05 18.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.075 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 m -110.26 129.2 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.326 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 118.16 24.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' HB ' ' A' ' 90' ' ' ILE . 2.7 m -122.75 147.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.503 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -119.38 107.27 13.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.499 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.655 ' C ' HD12 ' A' ' 9' ' ' LEU . 52.8 m-85 -85.25 128.71 34.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.655 HD12 ' C ' ' A' ' 8' ' ' PHE . 7.0 mp -135.98 149.62 48.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.956 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.72 -102.28 1.96 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.508 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.58 26.46 3.66 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.015 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.72 -41.58 8.02 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.868 0.334 . . . . 0.0 110.828 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.54 -33.05 74.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.04 73.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 -44.95 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.35 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.435 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 14.7 m-85 -65.02 -71.46 0.18 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.227 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.63 45.64 0.1 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.542 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 56.87 54.35 7.22 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 106.95 8.23 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.019 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -9.02 50.46 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.928 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.47 138.69 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.507 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.69 168.82 19.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -138.97 143.5 38.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 41' ' ' ILE . 2.9 mp -136.28 150.77 27.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.358 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.62 101.66 5.03 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.842 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG2' ' CG ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -77.67 124.45 27.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.742 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.15 68.68 9.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.93 -159.12 0.94 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.509 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -170.78 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.225 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -59.7 0.77 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.99 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 83' ' ' ILE . 86.8 Cg_endo -77.42 58.98 6.52 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.39 2.06 . . . . 0.0 112.733 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -72.6 132.23 33.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.8 p -73.91 149.26 41.56 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.64 -36.49 54.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.88 -27.79 59.81 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.64 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.93 -42.77 69.42 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.735 0.302 . . . . 0.0 110.424 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -53.5 -53.15 55.62 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' HG23 ' A' ' 42' ' ' VAL . 3.5 mt -61.01 -37.25 76.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.357 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -41.55 97.26 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG2' ' A' ' 26' ' ' MET . 1.3 t60 -62.16 -36.88 83.19 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 24' ' ' ILE . 33.1 mt -72.09 -27.65 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.296 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG21 ' CD1' ' A' ' 56' ' ' ILE . 28.8 t -94.53 -5.49 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.8 p -100.25 -72.41 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.1 p -87.32 -49.3 7.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.502 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.1 ttt -53.36 -54.74 32.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.918 HG21 HG23 ' A' ' 52' ' ' VAL . 26.0 mt -110.43 125.87 67.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.611 0.243 . . . . 0.0 110.829 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.46 74.69 1.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.188 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.78 119.93 0.42 Allowed Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.63 76.85 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.774 2.316 . . . . 0.0 112.067 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -166.14 -57.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.513 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -82.16 -36.13 27.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.758 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.918 HG23 HG21 ' A' ' 46' ' ' ILE . 1.8 t -89.43 -35.67 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.984 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 m -58.07 -34.35 70.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.38 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.0 mt -83.15 -39.12 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 111.0 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -68.44 -38.1 80.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.077 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.726 ' CD1' HG21 ' A' ' 42' ' ' VAL . 29.5 mt -132.08 129.55 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.288 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.0 122.79 48.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 55.25 52.72 11.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.76 26.61 11.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.72 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.573 ' C ' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -137.71 125.64 22.67 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 110.66 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -56.81 151.7 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.499 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -87.16 143.57 34.92 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.069 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.67 123.81 9.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.654 2.236 . . . . 0.0 112.208 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.15 -37.38 1.16 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.627 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 62' ' ' ARG . 1.9 mp -70.78 130.07 34.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 110.921 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.0 mm -110.31 152.76 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.963 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 t -146.33 142.56 28.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.692 0.282 . . . . 0.0 111.254 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 mt -131.12 108.16 9.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.562 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 32.3 mt -88.22 109.32 19.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.6 m120 58.67 43.34 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.96 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.59 30.62 18.73 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.023 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 163.99 25.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.59 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.91 117.2 20.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -50.53 -38.65 45.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.909 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.07 -43.87 94.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.655 0.264 . . . . 0.0 110.833 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.83 -26.14 65.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -111.02 30.43 6.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 111.192 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.66 96.22 0.53 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.487 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.58 -52.73 6.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.407 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -112.97 -36.45 5.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.67 56.61 2.28 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.562 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 33.1 t80 -119.08 114.98 23.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.859 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' A' ' 31' ' ' PRO . 2.9 mp -65.19 119.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 37' ' ' LEU . 27.3 mt -65.63 176.35 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 1.2 mt-10 -167.01 101.12 0.54 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.356 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -45.73 122.29 3.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.89 25.21 9.88 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.2 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.8 t70 -100.99 169.51 8.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -113.87 104.95 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.573 ' HB ' HG12 ' A' ' 6' ' ' VAL . 67.8 mt -118.79 100.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.15 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.089 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.62 103.22 5.57 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 159.48 15.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.593 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -142.22 110.47 6.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.779 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 110.803 179.825 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.694 HG23 ' HA ' ' A' ' 86' ' ' ASP . 9.0 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.654 0.264 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -105.07 89.78 3.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 37' ' ' LEU . 30.7 m -83.36 150.07 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.582 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -111.32 110.65 21.22 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 t -104.86 144.98 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.36 101.4 7.61 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.562 ' CD2' HD13 ' A' ' 12' ' ' LEU . 86.1 m-85 -89.74 128.81 36.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.39 118.45 13.45 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.302 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.06 -102.03 0.34 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.275 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.21 -33.39 3.2 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.961 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.656 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -54.91 -39.23 68.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.34 -37.8 75.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.055 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.45 68.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.997 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 45.5 mt -66.96 -34.07 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.263 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -71.89 -61.92 1.61 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.648 0.261 . . . . 0.0 111.301 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.58 48.0 0.01 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.318 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mttt 57.22 34.43 24.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 111.255 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.37 103.52 9.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.627 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -65.57 0.67 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.549 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -90.23 135.7 25.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.6 136.97 29.7 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.01 142.05 30.2 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.467 HD13 HG12 ' A' ' 41' ' ' ILE . 12.4 mt -132.78 143.64 39.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.94 123.89 45.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.54 120.09 31.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -127.57 48.16 2.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -36.79 23.24 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.017 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -157.47 -178.74 7.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -85.62 -54.04 0.43 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.949 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 3.1 Cg_exo -79.53 53.8 4.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.949 2.433 . . . . 0.0 112.333 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.8 t -74.44 139.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.645 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.21 163.87 13.2 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.531 ' O ' HD12 ' A' ' 38' ' ' ILE . 7.2 p -54.68 -40.44 51.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.995 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -29.28 58.86 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.192 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.76 -42.55 73.71 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -51.74 -53.37 40.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.091 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 34' ' ' VAL . 2.3 mp -59.08 -38.78 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.405 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.6 -41.42 94.72 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -60.49 -39.89 89.34 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.674 0.273 . . . . 0.0 110.611 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 46' ' ' ILE . 42.3 mt -64.87 -32.19 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.644 HG13 ' CG2' ' A' ' 52' ' ' VAL . 29.7 t -96.39 -1.41 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.92 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -100.29 -72.73 0.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 t -87.97 -40.56 13.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.478 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -59.56 4.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.054 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.75 HG21 HG23 ' A' ' 52' ' ' VAL . 4.4 mt -117.53 148.43 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 120.706 0.289 . . . . 0.0 111.272 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -165.2 41.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.94 139.75 36.56 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.86 73.45 3.63 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.705 2.27 . . . . 0.0 112.463 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -169.38 -47.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.622 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -93.39 -35.9 12.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.75 HG23 HG21 ' A' ' 46' ' ' ILE . 2.1 t -91.22 -35.4 7.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -54.4 -33.22 58.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.4 mt -84.51 -33.05 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.309 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.656 ' CE1' HD11 ' A' ' 12' ' ' LEU . 10.5 t80 -77.82 -35.57 51.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.03 133.26 69.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.393 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.1 -156.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.56 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.57 85.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.06 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.1 t0 60.7 40.75 15.95 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.163 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -178.57 138.92 0.17 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mt -65.78 142.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.42 ' O ' HD12 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -89.55 155.85 48.19 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.35 146.33 68.59 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.7 2.267 . . . . 0.0 112.467 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.67 -42.54 1.46 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.578 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.522 HG21 ' HE1' ' A' ' 55' ' ' PHE . 1.9 mp -73.1 122.44 25.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.982 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -94.68 131.45 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.419 ' HB ' ' CG ' ' A' ' 74' ' ' TRP . 0.3 OUTLIER -122.33 114.56 20.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 68' ' ' LEU . 24.7 mt -112.76 109.19 18.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.0 mt -88.16 98.58 7.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.55 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.1 m120 57.37 55.25 5.93 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.736 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 31.58 20.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.536 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.97 159.74 40.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.462 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.806 ' HB2' HD12 ' A' ' 76' ' ' LEU . 2.7 m-20 -79.79 120.4 24.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.419 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -57.12 -30.68 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.639 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.05 -30.58 44.13 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.584 0.23 . . . . 0.0 111.129 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' HB2' ' A' ' 73' ' ' ASP . 4.8 mt -65.55 -18.11 65.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.575 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -133.59 38.66 3.24 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 111.384 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.59 103.54 0.25 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.068 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' O ' HG11 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -47.77 -61.88 1.73 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.101 0.16 . . . . 0.0 111.267 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.15 -28.78 11.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.19 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.76 -29.45 18.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.453 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -58.87 114.4 2.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.807 0.337 . . . . 0.0 110.605 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mp -76.82 144.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 84' ' ' LEU . 20.1 mt -64.46 171.69 3.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.203 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -171.04 104.25 0.23 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.471 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.694 ' HA ' HG23 ' A' ' 2' ' ' VAL . 27.1 t70 -46.11 115.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.995 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 20.06 6.67 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.779 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.05 169.98 8.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.779 0.324 . . . . 0.0 111.403 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.452 ' O ' HD13 ' A' ' 90' ' ' ILE . 15.3 mt -127.53 152.34 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.753 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 89' ' ' ILE . 21.2 mm -135.5 150.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.222 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -130.11 138.92 50.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.019 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.85 90.76 2.95 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.019 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.19 104.24 16.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 80.98 1.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.761 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.675 0.274 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -155.85 96.03 1.7 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.74 153.85 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.448 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HG2' HG13 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -115.34 107.77 15.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.581 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.863 HG12 ' HB ' ' A' ' 90' ' ' ILE . 27.5 m -111.91 155.41 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.379 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 21' ' ' VAL . 2.2 mt-10 -124.88 152.64 43.76 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.592 ' O ' HD12 ' A' ' 9' ' ' LEU . 50.8 m-85 -128.92 114.12 16.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.352 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 8' ' ' PHE . 10.9 mp -128.66 108.39 10.45 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.701 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.8 -101.71 0.35 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.528 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.0 28.28 4.15 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.103 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -106.57 -45.34 4.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.737 0.269 . . . . 0.0 110.844 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.25 -33.57 71.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.08 86.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -72.01 -41.89 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -66.8 -71.59 0.19 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.62 43.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.626 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 54.7 34.51 21.79 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.545 0.338 . . . . 0.0 111.524 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.24 112.38 24.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -61.48 -67.05 0.44 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.905 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' A' ' 7' ' ' GLU . 36.3 t -90.83 117.89 34.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.986 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 148.32 38.19 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.052 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -115.84 137.67 51.88 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -134.37 139.84 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 123.4 21.55 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -38.29 54.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.576 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.08 43.48 26.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.92 0.39 . . . . 0.0 111.085 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.05 -74.13 0.62 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.591 ' HG2' HG22 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -133.72 -174.28 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -59.64 0.36 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.097 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.12 57.93 6.37 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.318 2.012 . . . . 0.0 112.573 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.591 HG22 ' HG2' ' A' ' 29' ' ' GLU . 21.7 t -74.85 118.9 21.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 p -66.21 147.01 53.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.37 -34.65 23.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.556 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.87 -26.77 58.44 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.117 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.5 -42.07 62.28 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.663 0.268 . . . . 0.0 110.615 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -54.04 -53.05 58.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.198 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.491 ' HA ' HD12 ' A' ' 41' ' ' ILE . 16.4 mt -62.36 -40.03 86.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.386 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.75 -42.71 99.32 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -58.94 -43.29 91.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.957 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 38' ' ' ILE . 15.2 mt -64.52 -32.21 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.141 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.603 HG13 ' CG2' ' A' ' 52' ' ' VAL . 21.9 t -97.14 -3.51 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -92.92 -75.44 0.49 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.507 0.194 . . . . 0.0 111.357 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -94.62 -43.02 8.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.187 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -38.45 67.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.776 HG21 HG23 ' A' ' 52' ' ' VAL . 47.0 mt -136.92 136.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.301 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -159.1 38.44 0.21 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 23.0 t30 -128.54 127.45 23.6 Favored Pre-proline 0 C--N 1.334 -0.088 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.866 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 24.9 Cg_exo -64.44 76.58 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.692 2.261 . . . . 0.0 112.254 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -168.25 -45.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.43 -31.54 12.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.135 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.776 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -102.57 -35.52 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.206 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -36.46 61.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.571 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.625 HD12 ' N ' ' A' ' 55' ' ' PHE . 1.4 pp -94.93 -22.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' N ' HD12 ' A' ' 54' ' ' ILE . 46.4 t80 -77.25 -49.07 15.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.594 0.235 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.1 mm -106.5 150.28 9.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.07 85.12 2.2 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 57.06 67.25 1.01 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.401 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 76.28 -42.87 0.45 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.336 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -82.04 129.93 34.94 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.724 0.297 . . . . 0.0 110.985 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.48 153.38 6.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.348 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -82.66 135.95 45.61 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.174 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.18 106.54 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.65 2.234 . . . . 0.0 111.965 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.13 -35.52 0.24 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.75 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 mt -67.21 121.57 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.836 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -90.01 97.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.8 t -104.75 136.28 44.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.9 mt -126.1 118.53 25.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.445 HG23 HG12 ' A' ' 90' ' ' ILE . 33.6 mt -102.01 109.5 26.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.492 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.03 48.14 13.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.61 38.77 21.97 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.362 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.62 161.95 38.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.721 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.72 124.77 29.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.403 ' CG ' HG23 ' A' ' 67' ' ' THR . 1.0 OUTLIER -55.84 -33.59 64.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.506 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -80.11 -33.4 38.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.669 0.271 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.74 -24.87 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -103.52 -58.21 1.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.513 0.197 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.3 98.22 0.11 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.626 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -47.04 -56.81 5.83 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.127 0.171 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -117.34 -30.64 5.52 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.937 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.92 56.62 2.38 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.168 0.509 . . . . 0.0 110.977 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -137.65 112.52 8.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.76 127.87 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 37' ' ' LEU . 15.6 mt -65.31 177.7 1.06 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 110.741 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -163.45 100.03 0.93 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.143 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -49.07 108.91 0.21 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.03 26.31 5.55 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.16 176.15 5.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.662 0.268 . . . . 0.0 111.041 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -116.77 111.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.362 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.863 ' HB ' HG12 ' A' ' 6' ' ' VAL . 62.6 mt -126.41 97.61 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.4 m -79.91 158.54 26.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.501 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -145.05 85.24 1.74 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -91.92 162.67 14.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.623 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.44 93.96 2.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.865 0.364 . . . . 0.0 110.823 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.918 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 86' ' ' ASP . 9.1 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.661 0.267 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -112.93 93.16 4.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.871 HG21 HD21 ' A' ' 37' ' ' LEU . 25.2 m -93.3 144.16 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -116.37 97.31 5.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.665 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -92.79 146.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -116.98 97.65 6.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' HD12 ' A' ' 9' ' ' LEU . 72.0 m-85 -87.23 117.92 26.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 8' ' ' PHE . 10.3 mp -127.23 176.47 7.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.467 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.94 -112.22 3.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.354 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.81 23.17 12.03 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.784 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.574 HD21 ' CE1' ' A' ' 55' ' ' PHE . 1.1 mt -100.27 -43.31 6.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.805 0.303 . . . . 0.0 111.212 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.12 -34.03 67.96 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.39 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -33.74 76.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.703 0.287 . . . . 0.0 111.097 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.7 mt -80.28 -41.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.326 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -61.96 -73.3 0.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.267 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.78 41.63 0.09 OUTLIER Glycine 0 C--N 1.335 0.472 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt 53.59 41.56 32.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.717 0.294 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -121.78 121.83 38.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -46.06 91.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.384 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 10.1 p -121.34 126.93 75.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.85 135.75 54.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.492 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 24' ' ' ILE . 11.8 pttt -102.46 146.35 28.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.361 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 23' ' ' LYS . 19.0 mm -132.22 147.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -121.52 98.14 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.774 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.457 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -96.18 139.55 32.18 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -138.16 81.51 1.86 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -120.62 -63.07 1.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -148.4 -175.51 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.797 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.26 -60.14 0.3 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.052 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.49 58.02 6.8 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.489 2.126 . . . . 0.0 112.297 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.59 ' HB ' HD12 ' A' ' 84' ' ' LEU . 22.5 t -81.17 152.67 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.339 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -103.36 163.8 12.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.327 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.472 ' HA ' HD21 ' A' ' 84' ' ' LEU . 7.5 p -58.55 -34.46 51.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.028 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -27.71 62.61 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.11 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -71.36 -41.86 69.2 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.641 0.258 . . . . 0.0 110.42 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -54.96 -51.79 65.05 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.328 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mt -59.18 -39.67 79.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.336 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.25 -41.94 89.96 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -60.76 -45.02 95.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.204 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.609 HG22 HD12 ' A' ' 46' ' ' ILE . 28.2 mt -62.68 -28.41 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.395 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 56' ' ' ILE . 32.8 t -100.52 -9.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -76.21 -75.62 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.58 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.3 m -100.33 -36.33 9.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.294 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.4 mmm -56.64 -53.49 57.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.431 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.613 ' CG2' HG23 ' A' ' 52' ' ' VAL . 9.6 mt -124.61 88.03 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 120.938 0.399 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -104.2 51.17 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.48 116.54 6.47 Favored Pre-proline 0 N--CA 1.457 -0.105 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.67 -30.92 30.4 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.77 2.313 . . . . 0.0 112.739 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -55.96 -48.91 74.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.319 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.14 31.48 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.755 HG21 HG13 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -150.56 -49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 p -56.68 -27.54 59.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.474 0.178 . . . . 0.0 111.447 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.2 mt -84.04 -33.87 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.666 0.27 . . . . 0.0 110.625 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.574 ' CE1' HD21 ' A' ' 12' ' ' LEU . 52.0 t80 -74.34 -44.21 53.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.085 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 42' ' ' VAL . 42.1 mt -111.57 148.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.899 0.381 . . . . 0.0 111.38 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.15 -158.33 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.851 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.28 92.63 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.109 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t0 53.35 37.0 24.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.874 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.45 141.04 1.48 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.557 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.498 HG22 HD12 ' A' ' 65' ' ' ILE . 2.6 mt -58.06 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.705 0.288 . . . . 0.0 111.334 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.99 120.2 58.91 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.72 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.57 101.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.676 2.251 . . . . 0.0 112.166 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.67 -42.65 0.63 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.694 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 61' ' ' ILE . 4.6 mt -59.12 140.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.937 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -108.3 137.71 38.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.118 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.9 t -137.63 125.9 23.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 41.0 mt -108.66 111.09 22.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.54 111.73 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.615 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 58.85 47.5 12.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.96 34.1 23.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.963 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.1 m -140.88 161.7 37.21 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.617 ' HB2' HD23 ' A' ' 76' ' ' LEU . 1.5 m-20 -79.89 150.79 30.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.377 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -62.44 -42.33 99.39 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.43 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.17 -9.07 58.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -63.26 -35.85 81.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.343 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.54 29.3 6.65 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 111.503 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 75' ' ' GLU . . . 121.51 -102.72 0.83 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.442 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.72 -81.13 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 122.546 0.338 . . . . 0.0 110.303 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -104.82 -24.55 12.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.273 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -52.98 -25.48 12.19 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -45.15 107.7 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 110.489 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mt -68.26 138.41 22.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.59 HD12 ' HB ' ' A' ' 32' ' ' VAL . 18.4 mt -66.52 174.07 3.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -170.85 104.22 0.24 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.504 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 2' ' ' VAL . 6.1 t0 -42.06 109.17 0.12 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.007 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.02 27.05 4.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.44 165.77 12.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.02 116.64 46.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.804 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 90' ' ' ILE . 4.0 mp -115.92 150.49 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 67' ' ' THR . 40.3 m -130.26 142.33 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.708 0.29 . . . . 0.0 111.413 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB3' HD13 ' A' ' 12' ' ' LEU . 11.1 m-85 -130.99 95.27 3.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 156.86 16.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.084 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 t -153.92 79.94 1.14 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 179.67 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -157.64 94.23 1.34 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.884 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 m -105.19 135.38 43.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -89.23 115.56 26.82 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.709 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 7.7 t -110.4 148.48 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.244 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -119.29 99.18 6.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CE1' HD22 ' A' ' 12' ' ' LEU . 93.8 m-85 -84.55 133.45 34.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.552 HD13 HG23 ' A' ' 93' ' ' THR . 5.4 mp -140.64 152.13 45.16 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -101.53 2.76 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.222 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.75 -28.74 4.66 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 8' ' ' PHE . 1.4 mt -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.897 0.349 . . . . 0.0 111.734 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.04 -33.48 75.9 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.419 0.152 . . . . 0.0 111.12 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.75 80.87 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.401 HG21 ' CB ' ' A' ' 51' ' ' ASP . 4.7 mt -81.69 -34.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.521 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.8 -73.22 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.58 0.228 . . . . 0.0 111.187 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.8 41.75 0.09 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.591 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 53.19 34.78 18.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.484 0.313 . . . . 0.0 111.705 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -121.61 123.55 42.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.613 0.244 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -26.87 68.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.598 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 7.5 p -132.46 135.27 58.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.838 0.352 . . . . 0.0 110.934 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.16 142.23 28.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -85.42 142.22 29.41 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.991 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.1 mm -123.9 140.75 46.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.135 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.3 115.62 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 40' ' ' HIS . 15.1 ttt -88.98 -42.36 11.83 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.141 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 86.25 0.1 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -66.09 0.37 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.58 -169.26 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.456 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -86.83 -54.2 0.39 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.082 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 4.8 Cg_exo -74.08 55.86 3.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.834 2.356 . . . . 0.0 112.588 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.59 124.78 49.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.619 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.73 153.98 30.42 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.14 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -56.19 -33.66 37.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.71 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.5 -27.64 54.45 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.82 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -40.74 68.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.677 0.275 . . . . 0.0 110.496 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.88 -52.89 61.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.344 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.445 HG23 ' CE2' ' A' ' 55' ' ' PHE . 16.3 mt -60.17 -41.29 86.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.107 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -61.23 -40.01 92.39 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG3' ' A' ' 26' ' ' MET . 72.6 t60 -58.52 -46.72 86.18 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 46' ' ' ILE . 17.9 mt -63.29 -30.01 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.279 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 56' ' ' ILE . 39.5 t -97.15 -4.9 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.76 -73.92 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.3 m -87.34 -45.14 10.84 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.465 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.428 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -54.77 -51.67 64.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.042 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.822 ' CG2' HG23 ' A' ' 52' ' ' VAL . 7.6 mt -121.79 150.96 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.106 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -160.81 65.53 0.3 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.42 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 8.9 t30 -170.88 138.51 1.22 Allowed Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 120.601 0.239 . . . . 0.0 111.572 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.88 75.17 3.23 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.735 2.29 . . . . 0.0 112.6 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 48' ' ' ASN . 20.3 p-10 -166.13 -41.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.401 ' CB ' HG21 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -100.98 -37.31 8.69 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.822 HG23 ' CG2' ' A' ' 46' ' ' ILE . 2.1 t -82.5 -34.45 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.412 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -50.88 -31.94 18.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.677 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.95 -46.31 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.755 0.312 . . . . 0.0 111.018 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.481 ' O ' HD13 ' A' ' 56' ' ' ILE . 17.8 t80 -66.59 -47.87 71.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.848 HG13 HG21 ' A' ' 42' ' ' VAL . 28.2 mm -129.57 143.55 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.813 0.34 . . . . 0.0 111.294 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.5 127.89 26.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 58.33 45.43 16.98 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.449 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 53.99 33.5 17.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.374 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.4 m -150.53 145.66 26.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.915 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.87 152.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -92.64 137.73 24.12 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 99.59 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.582 2.188 . . . . 0.0 111.89 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.17 -35.28 0.44 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.558 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -66.27 134.48 29.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.43 118.62 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 91' ' ' SER . 4.5 t -121.5 92.09 3.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.945 0.402 . . . . 0.0 111.016 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.4 mt -101.23 122.0 42.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.207 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mt -100.66 107.73 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.02 52.64 6.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.33 30.64 19.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.117 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -133.28 164.99 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -79.77 177.6 8.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.921 0.391 . . . . 0.0 111.18 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -102.88 -39.94 6.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.92 -27.62 28.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.763 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -54.27 -30.6 51.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -115.69 -62.15 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.522 0.201 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.75 103.86 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.686 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -57.5 6.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.59 0.234 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -117.4 -44.3 2.77 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.1 -27.0 5.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.018 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -48.99 109.53 0.27 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.428 HD12 ' H ' ' A' ' 83' ' ' ILE . 3.4 mp -68.95 133.33 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.138 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -67.63 172.44 5.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.804 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.16 102.6 0.29 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.395 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -48.91 114.51 1.01 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.71 -9.56 6.81 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.814 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.538 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -80.04 157.23 26.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.045 0.422 . . . . 0.0 111.163 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 89' ' ' ILE . 1.5 mp -107.69 125.45 64.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.764 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 6.5 mt -125.99 141.89 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.27 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -116.57 142.21 47.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.76 90.98 3.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.794 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.552 HG23 HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -108.04 95.52 5.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.874 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -88.04 89.4 7.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.707 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 86' ' ' ASP . 7.7 p . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.02 0.438 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -87.63 117.19 26.27 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.413 ' HB ' HD13 ' A' ' 90' ' ' ILE . 18.2 m -114.98 139.5 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.25 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.94 105.88 16.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.655 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.816 HG12 ' HB ' ' A' ' 90' ' ' ILE . 8.4 m -98.68 146.13 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.329 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -126.0 98.43 5.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.64 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.449 ' C ' HD12 ' A' ' 9' ' ' LEU . 98.0 m-85 -82.95 142.48 31.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' ' 8' ' ' PHE . 5.4 mp -146.04 172.45 13.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.213 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.75 -107.96 2.59 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.219 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.44 -6.04 13.76 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.664 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -65.72 -45.13 83.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.398 0.599 . . . . 0.0 111.284 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.56 -30.22 69.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.256 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.66 88.21 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.658 0.266 . . . . 0.0 111.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 11.0 mt -70.43 -40.14 77.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.601 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.5 m-85 -66.44 -70.16 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.45 48.04 0.04 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.366 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt 56.77 33.81 23.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.382 0.273 . . . . 0.0 111.344 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -104.16 110.65 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.755 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.45 -62.39 1.49 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.45 144.14 20.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.808 0.337 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -180.0 6.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.515 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.9 141.79 25.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.2 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 23' ' ' LYS . 20.0 mm -135.16 146.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.17 84.0 2.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.04 127.25 30.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.177 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.38 92.86 4.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.97 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -144.38 -66.04 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.43 -178.03 6.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.197 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.73 -59.78 0.35 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.002 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.94 58.78 6.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.558 2.172 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -92.38 132.86 35.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.2 p -75.37 153.02 37.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.859 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.14 -32.13 33.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.707 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -26.52 55.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.086 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.01 -45.71 69.84 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.584 0.231 . . . . 0.0 110.56 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -54.28 -46.82 72.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.221 178.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.3 mt -58.13 -41.12 79.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.322 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -37.63 80.53 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.835 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.6 -40.48 97.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.866 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.492 HD11 HG13 ' A' ' 24' ' ' ILE . 22.1 mm -65.75 -31.22 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.676 HG21 HG13 ' A' ' 56' ' ' ILE . 24.0 t -97.46 -2.9 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -99.54 -75.74 0.56 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -87.42 -48.07 8.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.359 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.17 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.746 HG21 HG23 ' A' ' 52' ' ' VAL . 16.1 mt -126.48 136.39 60.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -153.0 44.01 0.64 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -130.64 129.56 22.74 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.193 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.55 73.85 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.39 -52.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.575 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.456 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.3 p30 -83.91 -35.64 23.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.746 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -89.74 -35.67 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 t -58.43 -38.98 78.57 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.312 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.27 -36.86 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.316 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.06 -51.43 38.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.062 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.676 HG13 HG21 ' A' ' 42' ' ' VAL . 28.4 mm -111.71 125.35 69.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.134 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -114.5 122.77 47.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.766 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.11 45.14 21.3 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.73 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.29 32.33 21.58 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.362 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -143.89 147.87 34.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -61.58 152.32 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -93.64 148.44 35.42 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.92 122.16 9.26 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.752 2.301 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.47 -46.26 1.08 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.768 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.64 117.81 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.5 mm -80.55 147.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.524 HG23 ' CG ' ' A' ' 74' ' ' TRP . 7.4 t -147.49 99.86 3.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.19 143.11 32.41 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 89' ' ' ILE . 17.1 mt -126.09 112.22 29.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.37 44.74 11.87 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.984 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.31 39.09 25.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -142.93 166.36 24.84 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.42 28.54 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.533 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.87 -36.01 46.99 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.906 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -39.54 32.02 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.406 0.146 . . . . 0.0 111.358 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -25.22 62.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -106.56 -35.75 6.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.238 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.4 98.53 0.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.533 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 2.9 tt0 -42.06 -69.61 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.258 0.223 . . . . 0.0 111.552 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -116.66 -36.81 3.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.971 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.77 -24.94 24.77 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.494 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -52.12 110.94 0.54 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.837 0.351 . . . . 0.0 110.728 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.0 mt -68.49 141.0 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.12 176.43 0.75 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.04 103.52 0.3 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.41 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.569 ' HA ' HG23 ' A' ' 2' ' ' VAL . 17.3 t0 -43.01 108.29 0.1 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.819 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 29.91 3.4 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.66 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.636 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -103.81 165.06 11.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.636 HD12 ' C ' ' A' ' 88' ' ' ASP . 1.6 mp -115.92 141.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.78 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.816 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.7 mp -138.43 90.12 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -81.41 132.73 35.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -118.95 110.09 16.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.34 100.94 8.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.0 t -92.4 88.05 6.25 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 CA--C 1.538 0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.911 -179.759 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.607 0.241 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.04 112.13 10.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.16 134.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 116.74 33.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.764 HG12 ' HB ' ' A' ' 90' ' ' ILE . 6.6 m -122.47 143.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.403 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -110.95 153.79 25.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' C ' HD22 ' A' ' 9' ' ' LEU . 44.9 m-85 -128.57 118.23 22.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.048 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.628 ' CB ' HG23 ' A' ' 93' ' ' THR . 4.5 mm? -122.78 171.59 9.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.18 -103.14 1.54 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.436 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.05 27.27 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.948 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.586 HD21 ' CE1' ' A' ' 55' ' ' PHE . 3.4 mt -87.64 -41.41 13.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.825 0.313 . . . . 0.0 110.896 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.2 -33.93 71.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.165 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.77 -31.99 73.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.229 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mt -74.3 -46.89 42.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.216 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -62.76 -65.58 0.67 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.319 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.48 46.74 0.03 OUTLIER Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.444 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.9 mttt 57.44 51.72 9.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -125.82 122.33 35.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.992 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -68.86 -64.31 0.89 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.93 137.32 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -126.93 156.67 41.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.059 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -123.89 132.2 53.7 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.811 HG13 HD11 ' A' ' 41' ' ' ILE . 23.3 mm -116.69 144.07 25.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.338 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.45 108.31 10.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -100.11 110.12 22.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.993 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -102.39 63.83 0.89 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 110.904 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -112.44 -44.98 3.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.012 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' CG ' HG22 ' A' ' 32' ' ' VAL . 9.5 pt-20 -169.95 -176.66 2.38 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -86.29 -51.93 0.46 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.5 Cg_exo -78.67 54.09 4.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.961 2.44 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.462 HG22 ' CG ' ' A' ' 29' ' ' GLU . 26.8 t -85.65 122.48 38.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.026 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -74.4 150.45 40.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.234 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -52.59 -30.77 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.583 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.56 -25.71 61.27 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.279 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.4 -43.48 73.37 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -55.67 -47.06 77.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.775 178.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.68 -39.15 78.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.014 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.77 -41.07 94.76 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.829 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -59.89 -41.87 92.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.807 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.811 HD11 HG13 ' A' ' 24' ' ' ILE . 33.9 mm -63.81 -33.18 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.047 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.646 HG13 ' CG2' ' A' ' 52' ' ' VAL . 38.2 t -98.06 -3.89 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 m -95.54 -75.22 0.53 Allowed 'General case' 0 C--O 1.232 0.183 0 O-C-N 122.382 -0.199 . . . . 0.0 111.463 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 t -93.15 -38.78 11.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.458 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -46.81 88.62 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.079 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.717 HG21 HG23 ' A' ' 52' ' ' VAL . 20.1 mt -129.77 150.98 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.25 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -166.06 40.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.106 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.2 t-20 -128.58 128.44 23.56 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.484 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 25.0 Cg_exo -63.67 74.37 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.84 2.36 . . . . 0.0 112.191 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.07 -58.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.457 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.2 p30 -81.29 -34.56 31.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.758 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.717 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -91.78 -36.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.065 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.86 72.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.432 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.4 mt -86.63 -36.84 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.025 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CE1' HD21 ' A' ' 12' ' ' LEU . 31.9 t80 -69.09 -37.04 78.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.088 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 42' ' ' VAL . 35.1 mm -127.3 130.13 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.795 0.331 . . . . 0.0 111.353 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.41 -158.32 0.6 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.591 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.55 85.99 0.11 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.895 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 60.75 46.75 8.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.39 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.39 175.94 2.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.4 mt -97.07 153.4 3.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.832 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 125.31 79.04 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.85 105.33 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.62 2.213 . . . . 0.0 112.065 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 151.88 -31.25 0.9 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.557 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.522 HD12 ' CG2' ' A' ' 61' ' ' ILE . 31.2 mt -70.38 127.59 32.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mt -100.77 134.69 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.958 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 91' ' ' SER . 1.5 m -138.24 143.81 40.28 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.234 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.3 mt -139.4 126.21 20.82 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.447 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 77' ' ' GLU . 9.6 mt -100.73 102.35 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.0 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 59.99 59.75 2.33 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.304 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 57.83 26.02 12.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.58 173.27 11.04 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.036 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 2.3 m-20 -79.38 157.95 27.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -59.99 2.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.712 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.24 -37.42 77.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.185 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -60.36 -29.98 69.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.923 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.441 ' HB3' HD12 ' A' ' 69' ' ' ILE . 2.8 tp10 -93.57 28.4 2.31 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.069 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.95 -6.55 82.73 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.59 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 67.85 -72.41 0.09 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.027 0.414 . . . . 0.0 111.021 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -116.78 -29.71 5.97 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.03 54.88 1.68 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.227 0.537 . . . . 0.0 110.922 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -124.58 113.62 18.31 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.615 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.6 mt -61.45 128.5 22.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.8 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 84' ' ' LEU . 18.4 mt -64.2 174.5 1.57 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.858 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.39 103.65 0.21 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -46.68 113.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.026 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 23.98 5.69 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.02 177.65 4.83 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.337 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 mm -121.74 132.23 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.764 ' HB ' HG12 ' A' ' 6' ' ' VAL . 62.1 mt -143.06 92.55 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.631 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 67' ' ' THR . 12.9 m -79.88 149.11 31.05 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.711 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -134.46 86.87 2.3 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.776 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.628 HG23 ' CB ' ' A' ' 9' ' ' LEU . 1.2 m -91.23 144.72 25.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.604 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -148.66 79.98 1.44 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.004 0.43 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.432 HG13 ' CA ' ' A' ' 86' ' ' ASP . 5.1 t . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.737 0.303 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -80.18 125.28 29.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.551 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 37' ' ' LEU . 31.2 m -128.47 139.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.79 118.28 36.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.889 HG12 ' HB ' ' A' ' 90' ' ' ILE . 35.0 m -119.0 153.25 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.376 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.498 ' CD ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -125.77 158.86 33.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.809 ' C ' HD22 ' A' ' 9' ' ' LEU . 8.2 p90 -160.24 148.03 16.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.809 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.0 mm? -137.96 178.22 7.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.112 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.59 -109.97 3.04 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.83 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.19 -24.22 17.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.943 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 55' ' ' PHE . 4.3 mm? -55.03 -46.41 75.29 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.721 0.261 . . . . 0.0 111.362 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.89 -30.73 71.07 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.0 -38.2 45.4 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.271 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 22.3 mt -75.63 -44.59 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.71 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.451 ' HE2' HD12 ' A' ' 12' ' ' LEU . 3.0 m-85 -59.27 -69.78 0.19 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.521 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.74 46.85 0.03 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.452 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.74 44.89 22.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -121.3 -176.66 3.34 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 -56.44 0.56 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.498 HG22 ' CD ' ' A' ' 7' ' ' GLU . 20.8 t -99.91 117.67 45.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.31 153.57 28.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.21 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -124.47 119.08 28.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 24' ' ' ILE . 3.9 mp -99.45 143.07 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -116.22 80.42 1.45 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.293 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.97 106.75 18.62 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -93.92 43.83 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.121 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HB3' HG21 ' A' ' 32' ' ' VAL . 1.3 tttp -90.11 -162.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -65.07 -172.19 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.904 0.383 . . . . 0.0 111.365 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -83.47 -54.01 0.54 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.036 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.7 Cg_exo -78.66 50.22 3.35 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.858 2.372 . . . . 0.0 112.713 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.578 HG21 ' HB3' ' A' ' 28' ' ' LYS . 35.4 t -81.84 126.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 1.3 p -73.34 157.47 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.914 0.387 . . . . 0.0 111.2 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.54 -34.98 48.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.471 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 38' ' ' ILE . . . -56.33 -28.33 54.79 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.875 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -68.91 -43.39 75.31 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -53.04 -51.93 60.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.482 HD12 ' HA2' ' A' ' 35' ' ' GLY . 4.6 mt -59.97 -36.84 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.171 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -63.75 -37.85 88.89 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.766 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -60.85 -39.64 89.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.627 0.251 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.418 ' CG1' HG12 ' A' ' 24' ' ' ILE . 17.8 mt -72.74 -25.76 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.842 HG13 HG21 ' A' ' 52' ' ' VAL . 30.8 t -100.09 -1.44 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -93.72 -77.87 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.381 -0.199 . . . . 0.0 111.234 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.29 -40.87 14.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -56.88 16.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.148 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.903 HG21 HG23 ' A' ' 52' ' ' VAL . 22.2 mt -116.24 123.01 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 120.629 0.252 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.6 39.34 1.69 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.139 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -131.84 129.24 21.87 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.72 70.18 2.11 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.519 2.146 . . . . 0.0 112.044 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.9 -50.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.448 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.4 p30 -88.68 -36.88 15.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.947 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.903 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -94.08 -35.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.342 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 m -56.11 -32.1 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.447 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 33.2 mt -92.08 -32.03 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.56 0.219 . . . . 0.0 111.127 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CE1' HD11 ' A' ' 12' ' ' LEU . 58.3 t80 -73.37 -37.4 66.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.01 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CD1' HG21 ' A' ' 42' ' ' VAL . 27.1 mt -127.93 150.32 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.17 -163.98 1.02 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.695 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.62 92.41 0.07 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.735 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.5 33.66 22.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.471 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.1 p -165.93 122.55 1.37 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.867 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.82 151.61 9.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 20.1 mtt180 -74.5 142.36 77.71 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.16 97.14 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.689 2.26 . . . . 0.0 112.203 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.9 -39.2 0.09 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.49 132.92 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.5 mt -108.18 93.49 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.539 HG23 ' CG ' ' A' ' 74' ' ' TRP . 3.5 t -93.61 138.66 31.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -125.03 122.27 36.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.54 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.24 101.65 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 60.25 59.9 2.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.356 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 58.29 24.56 11.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.582 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -129.38 178.85 6.15 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.173 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -80.02 -177.07 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 111.009 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.539 ' CG ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.61 -39.8 6.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.94 -24.59 19.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.017 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.435 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -54.42 -29.76 50.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.22 -69.32 0.86 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.563 0.221 . . . . 0.0 111.167 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.71 106.81 0.3 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.434 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.11 -71.01 0.08 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.504 0.192 . . . . 0.0 111.067 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -107.83 -36.65 6.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.947 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.37 -29.15 22.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.783 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.53 121.25 4.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.677 0.275 . . . . 0.0 110.856 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.97 138.36 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.05 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.438 HD13 HD23 ' A' ' 37' ' ' LEU . 20.6 mt -66.52 177.9 1.41 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.856 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.85 103.28 0.11 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.909 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.432 ' CA ' HG13 ' A' ' 2' ' ' VAL . 12.4 t0 -35.22 111.91 0.14 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.44 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.4 6.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.946 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -95.26 164.33 12.89 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.823 0.344 . . . . 0.0 111.082 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm -119.49 134.5 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.172 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.889 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.4 mp -139.0 154.04 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.045 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 67' ' ' THR . 16.3 m -134.75 161.6 34.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.14 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.405 ' CD1' ' HB ' ' A' ' 67' ' ' THR . 94.1 m-85 -150.39 79.98 1.35 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -87.38 130.56 34.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.437 ' HB2' HD23 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -114.54 101.18 8.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.628 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.39 167.94 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.799 0.333 . . . . 0.0 111.818 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -151.5 132.55 14.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.13 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.36 120.29 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.38 102.09 13.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -99.47 142.12 15.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HG3' HG23 ' A' ' 21' ' ' VAL . 1.2 mt-10 -118.07 102.49 9.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.64 ' C ' HD12 ' A' ' 9' ' ' LEU . 88.2 m-85 -88.06 131.7 34.56 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 8' ' ' PHE . 6.8 mp -139.3 175.83 9.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.237 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 -85.96 1.35 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.625 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.15 28.1 1.55 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.869 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.777 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -105.93 -46.3 4.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.08 -26.35 66.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.367 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.75 80.42 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.827 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 4.3 mt -77.03 -40.5 30.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -63.74 -30.78 71.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.02 46.55 0.22 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.69 34.71 25.03 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.12 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.75 97.77 8.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.71 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -31.16 70.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 7' ' ' GLU . 8.0 p -139.9 128.39 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.917 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.69 138.63 37.92 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 142.23 27.58 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.539 HG13 HD11 ' A' ' 41' ' ' ILE . 25.8 mm -121.39 148.13 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.32 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 126.3 31.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 142.22 50.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.48 102.07 4.52 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -149.37 -69.33 0.21 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.489 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.66 -178.25 5.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.013 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.6 -57.98 0.67 Allowed Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.378 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.88 61.78 3.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.388 2.059 . . . . 0.0 112.724 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.509 ' CG1' HD12 ' A' ' 84' ' ' LEU . 21.4 t -77.58 116.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.561 HG22 HD13 ' A' ' 83' ' ' ILE . 56.8 p -84.84 160.1 20.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.898 0.38 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -58.15 -34.14 48.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.62 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.25 62.0 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.965 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -42.69 71.35 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.746 0.308 . . . . 0.0 110.303 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 84' ' ' LEU . 1.9 tm? -53.0 -52.39 58.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.254 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.4 mt -57.96 -39.6 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.256 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.93 -44.29 91.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.733 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -38.16 76.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.539 HD11 HG13 ' A' ' 24' ' ' ILE . 32.2 mm -68.68 -28.97 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.57 HG13 ' CG2' ' A' ' 52' ' ' VAL . 32.2 t -96.02 -6.53 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 p -99.33 -77.52 0.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.199 -0.313 . . . . 0.0 111.728 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -84.55 -44.02 13.96 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.475 0.179 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.48 ' HB2' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -56.31 -52.31 65.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.219 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.783 ' CG2' HG23 ' A' ' 52' ' ' VAL . 16.2 mt -122.4 141.53 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.566 0.222 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.15 74.05 0.77 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.134 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -165.94 139.07 3.44 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.444 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.95 70.57 5.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.59 2.193 . . . . 0.0 111.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -171.86 -44.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.799 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.472 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.68 -41.88 11.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.783 HG23 ' CG2' ' A' ' 46' ' ' ILE . 1.9 t -85.97 -35.3 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -55.55 -38.44 69.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.36 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.53 -30.87 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.598 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.777 ' CE1' HD21 ' A' ' 12' ' ' LEU . 14.5 t80 -79.52 -57.47 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.546 HG13 HG21 ' A' ' 42' ' ' VAL . 31.6 mm -106.18 135.66 43.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -124.87 97.16 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.982 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.64 66.27 1.28 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.09 28.62 9.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.799 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 m -147.19 122.57 10.32 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.358 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.12 152.48 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 111.158 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.3 116.63 60.59 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -52.68 119.33 5.8 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.85 -27.15 3.22 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.776 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 mt -72.51 125.31 31.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 mp -86.17 148.56 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.327 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.408 HG23 ' CE1' ' A' ' 92' ' ' PHE . 6.2 m -149.71 100.69 2.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 46.7 mt -91.6 114.87 27.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 HD12 ' A' ' 90' ' ' ILE . 10.3 pt -103.52 110.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.765 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 60.19 45.63 11.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.701 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.34 28.64 17.02 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 167.6 20.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.264 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.87 144.33 33.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 111.242 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -63.31 -50.61 69.38 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.976 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -24.59 67.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.25 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -50.03 63.76 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.018 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.15 -72.2 0.34 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.74 36.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.962 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 56.71 -83.98 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 111.808 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -101.86 3.54 39.35 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -91.56 31.09 1.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.696 0.284 . . . . 0.0 111.482 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -123.45 109.2 13.54 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.561 HD13 HG22 ' A' ' 33' ' ' THR . 42.5 mm -65.73 137.28 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.782 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 37' ' ' LEU . 21.6 mt -63.06 174.19 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -167.64 101.06 0.49 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -47.06 119.88 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.706 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.32 20.29 8.34 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.146 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.93 162.84 13.4 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.745 0.307 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.54 95.18 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.577 HD12 HG22 ' A' ' 69' ' ' ILE . 25.0 mm -90.84 149.75 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -133.97 137.96 45.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.297 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' HB3' HD13 ' A' ' 12' ' ' LEU . 9.8 m-85 -124.83 142.58 51.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -145.18 166.9 24.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.697 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 t -145.58 120.15 9.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.8 t -94.43 53.99 1.76 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.168 0.508 . . . . 0.0 110.6 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.3 126.3 15.43 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -143.48 109.94 5.45 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.604 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.02 110.19 0.06 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.288 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.443 -1.198 . . . . 0.0 112.589 179.666 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 2' ' ' VAL . 22.6 m -99.4 100.34 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 111.671 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -81.67 126.09 31.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.418 HG21 ' HG ' ' A' ' 37' ' ' LEU . 13.9 m -118.85 141.99 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.65 102.93 14.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 90' ' ' ILE . 26.0 m -108.03 154.09 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.294 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -123.0 152.38 40.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.686 ' C ' HD22 ' A' ' 9' ' ' LEU . 83.6 m-85 -137.85 125.02 21.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.686 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.8 mm? -130.26 172.26 12.0 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.493 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -97.99 1.69 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.711 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.74 -29.57 2.84 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.107 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.746 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -56.88 -38.39 72.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.831 0.315 . . . . 0.0 111.288 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -60.87 -38.2 84.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.09 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.94 78.85 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.624 0.249 . . . . 0.0 111.358 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 33.1 mt -71.67 -34.21 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.41 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.47 -34.14 63.05 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.84 45.77 0.15 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.447 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.35 35.92 26.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.888 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.52 13.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.974 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.57 -49.89 2.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.983 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.547 HG11 ' HE2' ' A' ' 5' ' ' LYS . 19.0 t -118.99 134.75 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.307 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -123.46 149.7 44.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.47 119.43 29.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.911 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mm -126.07 148.29 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 23.7 pttt -130.07 113.55 14.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.412 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.66 132.12 38.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.794 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -115.49 91.56 3.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.722 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -156.09 -50.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.972 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' HG22 ' A' ' 32' ' ' VAL . 1.8 pt-20 -161.04 -174.67 4.49 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -59.08 0.36 Allowed Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.91 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.84 58.97 6.23 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.432 2.088 . . . . 0.0 112.631 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 29' ' ' GLU . 41.2 t -80.21 125.4 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.612 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.5 p -72.93 155.47 39.84 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.984 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 79' ' ' GLU . 11.6 p -57.39 -33.32 43.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.53 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 38' ' ' ILE . . . -57.99 -28.45 60.92 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.769 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.41 -38.76 68.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.701 0.286 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.531 HD23 ' CD1' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -54.98 -48.27 73.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 42' ' ' VAL . 5.6 mt -63.07 -42.84 98.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.285 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.142 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -60.46 -44.28 96.04 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.575 HG23 ' SD ' ' A' ' 45' ' ' MET . 20.2 mt -70.04 -31.33 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.805 HG13 HG21 ' A' ' 52' ' ' VAL . 36.5 t -90.66 -4.27 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 t -81.87 -78.79 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.45 -0.156 . . . . 0.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -99.88 -33.74 10.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.525 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.575 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -58.87 -44.29 91.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.136 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.701 HG21 HG23 ' A' ' 52' ' ' VAL . 23.3 mt -131.64 100.57 4.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.091 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.24 55.08 1.41 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 1.1 t-20 -144.74 122.17 6.44 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.344 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 26.6 Cg_exo -63.52 77.56 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.911 2.408 . . . . 0.0 112.027 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -162.26 -54.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.11 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.426 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -91.42 -38.32 12.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.696 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.805 HG21 HG13 ' A' ' 42' ' ' VAL . 2.1 t -86.96 -36.24 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.122 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -54.84 -36.23 64.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.626 0.251 . . . . 0.0 110.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 mt -82.5 -33.88 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.326 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.746 ' CE1' HD21 ' A' ' 12' ' ' LEU . 29.3 t80 -80.07 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 42' ' ' VAL . 28.1 mm -91.89 137.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.616 0.246 . . . . 0.0 111.286 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.26 147.23 41.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.898 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.73 39.38 1.64 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.37 0.418 . . . . 0.0 111.58 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.04 43.02 18.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.57 165.2 35.06 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.419 HD13 ' HZ3' ' A' ' 74' ' ' TRP . 2.2 mp -70.25 154.2 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 61' ' ' ILE . 1.8 ttp85 -75.04 134.42 74.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.123 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.9 84.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.449 2.099 . . . . 0.0 111.459 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.53 -32.34 0.44 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.671 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 55' ' ' PHE . 32.1 mm -60.86 127.71 20.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.17 145.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' SER . 6.0 m -151.57 131.67 13.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.685 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -125.61 117.93 24.61 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.318 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.522 HG23 ' CD1' ' A' ' 74' ' ' TRP . 7.1 pt -90.96 106.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.17 50.21 6.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.05 32.25 20.95 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 175.86 9.21 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.586 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.71 158.96 26.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.465 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.522 ' CD1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -85.14 -56.22 3.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -25.39 63.26 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.665 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 tt -53.36 -32.5 49.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.521 0.201 . . . . 0.0 111.358 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.73 -54.84 2.23 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.782 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 106.12 0.2 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.699 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' O ' HG11 ' A' ' 34' ' ' VAL . 5.8 mt-10 -50.27 -57.63 7.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.483 0.141 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE2' ' HA3' ' A' ' 35' ' ' GLY . 43.4 tttm -110.83 -26.66 9.23 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.222 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.92 57.35 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -139.88 110.64 6.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.049 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.2 130.76 28.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.624 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.531 ' CD1' HD23 ' A' ' 37' ' ' LEU . 17.4 mt -64.78 175.05 1.59 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.848 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.42 102.08 0.72 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.274 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -48.67 114.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.4 26.07 5.54 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.43 164.05 12.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.706 0.288 . . . . 0.0 111.087 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.4 mm -104.39 133.53 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.664 ' HB ' HG12 ' A' ' 6' ' ' VAL . 35.6 mt -140.84 147.52 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 13.4 t -132.2 149.55 52.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.301 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -138.52 86.26 2.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -93.36 175.76 6.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.487 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -155.34 82.18 1.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.616 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t -136.07 82.06 1.92 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.196 0.522 . . . . 0.0 110.653 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -29.9 71.06 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.857 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.95 170.48 13.0 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.591 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.87 -176.86 42.65 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.944 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.562 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.2 122.42 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -96.94 101.62 13.24 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.6 127.38 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.26 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -96.79 108.46 21.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.075 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.856 HG12 ' HB ' ' A' ' 90' ' ' ILE . 27.3 m -114.62 146.35 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -122.52 129.75 52.31 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 97.3 m-85 -109.94 130.12 55.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.61 165.82 26.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.74 -21.2 40.37 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.649 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.01 -26.21 1.6 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.95 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 65' ' ' ILE . 9.4 mt -54.48 -37.75 65.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.75 0.275 . . . . 0.0 111.667 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -56.78 -31.34 64.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.226 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.67 78.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 23.2 mt -80.37 -35.21 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.283 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.38 -75.19 0.1 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.1 37.84 0.17 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.704 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt 52.01 34.29 13.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.447 0.299 . . . . 0.0 111.508 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -125.29 122.52 37.11 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.732 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -50.36 72.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.727 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.67 138.22 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.124 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.61 156.09 49.32 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.63 146.74 47.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.486 HD13 HD11 ' A' ' 37' ' ' LEU . 3.8 mp -134.39 146.9 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -134.1 119.77 19.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.148 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.11 131.96 54.59 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.091 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.34 98.49 5.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.49 -49.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.055 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -161.31 -176.55 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.11 -58.56 0.41 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.68 56.5 4.08 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.547 2.164 . . . . 0.0 112.749 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.84 126.33 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 p -78.67 151.17 32.37 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.24 -32.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.672 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -27.13 57.33 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.724 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -41.57 68.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.734 0.302 . . . . 0.0 110.385 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.566 ' CD1' HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -53.6 -52.22 60.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.189 179.02 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.478 ' HA ' HD12 ' A' ' 41' ' ' ILE . 34.1 mm -62.37 -38.82 82.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.39 -46.0 90.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.039 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -57.85 -42.22 84.03 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.045 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 37' ' ' LEU . 14.7 mt -65.64 -31.76 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.792 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.861 HG13 HG11 ' A' ' 52' ' ' VAL . 43.8 t -92.45 -2.9 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.901 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -74.83 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.462 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -95.7 -42.73 8.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.294 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -42.77 76.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.631 ' CG2' HG22 ' A' ' 52' ' ' VAL . 35.0 mt -131.73 131.56 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -162.24 74.96 0.44 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.018 0.437 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.03 121.03 1.42 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.611 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.67 79.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.44 2.093 . . . . 0.0 112.046 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -172.88 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.529 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.7 p30 -87.4 -41.79 13.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.602 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.861 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -77.63 -35.52 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 t -53.83 -31.56 49.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.333 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.4 mt -90.6 -44.53 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.501 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.654 ' CD1' HD21 ' A' ' 12' ' ' LEU . 35.2 t80 -72.86 -53.75 10.6 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.477 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.656 ' HB ' HG12 ' A' ' 52' ' ' VAL . 37.8 mm -99.87 114.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.305 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -71.85 -162.97 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.542 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -64.43 86.93 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.899 0.381 . . . . 0.0 111.046 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 60.38 43.55 13.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.93 176.5 3.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.07 149.82 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.713 0.292 . . . . 0.0 110.799 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HG2' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -96.11 148.89 35.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.79 159.06 47.42 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.633 2.222 . . . . 0.0 112.275 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.489 ' HA3' HD13 ' A' ' 96' ' ' LEU . . . 98.26 -23.66 35.19 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.798 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.691 HD12 HD11 ' A' ' 12' ' ' LEU . 33.8 mm -83.25 102.62 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.0 124.19 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.198 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 91' ' ' SER . 8.6 m -120.18 141.25 50.07 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.4 mt -135.95 115.06 12.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.289 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.2 mt -97.71 105.2 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.638 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 57.63 52.5 8.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 59.61 32.79 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.216 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.32 169.31 18.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.417 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.92 171.52 15.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.847 0.356 . . . . 0.0 111.093 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -100.98 -48.19 4.52 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.993 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -27.04 58.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.99 -27.63 53.67 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.269 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -120.96 -50.9 2.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.406 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.11 93.22 0.1 Allowed Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.726 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -43.5 73.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -124.58 -40.21 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.81 56.52 1.54 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.944 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.19 108.25 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.807 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.86 128.17 20.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.46 175.07 1.46 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.88 100.96 0.66 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.481 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -48.02 115.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.858 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.17 6.58 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.691 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.49 169.16 9.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.744 0.307 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.43 128.07 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.856 ' HB ' HG12 ' A' ' 6' ' ' VAL . 32.7 mt -136.24 145.66 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.842 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 67' ' ' THR . 0.7 OUTLIER -128.65 155.55 44.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.748 0.309 . . . . 0.0 111.348 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 41.8 m-85 -143.6 82.2 1.72 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 m -86.75 140.82 29.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.126 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 t -102.61 103.24 13.52 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.71 88.4 1.69 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.355 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.489 HD13 ' HA3' ' A' ' 64' ' ' GLY . 4.5 mm? -62.99 133.0 53.91 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.225 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -134.42 131.17 37.85 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.011 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.64 -95.65 0.54 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.377 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.828 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.585 0.231 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.7 136.06 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.28 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -97.94 140.49 32.21 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.432 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.934 HG21 HD21 ' A' ' 37' ' ' LEU . 35.7 m -136.01 146.11 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 113.33 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.886 HG12 ' HB ' ' A' ' 90' ' ' ILE . 31.2 m -115.78 151.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.479 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.7 tt0 -122.11 110.12 15.37 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HD1' HD22 ' A' ' 12' ' ' LEU . 79.3 m-85 -91.21 138.28 31.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.725 ' HB2' HG23 ' A' ' 93' ' ' THR . 3.9 mp -141.84 163.37 33.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.8 -107.87 3.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.402 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 26.73 5.25 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.047 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 65' ' ' ILE . 1.9 mp -96.38 -41.79 8.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.89 0.345 . . . . 0.0 110.983 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.29 -28.95 65.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.357 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.05 78.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.727 0.299 . . . . 0.0 111.047 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 24.7 mt -79.78 -43.75 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.509 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.6 m-85 -58.61 -70.4 0.15 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.455 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.7 44.08 0.07 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.395 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.59 32.96 18.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.505 0.322 . . . . 0.0 111.402 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -119.38 113.76 21.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.389 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -58.8 -62.56 1.78 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 14.9 p -94.87 143.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.153 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -129.06 161.29 30.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -145.31 133.41 21.49 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 4' ' ' VAL . 2.1 pt -147.2 178.76 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.326 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 132.09 15.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.38 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.25 108.07 19.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.475 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -91.93 48.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -45.06 6.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.985 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' A' ' 32' ' ' VAL . 10.1 pt-20 -166.7 -178.24 4.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.32 -59.13 0.3 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.773 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.8 58.93 6.66 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.363 2.042 . . . . 0.0 112.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.492 ' HB ' HD12 ' A' ' 84' ' ' LEU . 17.9 t -77.01 149.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.1 p -98.86 161.6 13.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' HD21 ' A' ' 84' ' ' LEU . 10.5 p -60.74 -39.85 83.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.711 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.8 -30.51 69.54 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.945 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -40.44 86.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.769 0.319 . . . . 0.0 110.314 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.934 HD21 HG21 ' A' ' 4' ' ' VAL . 2.6 tm? -56.64 -44.9 81.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.128 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.465 ' HA ' HD12 ' A' ' 41' ' ' ILE . 35.8 mm -59.89 -45.26 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.38 -37.97 82.45 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -60.07 -43.71 95.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.488 HG23 ' SD ' ' A' ' 45' ' ' MET . 14.6 mt -64.63 -30.21 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.153 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.739 HG21 HG13 ' A' ' 56' ' ' ILE . 28.8 t -95.99 -2.46 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -95.33 -64.59 1.05 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.3 p -98.03 -46.98 5.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.722 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.488 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -57.58 -56.8 17.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 52' ' ' VAL . 19.4 mt -115.61 149.08 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -173.87 72.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -163.76 133.46 3.11 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.148 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.98 65.52 3.32 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.441 2.094 . . . . 0.0 111.823 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -158.85 -49.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.028 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -89.52 -42.51 11.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.456 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.692 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -72.9 -36.28 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.223 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.7 -28.69 15.67 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.42 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -89.28 -34.41 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.722 ' HE1' HG21 ' A' ' 65' ' ' ILE . 51.2 t80 -86.95 -57.63 2.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.515 0.198 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.739 HG13 HG21 ' A' ' 42' ' ' VAL . 35.8 mm -98.53 139.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -148.86 129.6 14.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.96 42.98 15.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 59.2 38.99 23.34 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.51 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.9 t -166.91 162.31 15.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.908 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.0 148.88 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -78.48 147.7 72.3 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.057 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.22 75.69 2.8 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 111.842 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.03 -45.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.541 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.722 HG21 ' HE1' ' A' ' 55' ' ' PHE . 28.5 mm -67.17 137.21 25.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.857 0.36 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.4 mt -110.73 132.41 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -126.32 138.64 53.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.5 mt -125.48 109.87 13.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 74' ' ' TRP . 7.2 mt -86.73 105.74 15.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.8 t30 56.92 45.9 20.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 61.68 41.87 11.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.177 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.76 156.82 43.85 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.578 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -79.98 129.63 34.64 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.949 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.482 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.5 p-90 -57.65 -35.32 70.38 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.645 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.13 -1.94 58.26 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.636 HD12 ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -76.88 -16.08 59.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -137.31 -58.53 0.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.507 0.194 . . . . 0.0 111.26 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.92 112.57 0.53 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.673 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -49.61 -71.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.537 0.208 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -107.65 -28.23 9.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.931 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.71 -31.37 37.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.226 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.435 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 38.2 t80 -48.26 118.95 2.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 110.838 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.17 141.25 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD12 ' HB ' ' A' ' 32' ' ' VAL . 19.2 mt -62.74 178.23 0.47 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.955 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -162.74 99.71 1.0 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.824 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -43.5 105.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.828 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.13 5.4 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.035 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.83 170.19 8.31 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.714 0.292 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.3 123.27 68.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.402 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.886 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.8 mp -126.24 107.39 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.774 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -81.72 157.99 24.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 111.597 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -146.82 82.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -91.45 164.13 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.11 132.94 50.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.277 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.19 -63.98 1.22 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.638 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 97' ' ' HIS . 4.4 pp -131.01 165.56 22.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.319 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.623 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.9 OUTLIER 73.08 114.27 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.082 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.53 93.02 1.75 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.27 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.553 -1.137 . . . . 0.0 112.863 -179.873 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 86' ' ' ASP . 10.6 p -118.62 111.24 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 111.258 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -105.53 125.1 50.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 90' ' ' ILE . 38.9 t -125.09 110.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.271 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 112.98 20.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.526 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.76 HG12 ' HB ' ' A' ' 90' ' ' ILE . 7.2 m -113.35 139.79 36.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.336 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.7 115.46 29.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.54 ' C ' HD12 ' A' ' 9' ' ' LEU . 82.2 m-85 -96.46 124.03 40.31 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.405 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.54 HD12 ' C ' ' A' ' 8' ' ' PHE . 11.0 mp -125.47 159.69 31.33 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.299 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.37 -109.26 3.57 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.414 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.08 35.49 2.84 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.589 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 mt -104.15 -43.13 5.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.637 0.218 . . . . 0.0 111.178 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -59.38 -28.47 66.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.33 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.23 78.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.77 0.319 . . . . 0.0 111.032 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 41.9 mt -73.96 -37.99 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.219 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -69.65 -70.44 0.28 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.74 44.72 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 56.1 33.54 22.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.621 0.248 . . . . 0.0 111.401 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 129.1 51.55 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.603 0.24 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -83.44 -64.13 1.22 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.5 t -79.65 105.87 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -111.2 173.7 6.22 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.61 136.26 47.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.309 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 37' ' ' LEU . 17.6 mm -117.87 152.11 19.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -150.0 99.52 2.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.127 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -73.52 -53.77 9.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.049 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.59 76.13 0.32 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -136.67 -67.57 0.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.335 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -140.97 -175.73 4.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.72 -59.59 0.43 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.086 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.37 60.37 6.39 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.469 2.112 . . . . 0.0 112.598 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.661 ' CG1' HD12 ' A' ' 84' ' ' LEU . 26.7 t -77.8 142.27 14.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 155.24 18.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -57.74 -35.88 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.803 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.63 -27.74 66.71 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.978 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -39.13 65.69 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.551 ' HB2' HD11 ' A' ' 84' ' ' LEU . 1.3 tm? -54.97 -51.43 66.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.382 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.7 -43.15 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.18 -43.66 78.64 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.432 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 55.4 t60 -59.63 -46.52 88.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.31 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.48 -31.59 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.891 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.706 HG13 ' CG2' ' A' ' 52' ' ' VAL . 36.7 t -97.4 -4.13 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -92.7 -68.81 0.78 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.28 -41.48 7.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.614 0.245 . . . . 0.0 111.351 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -39.78 69.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.826 HG21 HG23 ' A' ' 52' ' ' VAL . 44.1 mt -131.65 129.79 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.664 0.269 . . . . 0.0 111.047 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -143.91 51.41 1.32 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -142.92 121.52 7.37 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.32 74.41 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.99 2.46 . . . . 0.0 112.238 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.63 -58.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.364 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.8 p30 -79.9 -36.49 36.38 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.706 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -88.77 -35.33 7.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.945 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -54.23 -36.24 63.31 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.121 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.2 -37.93 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.219 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -67.11 -39.93 86.77 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.006 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.31 116.22 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -115.01 130.89 57.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.64 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 58.81 43.78 17.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.966 0.413 . . . . 0.0 110.464 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.39 33.31 22.18 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.489 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.61 149.66 26.87 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.911 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.62 151.58 10.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.061 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.8 ttt180 -93.1 130.25 36.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.999 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 50.9 Cg_exo -54.42 118.66 5.3 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.79 2.327 . . . . 0.0 112.325 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.94 -37.88 0.93 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.555 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 mt -74.11 127.89 36.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.69 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.8 mm -103.04 127.54 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.059 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -121.92 134.8 54.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.235 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 72' ' ' THR . 2.4 mm? -110.58 98.54 7.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.681 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.665 HD11 ' CD1' ' A' ' 74' ' ' TRP . 24.1 mt -81.13 102.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 57.63 48.4 14.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.628 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 62.13 32.26 17.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.289 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.685 ' O ' HD13 ' A' ' 68' ' ' LEU . 1.3 m -128.58 162.97 26.04 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.49 134.64 36.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.665 ' CD1' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -57.48 -53.37 58.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.888 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.44 -36.54 83.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.306 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 76' ' ' LEU . 5.1 tt -56.4 -52.48 64.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.597 0.237 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.56 -35.73 81.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 34.08 0.8 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.185 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.76 -78.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.628 0.371 . . . . 0.0 111.432 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -109.2 16.73 22.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 47.52 1.25 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.993 0.425 . . . . 0.0 110.786 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 69' ' ' ILE . 24.1 t80 -144.23 138.23 27.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.421 HD12 ' H ' ' A' ' 83' ' ' ILE . 4.3 mp -92.91 129.96 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.661 HD12 ' CG1' ' A' ' 32' ' ' VAL . 18.7 mt -59.75 173.78 0.54 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.0 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.65 100.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.029 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.634 ' HA ' HG23 ' A' ' 2' ' ' VAL . 12.7 p-10 -43.07 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.53 26.96 5.43 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.482 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.584 ' OD1' HG13 ' A' ' 4' ' ' VAL . 3.3 p30 -95.4 174.76 6.86 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.64 0.257 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.2 mm -119.46 130.43 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.481 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.76 ' HB ' HG12 ' A' ' 6' ' ' VAL . 43.3 mt -133.39 153.17 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.385 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -127.55 156.45 42.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.05 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -143.88 105.76 4.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.229 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -109.6 142.19 41.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.032 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.3 t -116.63 97.56 6.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.567 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 68.0 p -73.65 -66.9 0.64 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.49 102.19 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.9 m80 65.36 17.17 10.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.275 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.89 69.71 1.18 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.385 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.385 -1.231 . . . . 0.0 112.643 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 m -108.63 129.62 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -111.02 139.68 46.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.572 HG21 ' HG ' ' A' ' 37' ' ' LEU . 9.7 m -140.88 136.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.541 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.25 115.54 27.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.362 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.663 HG12 ' HB ' ' A' ' 90' ' ' ILE . 2.9 m -113.27 143.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.461 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.35 154.95 20.54 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.527 ' HD1' HD13 ' A' ' 12' ' ' LEU . 52.9 m-85 -142.82 111.75 6.46 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.4 mm? -123.32 145.41 48.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.012 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.25 -111.16 3.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.524 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.87 28.43 6.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.929 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.683 HD21 ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -100.17 -48.75 4.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.81 0.305 . . . . 0.0 110.767 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.74 -27.0 68.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.621 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.78 -34.19 76.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.647 0.261 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 51' ' ' ASP . 19.4 mt -74.91 -37.4 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.63 -61.33 1.83 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.33 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.62 46.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.503 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp 57.35 33.87 23.91 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -112.24 103.93 12.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.713 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mtt-85 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.604 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 p -97.85 130.32 46.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.88 0.371 . . . . 0.0 111.003 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -128.61 164.67 22.37 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.259 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -128.68 133.48 48.22 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.305 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HB ' HD11 ' A' ' 37' ' ' LEU . 22.6 mm -117.19 145.96 22.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.23 89.72 3.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.1 148.56 51.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.175 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -123.59 101.76 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.386 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -166.29 -53.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -174.07 -166.59 0.3 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.78 -59.53 0.33 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 59.26 5.83 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.486 2.124 . . . . 0.0 112.548 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.66 131.24 34.23 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -66.69 146.38 54.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.492 HG21 ' HE1' ' A' ' 74' ' ' TRP . 13.9 p -54.62 -33.37 27.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.473 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.57 59.17 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.043 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -39.88 61.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 110.3 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 ' HG ' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -55.85 -56.57 19.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.304 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 41' ' ' ILE . 12.9 pt -59.12 -35.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.623 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -63.27 -43.86 96.75 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.662 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -58.07 -39.55 78.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 38' ' ' ILE . 16.5 mt -68.6 -30.23 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.038 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.698 HG13 HG21 ' A' ' 52' ' ' VAL . 29.8 t -97.01 -6.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.1 t -100.72 -64.33 1.05 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 m -87.77 -51.27 5.95 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.38 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -51.9 67.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.869 HG21 HG23 ' A' ' 52' ' ' VAL . 26.1 mt -116.2 143.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-O 120.759 0.314 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -162.56 41.22 0.12 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.587 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 50' ' ' ASN . 5.4 t30 -134.03 118.54 14.2 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.708 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.37 75.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.908 2.405 . . . . 0.0 112.711 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ASN . 9.5 m-20 -165.72 -61.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.354 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB2' HG22 ' A' ' 15' ' ' ILE . 29.8 p-10 -79.84 -33.25 40.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.33 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.869 HG23 HG21 ' A' ' 46' ' ' ILE . 1.4 t -93.83 -41.15 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.636 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -35.49 68.49 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.197 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.6 mt -89.0 -33.97 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.33 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 12' ' ' LEU . 19.3 t80 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.495 0.188 . . . . 0.0 111.004 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 42' ' ' VAL . 17.4 mt -131.84 141.8 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.446 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.18 -170.27 3.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -63.16 93.04 0.06 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.956 0.407 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 56.09 43.65 26.6 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.88 128.63 1.69 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.432 ' HA ' HG23 ' A' ' 56' ' ' ILE . 2.1 mp -71.97 153.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.293 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' N ' HG22 ' A' ' 61' ' ' ILE . 8.6 mtp-105 -88.48 139.48 29.92 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.016 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.21 125.1 17.95 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.811 2.341 . . . . 0.0 112.389 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.15 -46.97 1.02 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.866 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.43 112.92 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.45 146.77 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.561 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' SER . 2.0 m -141.52 138.19 32.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.633 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -145.87 128.05 15.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.058 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.642 HD11 ' HD1' ' A' ' 74' ' ' TRP . 21.6 mt -90.33 90.27 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.434 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.01 65.88 1.34 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.955 0.407 . . . . 0.0 111.253 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.2 24.29 14.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.595 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 m -130.17 164.6 24.12 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.317 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -79.71 165.87 22.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.898 0.38 . . . . 0.0 111.474 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.642 ' HD1' HD11 ' A' ' 69' ' ' ILE . 4.6 t90 -94.22 -41.14 9.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.796 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.24 -27.48 35.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.618 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -54.69 -27.45 40.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG3' ' CD1' ' A' ' 82' ' ' TYR . 1.4 pt-20 -128.41 27.33 5.59 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.68 102.75 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.743 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -54.14 -34.36 60.16 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -122.18 -40.51 2.49 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.448 0.166 . . . . 0.0 110.626 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -55.16 -29.19 57.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.369 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 77' ' ' GLU . 72.3 t80 -55.13 118.91 4.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.22 139.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.565 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.5 ' CD1' HD23 ' A' ' 37' ' ' LEU . 22.9 mt -64.07 175.25 1.28 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.942 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -167.11 100.84 0.53 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.595 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -44.35 114.31 0.66 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.99 18.98 6.58 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.017 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.17 177.54 4.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.746 0.273 . . . . 0.0 110.961 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 90' ' ' ILE . 27.4 mt -128.12 150.32 33.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.962 0.41 . . . . 0.0 111.71 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' HB ' HG12 ' A' ' 6' ' ' VAL . 5.3 mp -142.55 100.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.11 142.99 34.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.695 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -136.23 82.9 1.97 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 9' ' ' LEU . 4.2 m -94.02 150.05 20.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.675 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.594 ' OG ' HD12 ' A' ' 12' ' ' LEU . 20.4 m -133.98 99.31 4.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.59 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.3 p -78.14 -51.23 10.56 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 94' ' ' SER . 1.8 mp 65.43 -68.22 0.12 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.4 0.438 . . . . 0.0 111.656 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -77.1 119.99 21.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.751 0.31 . . . . 0.0 110.847 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -120.4 128.02 7.3 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.343 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.454 -179.787 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m -145.9 172.78 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.604 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -141.95 114.28 8.27 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 37' ' ' LEU . 15.0 m -117.75 132.76 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -106.41 105.26 15.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.725 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.708 HG12 ' HB ' ' A' ' 90' ' ' ILE . 15.3 m -105.53 144.37 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.371 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -107.32 135.56 48.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.542 ' C ' HD22 ' A' ' 9' ' ' LEU . 60.7 m-85 -119.01 115.42 24.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.746 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.542 HD22 ' C ' ' A' ' 8' ' ' PHE . 4.5 mm? -122.5 132.53 54.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.088 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 -109.27 1.82 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.386 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.03 -23.84 5.97 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.242 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.717 HD21 ' CD1' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -55.46 -48.24 74.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.994 0.397 . . . . 0.0 111.468 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -57.9 -36.01 71.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.129 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 12' ' ' LEU . 7.5 mt -75.19 -39.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.363 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.5 m-85 -67.38 -75.09 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.321 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.21 41.71 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.602 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.35 34.4 20.61 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.705 0.288 . . . . 0.0 111.159 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -110.16 117.5 33.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.721 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -28.98 69.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.67 142.28 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -122.73 170.35 10.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -135.24 121.71 20.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 24' ' ' ILE . 4.2 mp -116.1 143.93 24.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.065 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.96 91.79 2.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.442 ' HE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.3 156.73 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.052 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.92 113.91 7.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 111.586 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.68 -48.28 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.94 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -156.13 -177.7 6.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.26 -59.83 0.37 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.984 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.09 58.28 6.51 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.534 2.156 . . . . 0.0 112.409 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -75.14 121.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.657 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.6 p -68.75 153.47 43.73 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.876 0.369 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 ' HE1' ' A' ' 74' ' ' TRP . 9.1 p -57.68 -31.95 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.579 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.08 -28.04 57.99 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.33 -38.07 71.7 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.776 0.322 . . . . 0.0 110.324 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -56.28 -47.1 79.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.054 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.691 HD11 ' CH2' ' A' ' 74' ' ' TRP . 49.7 mt -61.39 -41.88 91.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.449 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -39.68 87.3 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.442 ' HB2' ' HE2' ' A' ' 26' ' ' MET . 22.2 t-80 -63.12 -46.1 88.9 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 45' ' ' MET . 57.2 mt -61.24 -31.41 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.825 HG13 HG11 ' A' ' 52' ' ' VAL . 42.1 t -97.57 -3.36 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.4 t -93.43 -74.87 0.51 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.388 -0.195 . . . . 0.0 111.494 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -96.58 -39.99 9.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.556 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.8 tpt -57.1 -38.56 73.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.024 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.717 HG22 HG22 ' A' ' 52' ' ' VAL . 15.0 mt -137.62 136.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.693 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -159.81 71.72 0.49 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.813 0.34 . . . . 0.0 111.365 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.5 t30 -162.88 134.64 3.9 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.38 64.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.21 1.94 . . . . 0.0 111.702 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.73 -45.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -91.24 -41.92 10.7 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.641 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.825 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -72.01 -34.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.29 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.29 -30.67 12.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.5 -65.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.466 0.174 . . . . 0.0 111.371 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.717 ' CD1' HD21 ' A' ' 12' ' ' LEU . 41.0 t80 -64.05 -36.53 84.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.324 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 52' ' ' VAL . 29.6 mm -125.37 93.84 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.89 119.22 38.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.57 64.65 1.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p30 43.23 33.81 0.62 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.247 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -157.36 149.07 22.2 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.661 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.519 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.2 mp -65.07 152.91 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.687 ' HD3' HD22 ' A' ' 96' ' ' LEU . 3.2 ttt85 -79.73 115.68 55.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.631 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.76 101.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.649 2.233 . . . . 0.0 111.959 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.05 -30.64 0.6 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.584 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.622 HD13 ' CD1' ' A' ' 55' ' ' PHE . 49.1 mt -64.22 136.42 26.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.819 0.343 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.3 mt -103.82 144.79 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.413 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 91' ' ' SER . 25.1 m -143.63 140.93 30.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.7 mt -141.04 121.13 13.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.264 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.726 HD11 ' CD1' ' A' ' 74' ' ' TRP . 35.2 mt -93.7 102.76 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.53 55.42 3.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t0 57.01 31.89 20.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.206 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -136.25 166.6 23.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -79.77 149.23 31.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 111.467 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.726 ' CD1' HD11 ' A' ' 69' ' ' ILE . 1.6 t90 -69.05 -54.1 16.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.73 -7.77 55.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.042 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 ' HB2' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -56.65 -31.45 64.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.597 0.237 . . . . 0.0 111.366 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.26 -52.06 1.52 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.96 109.15 0.35 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.926 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.46 -48.9 77.96 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.847 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -121.19 -42.82 2.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.865 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.76 -24.54 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.948 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -52.84 119.79 5.02 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.883 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -75.56 132.59 32.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.17 174.99 1.78 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.726 0.298 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -169.6 101.85 0.33 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.421 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -44.05 115.43 0.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 119.17 3.95 12.7 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.984 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.94 164.25 23.66 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.082 0.441 . . . . 0.0 111.155 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mm -123.05 93.22 2.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.708 ' HB ' HG12 ' A' ' 6' ' ' VAL . 41.6 mt -91.83 152.1 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 67' ' ' THR . 0.9 OUTLIER -128.12 146.62 50.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.228 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -138.32 94.75 2.9 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.54 132.91 45.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.04 96.56 5.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.223 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.29 -28.14 66.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.129 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.687 HD22 ' HD3' ' A' ' 62' ' ' ARG . 1.6 mp -60.85 117.25 5.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.765 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -109.1 138.86 44.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.291 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.61 81.32 0.52 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.423 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.605 -179.87 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.62 0.248 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m -144.25 127.41 11.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.176 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -104.41 131.88 51.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 37' ' ' LEU . 19.9 m -133.26 147.48 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 21' ' ' VAL . 3.2 tttp -103.66 100.64 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.727 HG12 ' HB ' ' A' ' 90' ' ' ILE . 7.5 m -106.01 151.88 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.543 ' OE1' HD11 ' A' ' 9' ' ' LEU . 7.7 pt-20 -125.2 159.09 32.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.182 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' C ' HD12 ' A' ' 9' ' ' LEU . 99.5 m-85 -130.17 143.13 50.61 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.395 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 93' ' ' THR . 4.2 mp -140.65 171.02 14.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.503 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.67 -111.42 3.28 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.353 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.84 27.44 5.42 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.829 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.49 HD11 HG23 ' A' ' 65' ' ' ILE . 15.4 mt -90.36 -51.52 5.38 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.763 0.281 . . . . 0.0 110.863 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.0 -27.06 61.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.519 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.28 80.56 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.729 0.3 . . . . 0.0 111.18 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.609 HD13 HD11 ' A' ' 54' ' ' ILE . 40.8 mt -78.62 -43.21 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.82 -69.2 0.24 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.367 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.01 42.33 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.778 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 57.5 6.33 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 111.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -143.81 119.42 10.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 14.0 mtm-85 -72.52 -72.02 0.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.407 HG11 ' HE3' ' A' ' 5' ' ' LYS . 21.8 t -78.59 138.76 19.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -145.55 143.81 30.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -108.57 125.42 51.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.59 145.61 19.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.56 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.61 95.56 4.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.234 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.415 ' HG3' ' HB3' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -62.78 -64.51 0.9 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.636 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 58.66 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.851 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.6 -45.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.089 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -150.6 -179.85 7.58 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.89 -58.67 0.41 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.756 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.0 57.76 6.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.481 2.121 . . . . 0.0 112.602 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.5 116.21 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.495 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.492 HG22 HD13 ' A' ' 83' ' ' ILE . 70.8 p -75.01 156.13 36.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.65 -31.88 40.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.396 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.86 -25.59 59.37 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.932 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB3' ' HG3' ' A' ' 26' ' ' MET . 1.0 OUTLIER -75.36 -39.49 59.2 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 110.282 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -54.82 -55.41 30.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.417 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.809 ' HA ' HD12 ' A' ' 41' ' ' ILE . 11.9 pt -61.07 -36.0 69.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.625 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -39.47 94.27 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.764 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -61.22 -40.09 92.7 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 38' ' ' ILE . 5.0 mt -67.86 -30.88 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.551 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.68 HG21 HG13 ' A' ' 56' ' ' ILE . 47.7 t -92.6 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.811 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.3 p -100.21 -60.83 1.45 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -100.22 -50.99 3.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -42.39 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.273 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.674 ' CG2' HG23 ' A' ' 52' ' ' VAL . 7.9 mt -130.87 129.63 63.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 64.87 1.15 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.786 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.24 131.14 6.86 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.93 74.41 2.35 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.617 2.211 . . . . 0.0 112.196 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -168.17 -47.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.53 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.85 -38.96 10.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.852 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.674 HG23 ' CG2' ' A' ' 46' ' ' ILE . 1.9 t -82.97 -37.44 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.409 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -53.24 -42.62 66.6 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.663 0.268 . . . . 0.0 111.098 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.609 HD11 HD13 ' A' ' 15' ' ' ILE . 1.2 pt -80.01 -34.15 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.583 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.03 -48.59 62.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.674 0.273 . . . . 0.0 110.649 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.68 HG13 HG21 ' A' ' 42' ' ' VAL . 28.2 mm -124.56 124.02 67.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -163.24 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.481 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.97 84.94 0.08 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 40.29 12.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.57 126.32 1.07 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.57 153.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.2 143.26 52.18 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.94 125.61 11.71 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.523 2.149 . . . . 0.0 112.084 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.54 -35.16 2.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.597 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 12' ' ' LEU . 9.2 mt -73.29 114.51 12.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.706 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.1 mt -96.31 149.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.057 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.514 HG22 ' CE3' ' A' ' 74' ' ' TRP . 9.3 t -143.73 128.26 18.04 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.861 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.8 mt -108.53 126.98 53.53 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 pt -106.31 109.2 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.099 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.32 44.74 21.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.2 41.62 16.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.0 167.67 21.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 125.32 29.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.514 ' CE3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -59.16 -26.83 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.732 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -97.66 -1.34 43.86 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -61.73 -32.37 72.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.482 0.182 . . . . 0.0 111.423 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 -68.63 0.66 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.22 110.15 0.54 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.033 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -72.68 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.115 0.166 . . . . 0.0 111.287 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.05 -31.03 16.44 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.555 0.217 . . . . 0.0 110.749 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -28.18 28.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.487 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -57.39 113.67 1.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 33' ' ' THR . 31.7 mm -77.62 141.53 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.462 ' CD1' HD23 ' A' ' 37' ' ' LEU . 31.8 mt -62.93 173.65 1.3 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.59 101.32 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -43.65 110.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.764 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.39 26.84 4.98 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.874 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.26 168.74 9.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -117.32 129.57 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.612 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.727 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.8 mp -135.51 101.84 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.61 152.0 28.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -134.23 93.15 3.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 9' ' ' LEU . 14.4 p -95.97 162.31 13.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 t -151.72 102.01 2.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.3 p -123.16 -45.6 2.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.415 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 tt 64.04 74.32 0.41 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.868 0.366 . . . . 0.0 111.449 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -164.11 40.47 0.09 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -120.69 -70.58 0.3 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.686 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.519 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 86' ' ' ASP . 18.7 m -97.59 164.5 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.698 0.285 . . . . 0.0 111.516 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -132.08 110.43 10.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 24' ' ' ILE . 13.1 m -117.44 135.0 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.304 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -104.55 99.18 8.86 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.622 HG12 ' HB ' ' A' ' 90' ' ' ILE . 26.2 m -93.31 144.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -116.61 103.06 10.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 9' ' ' LEU . 66.1 m-85 -88.74 119.54 29.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.762 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 8' ' ' PHE . 11.2 mp -126.0 161.88 26.54 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.6 -104.65 2.94 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.338 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.8 -12.82 8.3 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.397 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD21 ' CE2' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -62.83 -44.13 96.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.246 0.523 . . . . 0.0 111.294 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.89 -32.88 71.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.085 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.9 69.45 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.534 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 30.1 mt -74.43 -47.41 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.412 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -60.42 -61.15 2.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.357 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.63 0.02 OUTLIER Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.588 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp 59.09 65.01 1.27 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 111.97 8.57 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -34.05 77.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.002 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.8 122.99 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.49 174.73 5.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.066 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -137.94 129.14 27.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.067 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 4' ' ' VAL . 3.6 mp -122.42 140.3 46.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.78 86.41 2.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 128.84 37.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.842 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -112.01 82.53 1.64 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.595 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.3 -66.33 0.7 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -148.28 -173.33 4.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -87.71 -54.42 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.975 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.2 Cg_exo -78.47 53.96 4.8 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.872 2.381 . . . . 0.0 112.621 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 36' ' ' ASP . 17.6 t -80.08 129.78 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.709 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -81.99 156.6 24.6 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 110.743 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.653 ' O ' HD12 ' A' ' 38' ' ' ILE . 9.1 p -53.69 -37.7 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.748 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.02 59.19 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.413 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HB2' HG12 ' A' ' 32' ' ' VAL . 64.9 m-20 -69.91 -41.02 75.24 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.709 0.29 . . . . 0.0 110.385 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 HD13 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -54.81 -54.34 43.5 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.754 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.6 mp -61.89 -35.27 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.455 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -46.0 90.93 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.173 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.36 -40.62 87.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.649 0.262 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 38' ' ' ILE . 14.2 mt -64.32 -33.22 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.713 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.693 HG13 ' CG2' ' A' ' 52' ' ' VAL . 40.9 t -90.76 -6.37 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.846 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.3 -74.95 0.44 Allowed 'General case' 0 N--CA 1.462 0.167 0 O-C-N 122.384 -0.197 . . . . 0.0 111.444 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.5 m -99.19 -41.5 7.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.45 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.526 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -53.46 -38.31 63.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.118 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 52' ' ' VAL . 21.4 mt -133.42 103.59 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.726 0.298 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.23 71.22 1.19 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.07 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.2 130.16 2.79 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.185 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.48 75.18 2.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.599 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -168.5 -44.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.857 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -92.67 -38.71 11.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.663 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.748 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -89.17 -36.06 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -54.75 -39.07 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 111.029 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.9 mt -76.03 -35.04 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.167 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.725 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 6.7 t80 -72.48 -52.94 13.6 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.669 0.271 . . . . 0.0 110.912 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.607 HD12 HG11 ' A' ' 42' ' ' VAL . 30.6 mt -118.0 110.12 29.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.5 130.46 55.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 59.4 40.95 20.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.04 29.61 19.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.46 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 144.78 32.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 62' ' ' ARG . 2.1 mp -65.44 153.96 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.0 mtt180 -88.66 146.1 36.49 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.71 88.73 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.623 2.215 . . . . 0.0 111.957 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.12 -34.76 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.773 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.725 HG21 ' CZ ' ' A' ' 55' ' ' PHE . 28.6 mm -68.33 119.53 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.4 mt -96.72 147.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.557 HG22 ' CE2' ' A' ' 92' ' ' PHE . 64.2 p -136.83 112.61 9.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.5 mt -105.27 108.17 19.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.754 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.549 HG21 ' CE1' ' A' ' 82' ' ' TYR . 21.2 mt -89.3 100.87 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.747 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 t30 58.81 53.2 5.97 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.29 32.93 20.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.235 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 154.14 49.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 129.07 34.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.653 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -54.58 -33.24 59.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.648 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.17 -32.47 38.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.923 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.75 -30.99 64.14 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.44 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -121.38 26.26 8.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.534 0.207 . . . . 0.0 111.432 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.29 -101.54 0.64 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.838 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.8 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.575 0.35 . . . . 0.0 110.509 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -109.94 -25.15 10.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.219 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -53.48 -25.71 17.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.666 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CE1' HG21 ' A' ' 69' ' ' ILE . 48.5 t80 -52.75 115.56 1.88 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.678 0.275 . . . . 0.0 110.718 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.77 142.04 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -63.22 174.94 1.04 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.936 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -160.53 97.33 1.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.784 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.465 ' HB2' HG12 ' A' ' 2' ' ' VAL . 41.1 t0 -45.85 110.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.83 26.18 4.83 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.678 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.85 176.57 5.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.649 0.262 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 90' ' ' ILE . 19.8 mt -123.3 152.69 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.554 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.622 ' HB ' HG12 ' A' ' 6' ' ' VAL . 5.2 mp -141.5 153.12 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.72 139.39 48.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.557 ' CE2' HG22 ' A' ' 67' ' ' THR . 30.2 m-85 -127.99 91.07 3.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 162.13 14.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -155.22 103.9 2.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.005 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -104.07 -82.57 0.5 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt 51.19 86.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.821 0.343 . . . . 0.0 111.553 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -127.67 40.89 3.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.134 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.27 177.06 14.68 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.778 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.571 -1.127 . . . . 0.0 112.804 179.896 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mmt . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 2' ' ' VAL . 11.3 m -147.2 103.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -83.91 110.11 18.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 37' ' ' LEU . 12.5 m -117.06 138.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.95 116.74 33.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 21' ' ' VAL . 18.1 t -109.82 144.98 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HB3' HD11 ' A' ' 9' ' ' LEU . 3.7 mt-10 -127.49 101.27 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.92 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -87.7 123.89 33.0 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.826 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 7' ' ' GLU . 4.9 mp -143.6 167.81 21.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.07 -20.73 38.16 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.509 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.36 -34.85 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.746 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -37.24 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.65 0.225 . . . . 0.0 111.577 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.83 -36.7 72.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.56 0.219 . . . . 0.0 111.017 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.91 68.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.479 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 35.2 mt -73.56 -42.09 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -68.94 -71.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.36 41.58 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.57 44.81 27.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.65 -31.6 15.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.302 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 72.63 -67.44 0.26 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.853 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 6' ' ' VAL . 8.3 p -117.72 124.15 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 152.73 46.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.284 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -112.2 145.22 40.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 37' ' ' LEU . 29.9 mt -138.29 148.57 24.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 108.27 8.05 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.95 159.08 32.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.81 93.36 3.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.106 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -162.54 -67.91 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.243 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.28 -175.63 5.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -58.44 0.46 Allowed Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.37 59.22 6.01 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.485 2.123 . . . . 0.0 112.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.15 142.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.83 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.02 151.39 25.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 80' ' ' LYS . 11.4 p -55.5 -32.34 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.681 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' HE3' ' A' ' 80' ' ' LYS . . . -60.84 -25.96 64.57 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.063 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.29 75.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.738 0.304 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.793 HD21 HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -60.35 -47.84 84.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.312 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.565 ' HA ' HD12 ' A' ' 41' ' ' ILE . 34.2 mm -59.81 -38.52 76.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.406 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.36 -41.89 97.81 Favored 'General case' 0 C--N 1.335 -0.032 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -60.22 -38.32 83.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.022 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 38' ' ' ILE . 20.0 mt -67.83 -31.8 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.502 HG13 HG21 ' A' ' 52' ' ' VAL . 22.5 t -98.12 -2.9 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -94.46 -75.79 0.5 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -91.6 -45.19 8.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.658 0.265 . . . . 0.0 111.293 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.2 ttt -54.57 -44.34 72.88 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.816 HG21 HG23 ' A' ' 52' ' ' VAL . 17.5 mt -131.94 145.66 34.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.703 0.287 . . . . 0.0 111.237 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 47.28 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -138.84 126.28 13.27 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.073 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 32.2 Cg_exo -62.41 77.03 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.938 2.425 . . . . 0.0 112.23 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -170.83 -58.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.411 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.6 p30 -82.42 -36.9 26.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.816 HG23 HG21 ' A' ' 46' ' ' ILE . 1.7 t -93.92 -35.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 t -53.75 -38.67 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.037 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -85.87 -34.37 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.083 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.64 ' HE1' HG21 ' A' ' 65' ' ' ILE . 15.9 t80 -67.48 -53.31 29.87 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 HG21 ' A' ' 42' ' ' VAL . 28.7 mm -104.77 131.1 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.916 0.388 . . . . 0.0 111.397 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -124.37 100.32 6.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.767 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 57.62 77.27 0.28 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.067 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 41.6 35.34 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -161.32 137.38 8.12 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.751 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.29 151.94 4.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.889 0.376 . . . . 0.0 111.391 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -81.87 140.52 46.96 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 52.4 Cg_exo -54.89 118.1 4.75 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 112.31 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.05 -37.08 1.94 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.504 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.64 HG21 ' HE1' ' A' ' 55' ' ' PHE . 28.0 mm -74.5 139.5 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.966 0.412 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.709 HD11 HG23 ' A' ' 95' ' ' THR . 77.8 mt -105.4 145.29 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.971 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -139.86 84.51 1.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.654 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.05 124.41 28.71 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.332 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 74' ' ' TRP . 17.3 mt -105.63 105.44 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.87 54.43 4.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.01 30.51 20.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.503 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 169.9 16.81 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.424 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -82.01 162.03 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.477 ' HA ' HD12 ' A' ' 69' ' ' ILE . 45.1 p90 -77.88 -44.2 27.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.228 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.25 -24.97 46.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.368 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -53.49 -36.44 61.69 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.962 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.34 -32.15 10.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.835 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.83 -86.19 0.07 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.06 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.573 0.349 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' VAL . 2.6 ttmp? -114.67 -27.1 7.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.45 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.79 -22.58 25.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -45.24 117.7 1.47 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.42 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -69.19 177.36 2.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.86 103.89 0.11 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.954 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -38.67 106.35 0.05 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.942 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.45 -8.88 5.9 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.741 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -80.06 164.33 23.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.166 0.483 . . . . 0.0 111.21 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.8 mm -125.0 117.33 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.12 142.48 22.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.034 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.7 m -121.68 139.46 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.317 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -119.57 79.98 1.51 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -83.93 172.68 11.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.45 118.17 9.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.103 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.709 HG23 HD11 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -97.2 39.64 1.18 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.045 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.19 -39.36 11.6 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.834 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -152.95 -45.65 0.1 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.576 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.3 -176.76 33.09 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.723 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.399 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.615 0.245 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 86' ' ' ASP . 29.4 m -100.3 157.07 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.621 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -130.68 126.66 37.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 90' ' ' ILE . 17.9 t -128.75 138.31 54.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.47 103.28 15.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.2 t -92.63 143.47 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.937 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.34 105.92 9.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 110.896 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 9' ' ' LEU . 96.4 m-85 -92.62 127.76 38.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.069 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 8' ' ' PHE . 6.7 mp -132.94 168.12 19.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.743 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.19 -109.46 3.45 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.299 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.79 24.69 7.86 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.014 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 55' ' ' PHE . 13.0 mt -100.55 -37.1 8.94 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.939 0.37 . . . . 0.0 111.273 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.78 -17.31 62.94 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.33 -30.02 22.55 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 1.1 mt -93.55 -27.21 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.692 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.699 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 3.0 m-85 -69.84 -74.66 0.13 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.63 0.252 . . . . 0.0 111.203 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.27 0.1 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.807 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt 50.67 37.29 16.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.45 0.3 . . . . 0.0 111.731 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 102.96 3.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.736 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.552 ' HG3' HG23 ' A' ' 21' ' ' VAL . 23.7 ptt180 -66.9 -49.03 66.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.947 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.552 HG23 ' HG3' ' A' ' 20' ' ' ARG . 24.6 t -81.21 93.61 2.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.36 154.48 29.09 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.288 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 24' ' ' ILE . 8.8 mtmp? -109.07 152.4 25.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.485 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.585 HG13 HD11 ' A' ' 37' ' ' LEU . 22.1 mm -128.28 147.17 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.55 123.19 15.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.989 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 mmt -118.71 132.87 56.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.136 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.21 47.76 1.04 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.72 -164.73 1.02 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.778 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HG3' ' HD2' ' A' ' 31' ' ' PRO . 5.9 pt-20 -68.32 -171.27 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.021 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.15 -57.56 1.1 Allowed Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.36 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' ' HG3' ' A' ' 29' ' ' GLU . 65.1 Cg_endo -72.54 61.49 3.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.284 1.99 . . . . 0.0 113.067 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.15 125.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.598 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.74 152.23 35.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.806 0.336 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.65 -34.5 47.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.807 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.52 -27.95 59.04 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -40.85 75.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.649 0.261 . . . . 0.0 110.49 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.585 HD11 HG13 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.15 -50.23 71.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.089 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -58.91 -38.86 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.11 -42.24 85.28 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -62.04 -39.57 92.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.867 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' MET . 42.7 mt -62.74 -32.13 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.794 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.863 HG13 HG11 ' A' ' 52' ' ' VAL . 32.2 t -96.46 -3.64 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.8 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.3 t -100.22 -62.68 1.21 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.556 0.217 . . . . 0.0 111.56 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 p -98.1 -50.2 4.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.515 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -55.74 -38.0 69.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.169 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.699 HD11 ' CZ ' ' A' ' 16' ' ' PHE . 23.4 mt -136.25 145.26 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.988 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -171.23 72.88 0.05 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.926 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -165.48 126.2 1.32 Allowed Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.078 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.81 77.02 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.895 2.397 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.36 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -78.48 -42.14 30.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.187 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.863 HG11 HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.6 -36.46 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.164 179.546 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 -31.1 26.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.493 0.187 . . . . 0.0 111.345 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.0 mt -94.2 -30.81 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 65' ' ' ILE . 51.9 t80 -85.67 -52.17 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.381 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.534 ' HB ' HG12 ' A' ' 52' ' ' VAL . 43.0 mm -103.74 145.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.174 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -118.48 61.83 0.78 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 57.97 84.78 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 58.12 38.67 26.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.646 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.4 t -170.1 118.99 0.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.7 HG22 HD12 ' A' ' 65' ' ' ILE . 2.2 mp -63.65 151.94 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -76.44 147.62 79.19 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.44 128.08 14.93 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.773 2.315 . . . . 0.0 112.577 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.559 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . 122.62 -25.86 6.42 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.945 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 61' ' ' ILE . 20.0 mt -72.97 130.21 35.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 120.897 0.379 . . . . 0.0 110.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.68 121.79 45.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' SER . 91.1 m -125.66 111.18 14.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.834 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 mt -108.1 140.59 41.06 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.679 HG23 ' CD1' ' A' ' 90' ' ' ILE . 20.5 mt -119.18 111.54 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.704 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 46.92 8.58 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.78 33.44 17.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -141.3 178.46 7.4 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.38 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -80.18 -178.4 6.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.968 0.414 . . . . 0.0 111.325 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -104.45 -47.07 4.21 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.017 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.31 -30.2 30.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -26.68 62.2 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.533 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.7 -64.91 1.24 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.522 0.201 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.66 105.31 0.27 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.679 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -53.24 -65.74 0.51 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.409 0.147 . . . . 0.0 111.318 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -117.56 -39.52 3.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.25 -25.52 48.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.74 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' CE2' HG21 ' A' ' 69' ' ' ILE . 75.9 t80 -48.32 116.38 1.54 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.824 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mt -72.87 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.1 173.85 3.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.07 100.57 0.97 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.419 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' HB3' HG12 ' A' ' 2' ' ' VAL . 9.4 p-10 -46.33 118.13 1.83 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.08 15.99 9.45 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.384 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.33 171.29 9.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mm -126.94 101.16 7.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.757 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.679 ' CD1' HG23 ' A' ' 69' ' ' ILE . 8.0 mm -98.28 142.62 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -119.87 138.46 53.39 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.31 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.497 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 59.7 m-85 -130.34 82.39 2.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.471 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 9' ' ' LEU . 16.2 m -97.73 138.25 35.39 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 m -108.03 112.12 24.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t -118.13 72.5 0.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.311 0.577 . . . . 0.0 110.458 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.559 HD23 ' HA3' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -135.12 118.63 16.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.89 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -112.84 -42.99 3.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.014 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.33 97.63 1.27 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.353 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.651 -179.73 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.552 0.215 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 m -123.4 131.64 72.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.222 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.0 117.18 29.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.714 ' CG1' HD13 ' A' ' 90' ' ' ILE . 18.5 t -115.66 134.73 57.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -103.06 104.68 14.87 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 90' ' ' ILE . 3.5 m -111.71 155.96 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.525 ' HG2' HG22 ' A' ' 21' ' ' VAL . 18.9 mt-10 -119.15 154.2 33.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.684 ' C ' HD22 ' A' ' 9' ' ' LEU . 42.4 m-85 -136.29 104.75 5.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.684 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.6 mm? -129.82 121.0 25.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.957 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 46.56 0.45 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.833 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.63 -35.68 4.27 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.795 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.838 HD21 ' CE1' ' A' ' 55' ' ' PHE . 3.3 mt -54.95 -42.76 72.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.653 0.227 . . . . 0.0 111.415 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.23 -37.33 82.65 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.02 -33.58 75.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mt -79.77 -42.12 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.522 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 41' ' ' ILE . 3.4 m-85 -63.72 -73.8 0.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.392 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.55 40.38 0.07 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.758 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.3 mttm 54.51 59.71 3.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 111.26 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.29 113.04 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -61.42 -32.84 72.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 7' ' ' GLU . 21.1 t -125.52 119.28 54.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -113.63 146.03 40.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.959 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' O ' HD13 ' A' ' 24' ' ' ILE . 5.2 mtpm? -108.84 146.48 33.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.27 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.939 HD11 HD12 ' A' ' 41' ' ' ILE . 17.8 mm -128.57 146.61 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.679 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -128.2 87.38 2.59 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.302 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.87 135.83 45.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.534 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.77 90.29 2.96 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.44 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.71 -67.6 0.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.396 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.94 -171.59 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -59.18 0.5 Allowed Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.99 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.73 61.46 4.54 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.369 2.046 . . . . 0.0 112.547 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.5 ' CG1' HD12 ' A' ' 84' ' ' LEU . 23.6 t -73.85 131.14 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.6 p -97.8 161.16 13.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.628 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.76 -33.03 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.594 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.96 -27.38 62.1 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.044 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -41.37 71.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.692 HD21 ' HB ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -54.82 -44.84 74.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.907 178.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.609 HD11 ' HZ ' ' A' ' 92' ' ' PHE . 24.4 mm -68.92 -33.34 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.788 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -50.33 36.13 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.7 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 15.8 t60 -60.48 -48.07 83.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.939 HD12 HD11 ' A' ' 24' ' ' ILE . 7.1 tt -62.72 -30.96 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.633 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.674 HG13 ' CG2' ' A' ' 52' ' ' VAL . 89.0 t -94.88 -11.24 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.9 m -100.99 -69.57 0.77 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 p -76.75 -56.91 4.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.52 -55.62 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.938 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.821 HG21 HG23 ' A' ' 52' ' ' VAL . 41.5 mt -109.93 129.43 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -149.03 59.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.028 0.442 . . . . 0.0 110.703 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -150.12 131.8 7.63 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.183 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 60.7 Cg_endo -72.03 66.12 3.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.573 2.182 . . . . 0.0 112.327 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.11 -49.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.46 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.93 -39.08 15.04 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.679 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.821 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -93.57 -35.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.121 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.4 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 13.3 t -52.93 -36.19 59.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.642 0.258 . . . . 0.0 111.12 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.99 -34.19 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.391 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.838 ' CE1' HD21 ' A' ' 12' ' ' LEU . 38.0 t80 -73.28 -52.71 12.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.325 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.571 HG13 HG21 ' A' ' 42' ' ' VAL . 32.3 mm -111.87 136.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -132.14 134.52 45.52 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.018 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.65 38.77 25.06 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.775 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 33.44 21.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.68 152.67 35.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.062 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 62' ' ' ARG . 2.1 mp -65.57 154.5 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.256 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 61' ' ' ILE . 2.7 mtt-85 -101.04 138.94 20.12 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 51.9 Cg_exo -55.22 133.32 57.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.797 2.331 . . . . 0.0 112.426 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.35 -35.57 2.56 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.681 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.52 HD13 ' CE1' ' A' ' 55' ' ' PHE . 3.1 mt -83.37 111.84 20.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.962 0.411 . . . . 0.0 110.97 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.99 146.26 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 m -129.43 136.64 50.18 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.3 mt -130.04 113.78 14.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.003 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.47 109.53 25.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.34 49.05 9.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.637 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 58.54 31.7 21.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 73' ' ' ASP . 1.5 m -135.06 170.56 15.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.385 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.63 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -79.68 172.0 14.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.262 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.424 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 23.0 p-90 -103.86 -33.99 8.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.953 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -88.24 -26.76 22.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.468 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 73' ' ' ASP . 6.1 mt -60.62 -21.66 62.93 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.32 -71.55 0.72 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.525 0.203 . . . . 0.0 111.114 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.1 108.8 0.4 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.654 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 16.4 mt-10 -54.92 -72.54 0.06 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.457 0.17 . . . . 0.0 111.074 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -104.39 -33.89 8.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.952 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.21 -23.75 23.85 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.453 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -56.38 106.13 0.26 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.81 141.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.5 HD12 ' CG1' ' A' ' 32' ' ' VAL . 17.7 mt -63.8 175.79 1.07 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.36 97.83 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -47.8 104.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.79 27.94 4.43 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.693 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.97 170.48 7.89 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.602 0.239 . . . . 0.0 111.014 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -118.31 130.35 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.714 HD13 ' CG1' ' A' ' 4' ' ' VAL . 5.2 mp -136.15 150.64 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.064 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.03 146.83 50.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.388 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.609 ' HZ ' HD11 ' A' ' 38' ' ' ILE . 18.1 m-85 -133.02 82.11 1.98 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.723 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.05 141.61 28.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -119.89 97.34 5.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.429 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p -87.73 52.83 2.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.022 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.27 28.98 0.29 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 62.56 178.46 0.14 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.75 0.309 . . . . 0.0 111.09 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.92 83.87 0.06 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.843 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.604 179.846 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtm . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.668 0.271 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.33 99.5 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.072 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -82.26 112.05 18.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.075 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 m -110.26 129.2 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.326 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 118.16 24.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' HB ' ' A' ' 90' ' ' ILE . 2.7 m -122.75 147.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.503 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -119.38 107.27 13.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.499 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.655 ' C ' HD12 ' A' ' 9' ' ' LEU . 52.8 m-85 -85.25 128.71 34.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.655 HD12 ' C ' ' A' ' 8' ' ' PHE . 7.0 mp -135.98 149.62 48.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.956 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.72 -102.28 1.96 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.508 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.58 26.46 3.66 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.015 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.72 -41.58 8.02 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.868 0.334 . . . . 0.0 110.828 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.54 -33.05 74.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.04 73.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 -44.95 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.35 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.435 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 14.7 m-85 -65.02 -71.46 0.18 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.227 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.63 45.64 0.1 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.542 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 56.87 54.35 7.22 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 106.95 8.23 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.019 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -9.02 50.46 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.928 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.47 138.69 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.507 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.69 168.82 19.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -138.97 143.5 38.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 41' ' ' ILE . 2.9 mp -136.28 150.77 27.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.358 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.62 101.66 5.03 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.842 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG2' ' CG ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -77.67 124.45 27.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.742 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.15 68.68 9.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.93 -159.12 0.94 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.509 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -170.78 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.225 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -59.7 0.77 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.99 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 83' ' ' ILE . 86.8 Cg_endo -77.42 58.98 6.52 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.39 2.06 . . . . 0.0 112.733 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -72.6 132.23 33.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.8 p -73.91 149.26 41.56 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.64 -36.49 54.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.88 -27.79 59.81 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.64 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.93 -42.77 69.42 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.735 0.302 . . . . 0.0 110.424 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -53.5 -53.15 55.62 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' HG23 ' A' ' 42' ' ' VAL . 3.5 mt -61.01 -37.25 76.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.357 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -41.55 97.26 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG2' ' A' ' 26' ' ' MET . 1.3 t60 -62.16 -36.88 83.19 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 24' ' ' ILE . 33.1 mt -72.09 -27.65 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.296 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG21 ' CD1' ' A' ' 56' ' ' ILE . 28.8 t -94.53 -5.49 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.8 p -100.25 -72.41 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.1 p -87.32 -49.3 7.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.502 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.1 ttt -53.36 -54.74 32.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.918 HG21 HG23 ' A' ' 52' ' ' VAL . 26.0 mt -110.43 125.87 67.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.611 0.243 . . . . 0.0 110.829 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.46 74.69 1.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.188 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.78 119.93 0.42 Allowed Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.63 76.85 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.774 2.316 . . . . 0.0 112.067 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -166.14 -57.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.513 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -82.16 -36.13 27.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.758 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.918 HG23 HG21 ' A' ' 46' ' ' ILE . 1.8 t -89.43 -35.67 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.984 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 m -58.07 -34.35 70.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.38 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.0 mt -83.15 -39.12 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 111.0 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -68.44 -38.1 80.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.077 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.726 ' CD1' HG21 ' A' ' 42' ' ' VAL . 29.5 mt -132.08 129.55 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.288 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.0 122.79 48.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 55.25 52.72 11.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.76 26.61 11.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.72 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.573 ' C ' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -137.71 125.64 22.67 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 110.66 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -56.81 151.7 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.499 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -87.16 143.57 34.92 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.069 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.67 123.81 9.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.654 2.236 . . . . 0.0 112.208 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.15 -37.38 1.16 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.627 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 62' ' ' ARG . 1.9 mp -70.78 130.07 34.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 110.921 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.0 mm -110.31 152.76 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.963 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 t -146.33 142.56 28.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.692 0.282 . . . . 0.0 111.254 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 mt -131.12 108.16 9.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.562 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 32.3 mt -88.22 109.32 19.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.6 m120 58.67 43.34 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.96 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.59 30.62 18.73 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.023 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 163.99 25.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.59 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.91 117.2 20.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -50.53 -38.65 45.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.909 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.07 -43.87 94.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.655 0.264 . . . . 0.0 110.833 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.83 -26.14 65.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -111.02 30.43 6.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 111.192 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.66 96.22 0.53 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.487 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.58 -52.73 6.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.407 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -112.97 -36.45 5.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.67 56.61 2.28 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.562 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 33.1 t80 -119.08 114.98 23.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.859 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' A' ' 31' ' ' PRO . 2.9 mp -65.19 119.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 37' ' ' LEU . 27.3 mt -65.63 176.35 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 1.2 mt-10 -167.01 101.12 0.54 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.356 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -45.73 122.29 3.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.89 25.21 9.88 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.2 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.8 t70 -100.99 169.51 8.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -113.87 104.95 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.573 ' HB ' HG12 ' A' ' 6' ' ' VAL . 67.8 mt -118.79 100.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.15 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.089 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.62 103.22 5.57 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 159.48 15.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.593 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -142.22 110.47 6.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.779 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.1 t -90.98 52.73 2.21 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 110.803 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.69 -55.8 2.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.688 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -100.05 -41.98 6.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.171 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 128.23 -66.7 0.56 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.508 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.49 179.842 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.867 0.365 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.694 HG23 ' HA ' ' A' ' 86' ' ' ASP . 9.0 p -141.86 128.3 19.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.94 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -105.07 89.78 3.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 37' ' ' LEU . 30.7 m -83.36 150.07 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.582 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -111.32 110.65 21.22 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 t -104.86 144.98 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.36 101.4 7.61 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.562 ' CD2' HD13 ' A' ' 12' ' ' LEU . 86.1 m-85 -89.74 128.81 36.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.39 118.45 13.45 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.302 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.06 -102.03 0.34 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.275 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.21 -33.39 3.2 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.961 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.656 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -54.91 -39.23 68.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.34 -37.8 75.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.055 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.45 68.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.997 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 45.5 mt -66.96 -34.07 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.263 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -71.89 -61.92 1.61 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.648 0.261 . . . . 0.0 111.301 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.58 48.0 0.01 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.318 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mttt 57.22 34.43 24.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 111.255 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.37 103.52 9.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.627 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -65.57 0.67 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.549 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -90.23 135.7 25.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.6 136.97 29.7 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.01 142.05 30.2 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.467 HD13 HG12 ' A' ' 41' ' ' ILE . 12.4 mt -132.78 143.64 39.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.94 123.89 45.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.54 120.09 31.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -127.57 48.16 2.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -36.79 23.24 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.017 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -157.47 -178.74 7.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -85.62 -54.04 0.43 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.949 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 3.1 Cg_exo -79.53 53.8 4.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.949 2.433 . . . . 0.0 112.333 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.8 t -74.44 139.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.645 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.21 163.87 13.2 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.531 ' O ' HD12 ' A' ' 38' ' ' ILE . 7.2 p -54.68 -40.44 51.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.995 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -29.28 58.86 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.192 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.76 -42.55 73.71 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -51.74 -53.37 40.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.091 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 34' ' ' VAL . 2.3 mp -59.08 -38.78 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.405 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.6 -41.42 94.72 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -60.49 -39.89 89.34 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.674 0.273 . . . . 0.0 110.611 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 46' ' ' ILE . 42.3 mt -64.87 -32.19 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.644 HG13 ' CG2' ' A' ' 52' ' ' VAL . 29.7 t -96.39 -1.41 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.92 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -100.29 -72.73 0.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 t -87.97 -40.56 13.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.478 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -59.56 4.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.054 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.75 HG21 HG23 ' A' ' 52' ' ' VAL . 4.4 mt -117.53 148.43 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 120.706 0.289 . . . . 0.0 111.272 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -165.2 41.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.94 139.75 36.56 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.86 73.45 3.63 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.705 2.27 . . . . 0.0 112.463 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -169.38 -47.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.622 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -93.39 -35.9 12.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.75 HG23 HG21 ' A' ' 46' ' ' ILE . 2.1 t -91.22 -35.4 7.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -54.4 -33.22 58.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.4 mt -84.51 -33.05 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.309 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.656 ' CE1' HD11 ' A' ' 12' ' ' LEU . 10.5 t80 -77.82 -35.57 51.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.03 133.26 69.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.393 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.1 -156.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.56 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.57 85.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.06 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.1 t0 60.7 40.75 15.95 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.163 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -178.57 138.92 0.17 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mt -65.78 142.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.42 ' O ' HD12 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -89.55 155.85 48.19 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.35 146.33 68.59 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.7 2.267 . . . . 0.0 112.467 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.67 -42.54 1.46 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.578 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.522 HG21 ' HE1' ' A' ' 55' ' ' PHE . 1.9 mp -73.1 122.44 25.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.982 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -94.68 131.45 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.419 ' HB ' ' CG ' ' A' ' 74' ' ' TRP . 0.3 OUTLIER -122.33 114.56 20.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 68' ' ' LEU . 24.7 mt -112.76 109.19 18.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.0 mt -88.16 98.58 7.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.55 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.1 m120 57.37 55.25 5.93 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.736 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 31.58 20.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.536 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.97 159.74 40.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.462 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.806 ' HB2' HD12 ' A' ' 76' ' ' LEU . 2.7 m-20 -79.79 120.4 24.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.419 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -57.12 -30.68 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.639 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.05 -30.58 44.13 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.584 0.23 . . . . 0.0 111.129 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' HB2' ' A' ' 73' ' ' ASP . 4.8 mt -65.55 -18.11 65.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.575 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -133.59 38.66 3.24 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 111.384 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.59 103.54 0.25 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.068 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' O ' HG11 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -47.77 -61.88 1.73 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.101 0.16 . . . . 0.0 111.267 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.15 -28.78 11.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.19 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.76 -29.45 18.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.453 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -58.87 114.4 2.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.807 0.337 . . . . 0.0 110.605 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mp -76.82 144.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 84' ' ' LEU . 20.1 mt -64.46 171.69 3.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.203 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -171.04 104.25 0.23 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.471 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.694 ' HA ' HG23 ' A' ' 2' ' ' VAL . 27.1 t70 -46.11 115.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.995 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 20.06 6.67 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.779 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.05 169.98 8.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.779 0.324 . . . . 0.0 111.403 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.452 ' O ' HD13 ' A' ' 90' ' ' ILE . 15.3 mt -127.53 152.34 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.753 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 89' ' ' ILE . 21.2 mm -135.5 150.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.222 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -130.11 138.92 50.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.019 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.85 90.76 2.95 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.019 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.19 104.24 16.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 80.98 1.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.761 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 m -135.11 80.74 1.86 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.75 135.92 45.4 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.121 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -86.01 -45.17 11.7 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.982 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -171.21 -175.46 39.69 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.688 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.613 -1.104 . . . . 0.0 112.819 -179.765 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 m -142.53 165.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -155.85 96.03 1.7 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.74 153.85 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.448 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HG2' HG13 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -115.34 107.77 15.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.581 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.863 HG12 ' HB ' ' A' ' 90' ' ' ILE . 27.5 m -111.91 155.41 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.379 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 21' ' ' VAL . 2.2 mt-10 -124.88 152.64 43.76 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.592 ' O ' HD12 ' A' ' 9' ' ' LEU . 50.8 m-85 -128.92 114.12 16.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.352 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 8' ' ' PHE . 10.9 mp -128.66 108.39 10.45 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.701 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.8 -101.71 0.35 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.528 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.0 28.28 4.15 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.103 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -106.57 -45.34 4.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.737 0.269 . . . . 0.0 110.844 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.25 -33.57 71.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.08 86.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -72.01 -41.89 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -66.8 -71.59 0.19 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.62 43.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.626 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 54.7 34.51 21.79 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.545 0.338 . . . . 0.0 111.524 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.24 112.38 24.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -61.48 -67.05 0.44 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.905 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' A' ' 7' ' ' GLU . 36.3 t -90.83 117.89 34.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.986 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 148.32 38.19 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.052 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -115.84 137.67 51.88 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -134.37 139.84 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 123.4 21.55 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -38.29 54.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.576 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.08 43.48 26.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.92 0.39 . . . . 0.0 111.085 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.05 -74.13 0.62 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.591 ' HG2' HG22 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -133.72 -174.28 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -59.64 0.36 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.097 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.12 57.93 6.37 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.318 2.012 . . . . 0.0 112.573 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG22 ' HG2' ' A' ' 29' ' ' GLU . 21.7 t -74.85 118.9 21.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 p -66.21 147.01 53.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.37 -34.65 23.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.556 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.87 -26.77 58.44 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.117 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.5 -42.07 62.28 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.663 0.268 . . . . 0.0 110.615 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -54.04 -53.05 58.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.198 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.491 ' HA ' HD12 ' A' ' 41' ' ' ILE . 16.4 mt -62.36 -40.03 86.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.386 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.75 -42.71 99.32 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -58.94 -43.29 91.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.957 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 38' ' ' ILE . 15.2 mt -64.52 -32.21 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.141 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG13 ' CG2' ' A' ' 52' ' ' VAL . 21.9 t -97.14 -3.51 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -92.92 -75.44 0.49 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.507 0.194 . . . . 0.0 111.357 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -94.62 -43.02 8.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.187 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -38.45 67.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.776 HG21 HG23 ' A' ' 52' ' ' VAL . 47.0 mt -136.92 136.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.301 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -159.1 38.44 0.21 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 23.0 t30 -128.54 127.45 23.6 Favored Pre-proline 0 C--N 1.334 -0.088 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.866 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 24.9 Cg_exo -64.44 76.58 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.692 2.261 . . . . 0.0 112.254 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -168.25 -45.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.43 -31.54 12.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.135 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.776 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -102.57 -35.52 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.206 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -36.46 61.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.571 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.625 HD12 ' N ' ' A' ' 55' ' ' PHE . 1.4 pp -94.93 -22.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' N ' HD12 ' A' ' 54' ' ' ILE . 46.4 t80 -77.25 -49.07 15.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.594 0.235 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.1 mm -106.5 150.28 9.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.07 85.12 2.2 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 57.06 67.25 1.01 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.401 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 76.28 -42.87 0.45 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.336 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -82.04 129.93 34.94 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.724 0.297 . . . . 0.0 110.985 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.48 153.38 6.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.348 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -82.66 135.95 45.61 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.174 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.18 106.54 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.65 2.234 . . . . 0.0 111.965 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.13 -35.52 0.24 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.75 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 mt -67.21 121.57 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.836 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -90.01 97.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.8 t -104.75 136.28 44.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.9 mt -126.1 118.53 25.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.445 HG23 HG12 ' A' ' 90' ' ' ILE . 33.6 mt -102.01 109.5 26.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.492 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.03 48.14 13.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.61 38.77 21.97 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.362 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.62 161.95 38.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.721 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.72 124.77 29.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.403 ' CG ' HG23 ' A' ' 67' ' ' THR . 1.0 OUTLIER -55.84 -33.59 64.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.506 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -80.11 -33.4 38.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.669 0.271 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.74 -24.87 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -103.52 -58.21 1.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.513 0.197 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.3 98.22 0.11 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.626 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -47.04 -56.81 5.83 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.127 0.171 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -117.34 -30.64 5.52 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.937 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.92 56.62 2.38 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.168 0.509 . . . . 0.0 110.977 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -137.65 112.52 8.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.76 127.87 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 37' ' ' LEU . 15.6 mt -65.31 177.7 1.06 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 110.741 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -163.45 100.03 0.93 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.143 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -49.07 108.91 0.21 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.03 26.31 5.55 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.16 176.15 5.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.662 0.268 . . . . 0.0 111.041 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -116.77 111.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.362 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.863 ' HB ' HG12 ' A' ' 6' ' ' VAL . 62.6 mt -126.41 97.61 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.4 m -79.91 158.54 26.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.501 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -145.05 85.24 1.74 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -91.92 162.67 14.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.623 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.44 93.96 2.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.865 0.364 . . . . 0.0 110.823 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.76 39.23 2.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.918 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.93 121.89 17.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.629 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.86 77.92 3.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.705 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.98 -116.88 2.66 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.654 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.446 -1.197 . . . . 0.0 112.489 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 86' ' ' ASP . 9.1 p -121.84 142.31 38.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.661 0.267 . . . . 0.0 111.145 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -112.93 93.16 4.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.871 HG21 HD21 ' A' ' 37' ' ' LEU . 25.2 m -93.3 144.16 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -116.37 97.31 5.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.665 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -92.79 146.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -116.98 97.65 6.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' HD12 ' A' ' 9' ' ' LEU . 72.0 m-85 -87.23 117.92 26.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 8' ' ' PHE . 10.3 mp -127.23 176.47 7.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.467 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.94 -112.22 3.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.354 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.81 23.17 12.03 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.784 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD21 ' CE1' ' A' ' 55' ' ' PHE . 1.1 mt -100.27 -43.31 6.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.805 0.303 . . . . 0.0 111.212 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.12 -34.03 67.96 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.39 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -33.74 76.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.703 0.287 . . . . 0.0 111.097 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.7 mt -80.28 -41.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.326 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -61.96 -73.3 0.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.267 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.78 41.63 0.09 OUTLIER Glycine 0 C--N 1.335 0.472 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt 53.59 41.56 32.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.717 0.294 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -121.78 121.83 38.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -46.06 91.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.384 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 10.1 p -121.34 126.93 75.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.85 135.75 54.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.492 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 24' ' ' ILE . 11.8 pttt -102.46 146.35 28.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.361 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 23' ' ' LYS . 19.0 mm -132.22 147.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -121.52 98.14 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.774 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.457 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -96.18 139.55 32.18 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -138.16 81.51 1.86 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -120.62 -63.07 1.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -148.4 -175.51 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.797 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.26 -60.14 0.3 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.052 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.49 58.02 6.8 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.489 2.126 . . . . 0.0 112.297 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.59 ' HB ' HD12 ' A' ' 84' ' ' LEU . 22.5 t -81.17 152.67 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.339 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -103.36 163.8 12.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.327 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.472 ' HA ' HD21 ' A' ' 84' ' ' LEU . 7.5 p -58.55 -34.46 51.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.028 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -27.71 62.61 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.11 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -71.36 -41.86 69.2 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.641 0.258 . . . . 0.0 110.42 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -54.96 -51.79 65.05 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.328 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mt -59.18 -39.67 79.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.336 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.25 -41.94 89.96 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -60.76 -45.02 95.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.204 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.609 HG22 HD12 ' A' ' 46' ' ' ILE . 28.2 mt -62.68 -28.41 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.395 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 56' ' ' ILE . 32.8 t -100.52 -9.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -76.21 -75.62 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.58 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.3 m -100.33 -36.33 9.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.294 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.4 mmm -56.64 -53.49 57.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.431 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.613 ' CG2' HG23 ' A' ' 52' ' ' VAL . 9.6 mt -124.61 88.03 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 120.938 0.399 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -104.2 51.17 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.48 116.54 6.47 Favored Pre-proline 0 N--CA 1.457 -0.105 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.67 -30.92 30.4 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.77 2.313 . . . . 0.0 112.739 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -55.96 -48.91 74.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.319 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.14 31.48 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.755 HG21 HG13 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -150.56 -49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 p -56.68 -27.54 59.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.474 0.178 . . . . 0.0 111.447 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.2 mt -84.04 -33.87 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.666 0.27 . . . . 0.0 110.625 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.574 ' CE1' HD21 ' A' ' 12' ' ' LEU . 52.0 t80 -74.34 -44.21 53.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.085 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 42' ' ' VAL . 42.1 mt -111.57 148.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.899 0.381 . . . . 0.0 111.38 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.15 -158.33 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.851 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.28 92.63 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.109 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t0 53.35 37.0 24.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.874 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.45 141.04 1.48 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.557 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.498 HG22 HD12 ' A' ' 65' ' ' ILE . 2.6 mt -58.06 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.705 0.288 . . . . 0.0 111.334 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.99 120.2 58.91 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.72 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.57 101.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.676 2.251 . . . . 0.0 112.166 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.67 -42.65 0.63 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.694 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 61' ' ' ILE . 4.6 mt -59.12 140.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.937 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -108.3 137.71 38.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.118 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.9 t -137.63 125.9 23.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 41.0 mt -108.66 111.09 22.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.54 111.73 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.615 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 58.85 47.5 12.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.96 34.1 23.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.963 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.1 m -140.88 161.7 37.21 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.617 ' HB2' HD23 ' A' ' 76' ' ' LEU . 1.5 m-20 -79.89 150.79 30.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.377 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -62.44 -42.33 99.39 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.43 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.17 -9.07 58.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -63.26 -35.85 81.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.343 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.54 29.3 6.65 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 111.503 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 75' ' ' GLU . . . 121.51 -102.72 0.83 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.442 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.72 -81.13 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 122.546 0.338 . . . . 0.0 110.303 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -104.82 -24.55 12.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.273 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -52.98 -25.48 12.19 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -45.15 107.7 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 110.489 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mt -68.26 138.41 22.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.59 HD12 ' HB ' ' A' ' 32' ' ' VAL . 18.4 mt -66.52 174.07 3.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -170.85 104.22 0.24 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.504 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 2' ' ' VAL . 6.1 t0 -42.06 109.17 0.12 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.007 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.02 27.05 4.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.44 165.77 12.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.02 116.64 46.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.804 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 90' ' ' ILE . 4.0 mp -115.92 150.49 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 67' ' ' THR . 40.3 m -130.26 142.33 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.708 0.29 . . . . 0.0 111.413 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB3' HD13 ' A' ' 12' ' ' LEU . 11.1 m-85 -130.99 95.27 3.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 156.86 16.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.084 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 t -153.92 79.94 1.14 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p -69.59 -35.03 74.96 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 97' ' ' HIS . 4.3 pp -61.79 -25.21 67.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.745 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.421 ' N ' HD12 ' A' ' 96' ' ' LEU . 15.7 t-160 75.86 122.79 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.587 0.355 . . . . 0.0 111.232 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.66 -58.4 12.36 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.887 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.516 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.716 0.293 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 m -138.46 168.76 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.2 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -157.64 94.23 1.34 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.884 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 m -105.19 135.38 43.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -89.23 115.56 26.82 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.709 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 7.7 t -110.4 148.48 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.244 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -119.29 99.18 6.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CE1' HD22 ' A' ' 12' ' ' LEU . 93.8 m-85 -84.55 133.45 34.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.552 HD13 HG23 ' A' ' 93' ' ' THR . 5.4 mp -140.64 152.13 45.16 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -101.53 2.76 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.222 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.75 -28.74 4.66 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 8' ' ' PHE . 1.4 mt -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.897 0.349 . . . . 0.0 111.734 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.04 -33.48 75.9 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.419 0.152 . . . . 0.0 111.12 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.75 80.87 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.401 HG21 ' CB ' ' A' ' 51' ' ' ASP . 4.7 mt -81.69 -34.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.521 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.8 -73.22 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.58 0.228 . . . . 0.0 111.187 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.8 41.75 0.09 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.591 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 53.19 34.78 18.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.484 0.313 . . . . 0.0 111.705 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -121.61 123.55 42.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.613 0.244 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -26.87 68.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.598 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 7.5 p -132.46 135.27 58.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.838 0.352 . . . . 0.0 110.934 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.16 142.23 28.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -85.42 142.22 29.41 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.991 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.1 mm -123.9 140.75 46.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.135 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.3 115.62 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 40' ' ' HIS . 15.1 ttt -88.98 -42.36 11.83 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.141 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 86.25 0.1 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -66.09 0.37 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.58 -169.26 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.456 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -86.83 -54.2 0.39 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.082 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 4.8 Cg_exo -74.08 55.86 3.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.834 2.356 . . . . 0.0 112.588 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.59 124.78 49.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.619 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.73 153.98 30.42 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.14 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -56.19 -33.66 37.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.71 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.5 -27.64 54.45 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.82 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -40.74 68.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.677 0.275 . . . . 0.0 110.496 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.88 -52.89 61.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.344 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.445 HG23 ' CE2' ' A' ' 55' ' ' PHE . 16.3 mt -60.17 -41.29 86.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.107 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -61.23 -40.01 92.39 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG3' ' A' ' 26' ' ' MET . 72.6 t60 -58.52 -46.72 86.18 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 46' ' ' ILE . 17.9 mt -63.29 -30.01 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.279 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 56' ' ' ILE . 39.5 t -97.15 -4.9 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.76 -73.92 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.3 m -87.34 -45.14 10.84 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.465 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.428 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -54.77 -51.67 64.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.042 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.822 ' CG2' HG23 ' A' ' 52' ' ' VAL . 7.6 mt -121.79 150.96 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.106 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -160.81 65.53 0.3 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.42 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 8.9 t30 -170.88 138.51 1.22 Allowed Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 120.601 0.239 . . . . 0.0 111.572 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.88 75.17 3.23 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.735 2.29 . . . . 0.0 112.6 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 48' ' ' ASN . 20.3 p-10 -166.13 -41.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.401 ' CB ' HG21 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -100.98 -37.31 8.69 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.822 HG23 ' CG2' ' A' ' 46' ' ' ILE . 2.1 t -82.5 -34.45 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.412 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -50.88 -31.94 18.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.677 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.95 -46.31 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.755 0.312 . . . . 0.0 111.018 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.481 ' O ' HD13 ' A' ' 56' ' ' ILE . 17.8 t80 -66.59 -47.87 71.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.848 HG13 HG21 ' A' ' 42' ' ' VAL . 28.2 mm -129.57 143.55 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.813 0.34 . . . . 0.0 111.294 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.5 127.89 26.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 58.33 45.43 16.98 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.449 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 53.99 33.5 17.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.374 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.4 m -150.53 145.66 26.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.915 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.87 152.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -92.64 137.73 24.12 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 99.59 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.582 2.188 . . . . 0.0 111.89 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.17 -35.28 0.44 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.558 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -66.27 134.48 29.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.43 118.62 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 91' ' ' SER . 4.5 t -121.5 92.09 3.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.945 0.402 . . . . 0.0 111.016 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.4 mt -101.23 122.0 42.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.207 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mt -100.66 107.73 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.02 52.64 6.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.33 30.64 19.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.117 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -133.28 164.99 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -79.77 177.6 8.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.921 0.391 . . . . 0.0 111.18 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -102.88 -39.94 6.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.92 -27.62 28.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.763 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -54.27 -30.6 51.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -115.69 -62.15 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.522 0.201 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.75 103.86 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.686 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -57.5 6.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.59 0.234 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -117.4 -44.3 2.77 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.1 -27.0 5.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.018 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -48.99 109.53 0.27 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.428 HD12 ' H ' ' A' ' 83' ' ' ILE . 3.4 mp -68.95 133.33 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.138 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -67.63 172.44 5.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.804 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.16 102.6 0.29 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.395 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -48.91 114.51 1.01 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.71 -9.56 6.81 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.814 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.538 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -80.04 157.23 26.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.045 0.422 . . . . 0.0 111.163 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 89' ' ' ILE . 1.5 mp -107.69 125.45 64.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.764 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 6.5 mt -125.99 141.89 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.27 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -116.57 142.21 47.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.76 90.98 3.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.794 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.552 HG23 HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -108.04 95.52 5.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.874 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -88.04 89.4 7.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.406 ' O ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -115.52 -83.56 0.62 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.707 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER 176.67 -49.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.58 0.229 . . . . 0.0 110.858 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.28 -69.44 0.19 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.24 -86.77 0.4 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.123 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.688 -179.895 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.522 0.201 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 86' ' ' ASP . 7.7 p -126.69 108.96 19.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.02 0.438 . . . . 0.0 111.227 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -87.63 117.19 26.27 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.413 ' HB ' HD13 ' A' ' 90' ' ' ILE . 18.2 m -114.98 139.5 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.25 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.94 105.88 16.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.655 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.816 HG12 ' HB ' ' A' ' 90' ' ' ILE . 8.4 m -98.68 146.13 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.329 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -126.0 98.43 5.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.64 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.449 ' C ' HD12 ' A' ' 9' ' ' LEU . 98.0 m-85 -82.95 142.48 31.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' ' 8' ' ' PHE . 5.4 mp -146.04 172.45 13.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.213 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.75 -107.96 2.59 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.219 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.44 -6.04 13.76 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.664 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -65.72 -45.13 83.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.398 0.599 . . . . 0.0 111.284 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.56 -30.22 69.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.256 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.66 88.21 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.658 0.266 . . . . 0.0 111.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 11.0 mt -70.43 -40.14 77.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.601 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.5 m-85 -66.44 -70.16 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.45 48.04 0.04 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.366 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt 56.77 33.81 23.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.382 0.273 . . . . 0.0 111.344 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -104.16 110.65 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.755 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.45 -62.39 1.49 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.45 144.14 20.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.808 0.337 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -180.0 6.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.9 141.79 25.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.2 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 23' ' ' LYS . 20.0 mm -135.16 146.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.17 84.0 2.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.04 127.25 30.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.177 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.38 92.86 4.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.97 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -144.38 -66.04 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.43 -178.03 6.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.197 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.73 -59.78 0.35 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.002 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.94 58.78 6.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.558 2.172 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -92.38 132.86 35.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.2 p -75.37 153.02 37.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.859 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.14 -32.13 33.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.707 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -26.52 55.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.086 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.01 -45.71 69.84 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.584 0.231 . . . . 0.0 110.56 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -54.28 -46.82 72.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.221 178.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.3 mt -58.13 -41.12 79.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.322 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -37.63 80.53 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.835 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.6 -40.48 97.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.866 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.492 HD11 HG13 ' A' ' 24' ' ' ILE . 22.1 mm -65.75 -31.22 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.676 HG21 HG13 ' A' ' 56' ' ' ILE . 24.0 t -97.46 -2.9 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -99.54 -75.74 0.56 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -87.42 -48.07 8.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.359 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.17 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.746 HG21 HG23 ' A' ' 52' ' ' VAL . 16.1 mt -126.48 136.39 60.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -153.0 44.01 0.64 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -130.64 129.56 22.74 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.193 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.55 73.85 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.39 -52.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.575 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.456 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.3 p30 -83.91 -35.64 23.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -89.74 -35.67 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 t -58.43 -38.98 78.57 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.312 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.27 -36.86 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.316 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.06 -51.43 38.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.062 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.676 HG13 HG21 ' A' ' 42' ' ' VAL . 28.4 mm -111.71 125.35 69.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.134 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -114.5 122.77 47.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.766 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.11 45.14 21.3 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.73 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.29 32.33 21.58 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.362 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -143.89 147.87 34.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -61.58 152.32 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -93.64 148.44 35.42 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.92 122.16 9.26 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.752 2.301 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.47 -46.26 1.08 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.768 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.64 117.81 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.5 mm -80.55 147.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.524 HG23 ' CG ' ' A' ' 74' ' ' TRP . 7.4 t -147.49 99.86 3.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.19 143.11 32.41 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 89' ' ' ILE . 17.1 mt -126.09 112.22 29.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.37 44.74 11.87 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.984 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.31 39.09 25.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -142.93 166.36 24.84 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.42 28.54 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.533 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.87 -36.01 46.99 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.906 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -39.54 32.02 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.406 0.146 . . . . 0.0 111.358 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -25.22 62.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -106.56 -35.75 6.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.238 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.4 98.53 0.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.533 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 2.9 tt0 -42.06 -69.61 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.258 0.223 . . . . 0.0 111.552 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -116.66 -36.81 3.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.971 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.77 -24.94 24.77 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.494 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -52.12 110.94 0.54 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.837 0.351 . . . . 0.0 110.728 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.0 mt -68.49 141.0 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.12 176.43 0.75 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.04 103.52 0.3 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.41 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.569 ' HA ' HG23 ' A' ' 2' ' ' VAL . 17.3 t0 -43.01 108.29 0.1 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.819 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 29.91 3.4 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.66 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.636 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -103.81 165.06 11.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.636 HD12 ' C ' ' A' ' 88' ' ' ASP . 1.6 mp -115.92 141.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.78 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.816 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.7 mp -138.43 90.12 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -81.41 132.73 35.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -118.95 110.09 16.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.34 100.94 8.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.0 t -92.4 88.05 6.25 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m -119.35 -1.78 10.72 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.911 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 97' ' ' HIS . 13.5 mt 65.74 103.18 0.04 OUTLIER 'General case' 0 C--N 1.344 0.367 0 C-N-CA 122.447 0.299 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 24.4 m80 67.45 160.12 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.14 35.24 1.07 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.2 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.43 -1.205 . . . . 0.0 112.444 179.718 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mtp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.6 0.238 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.9 m -135.51 163.16 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.04 112.13 10.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.16 134.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 116.74 33.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.764 HG12 ' HB ' ' A' ' 90' ' ' ILE . 6.6 m -122.47 143.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.403 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -110.95 153.79 25.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' C ' HD22 ' A' ' 9' ' ' LEU . 44.9 m-85 -128.57 118.23 22.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.048 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.628 ' CB ' HG23 ' A' ' 93' ' ' THR . 4.5 mm? -122.78 171.59 9.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.18 -103.14 1.54 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.436 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.05 27.27 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.948 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.586 HD21 ' CE1' ' A' ' 55' ' ' PHE . 3.4 mt -87.64 -41.41 13.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.825 0.313 . . . . 0.0 110.896 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.2 -33.93 71.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.165 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.77 -31.99 73.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.229 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mt -74.3 -46.89 42.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.216 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -62.76 -65.58 0.67 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.319 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.48 46.74 0.03 OUTLIER Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.444 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.9 mttt 57.44 51.72 9.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -125.82 122.33 35.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.992 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -68.86 -64.31 0.89 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.93 137.32 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -126.93 156.67 41.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.059 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -123.89 132.2 53.7 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.811 HG13 HD11 ' A' ' 41' ' ' ILE . 23.3 mm -116.69 144.07 25.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.338 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.45 108.31 10.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -100.11 110.12 22.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.993 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -102.39 63.83 0.89 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 110.904 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -112.44 -44.98 3.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.012 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' CG ' HG22 ' A' ' 32' ' ' VAL . 9.5 pt-20 -169.95 -176.66 2.38 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -86.29 -51.93 0.46 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.5 Cg_exo -78.67 54.09 4.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.961 2.44 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG22 ' CG ' ' A' ' 29' ' ' GLU . 26.8 t -85.65 122.48 38.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.026 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -74.4 150.45 40.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.234 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -52.59 -30.77 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.583 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.56 -25.71 61.27 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.279 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.4 -43.48 73.37 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -55.67 -47.06 77.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.775 178.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.68 -39.15 78.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.014 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.77 -41.07 94.76 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.829 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -59.89 -41.87 92.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.807 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.811 HD11 HG13 ' A' ' 24' ' ' ILE . 33.9 mm -63.81 -33.18 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.047 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.646 HG13 ' CG2' ' A' ' 52' ' ' VAL . 38.2 t -98.06 -3.89 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 m -95.54 -75.22 0.53 Allowed 'General case' 0 C--O 1.232 0.183 0 O-C-N 122.382 -0.199 . . . . 0.0 111.463 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 t -93.15 -38.78 11.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.458 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -46.81 88.62 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.079 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.717 HG21 HG23 ' A' ' 52' ' ' VAL . 20.1 mt -129.77 150.98 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.25 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -166.06 40.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.106 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.2 t-20 -128.58 128.44 23.56 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.484 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 25.0 Cg_exo -63.67 74.37 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.84 2.36 . . . . 0.0 112.191 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.07 -58.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.457 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.2 p30 -81.29 -34.56 31.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.758 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.717 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -91.78 -36.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.065 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.86 72.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.432 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.4 mt -86.63 -36.84 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.025 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CE1' HD21 ' A' ' 12' ' ' LEU . 31.9 t80 -69.09 -37.04 78.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.088 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 42' ' ' VAL . 35.1 mm -127.3 130.13 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.795 0.331 . . . . 0.0 111.353 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.41 -158.32 0.6 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.591 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.55 85.99 0.11 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.895 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 60.75 46.75 8.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.39 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.39 175.94 2.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.4 mt -97.07 153.4 3.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.832 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 125.31 79.04 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.85 105.33 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.62 2.213 . . . . 0.0 112.065 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 151.88 -31.25 0.9 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.557 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.522 HD12 ' CG2' ' A' ' 61' ' ' ILE . 31.2 mt -70.38 127.59 32.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mt -100.77 134.69 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.958 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 91' ' ' SER . 1.5 m -138.24 143.81 40.28 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.234 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.3 mt -139.4 126.21 20.82 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.447 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 77' ' ' GLU . 9.6 mt -100.73 102.35 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.0 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 59.99 59.75 2.33 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.304 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 57.83 26.02 12.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.58 173.27 11.04 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.036 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 2.3 m-20 -79.38 157.95 27.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -59.99 2.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.712 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.24 -37.42 77.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.185 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -60.36 -29.98 69.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.923 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.441 ' HB3' HD12 ' A' ' 69' ' ' ILE . 2.8 tp10 -93.57 28.4 2.31 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.069 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.95 -6.55 82.73 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.59 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 67.85 -72.41 0.09 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.027 0.414 . . . . 0.0 111.021 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -116.78 -29.71 5.97 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.03 54.88 1.68 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.227 0.537 . . . . 0.0 110.922 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -124.58 113.62 18.31 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.615 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.6 mt -61.45 128.5 22.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.8 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 84' ' ' LEU . 18.4 mt -64.2 174.5 1.57 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.858 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.39 103.65 0.21 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -46.68 113.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.026 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 23.98 5.69 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.02 177.65 4.83 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.337 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 mm -121.74 132.23 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.764 ' HB ' HG12 ' A' ' 6' ' ' VAL . 62.1 mt -143.06 92.55 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.631 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 67' ' ' THR . 12.9 m -79.88 149.11 31.05 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.711 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -134.46 86.87 2.3 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.776 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.628 HG23 ' CB ' ' A' ' 9' ' ' LEU . 1.2 m -91.23 144.72 25.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.604 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -148.66 79.98 1.44 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.004 0.43 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.44 -54.81 4.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.201 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.0 28.65 17.98 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.27 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -175.23 -63.59 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.24 166.64 46.32 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.812 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.482 -1.177 . . . . 0.0 112.522 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 27' ' ' ASP . 1.8 mtp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.593 0.235 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.432 HG13 ' CA ' ' A' ' 86' ' ' ASP . 5.1 t -101.9 102.2 13.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.876 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -80.18 125.28 29.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.551 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 37' ' ' LEU . 31.2 m -128.47 139.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.79 118.28 36.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.889 HG12 ' HB ' ' A' ' 90' ' ' ILE . 35.0 m -119.0 153.25 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.376 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.498 ' CD ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -125.77 158.86 33.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.809 ' C ' HD22 ' A' ' 9' ' ' LEU . 8.2 p90 -160.24 148.03 16.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.809 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.0 mm? -137.96 178.22 7.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.112 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.59 -109.97 3.04 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.83 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.19 -24.22 17.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.943 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 55' ' ' PHE . 4.3 mm? -55.03 -46.41 75.29 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.721 0.261 . . . . 0.0 111.362 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.89 -30.73 71.07 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.0 -38.2 45.4 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.271 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 22.3 mt -75.63 -44.59 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.71 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.451 ' HE2' HD12 ' A' ' 12' ' ' LEU . 3.0 m-85 -59.27 -69.78 0.19 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.521 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.74 46.85 0.03 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.452 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.74 44.89 22.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -121.3 -176.66 3.34 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 -56.44 0.56 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.498 HG22 ' CD ' ' A' ' 7' ' ' GLU . 20.8 t -99.91 117.67 45.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.31 153.57 28.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.21 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -124.47 119.08 28.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 24' ' ' ILE . 3.9 mp -99.45 143.07 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -116.22 80.42 1.45 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.293 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.97 106.75 18.62 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 2.5 p30 -93.92 43.83 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HB3' HG21 ' A' ' 32' ' ' VAL . 1.3 tttp -90.11 -162.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -65.07 -172.19 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.904 0.383 . . . . 0.0 111.365 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -83.47 -54.01 0.54 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.036 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.7 Cg_exo -78.66 50.22 3.35 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.858 2.372 . . . . 0.0 112.713 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.578 HG21 ' HB3' ' A' ' 28' ' ' LYS . 35.4 t -81.84 126.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 1.3 p -73.34 157.47 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.914 0.387 . . . . 0.0 111.2 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.54 -34.98 48.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.471 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 38' ' ' ILE . . . -56.33 -28.33 54.79 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.875 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -68.91 -43.39 75.31 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -53.04 -51.93 60.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.482 HD12 ' HA2' ' A' ' 35' ' ' GLY . 4.6 mt -59.97 -36.84 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.171 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -63.75 -37.85 88.89 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.766 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -60.85 -39.64 89.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.627 0.251 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.418 ' CG1' HG12 ' A' ' 24' ' ' ILE . 17.8 mt -72.74 -25.76 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.842 HG13 HG21 ' A' ' 52' ' ' VAL . 30.8 t -100.09 -1.44 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -93.72 -77.87 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.381 -0.199 . . . . 0.0 111.234 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.29 -40.87 14.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -56.88 16.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.148 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.903 HG21 HG23 ' A' ' 52' ' ' VAL . 22.2 mt -116.24 123.01 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 120.629 0.252 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.6 39.34 1.69 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.139 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -131.84 129.24 21.87 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.72 70.18 2.11 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.519 2.146 . . . . 0.0 112.044 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.9 -50.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.448 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.4 p30 -88.68 -36.88 15.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.947 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.903 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -94.08 -35.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.342 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 m -56.11 -32.1 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.447 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 33.2 mt -92.08 -32.03 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.56 0.219 . . . . 0.0 111.127 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CE1' HD11 ' A' ' 12' ' ' LEU . 58.3 t80 -73.37 -37.4 66.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.01 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CD1' HG21 ' A' ' 42' ' ' VAL . 27.1 mt -127.93 150.32 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.17 -163.98 1.02 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.695 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.62 92.41 0.07 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.735 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.5 33.66 22.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.471 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.1 p -165.93 122.55 1.37 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.867 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.82 151.61 9.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 20.1 mtt180 -74.5 142.36 77.71 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.16 97.14 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.689 2.26 . . . . 0.0 112.203 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.9 -39.2 0.09 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.49 132.92 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.5 mt -108.18 93.49 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.539 HG23 ' CG ' ' A' ' 74' ' ' TRP . 3.5 t -93.61 138.66 31.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -125.03 122.27 36.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.54 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.24 101.65 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 60.25 59.9 2.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.356 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 58.29 24.56 11.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.582 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -129.38 178.85 6.15 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.173 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -80.02 -177.07 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 111.009 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.539 ' CG ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.61 -39.8 6.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.94 -24.59 19.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.017 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.435 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -54.42 -29.76 50.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.22 -69.32 0.86 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.563 0.221 . . . . 0.0 111.167 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.71 106.81 0.3 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.434 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.11 -71.01 0.08 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.504 0.192 . . . . 0.0 111.067 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -107.83 -36.65 6.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.947 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.37 -29.15 22.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.783 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.53 121.25 4.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.677 0.275 . . . . 0.0 110.856 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.97 138.36 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.05 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.438 HD13 HD23 ' A' ' 37' ' ' LEU . 20.6 mt -66.52 177.9 1.41 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.856 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.85 103.28 0.11 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.909 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' CA ' HG13 ' A' ' 2' ' ' VAL . 12.4 t0 -35.22 111.91 0.14 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.44 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.4 6.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.946 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -95.26 164.33 12.89 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.823 0.344 . . . . 0.0 111.082 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm -119.49 134.5 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.172 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.889 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.4 mp -139.0 154.04 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.045 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 67' ' ' THR . 16.3 m -134.75 161.6 34.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.14 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.405 ' CD1' ' HB ' ' A' ' 67' ' ' THR . 94.1 m-85 -150.39 79.98 1.35 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -87.38 130.56 34.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.437 ' HB2' HD23 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -114.54 101.18 8.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.24 -43.63 14.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.628 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 97' ' ' HIS . 1.0 OUTLIER -92.86 139.51 30.46 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 96' ' ' LEU . 3.2 m80 61.3 32.36 19.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.213 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.34 -77.94 1.25 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.359 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.604 179.759 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 120.799 0.333 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -151.5 132.55 14.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.13 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.36 120.29 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.38 102.09 13.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -99.47 142.12 15.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HG3' HG23 ' A' ' 21' ' ' VAL . 1.2 mt-10 -118.07 102.49 9.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.64 ' C ' HD12 ' A' ' 9' ' ' LEU . 88.2 m-85 -88.06 131.7 34.56 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 8' ' ' PHE . 6.8 mp -139.3 175.83 9.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.237 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 -85.96 1.35 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.625 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.15 28.1 1.55 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.869 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.777 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -105.93 -46.3 4.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.08 -26.35 66.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.367 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.75 80.42 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.827 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 4.3 mt -77.03 -40.5 30.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -63.74 -30.78 71.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.02 46.55 0.22 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.69 34.71 25.03 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.12 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.75 97.77 8.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.71 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -31.16 70.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 7' ' ' GLU . 8.0 p -139.9 128.39 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.917 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.69 138.63 37.92 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 142.23 27.58 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.539 HG13 HD11 ' A' ' 41' ' ' ILE . 25.8 mm -121.39 148.13 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.32 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 126.3 31.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 142.22 50.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.48 102.07 4.52 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -149.37 -69.33 0.21 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.489 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.66 -178.25 5.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.013 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.6 -57.98 0.67 Allowed Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.378 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.88 61.78 3.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.388 2.059 . . . . 0.0 112.724 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.509 ' CG1' HD12 ' A' ' 84' ' ' LEU . 21.4 t -77.58 116.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.561 HG22 HD13 ' A' ' 83' ' ' ILE . 56.8 p -84.84 160.1 20.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.898 0.38 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -58.15 -34.14 48.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.62 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.25 62.0 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.965 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -42.69 71.35 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.746 0.308 . . . . 0.0 110.303 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 84' ' ' LEU . 1.9 tm? -53.0 -52.39 58.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.254 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.4 mt -57.96 -39.6 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.256 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.93 -44.29 91.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.733 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -38.16 76.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.539 HD11 HG13 ' A' ' 24' ' ' ILE . 32.2 mm -68.68 -28.97 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.57 HG13 ' CG2' ' A' ' 52' ' ' VAL . 32.2 t -96.02 -6.53 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 p -99.33 -77.52 0.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.199 -0.313 . . . . 0.0 111.728 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -84.55 -44.02 13.96 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.475 0.179 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.48 ' HB2' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -56.31 -52.31 65.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.219 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.783 ' CG2' HG23 ' A' ' 52' ' ' VAL . 16.2 mt -122.4 141.53 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.566 0.222 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.15 74.05 0.77 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.134 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -165.94 139.07 3.44 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.444 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.95 70.57 5.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.59 2.193 . . . . 0.0 111.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -171.86 -44.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.799 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.472 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.68 -41.88 11.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.783 HG23 ' CG2' ' A' ' 46' ' ' ILE . 1.9 t -85.97 -35.3 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -55.55 -38.44 69.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.36 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.53 -30.87 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.598 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.777 ' CE1' HD21 ' A' ' 12' ' ' LEU . 14.5 t80 -79.52 -57.47 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.546 HG13 HG21 ' A' ' 42' ' ' VAL . 31.6 mm -106.18 135.66 43.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -124.87 97.16 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.982 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.64 66.27 1.28 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.09 28.62 9.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.799 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 m -147.19 122.57 10.32 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.358 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.12 152.48 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 111.158 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.3 116.63 60.59 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -52.68 119.33 5.8 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.85 -27.15 3.22 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.776 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 mt -72.51 125.31 31.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 mp -86.17 148.56 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.327 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.408 HG23 ' CE1' ' A' ' 92' ' ' PHE . 6.2 m -149.71 100.69 2.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 46.7 mt -91.6 114.87 27.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 HD12 ' A' ' 90' ' ' ILE . 10.3 pt -103.52 110.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.765 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 60.19 45.63 11.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.701 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.34 28.64 17.02 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 167.6 20.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.264 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.87 144.33 33.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 111.242 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -63.31 -50.61 69.38 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.976 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -24.59 67.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.25 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -50.03 63.76 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.018 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.15 -72.2 0.34 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.74 36.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.962 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 56.71 -83.98 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 111.808 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -101.86 3.54 39.35 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -91.56 31.09 1.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.696 0.284 . . . . 0.0 111.482 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -123.45 109.2 13.54 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.561 HD13 HG22 ' A' ' 33' ' ' THR . 42.5 mm -65.73 137.28 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.782 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 37' ' ' LEU . 21.6 mt -63.06 174.19 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -167.64 101.06 0.49 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -47.06 119.88 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.706 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.32 20.29 8.34 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.146 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.93 162.84 13.4 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.745 0.307 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.54 95.18 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.577 HD12 HG22 ' A' ' 69' ' ' ILE . 25.0 mm -90.84 149.75 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -133.97 137.96 45.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.297 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' HB3' HD13 ' A' ' 12' ' ' LEU . 9.8 m-85 -124.83 142.58 51.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -145.18 166.9 24.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.697 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 t -145.58 120.15 9.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 121.168 0.508 . . . . 0.0 110.6 179.567 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 2' ' ' VAL . 22.6 m . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 111.671 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -81.67 126.09 31.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.418 HG21 ' HG ' ' A' ' 37' ' ' LEU . 13.9 m -118.85 141.99 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.65 102.93 14.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 90' ' ' ILE . 26.0 m -108.03 154.09 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.294 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -123.0 152.38 40.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.686 ' C ' HD22 ' A' ' 9' ' ' LEU . 83.6 m-85 -137.85 125.02 21.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.686 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.8 mm? -130.26 172.26 12.0 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.493 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -97.99 1.69 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.711 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.74 -29.57 2.84 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.107 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.746 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -56.88 -38.39 72.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.831 0.315 . . . . 0.0 111.288 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -60.87 -38.2 84.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.09 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.94 78.85 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.624 0.249 . . . . 0.0 111.358 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 33.1 mt -71.67 -34.21 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.41 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.47 -34.14 63.05 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.84 45.77 0.15 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.447 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.35 35.92 26.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.888 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.52 13.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.974 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.57 -49.89 2.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.983 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.547 HG11 ' HE2' ' A' ' 5' ' ' LYS . 19.0 t -118.99 134.75 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.307 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -123.46 149.7 44.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.47 119.43 29.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.911 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mm -126.07 148.29 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 23.7 pttt -130.07 113.55 14.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.412 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.66 132.12 38.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.794 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -115.49 91.56 3.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.722 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -156.09 -50.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.972 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' HG22 ' A' ' 32' ' ' VAL . 1.8 pt-20 -161.04 -174.67 4.49 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -59.08 0.36 Allowed Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.91 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.84 58.97 6.23 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.432 2.088 . . . . 0.0 112.631 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 29' ' ' GLU . 41.2 t -80.21 125.4 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.612 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.5 p -72.93 155.47 39.84 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.984 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 79' ' ' GLU . 11.6 p -57.39 -33.32 43.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.53 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 38' ' ' ILE . . . -57.99 -28.45 60.92 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.769 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.41 -38.76 68.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.701 0.286 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.531 HD23 ' CD1' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -54.98 -48.27 73.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 42' ' ' VAL . 5.6 mt -63.07 -42.84 98.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.285 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.142 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -60.46 -44.28 96.04 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.575 HG23 ' SD ' ' A' ' 45' ' ' MET . 20.2 mt -70.04 -31.33 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.805 HG13 HG21 ' A' ' 52' ' ' VAL . 36.5 t -90.66 -4.27 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 t -81.87 -78.79 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.45 -0.156 . . . . 0.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -99.88 -33.74 10.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.525 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.575 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -58.87 -44.29 91.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.136 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.701 HG21 HG23 ' A' ' 52' ' ' VAL . 23.3 mt -131.64 100.57 4.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.091 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.24 55.08 1.41 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 1.1 t-20 -144.74 122.17 6.44 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.344 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 26.6 Cg_exo -63.52 77.56 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.911 2.408 . . . . 0.0 112.027 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -162.26 -54.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.11 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.426 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -91.42 -38.32 12.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.696 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.805 HG21 HG13 ' A' ' 42' ' ' VAL . 2.1 t -86.96 -36.24 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.122 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -54.84 -36.23 64.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.626 0.251 . . . . 0.0 110.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 mt -82.5 -33.88 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.326 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.746 ' CE1' HD21 ' A' ' 12' ' ' LEU . 29.3 t80 -80.07 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 42' ' ' VAL . 28.1 mm -91.89 137.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.616 0.246 . . . . 0.0 111.286 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.26 147.23 41.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.898 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.73 39.38 1.64 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.37 0.418 . . . . 0.0 111.58 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.04 43.02 18.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.57 165.2 35.06 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.419 HD13 ' HZ3' ' A' ' 74' ' ' TRP . 2.2 mp -70.25 154.2 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 61' ' ' ILE . 1.8 ttp85 -75.04 134.42 74.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.123 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.9 84.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.449 2.099 . . . . 0.0 111.459 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.53 -32.34 0.44 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.671 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 55' ' ' PHE . 32.1 mm -60.86 127.71 20.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.17 145.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' SER . 6.0 m -151.57 131.67 13.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.685 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -125.61 117.93 24.61 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.318 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.522 HG23 ' CD1' ' A' ' 74' ' ' TRP . 7.1 pt -90.96 106.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.17 50.21 6.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.05 32.25 20.95 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 175.86 9.21 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.586 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.71 158.96 26.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.465 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.522 ' CD1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -85.14 -56.22 3.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -25.39 63.26 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.665 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 tt -53.36 -32.5 49.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.521 0.201 . . . . 0.0 111.358 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.73 -54.84 2.23 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.782 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 106.12 0.2 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.699 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' O ' HG11 ' A' ' 34' ' ' VAL . 5.8 mt-10 -50.27 -57.63 7.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.483 0.141 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE2' ' HA3' ' A' ' 35' ' ' GLY . 43.4 tttm -110.83 -26.66 9.23 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.222 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.92 57.35 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -139.88 110.64 6.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.049 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.2 130.76 28.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.624 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.531 ' CD1' HD23 ' A' ' 37' ' ' LEU . 17.4 mt -64.78 175.05 1.59 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.848 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.42 102.08 0.72 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.274 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -48.67 114.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.4 26.07 5.54 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.43 164.05 12.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.706 0.288 . . . . 0.0 111.087 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.4 mm -104.39 133.53 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.664 ' HB ' HG12 ' A' ' 6' ' ' VAL . 35.6 mt -140.84 147.52 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 13.4 t -132.2 149.55 52.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.301 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -138.52 86.26 2.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -93.36 175.76 6.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.487 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -155.34 82.18 1.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.616 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 121.196 0.522 . . . . 0.0 110.653 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -96.94 101.62 13.24 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.6 127.38 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.26 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -96.79 108.46 21.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.075 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.856 HG12 ' HB ' ' A' ' 90' ' ' ILE . 27.3 m -114.62 146.35 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -122.52 129.75 52.31 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 97.3 m-85 -109.94 130.12 55.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.61 165.82 26.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.74 -21.2 40.37 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.649 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.01 -26.21 1.6 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.95 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 65' ' ' ILE . 9.4 mt -54.48 -37.75 65.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.75 0.275 . . . . 0.0 111.667 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -56.78 -31.34 64.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.226 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.67 78.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 23.2 mt -80.37 -35.21 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.283 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.38 -75.19 0.1 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.1 37.84 0.17 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.704 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt 52.01 34.29 13.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.447 0.299 . . . . 0.0 111.508 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -125.29 122.52 37.11 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.732 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -50.36 72.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.727 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.67 138.22 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.124 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.61 156.09 49.32 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.63 146.74 47.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.486 HD13 HD11 ' A' ' 37' ' ' LEU . 3.8 mp -134.39 146.9 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -134.1 119.77 19.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.148 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.11 131.96 54.59 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.091 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.34 98.49 5.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.49 -49.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.055 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -161.31 -176.55 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.11 -58.56 0.41 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.68 56.5 4.08 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.547 2.164 . . . . 0.0 112.749 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.84 126.33 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 p -78.67 151.17 32.37 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.24 -32.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.672 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -27.13 57.33 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.724 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -41.57 68.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.734 0.302 . . . . 0.0 110.385 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.566 ' CD1' HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -53.6 -52.22 60.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.189 179.02 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.478 ' HA ' HD12 ' A' ' 41' ' ' ILE . 34.1 mm -62.37 -38.82 82.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.39 -46.0 90.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.039 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -57.85 -42.22 84.03 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.045 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 37' ' ' LEU . 14.7 mt -65.64 -31.76 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.792 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.861 HG13 HG11 ' A' ' 52' ' ' VAL . 43.8 t -92.45 -2.9 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.901 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -74.83 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.462 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -95.7 -42.73 8.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.294 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -42.77 76.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.631 ' CG2' HG22 ' A' ' 52' ' ' VAL . 35.0 mt -131.73 131.56 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -162.24 74.96 0.44 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.018 0.437 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.03 121.03 1.42 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.611 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.67 79.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.44 2.093 . . . . 0.0 112.046 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -172.88 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.529 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.7 p30 -87.4 -41.79 13.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.602 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.861 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -77.63 -35.52 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 t -53.83 -31.56 49.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.333 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.4 mt -90.6 -44.53 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.501 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.654 ' CD1' HD21 ' A' ' 12' ' ' LEU . 35.2 t80 -72.86 -53.75 10.6 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.477 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.656 ' HB ' HG12 ' A' ' 52' ' ' VAL . 37.8 mm -99.87 114.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.305 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -71.85 -162.97 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.542 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -64.43 86.93 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.899 0.381 . . . . 0.0 111.046 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 60.38 43.55 13.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.93 176.5 3.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.07 149.82 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.713 0.292 . . . . 0.0 110.799 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HG2' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -96.11 148.89 35.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.79 159.06 47.42 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.633 2.222 . . . . 0.0 112.275 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.26 -23.66 35.19 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.798 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.691 HD12 HD11 ' A' ' 12' ' ' LEU . 33.8 mm -83.25 102.62 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.0 124.19 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.198 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 91' ' ' SER . 8.6 m -120.18 141.25 50.07 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.4 mt -135.95 115.06 12.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.289 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.2 mt -97.71 105.2 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.638 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 57.63 52.5 8.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 59.61 32.79 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.216 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.32 169.31 18.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.417 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.92 171.52 15.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.847 0.356 . . . . 0.0 111.093 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -100.98 -48.19 4.52 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.993 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -27.04 58.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.99 -27.63 53.67 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.269 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -120.96 -50.9 2.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.406 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.11 93.22 0.1 Allowed Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.726 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -43.5 73.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -124.58 -40.21 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.81 56.52 1.54 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.944 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.19 108.25 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.807 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.86 128.17 20.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.46 175.07 1.46 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.88 100.96 0.66 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.481 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -48.02 115.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.858 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.17 6.58 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.691 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.49 169.16 9.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.744 0.307 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.43 128.07 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.856 ' HB ' HG12 ' A' ' 6' ' ' VAL . 32.7 mt -136.24 145.66 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.842 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 67' ' ' THR . 0.7 OUTLIER -128.65 155.55 44.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.748 0.309 . . . . 0.0 111.348 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 41.8 m-85 -143.6 82.2 1.72 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 m -86.75 140.82 29.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.126 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 t -102.61 103.24 13.52 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.355 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.675 0.274 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -97.94 140.49 32.21 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.432 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.934 HG21 HD21 ' A' ' 37' ' ' LEU . 35.7 m -136.01 146.11 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 113.33 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.886 HG12 ' HB ' ' A' ' 90' ' ' ILE . 31.2 m -115.78 151.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.479 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.7 tt0 -122.11 110.12 15.37 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HD1' HD22 ' A' ' 12' ' ' LEU . 79.3 m-85 -91.21 138.28 31.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.725 ' HB2' HG23 ' A' ' 93' ' ' THR . 3.9 mp -141.84 163.37 33.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.8 -107.87 3.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.402 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 26.73 5.25 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.047 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 65' ' ' ILE . 1.9 mp -96.38 -41.79 8.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.89 0.345 . . . . 0.0 110.983 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.29 -28.95 65.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.357 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.05 78.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.727 0.299 . . . . 0.0 111.047 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 24.7 mt -79.78 -43.75 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.509 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.6 m-85 -58.61 -70.4 0.15 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.455 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.7 44.08 0.07 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.395 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.59 32.96 18.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.505 0.322 . . . . 0.0 111.402 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -119.38 113.76 21.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.389 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -58.8 -62.56 1.78 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 14.9 p -94.87 143.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.153 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -129.06 161.29 30.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -145.31 133.41 21.49 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 4' ' ' VAL . 2.1 pt -147.2 178.76 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.326 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 132.09 15.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.38 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.25 108.07 19.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.475 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -91.93 48.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -45.06 6.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.985 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' A' ' 32' ' ' VAL . 10.1 pt-20 -166.7 -178.24 4.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.32 -59.13 0.3 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.773 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.8 58.93 6.66 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.363 2.042 . . . . 0.0 112.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.492 ' HB ' HD12 ' A' ' 84' ' ' LEU . 17.9 t -77.01 149.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.1 p -98.86 161.6 13.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' HD21 ' A' ' 84' ' ' LEU . 10.5 p -60.74 -39.85 83.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.711 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.8 -30.51 69.54 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.945 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -40.44 86.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.769 0.319 . . . . 0.0 110.314 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.934 HD21 HG21 ' A' ' 4' ' ' VAL . 2.6 tm? -56.64 -44.9 81.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.128 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.465 ' HA ' HD12 ' A' ' 41' ' ' ILE . 35.8 mm -59.89 -45.26 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.38 -37.97 82.45 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -60.07 -43.71 95.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.488 HG23 ' SD ' ' A' ' 45' ' ' MET . 14.6 mt -64.63 -30.21 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.153 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.739 HG21 HG13 ' A' ' 56' ' ' ILE . 28.8 t -95.99 -2.46 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -95.33 -64.59 1.05 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.3 p -98.03 -46.98 5.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.722 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.488 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -57.58 -56.8 17.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 52' ' ' VAL . 19.4 mt -115.61 149.08 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -173.87 72.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -163.76 133.46 3.11 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.148 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.98 65.52 3.32 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.441 2.094 . . . . 0.0 111.823 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -158.85 -49.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.028 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -89.52 -42.51 11.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.456 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.692 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -72.9 -36.28 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.223 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.7 -28.69 15.67 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.42 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -89.28 -34.41 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.722 ' HE1' HG21 ' A' ' 65' ' ' ILE . 51.2 t80 -86.95 -57.63 2.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.515 0.198 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.739 HG13 HG21 ' A' ' 42' ' ' VAL . 35.8 mm -98.53 139.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -148.86 129.6 14.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.96 42.98 15.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 59.2 38.99 23.34 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.51 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.9 t -166.91 162.31 15.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.908 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.0 148.88 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -78.48 147.7 72.3 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.057 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.22 75.69 2.8 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 111.842 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.03 -45.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.541 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.722 HG21 ' HE1' ' A' ' 55' ' ' PHE . 28.5 mm -67.17 137.21 25.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.857 0.36 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.4 mt -110.73 132.41 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -126.32 138.64 53.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.5 mt -125.48 109.87 13.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 74' ' ' TRP . 7.2 mt -86.73 105.74 15.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.8 t30 56.92 45.9 20.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 61.68 41.87 11.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.177 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.76 156.82 43.85 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.578 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -79.98 129.63 34.64 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.949 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.482 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.5 p-90 -57.65 -35.32 70.38 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.645 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.13 -1.94 58.26 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.636 HD12 ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -76.88 -16.08 59.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -137.31 -58.53 0.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.507 0.194 . . . . 0.0 111.26 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.92 112.57 0.53 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.673 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -49.61 -71.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.537 0.208 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -107.65 -28.23 9.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.931 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.71 -31.37 37.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.226 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.435 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 38.2 t80 -48.26 118.95 2.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 110.838 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.17 141.25 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD12 ' HB ' ' A' ' 32' ' ' VAL . 19.2 mt -62.74 178.23 0.47 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.955 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -162.74 99.71 1.0 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.824 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -43.5 105.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.828 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.13 5.4 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.035 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.83 170.19 8.31 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.714 0.292 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.3 123.27 68.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.402 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.886 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.8 mp -126.24 107.39 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.774 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -81.72 157.99 24.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 111.597 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -146.82 82.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -91.45 164.13 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.11 132.94 50.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.277 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.638 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 86' ' ' ASP . 10.6 p . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -105.53 125.1 50.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 90' ' ' ILE . 38.9 t -125.09 110.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.271 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 112.98 20.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.526 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.76 HG12 ' HB ' ' A' ' 90' ' ' ILE . 7.2 m -113.35 139.79 36.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.336 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.7 115.46 29.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.54 ' C ' HD12 ' A' ' 9' ' ' LEU . 82.2 m-85 -96.46 124.03 40.31 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.405 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.54 HD12 ' C ' ' A' ' 8' ' ' PHE . 11.0 mp -125.47 159.69 31.33 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.299 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.37 -109.26 3.57 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.414 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.08 35.49 2.84 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.589 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 mt -104.15 -43.13 5.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.637 0.218 . . . . 0.0 111.178 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -59.38 -28.47 66.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.33 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.23 78.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.77 0.319 . . . . 0.0 111.032 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 41.9 mt -73.96 -37.99 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.219 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -69.65 -70.44 0.28 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.74 44.72 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 56.1 33.54 22.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.621 0.248 . . . . 0.0 111.401 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -122.57 129.1 51.55 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.603 0.24 . . . . 0.0 110.959 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -83.44 -64.13 1.22 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.5 t -79.65 105.87 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.404 ' CE1' ' HB3' ' A' ' 19' ' ' GLN . 1.0 OUTLIER -111.2 173.7 6.22 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.61 136.26 47.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.309 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 37' ' ' LEU . 17.6 mm -117.87 152.11 19.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -150.0 99.52 2.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.127 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -73.52 -53.77 9.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.049 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.59 76.13 0.32 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -136.67 -67.57 0.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.335 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -140.97 -175.73 4.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.72 -59.59 0.43 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.086 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.37 60.37 6.39 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.469 2.112 . . . . 0.0 112.598 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.661 ' CG1' HD12 ' A' ' 84' ' ' LEU . 26.7 t -77.8 142.27 14.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 155.24 18.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -57.74 -35.88 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.803 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.63 -27.74 66.71 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.978 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -39.13 65.69 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.551 ' HB2' HD11 ' A' ' 84' ' ' LEU . 1.3 tm? -54.97 -51.43 66.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.382 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.7 -43.15 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.18 -43.66 78.64 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.432 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 55.4 t60 -59.63 -46.52 88.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.31 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.48 -31.59 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.891 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.706 HG13 ' CG2' ' A' ' 52' ' ' VAL . 36.7 t -97.4 -4.13 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -92.7 -68.81 0.78 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.28 -41.48 7.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.614 0.245 . . . . 0.0 111.351 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -39.78 69.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.826 HG21 HG23 ' A' ' 52' ' ' VAL . 44.1 mt -131.65 129.79 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.664 0.269 . . . . 0.0 111.047 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -143.91 51.41 1.32 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -142.92 121.52 7.37 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.32 74.41 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.99 2.46 . . . . 0.0 112.238 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.63 -58.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.364 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.8 p30 -79.9 -36.49 36.38 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.706 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -88.77 -35.33 7.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.945 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -54.23 -36.24 63.31 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.121 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.2 -37.93 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.219 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -67.11 -39.93 86.77 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.006 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.31 116.22 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -115.01 130.89 57.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.64 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 58.81 43.78 17.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.966 0.413 . . . . 0.0 110.464 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.39 33.31 22.18 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.489 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.61 149.66 26.87 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.911 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.62 151.58 10.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.061 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.8 ttt180 -93.1 130.25 36.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.999 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 50.9 Cg_exo -54.42 118.66 5.3 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.79 2.327 . . . . 0.0 112.325 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.94 -37.88 0.93 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.555 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 mt -74.11 127.89 36.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.69 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.8 mm -103.04 127.54 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.059 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -121.92 134.8 54.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.235 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 72' ' ' THR . 2.4 mm? -110.58 98.54 7.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.681 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.665 HD11 ' CD1' ' A' ' 74' ' ' TRP . 24.1 mt -81.13 102.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 57.63 48.4 14.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.628 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 62.13 32.26 17.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.289 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.685 ' O ' HD13 ' A' ' 68' ' ' LEU . 1.3 m -128.58 162.97 26.04 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.49 134.64 36.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.665 ' CD1' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -57.48 -53.37 58.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.888 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.44 -36.54 83.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.306 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 76' ' ' LEU . 5.1 tt -56.4 -52.48 64.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.597 0.237 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.56 -35.73 81.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 34.08 0.8 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.185 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.76 -78.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.628 0.371 . . . . 0.0 111.432 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -109.2 16.73 22.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 47.52 1.25 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.993 0.425 . . . . 0.0 110.786 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 69' ' ' ILE . 24.1 t80 -144.23 138.23 27.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 83' ' ' ILE . 4.3 mp -92.91 129.96 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.661 HD12 ' CG1' ' A' ' 32' ' ' VAL . 18.7 mt -59.75 173.78 0.54 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.0 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.65 100.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.029 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.634 ' HA ' HG23 ' A' ' 2' ' ' VAL . 12.7 p-10 -43.07 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.53 26.96 5.43 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.482 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.584 ' OD1' HG13 ' A' ' 4' ' ' VAL . 3.3 p30 -95.4 174.76 6.86 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.64 0.257 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.2 mm -119.46 130.43 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.481 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.76 ' HB ' HG12 ' A' ' 6' ' ' VAL . 43.3 mt -133.39 153.17 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.385 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -127.55 156.45 42.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.05 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -143.88 105.76 4.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.229 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -109.6 142.19 41.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.032 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.3 t -116.63 97.56 6.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.567 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 -179.701 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -111.02 139.68 46.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.572 HG21 ' HG ' ' A' ' 37' ' ' LEU . 9.7 m -140.88 136.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.541 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.25 115.54 27.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.362 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.663 HG12 ' HB ' ' A' ' 90' ' ' ILE . 2.9 m -113.27 143.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.461 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.35 154.95 20.54 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.527 ' HD1' HD13 ' A' ' 12' ' ' LEU . 52.9 m-85 -142.82 111.75 6.46 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.4 mm? -123.32 145.41 48.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.012 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.25 -111.16 3.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.524 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.87 28.43 6.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.929 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.683 HD21 ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -100.17 -48.75 4.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.81 0.305 . . . . 0.0 110.767 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.74 -27.0 68.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.621 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.78 -34.19 76.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.647 0.261 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 51' ' ' ASP . 19.4 mt -74.91 -37.4 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.63 -61.33 1.83 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.33 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.62 46.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.503 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp 57.35 33.87 23.91 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -112.24 103.93 12.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.713 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mtt-85 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.604 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 p -97.85 130.32 46.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.88 0.371 . . . . 0.0 111.003 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -128.61 164.67 22.37 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.259 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -128.68 133.48 48.22 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.305 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HB ' HD11 ' A' ' 37' ' ' LEU . 22.6 mm -117.19 145.96 22.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.23 89.72 3.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.1 148.56 51.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.175 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -123.59 101.76 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.386 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -166.29 -53.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -174.07 -166.59 0.3 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.78 -59.53 0.33 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 59.26 5.83 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.486 2.124 . . . . 0.0 112.548 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.66 131.24 34.23 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -66.69 146.38 54.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.492 HG21 ' HE1' ' A' ' 74' ' ' TRP . 13.9 p -54.62 -33.37 27.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.473 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.57 59.17 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.043 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -39.88 61.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 110.3 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.572 ' HG ' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -55.85 -56.57 19.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.304 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 41' ' ' ILE . 12.9 pt -59.12 -35.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.623 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -63.27 -43.86 96.75 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.662 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -58.07 -39.55 78.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 38' ' ' ILE . 16.5 mt -68.6 -30.23 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.038 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.698 HG13 HG21 ' A' ' 52' ' ' VAL . 29.8 t -97.01 -6.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.1 t -100.72 -64.33 1.05 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 m -87.77 -51.27 5.95 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.38 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -51.9 67.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.869 HG21 HG23 ' A' ' 52' ' ' VAL . 26.1 mt -116.2 143.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-O 120.759 0.314 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -162.56 41.22 0.12 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.587 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 50' ' ' ASN . 5.4 t30 -134.03 118.54 14.2 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.708 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.37 75.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.908 2.405 . . . . 0.0 112.711 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ASN . 9.5 m-20 -165.72 -61.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.354 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB2' HG22 ' A' ' 15' ' ' ILE . 29.8 p-10 -79.84 -33.25 40.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.33 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.869 HG23 HG21 ' A' ' 46' ' ' ILE . 1.4 t -93.83 -41.15 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.636 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -35.49 68.49 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.197 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.6 mt -89.0 -33.97 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.33 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 12' ' ' LEU . 19.3 t80 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.495 0.188 . . . . 0.0 111.004 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 42' ' ' VAL . 17.4 mt -131.84 141.8 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.446 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.18 -170.27 3.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -63.16 93.04 0.06 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.956 0.407 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 56.09 43.65 26.6 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.88 128.63 1.69 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.432 ' HA ' HG23 ' A' ' 56' ' ' ILE . 2.1 mp -71.97 153.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.293 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' N ' HG22 ' A' ' 61' ' ' ILE . 8.6 mtp-105 -88.48 139.48 29.92 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.016 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.21 125.1 17.95 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.811 2.341 . . . . 0.0 112.389 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.15 -46.97 1.02 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.866 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.43 112.92 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.45 146.77 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.561 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' SER . 2.0 m -141.52 138.19 32.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.633 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -145.87 128.05 15.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.058 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.642 HD11 ' HD1' ' A' ' 74' ' ' TRP . 21.6 mt -90.33 90.27 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.434 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.01 65.88 1.34 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.955 0.407 . . . . 0.0 111.253 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.2 24.29 14.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.595 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 m -130.17 164.6 24.12 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.317 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -79.71 165.87 22.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.898 0.38 . . . . 0.0 111.474 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.642 ' HD1' HD11 ' A' ' 69' ' ' ILE . 4.6 t90 -94.22 -41.14 9.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.796 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.24 -27.48 35.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.618 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -54.69 -27.45 40.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG3' ' CD1' ' A' ' 82' ' ' TYR . 1.4 pt-20 -128.41 27.33 5.59 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.68 102.75 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.743 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -54.14 -34.36 60.16 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -122.18 -40.51 2.49 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.448 0.166 . . . . 0.0 110.626 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -55.16 -29.19 57.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.369 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 77' ' ' GLU . 72.3 t80 -55.13 118.91 4.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.22 139.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.565 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.5 ' CD1' HD23 ' A' ' 37' ' ' LEU . 22.9 mt -64.07 175.25 1.28 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.942 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -167.11 100.84 0.53 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.595 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -44.35 114.31 0.66 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.99 18.98 6.58 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.017 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.17 177.54 4.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.746 0.273 . . . . 0.0 110.961 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 90' ' ' ILE . 27.4 mt -128.12 150.32 33.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.962 0.41 . . . . 0.0 111.71 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.663 ' HB ' HG12 ' A' ' 6' ' ' VAL . 5.3 mp -142.55 100.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.11 142.99 34.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.695 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -136.23 82.9 1.97 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 9' ' ' LEU . 4.2 m -94.02 150.05 20.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.675 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.594 ' OG ' HD12 ' A' ' 12' ' ' LEU . 20.4 m -133.98 99.31 4.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.59 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.464 0.226 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.927 -179.921 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 120.643 0.259 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -141.95 114.28 8.27 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 37' ' ' LEU . 15.0 m -117.75 132.76 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -106.41 105.26 15.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.725 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.708 HG12 ' HB ' ' A' ' 90' ' ' ILE . 15.3 m -105.53 144.37 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.371 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -107.32 135.56 48.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.542 ' C ' HD22 ' A' ' 9' ' ' LEU . 60.7 m-85 -119.01 115.42 24.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.746 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.542 HD22 ' C ' ' A' ' 8' ' ' PHE . 4.5 mm? -122.5 132.53 54.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.088 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 -109.27 1.82 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.386 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.03 -23.84 5.97 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.242 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.717 HD21 ' CD1' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -55.46 -48.24 74.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.994 0.397 . . . . 0.0 111.468 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -57.9 -36.01 71.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.129 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 12' ' ' LEU . 7.5 mt -75.19 -39.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.363 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.5 m-85 -67.38 -75.09 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.321 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.21 41.71 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.602 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.35 34.4 20.61 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.705 0.288 . . . . 0.0 111.159 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -110.16 117.5 33.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.721 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -28.98 69.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.67 142.28 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -122.73 170.35 10.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -135.24 121.71 20.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -116.1 143.93 24.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.065 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.96 91.79 2.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.442 ' HE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.3 156.73 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.052 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.92 113.91 7.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 111.586 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.68 -48.28 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.94 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -156.13 -177.7 6.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.26 -59.83 0.37 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.984 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.09 58.28 6.51 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.534 2.156 . . . . 0.0 112.409 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -75.14 121.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.657 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.6 p -68.75 153.47 43.73 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.876 0.369 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 ' HE1' ' A' ' 74' ' ' TRP . 9.1 p -57.68 -31.95 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.579 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.08 -28.04 57.99 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.33 -38.07 71.7 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.776 0.322 . . . . 0.0 110.324 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -56.28 -47.1 79.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.054 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.691 HD11 ' CH2' ' A' ' 74' ' ' TRP . 49.7 mt -61.39 -41.88 91.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.449 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -39.68 87.3 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.442 ' HB2' ' HE2' ' A' ' 26' ' ' MET . 47.5 t60 -63.12 -46.1 88.9 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 45' ' ' MET . 57.2 mt -61.24 -31.41 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.825 HG13 HG11 ' A' ' 52' ' ' VAL . 42.1 t -97.57 -3.36 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.4 t -93.43 -74.87 0.51 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.388 -0.195 . . . . 0.0 111.494 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -96.58 -39.99 9.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.556 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.8 tpt -57.1 -38.56 73.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.024 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.717 HG22 HG22 ' A' ' 52' ' ' VAL . 15.0 mt -137.62 136.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.693 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -159.81 71.72 0.49 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.813 0.34 . . . . 0.0 111.365 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.5 t30 -162.88 134.64 3.9 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.38 64.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.21 1.94 . . . . 0.0 111.702 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.73 -45.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -91.24 -41.92 10.7 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.641 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.825 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -72.01 -34.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.29 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.29 -30.67 12.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.5 -65.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.466 0.174 . . . . 0.0 111.371 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.717 ' CD1' HD21 ' A' ' 12' ' ' LEU . 41.0 t80 -64.05 -36.53 84.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.324 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 52' ' ' VAL . 29.6 mm -125.37 93.84 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.89 119.22 38.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.57 64.65 1.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p30 43.23 33.81 0.62 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.247 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -157.36 149.07 22.2 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.661 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.519 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.2 mp -65.07 152.91 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -79.73 115.68 55.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.631 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.76 101.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.649 2.233 . . . . 0.0 111.959 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.05 -30.64 0.6 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.584 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.622 HD13 ' CD1' ' A' ' 55' ' ' PHE . 49.1 mt -64.22 136.42 26.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.819 0.343 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.3 mt -103.82 144.79 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.413 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 91' ' ' SER . 25.1 m -143.63 140.93 30.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.7 mt -141.04 121.13 13.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.264 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.726 HD11 ' CD1' ' A' ' 74' ' ' TRP . 35.2 mt -93.7 102.76 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.53 55.42 3.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t0 57.01 31.89 20.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.206 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -136.25 166.6 23.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -79.77 149.23 31.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 111.467 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.726 ' CD1' HD11 ' A' ' 69' ' ' ILE . 1.6 t90 -69.05 -54.1 16.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.73 -7.77 55.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.042 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 ' HB2' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -56.65 -31.45 64.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.597 0.237 . . . . 0.0 111.366 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.26 -52.06 1.52 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.96 109.15 0.35 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.926 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.46 -48.9 77.96 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.847 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -121.19 -42.82 2.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.865 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.76 -24.54 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.948 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -52.84 119.79 5.02 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.883 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -75.56 132.59 32.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.17 174.99 1.78 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.726 0.298 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -169.6 101.85 0.33 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.421 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -44.05 115.43 0.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 119.17 3.95 12.7 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.984 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.94 164.25 23.66 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.082 0.441 . . . . 0.0 111.155 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mm -123.05 93.22 2.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.708 ' HB ' HG12 ' A' ' 6' ' ' VAL . 41.6 mt -91.83 152.1 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 67' ' ' THR . 0.9 OUTLIER -128.12 146.62 50.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.228 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -138.32 94.75 2.9 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.54 132.91 45.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.04 96.56 5.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.223 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.129 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -104.41 131.88 51.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 37' ' ' LEU . 19.9 m -133.26 147.48 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 21' ' ' VAL . 3.2 tttp -103.66 100.64 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.727 HG12 ' HB ' ' A' ' 90' ' ' ILE . 7.5 m -106.01 151.88 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.543 ' OE1' HD11 ' A' ' 9' ' ' LEU . 7.7 pt-20 -125.2 159.09 32.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.182 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' C ' HD12 ' A' ' 9' ' ' LEU . 99.5 m-85 -130.17 143.13 50.61 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.395 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 93' ' ' THR . 4.2 mp -140.65 171.02 14.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.503 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.67 -111.42 3.28 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.353 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.84 27.44 5.42 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.829 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.49 HD11 HG23 ' A' ' 65' ' ' ILE . 15.4 mt -90.36 -51.52 5.38 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.763 0.281 . . . . 0.0 110.863 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.0 -27.06 61.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.519 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.28 80.56 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.729 0.3 . . . . 0.0 111.18 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.609 HD13 HD11 ' A' ' 54' ' ' ILE . 40.8 mt -78.62 -43.21 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.82 -69.2 0.24 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.367 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.01 42.33 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.778 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 57.5 6.33 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 111.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -143.81 119.42 10.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 14.0 mtm-85 -72.52 -72.02 0.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.407 HG11 ' HE3' ' A' ' 5' ' ' LYS . 21.8 t -78.59 138.76 19.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -145.55 143.81 30.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -108.57 125.42 51.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.59 145.61 19.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.56 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.61 95.56 4.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.234 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.445 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -62.78 -64.51 0.9 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.636 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 58.66 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.851 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.6 -45.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.089 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -150.6 -179.85 7.58 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.89 -58.67 0.41 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.756 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.0 57.76 6.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.481 2.121 . . . . 0.0 112.602 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.5 116.21 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.495 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.492 HG22 HD13 ' A' ' 83' ' ' ILE . 70.8 p -75.01 156.13 36.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.65 -31.88 40.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.396 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.86 -25.59 59.37 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.932 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB3' ' HG3' ' A' ' 26' ' ' MET . 1.0 OUTLIER -75.36 -39.49 59.2 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 110.282 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -54.82 -55.41 30.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.417 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.809 ' HA ' HD12 ' A' ' 41' ' ' ILE . 11.9 pt -61.07 -36.0 69.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.625 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -39.47 94.27 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.764 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.445 ' CD2' ' HA ' ' A' ' 26' ' ' MET . 18.4 t-80 -61.22 -40.09 92.7 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 38' ' ' ILE . 5.0 mt -67.86 -30.88 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.551 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.68 HG21 HG13 ' A' ' 56' ' ' ILE . 47.7 t -92.6 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.811 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.3 p -100.21 -60.83 1.45 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -100.22 -50.99 3.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -42.39 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.273 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.674 ' CG2' HG23 ' A' ' 52' ' ' VAL . 7.9 mt -130.87 129.63 63.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 64.87 1.15 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.786 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.24 131.14 6.86 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.93 74.41 2.35 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.617 2.211 . . . . 0.0 112.196 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -168.17 -47.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.53 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.85 -38.96 10.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.852 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.674 HG23 ' CG2' ' A' ' 46' ' ' ILE . 1.9 t -82.97 -37.44 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.409 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -53.24 -42.62 66.6 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.663 0.268 . . . . 0.0 111.098 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.609 HD11 HD13 ' A' ' 15' ' ' ILE . 1.2 pt -80.01 -34.15 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.583 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.03 -48.59 62.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.674 0.273 . . . . 0.0 110.649 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.68 HG13 HG21 ' A' ' 42' ' ' VAL . 28.2 mm -124.56 124.02 67.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -163.24 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.481 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.97 84.94 0.08 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 40.29 12.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.57 126.32 1.07 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.57 153.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.2 143.26 52.18 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.94 125.61 11.71 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.523 2.149 . . . . 0.0 112.084 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.54 -35.16 2.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.597 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 12' ' ' LEU . 9.2 mt -73.29 114.51 12.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.706 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.1 mt -96.31 149.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.057 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.514 HG22 ' CE3' ' A' ' 74' ' ' TRP . 9.3 t -143.73 128.26 18.04 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.861 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.8 mt -108.53 126.98 53.53 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 pt -106.31 109.2 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.099 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.32 44.74 21.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.2 41.62 16.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.0 167.67 21.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 125.32 29.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.514 ' CE3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -59.16 -26.83 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.732 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -97.66 -1.34 43.86 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -61.73 -32.37 72.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.482 0.182 . . . . 0.0 111.423 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 -68.63 0.66 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.22 110.15 0.54 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.033 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -72.68 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.115 0.166 . . . . 0.0 111.287 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.05 -31.03 16.44 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.555 0.217 . . . . 0.0 110.749 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -28.18 28.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.487 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -57.39 113.67 1.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 33' ' ' THR . 31.7 mm -77.62 141.53 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.462 ' CD1' HD23 ' A' ' 37' ' ' LEU . 31.8 mt -62.93 173.65 1.3 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.59 101.32 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -43.65 110.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.764 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.39 26.84 4.98 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.874 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.26 168.74 9.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -117.32 129.57 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.612 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.727 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.8 mp -135.51 101.84 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.61 152.0 28.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -134.23 93.15 3.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 9' ' ' LEU . 14.4 p -95.97 162.31 13.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 t -151.72 102.01 2.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.3 p . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.415 -179.541 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 86' ' ' ASP . 18.7 m . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 120.698 0.285 . . . . 0.0 111.516 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -132.08 110.43 10.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 24' ' ' ILE . 13.1 m -117.44 135.0 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.304 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -104.55 99.18 8.86 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.622 HG12 ' HB ' ' A' ' 90' ' ' ILE . 26.2 m -93.31 144.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -116.61 103.06 10.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 9' ' ' LEU . 66.1 m-85 -88.74 119.54 29.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.762 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 8' ' ' PHE . 11.2 mp -126.0 161.88 26.54 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.6 -104.65 2.94 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.338 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.8 -12.82 8.3 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.397 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD21 ' CE2' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -62.83 -44.13 96.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.246 0.523 . . . . 0.0 111.294 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.89 -32.88 71.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.085 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.9 69.45 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.534 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 30.1 mt -74.43 -47.41 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.412 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -60.42 -61.15 2.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.357 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.63 0.02 OUTLIER Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.588 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp 59.09 65.01 1.27 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 111.97 8.57 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -34.05 77.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.002 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.8 122.99 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.49 174.73 5.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.066 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -137.94 129.14 27.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.067 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 4' ' ' VAL . 3.6 mp -122.42 140.3 46.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.78 86.41 2.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 128.84 37.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.842 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -112.01 82.53 1.64 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.595 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.3 -66.33 0.7 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -148.28 -173.33 4.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -87.71 -54.42 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.975 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.2 Cg_exo -78.47 53.96 4.8 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.872 2.381 . . . . 0.0 112.621 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 36' ' ' ASP . 17.6 t -80.08 129.78 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.709 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -81.99 156.6 24.6 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 110.743 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.653 ' O ' HD12 ' A' ' 38' ' ' ILE . 9.1 p -53.69 -37.7 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.748 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.02 59.19 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.413 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HB2' HG12 ' A' ' 32' ' ' VAL . 64.9 m-20 -69.91 -41.02 75.24 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.709 0.29 . . . . 0.0 110.385 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 HD13 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -54.81 -54.34 43.5 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.754 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.6 mp -61.89 -35.27 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.455 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -46.0 90.93 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.173 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.36 -40.62 87.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.649 0.262 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 38' ' ' ILE . 14.2 mt -64.32 -33.22 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.713 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.693 HG13 ' CG2' ' A' ' 52' ' ' VAL . 40.9 t -90.76 -6.37 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.846 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.3 -74.95 0.44 Allowed 'General case' 0 N--CA 1.462 0.167 0 O-C-N 122.384 -0.197 . . . . 0.0 111.444 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.5 m -99.19 -41.5 7.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.45 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.526 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -53.46 -38.31 63.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.118 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 52' ' ' VAL . 21.4 mt -133.42 103.59 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.726 0.298 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.23 71.22 1.19 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.07 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.2 130.16 2.79 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.185 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.48 75.18 2.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.599 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -168.5 -44.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.857 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -92.67 -38.71 11.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.663 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.748 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -89.17 -36.06 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -54.75 -39.07 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 111.029 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.9 mt -76.03 -35.04 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.167 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.725 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 6.7 t80 -72.48 -52.94 13.6 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.669 0.271 . . . . 0.0 110.912 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.607 HD12 HG11 ' A' ' 42' ' ' VAL . 30.6 mt -118.0 110.12 29.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.5 130.46 55.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 59.4 40.95 20.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.04 29.61 19.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.46 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 144.78 32.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 62' ' ' ARG . 2.1 mp -65.44 153.96 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.0 mtt180 -88.66 146.1 36.49 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.71 88.73 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.623 2.215 . . . . 0.0 111.957 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.12 -34.76 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.773 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.725 HG21 ' CZ ' ' A' ' 55' ' ' PHE . 28.6 mm -68.33 119.53 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.4 mt -96.72 147.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.557 HG22 ' CE2' ' A' ' 92' ' ' PHE . 64.2 p -136.83 112.61 9.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.5 mt -105.27 108.17 19.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.754 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.549 HG21 ' CE1' ' A' ' 82' ' ' TYR . 21.2 mt -89.3 100.87 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.747 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 t30 58.81 53.2 5.97 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.29 32.93 20.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.235 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 154.14 49.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 129.07 34.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.653 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -54.58 -33.24 59.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.648 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.17 -32.47 38.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.923 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.75 -30.99 64.14 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.44 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -121.38 26.26 8.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.534 0.207 . . . . 0.0 111.432 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.29 -101.54 0.64 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.838 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.8 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.575 0.35 . . . . 0.0 110.509 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -109.94 -25.15 10.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.219 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -53.48 -25.71 17.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.666 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CE1' HG21 ' A' ' 69' ' ' ILE . 48.5 t80 -52.75 115.56 1.88 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.678 0.275 . . . . 0.0 110.718 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.77 142.04 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -63.22 174.94 1.04 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.936 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -160.53 97.33 1.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.784 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.465 ' HB2' HG12 ' A' ' 2' ' ' VAL . 41.1 t0 -45.85 110.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.83 26.18 4.83 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.678 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.85 176.57 5.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.649 0.262 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 90' ' ' ILE . 19.8 mt -123.3 152.69 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.554 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.622 ' HB ' HG12 ' A' ' 6' ' ' VAL . 5.2 mp -141.5 153.12 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.72 139.39 48.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.557 ' CE2' HG22 ' A' ' 67' ' ' THR . 30.2 m-85 -127.99 91.07 3.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 162.13 14.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -155.22 103.9 2.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.005 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 CA--C 1.533 0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 2' ' ' VAL . 11.3 m . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -83.91 110.11 18.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 37' ' ' LEU . 12.5 m -117.06 138.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.95 116.74 33.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 21' ' ' VAL . 18.1 t -109.82 144.98 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HB3' HD11 ' A' ' 9' ' ' LEU . 3.7 mt-10 -127.49 101.27 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.92 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -87.7 123.89 33.0 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.826 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 7' ' ' GLU . 4.9 mp -143.6 167.81 21.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.07 -20.73 38.16 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.509 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.36 -34.85 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.746 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -37.24 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.65 0.225 . . . . 0.0 111.577 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.83 -36.7 72.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.56 0.219 . . . . 0.0 111.017 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.91 68.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.479 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 35.2 mt -73.56 -42.09 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -68.94 -71.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.36 41.58 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.57 44.81 27.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.65 -31.6 15.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.302 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 72.63 -67.44 0.26 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.853 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 6' ' ' VAL . 8.3 p -117.72 124.15 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 152.73 46.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.284 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -112.2 145.22 40.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 37' ' ' LEU . 29.9 mt -138.29 148.57 24.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 108.27 8.05 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.95 159.08 32.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.81 93.36 3.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.106 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -162.54 -67.91 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.243 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.28 -175.63 5.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -58.44 0.46 Allowed Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.37 59.22 6.01 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.485 2.123 . . . . 0.0 112.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.15 142.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.83 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.02 151.39 25.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 80' ' ' LYS . 11.4 p -55.5 -32.34 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.681 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' HE3' ' A' ' 80' ' ' LYS . . . -60.84 -25.96 64.57 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.063 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.29 75.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.738 0.304 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.793 HD21 HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -60.35 -47.84 84.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.312 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.565 ' HA ' HD12 ' A' ' 41' ' ' ILE . 34.2 mm -59.81 -38.52 76.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.406 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.36 -41.89 97.81 Favored 'General case' 0 C--N 1.335 -0.032 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -60.22 -38.32 83.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.022 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 38' ' ' ILE . 20.0 mt -67.83 -31.8 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.502 HG13 HG21 ' A' ' 52' ' ' VAL . 22.5 t -98.12 -2.9 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -94.46 -75.79 0.5 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -91.6 -45.19 8.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.658 0.265 . . . . 0.0 111.293 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.2 ttt -54.57 -44.34 72.88 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.816 HG21 HG23 ' A' ' 52' ' ' VAL . 17.5 mt -131.94 145.66 34.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.703 0.287 . . . . 0.0 111.237 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 47.28 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -138.84 126.28 13.27 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.073 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 32.2 Cg_exo -62.41 77.03 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.938 2.425 . . . . 0.0 112.23 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -170.83 -58.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.411 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.4 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.6 p30 -82.42 -36.9 26.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.816 HG23 HG21 ' A' ' 46' ' ' ILE . 1.7 t -93.92 -35.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 t -53.75 -38.67 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.037 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -85.87 -34.37 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.083 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.64 ' HE1' HG21 ' A' ' 65' ' ' ILE . 15.9 t80 -67.48 -53.31 29.87 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 HG21 ' A' ' 42' ' ' VAL . 28.7 mm -104.77 131.1 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.916 0.388 . . . . 0.0 111.397 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -124.37 100.32 6.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.767 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 57.62 77.27 0.28 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.067 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 41.6 35.34 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -161.32 137.38 8.12 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.751 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.29 151.94 4.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.889 0.376 . . . . 0.0 111.391 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -81.87 140.52 46.96 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 52.4 Cg_exo -54.89 118.1 4.75 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 112.31 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.05 -37.08 1.94 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.504 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.64 HG21 ' HE1' ' A' ' 55' ' ' PHE . 28.0 mm -74.5 139.5 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.966 0.412 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.709 HD11 HG23 ' A' ' 95' ' ' THR . 77.8 mt -105.4 145.29 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.971 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -139.86 84.51 1.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.654 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.05 124.41 28.71 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.332 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 74' ' ' TRP . 17.3 mt -105.63 105.44 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.87 54.43 4.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.01 30.51 20.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.503 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 169.9 16.81 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.424 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -82.01 162.03 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.477 ' HA ' HD12 ' A' ' 69' ' ' ILE . 45.1 p90 -77.88 -44.2 27.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.228 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.25 -24.97 46.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.368 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -53.49 -36.44 61.69 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.962 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.34 -32.15 10.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.835 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.83 -86.19 0.07 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.06 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.573 0.349 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' VAL . 2.6 ttmp? -114.67 -27.1 7.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.45 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.79 -22.58 25.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -45.24 117.7 1.47 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.42 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -69.19 177.36 2.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.86 103.89 0.11 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.954 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -38.67 106.35 0.05 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.942 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.45 -8.88 5.9 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.741 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -80.06 164.33 23.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.166 0.483 . . . . 0.0 111.21 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.8 mm -125.0 117.33 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.12 142.48 22.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.034 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.7 m -121.68 139.46 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.317 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -119.57 79.98 1.51 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -83.93 172.68 11.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.45 118.17 9.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.103 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.709 HG23 HD11 ' A' ' 66' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.045 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 86' ' ' ASP . 29.4 m . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.753 0.311 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -130.68 126.66 37.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 90' ' ' ILE . 17.9 t -128.75 138.31 54.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.47 103.28 15.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.2 t -92.63 143.47 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.937 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.34 105.92 9.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 110.896 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 9' ' ' LEU . 96.4 m-85 -92.62 127.76 38.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.069 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 8' ' ' PHE . 6.7 mp -132.94 168.12 19.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.743 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.19 -109.46 3.45 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.299 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.79 24.69 7.86 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.014 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 55' ' ' PHE . 13.0 mt -100.55 -37.1 8.94 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.939 0.37 . . . . 0.0 111.273 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.78 -17.31 62.94 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.33 -30.02 22.55 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 1.1 mt -93.55 -27.21 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.692 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.699 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 3.0 m-85 -69.84 -74.66 0.13 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.63 0.252 . . . . 0.0 111.203 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.27 0.1 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.807 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt 50.67 37.29 16.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.45 0.3 . . . . 0.0 111.731 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 102.96 3.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.736 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.552 ' HG3' HG23 ' A' ' 21' ' ' VAL . 23.7 ptt180 -66.9 -49.03 66.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.947 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.552 HG23 ' HG3' ' A' ' 20' ' ' ARG . 24.6 t -81.21 93.61 2.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.36 154.48 29.09 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.288 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 24' ' ' ILE . 8.8 mtmp? -109.07 152.4 25.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.485 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.585 HG13 HD11 ' A' ' 37' ' ' LEU . 22.1 mm -128.28 147.17 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.55 123.19 15.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.989 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 mmt -118.71 132.87 56.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.136 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.21 47.76 1.04 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.72 -164.73 1.02 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.778 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HG3' ' HD2' ' A' ' 31' ' ' PRO . 5.9 pt-20 -68.32 -171.27 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.021 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.15 -57.56 1.1 Allowed Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.36 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' ' HG3' ' A' ' 29' ' ' GLU . 65.1 Cg_endo -72.54 61.49 3.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.284 1.99 . . . . 0.0 113.067 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.15 125.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.598 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.74 152.23 35.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.806 0.336 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.65 -34.5 47.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.807 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.52 -27.95 59.04 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -40.85 75.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.649 0.261 . . . . 0.0 110.49 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.585 HD11 HG13 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.15 -50.23 71.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.089 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -58.91 -38.86 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.11 -42.24 85.28 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -62.04 -39.57 92.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.867 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' MET . 42.7 mt -62.74 -32.13 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.794 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.863 HG13 HG11 ' A' ' 52' ' ' VAL . 32.2 t -96.46 -3.64 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.8 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.3 t -100.22 -62.68 1.21 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.556 0.217 . . . . 0.0 111.56 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 p -98.1 -50.2 4.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.515 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -55.74 -38.0 69.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.169 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.699 HD11 ' CZ ' ' A' ' 16' ' ' PHE . 23.4 mt -136.25 145.26 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.988 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -171.23 72.88 0.05 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.926 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -165.48 126.2 1.32 Allowed Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.078 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.81 77.02 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.895 2.397 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.36 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -78.48 -42.14 30.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.187 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.863 HG11 HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.6 -36.46 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.164 179.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 -31.1 26.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.493 0.187 . . . . 0.0 111.345 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.0 mt -94.2 -30.81 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 65' ' ' ILE . 51.9 t80 -85.67 -52.17 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.381 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.534 ' HB ' HG12 ' A' ' 52' ' ' VAL . 43.0 mm -103.74 145.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.174 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -118.48 61.83 0.78 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 57.97 84.78 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 58.12 38.67 26.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.646 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.4 t -170.1 118.99 0.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.7 HG22 HD12 ' A' ' 65' ' ' ILE . 2.2 mp -63.65 151.94 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -76.44 147.62 79.19 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.44 128.08 14.93 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.773 2.315 . . . . 0.0 112.577 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.62 -25.86 6.42 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.945 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 61' ' ' ILE . 20.0 mt -72.97 130.21 35.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 120.897 0.379 . . . . 0.0 110.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.68 121.79 45.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' SER . 91.1 m -125.66 111.18 14.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.834 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 mt -108.1 140.59 41.06 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.679 HG23 ' CD1' ' A' ' 90' ' ' ILE . 20.5 mt -119.18 111.54 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.704 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 46.92 8.58 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.78 33.44 17.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -141.3 178.46 7.4 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.38 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -80.18 -178.4 6.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.968 0.414 . . . . 0.0 111.325 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -104.45 -47.07 4.21 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.017 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.31 -30.2 30.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -26.68 62.2 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.533 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.7 -64.91 1.24 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.522 0.201 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.66 105.31 0.27 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.679 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -53.24 -65.74 0.51 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.409 0.147 . . . . 0.0 111.318 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -117.56 -39.52 3.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.25 -25.52 48.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.74 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' CE2' HG21 ' A' ' 69' ' ' ILE . 75.9 t80 -48.32 116.38 1.54 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.824 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mt -72.87 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.1 173.85 3.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.07 100.57 0.97 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.419 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' HB3' HG12 ' A' ' 2' ' ' VAL . 9.4 p-10 -46.33 118.13 1.83 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.08 15.99 9.45 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.384 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.33 171.29 9.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mm -126.94 101.16 7.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.757 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.679 ' CD1' HG23 ' A' ' 69' ' ' ILE . 8.0 mm -98.28 142.62 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -119.87 138.46 53.39 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.31 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.497 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 59.7 m-85 -130.34 82.39 2.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.471 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 9' ' ' LEU . 16.2 m -97.73 138.25 35.39 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 m -108.03 112.12 24.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 121.311 0.577 . . . . 0.0 110.458 179.835 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.75 0.309 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.0 117.18 29.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.714 ' CG1' HD13 ' A' ' 90' ' ' ILE . 18.5 t -115.66 134.73 57.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -103.06 104.68 14.87 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 90' ' ' ILE . 3.5 m -111.71 155.96 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.525 ' HG2' HG22 ' A' ' 21' ' ' VAL . 18.9 mt-10 -119.15 154.2 33.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.684 ' C ' HD22 ' A' ' 9' ' ' LEU . 42.4 m-85 -136.29 104.75 5.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.684 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.6 mm? -129.82 121.0 25.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.957 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 46.56 0.45 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.833 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.63 -35.68 4.27 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.795 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.838 HD21 ' CE1' ' A' ' 55' ' ' PHE . 3.3 mt -54.95 -42.76 72.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.653 0.227 . . . . 0.0 111.415 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.23 -37.33 82.65 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.02 -33.58 75.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mt -79.77 -42.12 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.522 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 41' ' ' ILE . 3.4 m-85 -63.72 -73.8 0.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.392 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.55 40.38 0.07 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.758 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.3 mttm 54.51 59.71 3.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 111.26 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.29 113.04 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -61.42 -32.84 72.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 7' ' ' GLU . 21.1 t -125.52 119.28 54.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -113.63 146.03 40.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.959 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.447 ' O ' HD13 ' A' ' 24' ' ' ILE . 5.2 mtpm? -108.84 146.48 33.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.27 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.939 HD11 HD12 ' A' ' 41' ' ' ILE . 17.8 mm -128.57 146.61 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.679 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -128.2 87.38 2.59 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.302 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.87 135.83 45.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.534 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.77 90.29 2.96 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.44 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.71 -67.6 0.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.396 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.94 -171.59 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -59.18 0.5 Allowed Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.99 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.73 61.46 4.54 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.369 2.046 . . . . 0.0 112.547 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.5 ' CG1' HD12 ' A' ' 84' ' ' LEU . 23.6 t -73.85 131.14 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.6 p -97.8 161.16 13.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.628 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.76 -33.03 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.594 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.96 -27.38 62.1 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.044 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -41.37 71.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.692 HD21 ' HB ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -54.82 -44.84 74.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.907 178.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.609 HD11 ' HZ ' ' A' ' 92' ' ' PHE . 24.4 mm -68.92 -33.34 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.788 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -50.33 36.13 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.7 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 26.0 t-80 -60.48 -48.07 83.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.939 HD12 HD11 ' A' ' 24' ' ' ILE . 7.1 tt -62.72 -30.96 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.633 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.674 HG13 ' CG2' ' A' ' 52' ' ' VAL . 89.0 t -94.88 -11.24 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.9 m -100.99 -69.57 0.77 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 p -76.75 -56.91 4.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.52 -55.62 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.938 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.821 HG21 HG23 ' A' ' 52' ' ' VAL . 41.5 mt -109.93 129.43 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -149.03 59.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.028 0.442 . . . . 0.0 110.703 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -150.12 131.8 7.63 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.183 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 60.7 Cg_endo -72.03 66.12 3.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.573 2.182 . . . . 0.0 112.327 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.11 -49.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.46 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.93 -39.08 15.04 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.679 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.821 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -93.57 -35.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.121 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.4 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 13.3 t -52.93 -36.19 59.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.642 0.258 . . . . 0.0 111.12 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.99 -34.19 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.391 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.838 ' CE1' HD21 ' A' ' 12' ' ' LEU . 38.0 t80 -73.28 -52.71 12.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.325 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.571 HG13 HG21 ' A' ' 42' ' ' VAL . 32.3 mm -111.87 136.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -132.14 134.52 45.52 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.018 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.65 38.77 25.06 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.775 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 33.44 21.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.68 152.67 35.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.062 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 62' ' ' ARG . 2.1 mp -65.57 154.5 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.256 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 61' ' ' ILE . 2.7 mtt-85 -101.04 138.94 20.12 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 51.9 Cg_exo -55.22 133.32 57.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.797 2.331 . . . . 0.0 112.426 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.35 -35.57 2.56 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.681 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.52 HD13 ' CE1' ' A' ' 55' ' ' PHE . 3.1 mt -83.37 111.84 20.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.962 0.411 . . . . 0.0 110.97 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.99 146.26 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 m -129.43 136.64 50.18 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.3 mt -130.04 113.78 14.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.003 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.47 109.53 25.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.34 49.05 9.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.637 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 58.54 31.7 21.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 73' ' ' ASP . 1.5 m -135.06 170.56 15.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.385 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.63 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -79.68 172.0 14.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.262 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.424 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 23.0 p-90 -103.86 -33.99 8.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.953 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -88.24 -26.76 22.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.468 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 73' ' ' ASP . 6.1 mt -60.62 -21.66 62.93 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.32 -71.55 0.72 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.525 0.203 . . . . 0.0 111.114 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.1 108.8 0.4 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.654 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 16.4 mt-10 -54.92 -72.54 0.06 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.457 0.17 . . . . 0.0 111.074 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -104.39 -33.89 8.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.952 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.21 -23.75 23.85 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.453 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -56.38 106.13 0.26 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.81 141.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.5 HD12 ' CG1' ' A' ' 32' ' ' VAL . 17.7 mt -63.8 175.79 1.07 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.36 97.83 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -47.8 104.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.79 27.94 4.43 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.693 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.97 170.48 7.89 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.602 0.239 . . . . 0.0 111.014 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -118.31 130.35 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.714 HD13 ' CG1' ' A' ' 4' ' ' VAL . 5.2 mp -136.15 150.64 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.064 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.03 146.83 50.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.388 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.609 ' HZ ' HD11 ' A' ' 38' ' ' ILE . 18.1 m-85 -133.02 82.11 1.98 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.723 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.05 141.61 28.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -119.89 97.34 5.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.429 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 CA--C 1.534 0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.022 -179.858 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.771 0.319 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -82.26 112.05 18.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.075 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 m -110.26 129.2 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.326 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 118.16 24.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' HB ' ' A' ' 90' ' ' ILE . 2.7 m -122.75 147.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.503 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -119.38 107.27 13.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.499 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.655 ' C ' HD12 ' A' ' 9' ' ' LEU . 52.8 m-85 -85.25 128.71 34.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.655 HD12 ' C ' ' A' ' 8' ' ' PHE . 7.0 mp -135.98 149.62 48.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.956 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.72 -102.28 1.96 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.508 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.58 26.46 3.66 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.015 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.72 -41.58 8.02 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.868 0.334 . . . . 0.0 110.828 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.54 -33.05 74.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.04 73.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 -44.95 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.35 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.435 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 14.7 m-85 -65.02 -71.46 0.18 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.227 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.63 45.64 0.1 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.542 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 56.87 54.35 7.22 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 106.95 8.23 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.019 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -9.02 50.46 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.928 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.47 138.69 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.507 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.69 168.82 19.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -138.97 143.5 38.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 41' ' ' ILE . 2.9 mp -136.28 150.77 27.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.358 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.62 101.66 5.03 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.842 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG2' ' CG ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -77.67 124.45 27.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.742 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.15 68.68 9.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.93 -159.12 0.94 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.509 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -170.78 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.225 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -59.7 0.77 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.99 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 83' ' ' ILE . 86.8 Cg_endo -77.42 58.98 6.52 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.39 2.06 . . . . 0.0 112.733 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -72.6 132.23 33.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.8 p -73.91 149.26 41.56 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.64 -36.49 54.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.88 -27.79 59.81 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.64 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.93 -42.77 69.42 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.735 0.302 . . . . 0.0 110.424 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -53.5 -53.15 55.62 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' HG23 ' A' ' 42' ' ' VAL . 3.5 mt -61.01 -37.25 76.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.357 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -41.55 97.26 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG2' ' A' ' 26' ' ' MET . 1.3 t60 -62.16 -36.88 83.19 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 24' ' ' ILE . 33.1 mt -72.09 -27.65 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.296 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG21 ' CD1' ' A' ' 56' ' ' ILE . 28.8 t -94.53 -5.49 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.8 p -100.25 -72.41 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.1 p -87.32 -49.3 7.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.502 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.1 ttt -53.36 -54.74 32.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.918 HG21 HG23 ' A' ' 52' ' ' VAL . 26.0 mt -110.43 125.87 67.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.611 0.243 . . . . 0.0 110.829 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.46 74.69 1.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.188 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.78 119.93 0.42 Allowed Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.63 76.85 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.774 2.316 . . . . 0.0 112.067 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -166.14 -57.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.513 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -82.16 -36.13 27.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.758 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.918 HG23 HG21 ' A' ' 46' ' ' ILE . 1.8 t -89.43 -35.67 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.984 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 m -58.07 -34.35 70.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.38 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.0 mt -83.15 -39.12 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 111.0 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -68.44 -38.1 80.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.077 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.726 ' CD1' HG21 ' A' ' 42' ' ' VAL . 29.5 mt -132.08 129.55 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.288 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.0 122.79 48.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 55.25 52.72 11.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.76 26.61 11.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.72 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.573 ' C ' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -137.71 125.64 22.67 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 110.66 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -56.81 151.7 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.499 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -87.16 143.57 34.92 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.069 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.67 123.81 9.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.654 2.236 . . . . 0.0 112.208 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.15 -37.38 1.16 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.627 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 62' ' ' ARG . 1.9 mp -70.78 130.07 34.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 110.921 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.0 mm -110.31 152.76 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.963 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 t -146.33 142.56 28.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.692 0.282 . . . . 0.0 111.254 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 mt -131.12 108.16 9.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.562 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 32.3 mt -88.22 109.32 19.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.6 m120 58.67 43.34 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.96 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.59 30.62 18.73 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.023 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 163.99 25.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.59 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.91 117.2 20.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -50.53 -38.65 45.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.909 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.07 -43.87 94.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.655 0.264 . . . . 0.0 110.833 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.83 -26.14 65.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -111.02 30.43 6.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 111.192 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.66 96.22 0.53 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.487 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.58 -52.73 6.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.407 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -112.97 -36.45 5.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.67 56.61 2.28 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.562 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 33.1 t80 -119.08 114.98 23.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.859 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' A' ' 31' ' ' PRO . 2.9 mp -65.19 119.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 37' ' ' LEU . 27.3 mt -65.63 176.35 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 1.2 mt-10 -167.01 101.12 0.54 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.356 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -45.73 122.29 3.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.89 25.21 9.88 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.2 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.8 t70 -100.99 169.51 8.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -113.87 104.95 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.573 ' HB ' HG12 ' A' ' 6' ' ' VAL . 67.8 mt -118.79 100.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.15 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.089 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.62 103.22 5.57 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 159.48 15.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.593 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -142.22 110.47 6.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.779 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 110.803 179.825 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.694 HG23 ' HA ' ' A' ' 86' ' ' ASP . 9.0 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.654 0.264 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -105.07 89.78 3.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 37' ' ' LEU . 30.7 m -83.36 150.07 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.582 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -111.32 110.65 21.22 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 t -104.86 144.98 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.36 101.4 7.61 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.562 ' CD2' HD13 ' A' ' 12' ' ' LEU . 86.1 m-85 -89.74 128.81 36.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.39 118.45 13.45 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.302 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.06 -102.03 0.34 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.275 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.21 -33.39 3.2 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.961 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.656 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -54.91 -39.23 68.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.34 -37.8 75.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.055 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.45 68.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.997 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 45.5 mt -66.96 -34.07 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.263 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -71.89 -61.92 1.61 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.648 0.261 . . . . 0.0 111.301 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.58 48.0 0.01 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.318 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mttt 57.22 34.43 24.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 111.255 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.37 103.52 9.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.627 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -65.57 0.67 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.549 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -90.23 135.7 25.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.6 136.97 29.7 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.01 142.05 30.2 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.467 HD13 HG12 ' A' ' 41' ' ' ILE . 12.4 mt -132.78 143.64 39.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.94 123.89 45.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.54 120.09 31.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -127.57 48.16 2.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -36.79 23.24 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.017 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -157.47 -178.74 7.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -85.62 -54.04 0.43 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.949 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 3.1 Cg_exo -79.53 53.8 4.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.949 2.433 . . . . 0.0 112.333 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.8 t -74.44 139.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.645 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.21 163.87 13.2 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.531 ' O ' HD12 ' A' ' 38' ' ' ILE . 7.2 p -54.68 -40.44 51.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.995 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -29.28 58.86 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.192 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.76 -42.55 73.71 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -51.74 -53.37 40.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.091 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 34' ' ' VAL . 2.3 mp -59.08 -38.78 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.405 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.6 -41.42 94.72 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -60.49 -39.89 89.34 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.674 0.273 . . . . 0.0 110.611 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 46' ' ' ILE . 42.3 mt -64.87 -32.19 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.644 HG13 ' CG2' ' A' ' 52' ' ' VAL . 29.7 t -96.39 -1.41 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.92 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -100.29 -72.73 0.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 t -87.97 -40.56 13.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.478 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -59.56 4.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.054 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.75 HG21 HG23 ' A' ' 52' ' ' VAL . 4.4 mt -117.53 148.43 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 120.706 0.289 . . . . 0.0 111.272 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -165.2 41.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.94 139.75 36.56 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.86 73.45 3.63 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.705 2.27 . . . . 0.0 112.463 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -169.38 -47.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.622 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -93.39 -35.9 12.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.75 HG23 HG21 ' A' ' 46' ' ' ILE . 2.1 t -91.22 -35.4 7.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -54.4 -33.22 58.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.4 mt -84.51 -33.05 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.309 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.656 ' CE1' HD11 ' A' ' 12' ' ' LEU . 10.5 t80 -77.82 -35.57 51.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.03 133.26 69.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.393 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.1 -156.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.56 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.57 85.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.06 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.1 t0 60.7 40.75 15.95 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.163 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -178.57 138.92 0.17 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mt -65.78 142.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.42 ' O ' HD12 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -89.55 155.85 48.19 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.35 146.33 68.59 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.7 2.267 . . . . 0.0 112.467 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.67 -42.54 1.46 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.578 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.522 HG21 ' HE1' ' A' ' 55' ' ' PHE . 1.9 mp -73.1 122.44 25.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.982 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -94.68 131.45 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.419 ' HB ' ' CG ' ' A' ' 74' ' ' TRP . 0.3 OUTLIER -122.33 114.56 20.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 68' ' ' LEU . 24.7 mt -112.76 109.19 18.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.0 mt -88.16 98.58 7.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.55 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.1 m120 57.37 55.25 5.93 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.736 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 31.58 20.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.536 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.97 159.74 40.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.462 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.806 ' HB2' HD12 ' A' ' 76' ' ' LEU . 2.7 m-20 -79.79 120.4 24.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.419 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -57.12 -30.68 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.639 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.05 -30.58 44.13 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.584 0.23 . . . . 0.0 111.129 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' HB2' ' A' ' 73' ' ' ASP . 4.8 mt -65.55 -18.11 65.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.575 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -133.59 38.66 3.24 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 111.384 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.59 103.54 0.25 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.068 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' O ' HG11 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -47.77 -61.88 1.73 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.101 0.16 . . . . 0.0 111.267 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.15 -28.78 11.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.19 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.76 -29.45 18.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.453 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -58.87 114.4 2.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.807 0.337 . . . . 0.0 110.605 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mp -76.82 144.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 84' ' ' LEU . 20.1 mt -64.46 171.69 3.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.203 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -171.04 104.25 0.23 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.471 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.694 ' HA ' HG23 ' A' ' 2' ' ' VAL . 27.1 t70 -46.11 115.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.995 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 20.06 6.67 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.779 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.05 169.98 8.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.779 0.324 . . . . 0.0 111.403 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.452 ' O ' HD13 ' A' ' 90' ' ' ILE . 15.3 mt -127.53 152.34 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.753 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 89' ' ' ILE . 21.2 mm -135.5 150.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.222 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -130.11 138.92 50.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.019 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.85 90.76 2.95 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.019 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.19 104.24 16.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 80.98 1.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.761 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 120.675 0.274 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -155.85 96.03 1.7 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.74 153.85 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.448 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HG2' HG13 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -115.34 107.77 15.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.581 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.863 HG12 ' HB ' ' A' ' 90' ' ' ILE . 27.5 m -111.91 155.41 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.379 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 21' ' ' VAL . 2.2 mt-10 -124.88 152.64 43.76 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.592 ' O ' HD12 ' A' ' 9' ' ' LEU . 50.8 m-85 -128.92 114.12 16.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.352 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 8' ' ' PHE . 10.9 mp -128.66 108.39 10.45 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.701 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.8 -101.71 0.35 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.528 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.0 28.28 4.15 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.103 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -106.57 -45.34 4.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.737 0.269 . . . . 0.0 110.844 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.25 -33.57 71.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.08 86.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -72.01 -41.89 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -66.8 -71.59 0.19 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.62 43.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.626 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 54.7 34.51 21.79 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.545 0.338 . . . . 0.0 111.524 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.24 112.38 24.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -61.48 -67.05 0.44 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.905 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' A' ' 7' ' ' GLU . 36.3 t -90.83 117.89 34.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.986 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 148.32 38.19 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.052 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -115.84 137.67 51.88 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -134.37 139.84 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 123.4 21.55 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -38.29 54.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.576 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.08 43.48 26.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.92 0.39 . . . . 0.0 111.085 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.05 -74.13 0.62 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.591 ' HG2' HG22 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -133.72 -174.28 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -59.64 0.36 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.097 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.12 57.93 6.37 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.318 2.012 . . . . 0.0 112.573 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.591 HG22 ' HG2' ' A' ' 29' ' ' GLU . 21.7 t -74.85 118.9 21.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 p -66.21 147.01 53.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.37 -34.65 23.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.556 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.87 -26.77 58.44 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.117 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.5 -42.07 62.28 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.663 0.268 . . . . 0.0 110.615 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -54.04 -53.05 58.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.198 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.491 ' HA ' HD12 ' A' ' 41' ' ' ILE . 16.4 mt -62.36 -40.03 86.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.386 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.75 -42.71 99.32 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -58.94 -43.29 91.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.957 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 38' ' ' ILE . 15.2 mt -64.52 -32.21 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.141 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.603 HG13 ' CG2' ' A' ' 52' ' ' VAL . 21.9 t -97.14 -3.51 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -92.92 -75.44 0.49 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.507 0.194 . . . . 0.0 111.357 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -94.62 -43.02 8.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.187 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -38.45 67.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.776 HG21 HG23 ' A' ' 52' ' ' VAL . 47.0 mt -136.92 136.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.301 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -159.1 38.44 0.21 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 23.0 t30 -128.54 127.45 23.6 Favored Pre-proline 0 C--N 1.334 -0.088 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.866 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 24.9 Cg_exo -64.44 76.58 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.692 2.261 . . . . 0.0 112.254 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -168.25 -45.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.43 -31.54 12.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.135 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.776 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -102.57 -35.52 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.206 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -36.46 61.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.571 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.625 HD12 ' N ' ' A' ' 55' ' ' PHE . 1.4 pp -94.93 -22.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' N ' HD12 ' A' ' 54' ' ' ILE . 46.4 t80 -77.25 -49.07 15.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.594 0.235 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.1 mm -106.5 150.28 9.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.07 85.12 2.2 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 57.06 67.25 1.01 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.401 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 76.28 -42.87 0.45 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.336 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -82.04 129.93 34.94 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.724 0.297 . . . . 0.0 110.985 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.48 153.38 6.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.348 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -82.66 135.95 45.61 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.174 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.18 106.54 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.65 2.234 . . . . 0.0 111.965 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.13 -35.52 0.24 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.75 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 mt -67.21 121.57 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.836 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -90.01 97.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.8 t -104.75 136.28 44.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.9 mt -126.1 118.53 25.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.445 HG23 HG12 ' A' ' 90' ' ' ILE . 33.6 mt -102.01 109.5 26.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.492 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.03 48.14 13.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.61 38.77 21.97 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.362 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.62 161.95 38.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.721 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.72 124.77 29.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.403 ' CG ' HG23 ' A' ' 67' ' ' THR . 1.0 OUTLIER -55.84 -33.59 64.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.506 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -80.11 -33.4 38.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.669 0.271 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.74 -24.87 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -103.52 -58.21 1.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.513 0.197 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.3 98.22 0.11 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.626 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -47.04 -56.81 5.83 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.127 0.171 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -117.34 -30.64 5.52 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.937 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.92 56.62 2.38 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.168 0.509 . . . . 0.0 110.977 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -137.65 112.52 8.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.76 127.87 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 37' ' ' LEU . 15.6 mt -65.31 177.7 1.06 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 110.741 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -163.45 100.03 0.93 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.143 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -49.07 108.91 0.21 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.03 26.31 5.55 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.16 176.15 5.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.662 0.268 . . . . 0.0 111.041 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -116.77 111.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.362 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.863 ' HB ' HG12 ' A' ' 6' ' ' VAL . 62.6 mt -126.41 97.61 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.4 m -79.91 158.54 26.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.501 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -145.05 85.24 1.74 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -91.92 162.67 14.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.623 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.44 93.96 2.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.865 0.364 . . . . 0.0 110.823 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.918 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 86' ' ' ASP . 9.1 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.661 0.267 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -112.93 93.16 4.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.871 HG21 HD21 ' A' ' 37' ' ' LEU . 25.2 m -93.3 144.16 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -116.37 97.31 5.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.665 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -92.79 146.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -116.98 97.65 6.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' HD12 ' A' ' 9' ' ' LEU . 72.0 m-85 -87.23 117.92 26.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 8' ' ' PHE . 10.3 mp -127.23 176.47 7.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.467 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.94 -112.22 3.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.354 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.81 23.17 12.03 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.784 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.574 HD21 ' CE1' ' A' ' 55' ' ' PHE . 1.1 mt -100.27 -43.31 6.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.805 0.303 . . . . 0.0 111.212 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.12 -34.03 67.96 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.39 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -33.74 76.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.703 0.287 . . . . 0.0 111.097 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.7 mt -80.28 -41.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.326 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -61.96 -73.3 0.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.267 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.78 41.63 0.09 OUTLIER Glycine 0 C--N 1.335 0.472 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt 53.59 41.56 32.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.717 0.294 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -121.78 121.83 38.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -46.06 91.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.384 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 10.1 p -121.34 126.93 75.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.85 135.75 54.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.492 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 24' ' ' ILE . 11.8 pttt -102.46 146.35 28.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.361 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 23' ' ' LYS . 19.0 mm -132.22 147.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -121.52 98.14 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.774 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.457 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -96.18 139.55 32.18 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -138.16 81.51 1.86 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -120.62 -63.07 1.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -148.4 -175.51 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.797 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.26 -60.14 0.3 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.052 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.49 58.02 6.8 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.489 2.126 . . . . 0.0 112.297 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.59 ' HB ' HD12 ' A' ' 84' ' ' LEU . 22.5 t -81.17 152.67 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.339 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -103.36 163.8 12.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.327 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.472 ' HA ' HD21 ' A' ' 84' ' ' LEU . 7.5 p -58.55 -34.46 51.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.028 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -27.71 62.61 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.11 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -71.36 -41.86 69.2 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.641 0.258 . . . . 0.0 110.42 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -54.96 -51.79 65.05 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.328 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mt -59.18 -39.67 79.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.336 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.25 -41.94 89.96 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -60.76 -45.02 95.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.204 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.609 HG22 HD12 ' A' ' 46' ' ' ILE . 28.2 mt -62.68 -28.41 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.395 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 56' ' ' ILE . 32.8 t -100.52 -9.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -76.21 -75.62 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.58 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.3 m -100.33 -36.33 9.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.294 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.4 mmm -56.64 -53.49 57.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.431 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.613 ' CG2' HG23 ' A' ' 52' ' ' VAL . 9.6 mt -124.61 88.03 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 120.938 0.399 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -104.2 51.17 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.48 116.54 6.47 Favored Pre-proline 0 N--CA 1.457 -0.105 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.67 -30.92 30.4 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.77 2.313 . . . . 0.0 112.739 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -55.96 -48.91 74.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.319 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.14 31.48 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.755 HG21 HG13 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -150.56 -49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 p -56.68 -27.54 59.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.474 0.178 . . . . 0.0 111.447 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.2 mt -84.04 -33.87 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.666 0.27 . . . . 0.0 110.625 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.574 ' CE1' HD21 ' A' ' 12' ' ' LEU . 52.0 t80 -74.34 -44.21 53.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.085 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 42' ' ' VAL . 42.1 mt -111.57 148.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.899 0.381 . . . . 0.0 111.38 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.15 -158.33 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.851 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.28 92.63 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.109 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t0 53.35 37.0 24.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.874 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.45 141.04 1.48 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.557 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.498 HG22 HD12 ' A' ' 65' ' ' ILE . 2.6 mt -58.06 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.705 0.288 . . . . 0.0 111.334 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.99 120.2 58.91 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.72 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.57 101.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.676 2.251 . . . . 0.0 112.166 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.67 -42.65 0.63 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.694 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 61' ' ' ILE . 4.6 mt -59.12 140.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.937 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -108.3 137.71 38.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.118 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.9 t -137.63 125.9 23.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 41.0 mt -108.66 111.09 22.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.54 111.73 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.615 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 58.85 47.5 12.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.96 34.1 23.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.963 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.1 m -140.88 161.7 37.21 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.617 ' HB2' HD23 ' A' ' 76' ' ' LEU . 1.5 m-20 -79.89 150.79 30.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.377 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -62.44 -42.33 99.39 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.43 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.17 -9.07 58.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -63.26 -35.85 81.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.343 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.54 29.3 6.65 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 111.503 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 75' ' ' GLU . . . 121.51 -102.72 0.83 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.442 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.72 -81.13 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 122.546 0.338 . . . . 0.0 110.303 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -104.82 -24.55 12.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.273 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -52.98 -25.48 12.19 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -45.15 107.7 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 110.489 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mt -68.26 138.41 22.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.59 HD12 ' HB ' ' A' ' 32' ' ' VAL . 18.4 mt -66.52 174.07 3.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -170.85 104.22 0.24 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.504 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 2' ' ' VAL . 6.1 t0 -42.06 109.17 0.12 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.007 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.02 27.05 4.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.44 165.77 12.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.02 116.64 46.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.804 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 90' ' ' ILE . 4.0 mp -115.92 150.49 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 67' ' ' THR . 40.3 m -130.26 142.33 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.708 0.29 . . . . 0.0 111.413 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB3' HD13 ' A' ' 12' ' ' LEU . 11.1 m-85 -130.99 95.27 3.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 156.86 16.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.084 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 t -153.92 79.94 1.14 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 179.67 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -157.64 94.23 1.34 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.884 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 m -105.19 135.38 43.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -89.23 115.56 26.82 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.709 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 7.7 t -110.4 148.48 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.244 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -119.29 99.18 6.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CE1' HD22 ' A' ' 12' ' ' LEU . 93.8 m-85 -84.55 133.45 34.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.552 HD13 HG23 ' A' ' 93' ' ' THR . 5.4 mp -140.64 152.13 45.16 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -101.53 2.76 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.222 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.75 -28.74 4.66 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 8' ' ' PHE . 1.4 mt -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.897 0.349 . . . . 0.0 111.734 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.04 -33.48 75.9 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.419 0.152 . . . . 0.0 111.12 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.75 80.87 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.401 HG21 ' CB ' ' A' ' 51' ' ' ASP . 4.7 mt -81.69 -34.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.521 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.8 -73.22 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.58 0.228 . . . . 0.0 111.187 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.8 41.75 0.09 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.591 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 53.19 34.78 18.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.484 0.313 . . . . 0.0 111.705 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -121.61 123.55 42.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.613 0.244 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -26.87 68.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.598 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 7.5 p -132.46 135.27 58.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.838 0.352 . . . . 0.0 110.934 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.16 142.23 28.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -85.42 142.22 29.41 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.991 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.1 mm -123.9 140.75 46.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.135 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.3 115.62 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 40' ' ' HIS . 15.1 ttt -88.98 -42.36 11.83 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.141 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 86.25 0.1 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -66.09 0.37 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.58 -169.26 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.456 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -86.83 -54.2 0.39 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.082 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 4.8 Cg_exo -74.08 55.86 3.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.834 2.356 . . . . 0.0 112.588 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.59 124.78 49.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.619 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.73 153.98 30.42 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.14 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -56.19 -33.66 37.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.71 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.5 -27.64 54.45 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.82 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -40.74 68.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.677 0.275 . . . . 0.0 110.496 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.88 -52.89 61.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.344 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.445 HG23 ' CE2' ' A' ' 55' ' ' PHE . 16.3 mt -60.17 -41.29 86.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.107 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -61.23 -40.01 92.39 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG3' ' A' ' 26' ' ' MET . 72.6 t60 -58.52 -46.72 86.18 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 46' ' ' ILE . 17.9 mt -63.29 -30.01 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.279 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 56' ' ' ILE . 39.5 t -97.15 -4.9 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.76 -73.92 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.3 m -87.34 -45.14 10.84 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.465 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.428 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -54.77 -51.67 64.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.042 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.822 ' CG2' HG23 ' A' ' 52' ' ' VAL . 7.6 mt -121.79 150.96 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.106 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -160.81 65.53 0.3 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.42 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 8.9 t30 -170.88 138.51 1.22 Allowed Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 120.601 0.239 . . . . 0.0 111.572 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.88 75.17 3.23 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.735 2.29 . . . . 0.0 112.6 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 48' ' ' ASN . 20.3 p-10 -166.13 -41.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.401 ' CB ' HG21 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -100.98 -37.31 8.69 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.822 HG23 ' CG2' ' A' ' 46' ' ' ILE . 2.1 t -82.5 -34.45 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.412 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -50.88 -31.94 18.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.677 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.95 -46.31 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.755 0.312 . . . . 0.0 111.018 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.481 ' O ' HD13 ' A' ' 56' ' ' ILE . 17.8 t80 -66.59 -47.87 71.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.848 HG13 HG21 ' A' ' 42' ' ' VAL . 28.2 mm -129.57 143.55 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.813 0.34 . . . . 0.0 111.294 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.5 127.89 26.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 58.33 45.43 16.98 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.449 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 53.99 33.5 17.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.374 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.4 m -150.53 145.66 26.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.915 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.87 152.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -92.64 137.73 24.12 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 99.59 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.582 2.188 . . . . 0.0 111.89 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.17 -35.28 0.44 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.558 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -66.27 134.48 29.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.43 118.62 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 91' ' ' SER . 4.5 t -121.5 92.09 3.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.945 0.402 . . . . 0.0 111.016 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.4 mt -101.23 122.0 42.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.207 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mt -100.66 107.73 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.02 52.64 6.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.33 30.64 19.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.117 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -133.28 164.99 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -79.77 177.6 8.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.921 0.391 . . . . 0.0 111.18 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -102.88 -39.94 6.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.92 -27.62 28.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.763 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -54.27 -30.6 51.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -115.69 -62.15 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.522 0.201 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.75 103.86 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.686 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -57.5 6.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.59 0.234 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -117.4 -44.3 2.77 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.1 -27.0 5.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.018 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -48.99 109.53 0.27 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 83' ' ' ILE . 3.4 mp -68.95 133.33 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.138 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -67.63 172.44 5.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.804 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.16 102.6 0.29 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.395 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -48.91 114.51 1.01 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.71 -9.56 6.81 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.814 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.538 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -80.04 157.23 26.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.045 0.422 . . . . 0.0 111.163 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 89' ' ' ILE . 1.5 mp -107.69 125.45 64.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.764 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 6.5 mt -125.99 141.89 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.27 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -116.57 142.21 47.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.76 90.98 3.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.794 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.552 HG23 HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -108.04 95.52 5.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.874 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -88.04 89.4 7.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.707 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 86' ' ' ASP . 7.7 p . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.02 0.438 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -87.63 117.19 26.27 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.413 ' HB ' HD13 ' A' ' 90' ' ' ILE . 18.2 m -114.98 139.5 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.25 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.94 105.88 16.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.655 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.816 HG12 ' HB ' ' A' ' 90' ' ' ILE . 8.4 m -98.68 146.13 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.329 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -126.0 98.43 5.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.64 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.449 ' C ' HD12 ' A' ' 9' ' ' LEU . 98.0 m-85 -82.95 142.48 31.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' ' 8' ' ' PHE . 5.4 mp -146.04 172.45 13.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.213 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.75 -107.96 2.59 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.219 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.44 -6.04 13.76 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.664 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -65.72 -45.13 83.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.398 0.599 . . . . 0.0 111.284 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.56 -30.22 69.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.256 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.66 88.21 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.658 0.266 . . . . 0.0 111.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 11.0 mt -70.43 -40.14 77.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.601 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.5 m-85 -66.44 -70.16 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.45 48.04 0.04 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.366 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt 56.77 33.81 23.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.382 0.273 . . . . 0.0 111.344 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -104.16 110.65 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.755 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.45 -62.39 1.49 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.45 144.14 20.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.808 0.337 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -180.0 6.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.515 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.9 141.79 25.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.2 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 23' ' ' LYS . 20.0 mm -135.16 146.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.17 84.0 2.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.04 127.25 30.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.177 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.38 92.86 4.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.97 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -144.38 -66.04 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.43 -178.03 6.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.197 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.73 -59.78 0.35 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.002 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.94 58.78 6.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.558 2.172 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -92.38 132.86 35.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.2 p -75.37 153.02 37.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.859 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.14 -32.13 33.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.707 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -26.52 55.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.086 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.01 -45.71 69.84 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.584 0.231 . . . . 0.0 110.56 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -54.28 -46.82 72.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.221 178.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.3 mt -58.13 -41.12 79.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.322 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -37.63 80.53 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.835 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.6 -40.48 97.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.866 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.492 HD11 HG13 ' A' ' 24' ' ' ILE . 22.1 mm -65.75 -31.22 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.676 HG21 HG13 ' A' ' 56' ' ' ILE . 24.0 t -97.46 -2.9 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -99.54 -75.74 0.56 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -87.42 -48.07 8.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.359 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.17 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.746 HG21 HG23 ' A' ' 52' ' ' VAL . 16.1 mt -126.48 136.39 60.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -153.0 44.01 0.64 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -130.64 129.56 22.74 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.193 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.55 73.85 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.39 -52.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.575 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.456 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.3 p30 -83.91 -35.64 23.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.746 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -89.74 -35.67 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 t -58.43 -38.98 78.57 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.312 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.27 -36.86 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.316 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.06 -51.43 38.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.062 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.676 HG13 HG21 ' A' ' 42' ' ' VAL . 28.4 mm -111.71 125.35 69.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.134 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -114.5 122.77 47.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.766 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.11 45.14 21.3 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.73 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.29 32.33 21.58 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.362 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -143.89 147.87 34.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -61.58 152.32 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -93.64 148.44 35.42 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.92 122.16 9.26 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.752 2.301 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.47 -46.26 1.08 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.768 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.64 117.81 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.5 mm -80.55 147.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.524 HG23 ' CG ' ' A' ' 74' ' ' TRP . 7.4 t -147.49 99.86 3.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.19 143.11 32.41 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 89' ' ' ILE . 17.1 mt -126.09 112.22 29.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.37 44.74 11.87 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.984 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.31 39.09 25.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -142.93 166.36 24.84 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.42 28.54 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.533 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.87 -36.01 46.99 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.906 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -39.54 32.02 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.406 0.146 . . . . 0.0 111.358 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -25.22 62.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -106.56 -35.75 6.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.238 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.4 98.53 0.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.533 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 2.9 tt0 -42.06 -69.61 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.258 0.223 . . . . 0.0 111.552 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -116.66 -36.81 3.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.971 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.77 -24.94 24.77 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.494 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -52.12 110.94 0.54 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.837 0.351 . . . . 0.0 110.728 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.0 mt -68.49 141.0 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.12 176.43 0.75 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.04 103.52 0.3 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.41 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.569 ' HA ' HG23 ' A' ' 2' ' ' VAL . 17.3 t0 -43.01 108.29 0.1 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.819 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 29.91 3.4 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.66 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.636 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -103.81 165.06 11.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.636 HD12 ' C ' ' A' ' 88' ' ' ASP . 1.6 mp -115.92 141.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.78 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.816 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.7 mp -138.43 90.12 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -81.41 132.73 35.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -118.95 110.09 16.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.34 100.94 8.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.0 t -92.4 88.05 6.25 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 CA--C 1.538 0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.911 -179.759 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.607 0.241 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.04 112.13 10.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.16 134.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 116.74 33.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.764 HG12 ' HB ' ' A' ' 90' ' ' ILE . 6.6 m -122.47 143.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.403 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -110.95 153.79 25.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' C ' HD22 ' A' ' 9' ' ' LEU . 44.9 m-85 -128.57 118.23 22.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.048 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.628 ' CB ' HG23 ' A' ' 93' ' ' THR . 4.5 mm? -122.78 171.59 9.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.18 -103.14 1.54 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.436 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.05 27.27 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.948 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.586 HD21 ' CE1' ' A' ' 55' ' ' PHE . 3.4 mt -87.64 -41.41 13.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.825 0.313 . . . . 0.0 110.896 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.2 -33.93 71.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.165 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.77 -31.99 73.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.229 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mt -74.3 -46.89 42.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.216 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -62.76 -65.58 0.67 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.319 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.48 46.74 0.03 OUTLIER Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.444 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.9 mttt 57.44 51.72 9.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -125.82 122.33 35.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.992 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -68.86 -64.31 0.89 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.93 137.32 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -126.93 156.67 41.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.059 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -123.89 132.2 53.7 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.811 HG13 HD11 ' A' ' 41' ' ' ILE . 23.3 mm -116.69 144.07 25.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.338 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.45 108.31 10.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -100.11 110.12 22.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.993 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -102.39 63.83 0.89 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 110.904 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -112.44 -44.98 3.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.012 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' CG ' HG22 ' A' ' 32' ' ' VAL . 9.5 pt-20 -169.95 -176.66 2.38 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -86.29 -51.93 0.46 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.5 Cg_exo -78.67 54.09 4.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.961 2.44 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.462 HG22 ' CG ' ' A' ' 29' ' ' GLU . 26.8 t -85.65 122.48 38.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.026 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -74.4 150.45 40.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.234 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -52.59 -30.77 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.583 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.56 -25.71 61.27 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.279 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.4 -43.48 73.37 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -55.67 -47.06 77.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.775 178.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.68 -39.15 78.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.014 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.77 -41.07 94.76 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.829 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -59.89 -41.87 92.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.807 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.811 HD11 HG13 ' A' ' 24' ' ' ILE . 33.9 mm -63.81 -33.18 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.047 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.646 HG13 ' CG2' ' A' ' 52' ' ' VAL . 38.2 t -98.06 -3.89 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 m -95.54 -75.22 0.53 Allowed 'General case' 0 C--O 1.232 0.183 0 O-C-N 122.382 -0.199 . . . . 0.0 111.463 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 t -93.15 -38.78 11.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.458 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -46.81 88.62 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.079 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.717 HG21 HG23 ' A' ' 52' ' ' VAL . 20.1 mt -129.77 150.98 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.25 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -166.06 40.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.106 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.2 t-20 -128.58 128.44 23.56 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.484 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 25.0 Cg_exo -63.67 74.37 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.84 2.36 . . . . 0.0 112.191 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.07 -58.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.457 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.2 p30 -81.29 -34.56 31.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.758 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.717 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -91.78 -36.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.065 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.86 72.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.432 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.4 mt -86.63 -36.84 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.025 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CE1' HD21 ' A' ' 12' ' ' LEU . 31.9 t80 -69.09 -37.04 78.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.088 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 42' ' ' VAL . 35.1 mm -127.3 130.13 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.795 0.331 . . . . 0.0 111.353 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.41 -158.32 0.6 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.591 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.55 85.99 0.11 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.895 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 60.75 46.75 8.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.39 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.39 175.94 2.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.4 mt -97.07 153.4 3.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.832 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 125.31 79.04 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.85 105.33 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.62 2.213 . . . . 0.0 112.065 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 151.88 -31.25 0.9 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.557 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.522 HD12 ' CG2' ' A' ' 61' ' ' ILE . 31.2 mt -70.38 127.59 32.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mt -100.77 134.69 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.958 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 91' ' ' SER . 1.5 m -138.24 143.81 40.28 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.234 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.3 mt -139.4 126.21 20.82 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.447 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 77' ' ' GLU . 9.6 mt -100.73 102.35 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.0 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 59.99 59.75 2.33 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.304 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 57.83 26.02 12.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.58 173.27 11.04 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.036 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 2.3 m-20 -79.38 157.95 27.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -59.99 2.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.712 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.24 -37.42 77.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.185 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -60.36 -29.98 69.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.923 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.441 ' HB3' HD12 ' A' ' 69' ' ' ILE . 2.8 tp10 -93.57 28.4 2.31 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.069 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.95 -6.55 82.73 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.59 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 67.85 -72.41 0.09 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.027 0.414 . . . . 0.0 111.021 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -116.78 -29.71 5.97 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.03 54.88 1.68 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.227 0.537 . . . . 0.0 110.922 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -124.58 113.62 18.31 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.615 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.6 mt -61.45 128.5 22.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.8 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 84' ' ' LEU . 18.4 mt -64.2 174.5 1.57 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.858 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.39 103.65 0.21 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -46.68 113.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.026 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 23.98 5.69 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.02 177.65 4.83 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.337 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 mm -121.74 132.23 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.764 ' HB ' HG12 ' A' ' 6' ' ' VAL . 62.1 mt -143.06 92.55 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.631 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 67' ' ' THR . 12.9 m -79.88 149.11 31.05 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.711 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -134.46 86.87 2.3 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.776 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.628 HG23 ' CB ' ' A' ' 9' ' ' LEU . 1.2 m -91.23 144.72 25.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.604 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -148.66 79.98 1.44 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.004 0.43 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.432 HG13 ' CA ' ' A' ' 86' ' ' ASP . 5.1 t . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.737 0.303 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -80.18 125.28 29.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.551 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 37' ' ' LEU . 31.2 m -128.47 139.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.79 118.28 36.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.889 HG12 ' HB ' ' A' ' 90' ' ' ILE . 35.0 m -119.0 153.25 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.376 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.498 ' CD ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -125.77 158.86 33.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.809 ' C ' HD22 ' A' ' 9' ' ' LEU . 8.2 p90 -160.24 148.03 16.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.809 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.0 mm? -137.96 178.22 7.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.112 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.59 -109.97 3.04 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.83 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.19 -24.22 17.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.943 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 55' ' ' PHE . 4.3 mm? -55.03 -46.41 75.29 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.721 0.261 . . . . 0.0 111.362 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.89 -30.73 71.07 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.0 -38.2 45.4 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.271 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 22.3 mt -75.63 -44.59 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.71 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.451 ' HE2' HD12 ' A' ' 12' ' ' LEU . 3.0 m-85 -59.27 -69.78 0.19 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.521 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.74 46.85 0.03 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.452 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.74 44.89 22.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -121.3 -176.66 3.34 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 -56.44 0.56 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.498 HG22 ' CD ' ' A' ' 7' ' ' GLU . 20.8 t -99.91 117.67 45.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.31 153.57 28.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.21 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -124.47 119.08 28.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -99.45 143.07 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -116.22 80.42 1.45 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.293 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.97 106.75 18.62 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -93.92 43.83 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.121 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HB3' HG21 ' A' ' 32' ' ' VAL . 1.3 tttp -90.11 -162.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -65.07 -172.19 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.904 0.383 . . . . 0.0 111.365 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -83.47 -54.01 0.54 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.036 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.7 Cg_exo -78.66 50.22 3.35 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.858 2.372 . . . . 0.0 112.713 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.578 HG21 ' HB3' ' A' ' 28' ' ' LYS . 35.4 t -81.84 126.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 1.3 p -73.34 157.47 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.914 0.387 . . . . 0.0 111.2 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.54 -34.98 48.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.471 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 38' ' ' ILE . . . -56.33 -28.33 54.79 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.875 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -68.91 -43.39 75.31 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -53.04 -51.93 60.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.482 HD12 ' HA2' ' A' ' 35' ' ' GLY . 4.6 mt -59.97 -36.84 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.171 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -63.75 -37.85 88.89 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.766 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -60.85 -39.64 89.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.627 0.251 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.418 ' CG1' HG12 ' A' ' 24' ' ' ILE . 17.8 mt -72.74 -25.76 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.842 HG13 HG21 ' A' ' 52' ' ' VAL . 30.8 t -100.09 -1.44 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -93.72 -77.87 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.381 -0.199 . . . . 0.0 111.234 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.29 -40.87 14.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -56.88 16.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.148 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.903 HG21 HG23 ' A' ' 52' ' ' VAL . 22.2 mt -116.24 123.01 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 120.629 0.252 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.6 39.34 1.69 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.139 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -131.84 129.24 21.87 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.72 70.18 2.11 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.519 2.146 . . . . 0.0 112.044 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.9 -50.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.448 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.4 p30 -88.68 -36.88 15.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.947 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.903 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -94.08 -35.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.342 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 m -56.11 -32.1 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.447 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 33.2 mt -92.08 -32.03 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.56 0.219 . . . . 0.0 111.127 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CE1' HD11 ' A' ' 12' ' ' LEU . 58.3 t80 -73.37 -37.4 66.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.01 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CD1' HG21 ' A' ' 42' ' ' VAL . 27.1 mt -127.93 150.32 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.17 -163.98 1.02 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.695 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.62 92.41 0.07 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.735 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.5 33.66 22.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.471 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.1 p -165.93 122.55 1.37 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.867 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.82 151.61 9.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 20.1 mtt180 -74.5 142.36 77.71 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.16 97.14 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.689 2.26 . . . . 0.0 112.203 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.9 -39.2 0.09 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.49 132.92 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.5 mt -108.18 93.49 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.539 HG23 ' CG ' ' A' ' 74' ' ' TRP . 3.5 t -93.61 138.66 31.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -125.03 122.27 36.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.54 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.24 101.65 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 60.25 59.9 2.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.356 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 58.29 24.56 11.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.582 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -129.38 178.85 6.15 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.173 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -80.02 -177.07 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 111.009 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.539 ' CG ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.61 -39.8 6.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.94 -24.59 19.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.017 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.435 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -54.42 -29.76 50.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.22 -69.32 0.86 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.563 0.221 . . . . 0.0 111.167 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.71 106.81 0.3 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.434 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.11 -71.01 0.08 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.504 0.192 . . . . 0.0 111.067 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -107.83 -36.65 6.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.947 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.37 -29.15 22.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.783 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.53 121.25 4.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.677 0.275 . . . . 0.0 110.856 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.97 138.36 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.05 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.438 HD13 HD23 ' A' ' 37' ' ' LEU . 20.6 mt -66.52 177.9 1.41 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.856 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.85 103.28 0.11 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.909 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.432 ' CA ' HG13 ' A' ' 2' ' ' VAL . 12.4 t0 -35.22 111.91 0.14 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.44 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.4 6.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.946 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -95.26 164.33 12.89 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.823 0.344 . . . . 0.0 111.082 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm -119.49 134.5 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.172 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.889 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.4 mp -139.0 154.04 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.045 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 67' ' ' THR . 16.3 m -134.75 161.6 34.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.14 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.405 ' CD1' ' HB ' ' A' ' 67' ' ' THR . 94.1 m-85 -150.39 79.98 1.35 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -87.38 130.56 34.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.437 ' HB2' HD23 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -114.54 101.18 8.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.628 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.39 167.94 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.799 0.333 . . . . 0.0 111.818 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -151.5 132.55 14.33 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.13 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.9 m -132.36 120.29 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.38 102.09 13.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.708 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 t -99.47 142.12 15.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HG3' HG23 ' A' ' 21' ' ' VAL . 1.2 mt-10 -118.07 102.49 9.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.909 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.64 ' C ' HD12 ' A' ' 9' ' ' LEU . 88.2 m-85 -88.06 131.7 34.56 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.042 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 8' ' ' PHE . 6.8 mp -139.3 175.83 9.22 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.237 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 -85.96 1.35 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.625 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.15 28.1 1.55 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.869 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.777 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -105.93 -46.3 4.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 110.851 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -60.08 -26.35 66.12 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.367 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -36.75 80.42 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.837 0.351 . . . . 0.0 110.827 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 4.3 mt -77.03 -40.5 30.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -63.74 -30.78 71.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.537 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.02 46.55 0.22 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.69 34.71 25.03 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 111.12 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.75 97.77 8.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.71 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -31.16 70.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 7' ' ' GLU . 8.0 p -139.9 128.39 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.917 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -138.69 138.63 37.92 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 142.23 27.58 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.539 HG13 HD11 ' A' ' 41' ' ' ILE . 25.8 mm -121.39 148.13 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.32 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 126.3 31.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.105 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 142.22 50.99 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.48 102.07 4.52 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -149.37 -69.33 0.21 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.489 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.66 -178.25 5.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.013 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.6 -57.98 0.67 Allowed Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.378 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.88 61.78 3.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.388 2.059 . . . . 0.0 112.724 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.509 ' CG1' HD12 ' A' ' 84' ' ' LEU . 21.4 t -77.58 116.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.751 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.561 HG22 HD13 ' A' ' 83' ' ' ILE . 56.8 p -84.84 160.1 20.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.898 0.38 . . . . 0.0 110.957 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -58.15 -34.14 48.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.62 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.25 62.0 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.965 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -42.69 71.35 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.746 0.308 . . . . 0.0 110.303 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 84' ' ' LEU . 1.9 tm? -53.0 -52.39 58.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.254 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.4 mt -57.96 -39.6 72.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.256 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.93 -44.29 91.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.733 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -38.16 76.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.539 HD11 HG13 ' A' ' 24' ' ' ILE . 32.2 mm -68.68 -28.97 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.57 HG13 ' CG2' ' A' ' 52' ' ' VAL . 32.2 t -96.02 -6.53 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 p -99.33 -77.52 0.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.199 -0.313 . . . . 0.0 111.728 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.4 p -84.55 -44.02 13.96 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.475 0.179 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.48 ' HB2' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -56.31 -52.31 65.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.219 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.783 ' CG2' HG23 ' A' ' 52' ' ' VAL . 16.2 mt -122.4 141.53 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.566 0.222 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.15 74.05 0.77 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.134 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -165.94 139.07 3.44 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.444 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.95 70.57 5.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.59 2.193 . . . . 0.0 111.871 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -171.86 -44.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.799 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.472 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.68 -41.88 11.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.783 HG23 ' CG2' ' A' ' 46' ' ' ILE . 1.9 t -85.97 -35.3 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 p -55.55 -38.44 69.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.36 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.53 -30.87 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.598 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.777 ' CE1' HD21 ' A' ' 12' ' ' LEU . 14.5 t80 -79.52 -57.47 3.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.024 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.546 HG13 HG21 ' A' ' 42' ' ' VAL . 31.6 mm -106.18 135.66 43.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.014 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -124.87 97.16 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.982 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.64 66.27 1.28 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.09 28.62 9.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.799 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.0 m -147.19 122.57 10.32 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.358 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.12 152.48 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 111.158 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.3 116.63 60.59 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -52.68 119.33 5.8 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.809 2.339 . . . . 0.0 112.371 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.85 -27.15 3.22 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.776 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 mt -72.51 125.31 31.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.2 mp -86.17 148.56 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.327 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.408 HG23 ' CE1' ' A' ' 92' ' ' PHE . 6.2 m -149.71 100.69 2.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 46.7 mt -91.6 114.87 27.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.738 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 HD12 ' A' ' 90' ' ' ILE . 10.3 pt -103.52 110.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.765 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 60.19 45.63 11.37 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.701 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.34 28.64 17.02 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 167.6 20.48 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.264 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.87 144.33 33.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.349 . . . . 0.0 111.242 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -63.31 -50.61 69.38 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.976 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -24.59 67.94 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.25 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -50.03 63.76 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.018 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.15 -72.2 0.34 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.913 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.74 36.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.962 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 56.71 -83.98 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.978 0.511 . . . . 0.0 111.808 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 tttm -101.86 3.54 39.35 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -91.56 31.09 1.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.696 0.284 . . . . 0.0 111.482 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -123.45 109.2 13.54 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.561 HD13 HG22 ' A' ' 33' ' ' THR . 42.5 mm -65.73 137.28 25.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.782 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 37' ' ' LEU . 21.6 mt -63.06 174.19 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -167.64 101.06 0.49 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.588 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -47.06 119.88 2.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.706 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.32 20.29 8.34 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.146 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.93 162.84 13.4 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.745 0.307 . . . . 0.0 111.051 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.54 95.18 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.577 HD12 HG22 ' A' ' 69' ' ' ILE . 25.0 mm -90.84 149.75 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -133.97 137.96 45.13 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.297 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' HB3' HD13 ' A' ' 12' ' ' LEU . 9.8 m-85 -124.83 142.58 51.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -145.18 166.9 24.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.697 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 t -145.58 120.15 9.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.8 t -94.43 53.99 1.76 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.168 0.508 . . . . 0.0 110.6 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.3 126.3 15.43 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -143.48 109.94 5.45 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.604 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.02 110.19 0.06 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.288 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.443 -1.198 . . . . 0.0 112.589 179.666 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 2' ' ' VAL . 22.6 m -99.4 100.34 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 111.671 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -81.67 126.09 31.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.418 HG21 ' HG ' ' A' ' 37' ' ' LEU . 13.9 m -118.85 141.99 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.267 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -96.65 102.93 14.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 90' ' ' ILE . 26.0 m -108.03 154.09 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.294 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -123.0 152.38 40.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.686 ' C ' HD22 ' A' ' 9' ' ' LEU . 83.6 m-85 -137.85 125.02 21.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.818 0.342 . . . . 0.0 111.184 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.686 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.8 mm? -130.26 172.26 12.0 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.493 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.03 -97.99 1.69 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.711 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.74 -29.57 2.84 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.107 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.746 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -56.88 -38.39 72.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.831 0.315 . . . . 0.0 111.288 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -60.87 -38.2 84.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.09 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.94 78.85 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.624 0.249 . . . . 0.0 111.358 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 33.1 mt -71.67 -34.21 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.41 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.47 -34.14 63.05 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.84 45.77 0.15 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.447 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.35 35.92 26.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.888 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.72 162.52 13.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.974 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.57 -49.89 2.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.983 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.547 HG11 ' HE2' ' A' ' 5' ' ' LYS . 19.0 t -118.99 134.75 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.307 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -123.46 149.7 44.78 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.962 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.47 119.43 29.12 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.911 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mm -126.07 148.29 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 23.7 pttt -130.07 113.55 14.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.412 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.66 132.12 38.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.794 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -115.49 91.56 3.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.722 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -156.09 -50.49 0.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.972 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' HG22 ' A' ' 32' ' ' VAL . 1.8 pt-20 -161.04 -174.67 4.49 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -59.08 0.36 Allowed Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.91 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.84 58.97 6.23 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.432 2.088 . . . . 0.0 112.631 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 29' ' ' GLU . 41.2 t -80.21 125.4 39.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.612 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.5 p -72.93 155.47 39.84 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.957 0.408 . . . . 0.0 110.984 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 79' ' ' GLU . 11.6 p -57.39 -33.32 43.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.53 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 38' ' ' ILE . . . -57.99 -28.45 60.92 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.769 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.41 -38.76 68.32 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.701 0.286 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.531 HD23 ' CD1' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -54.98 -48.27 73.48 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.128 179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 42' ' ' VAL . 5.6 mt -63.07 -42.84 98.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.285 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.142 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -60.46 -44.28 96.04 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.575 HG23 ' SD ' ' A' ' 45' ' ' MET . 20.2 mt -70.04 -31.33 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.805 HG13 HG21 ' A' ' 52' ' ' VAL . 36.5 t -90.66 -4.27 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 t -81.87 -78.79 0.19 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.45 -0.156 . . . . 0.0 111.059 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -99.88 -33.74 10.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.525 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.575 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -58.87 -44.29 91.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.136 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.701 HG21 HG23 ' A' ' 52' ' ' VAL . 23.3 mt -131.64 100.57 4.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.091 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.24 55.08 1.41 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.856 0.36 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 1.1 t-20 -144.74 122.17 6.44 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.344 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 26.6 Cg_exo -63.52 77.56 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.911 2.408 . . . . 0.0 112.027 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -162.26 -54.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.11 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.426 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -91.42 -38.32 12.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.696 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.805 HG21 HG13 ' A' ' 42' ' ' VAL . 2.1 t -86.96 -36.24 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.122 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.0 t -54.84 -36.23 64.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.626 0.251 . . . . 0.0 110.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 29.7 mt -82.5 -33.88 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.326 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.746 ' CE1' HD21 ' A' ' 12' ' ' LEU . 29.3 t80 -80.07 -63.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 42' ' ' VAL . 28.1 mm -91.89 137.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.616 0.246 . . . . 0.0 111.286 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.26 147.23 41.41 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.898 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 42.73 39.38 1.64 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.37 0.418 . . . . 0.0 111.58 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.04 43.02 18.18 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.336 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.57 165.2 35.06 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.419 HD13 ' HZ3' ' A' ' 74' ' ' TRP . 2.2 mp -70.25 154.2 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 61' ' ' ILE . 1.8 ttp85 -75.04 134.42 74.55 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.123 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.9 84.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.449 2.099 . . . . 0.0 111.459 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.53 -32.34 0.44 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.671 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 55' ' ' PHE . 32.1 mm -60.86 127.71 20.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.847 0.355 . . . . 0.0 110.869 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.8 mm -85.17 145.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.957 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' SER . 6.0 m -151.57 131.67 13.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.685 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -125.61 117.93 24.61 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.318 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.522 HG23 ' CD1' ' A' ' 74' ' ' TRP . 7.1 pt -90.96 106.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.17 50.21 6.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.05 32.25 20.95 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.56 175.86 9.21 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.586 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.71 158.96 26.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.865 0.364 . . . . 0.0 111.465 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.522 ' CD1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -85.14 -56.22 3.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.883 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -25.39 63.26 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.665 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 tt -53.36 -32.5 49.59 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.521 0.201 . . . . 0.0 111.358 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.73 -54.84 2.23 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.782 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 106.12 0.2 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.699 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' O ' HG11 ' A' ' 34' ' ' VAL . 5.8 mt-10 -50.27 -57.63 7.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.483 0.141 . . . . 0.0 110.99 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE2' ' HA3' ' A' ' 35' ' ' GLY . 43.4 tttm -110.83 -26.66 9.23 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.222 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.92 57.35 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -139.88 110.64 6.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.049 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mt -63.2 130.76 28.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.624 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.531 ' CD1' HD23 ' A' ' 37' ' ' LEU . 17.4 mt -64.78 175.05 1.59 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.848 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.42 102.08 0.72 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.274 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -48.67 114.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.826 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.4 26.07 5.54 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.43 164.05 12.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.706 0.288 . . . . 0.0 111.087 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.4 mm -104.39 133.53 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.256 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.664 ' HB ' HG12 ' A' ' 6' ' ' VAL . 35.6 mt -140.84 147.52 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.14 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 67' ' ' THR . 13.4 t -132.2 149.55 52.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.301 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -138.52 86.26 2.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.328 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -93.36 175.76 6.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.487 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -155.34 82.18 1.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.616 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.6 t -136.07 82.06 1.92 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.196 0.522 . . . . 0.0 110.653 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -29.9 71.06 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.857 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.95 170.48 13.0 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.591 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.87 -176.86 42.65 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.944 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.436 -1.202 . . . . 0.0 112.562 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.2 122.42 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -96.94 101.62 13.24 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.6 127.38 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.26 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -96.79 108.46 21.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.075 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.856 HG12 ' HB ' ' A' ' 90' ' ' ILE . 27.3 m -114.62 146.35 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -122.52 129.75 52.31 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 92' ' ' PHE . 97.3 m-85 -109.94 130.12 55.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.61 165.82 26.44 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.74 -21.2 40.37 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.649 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.01 -26.21 1.6 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.95 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 65' ' ' ILE . 9.4 mt -54.48 -37.75 65.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.75 0.275 . . . . 0.0 111.667 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -56.78 -31.34 64.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.226 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 -34.67 78.83 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 23.2 mt -80.37 -35.21 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.283 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -67.38 -75.19 0.1 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.28 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -171.1 37.84 0.17 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.704 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt 52.01 34.29 13.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.447 0.299 . . . . 0.0 111.508 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -125.29 122.52 37.11 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.732 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -50.36 72.62 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.727 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.67 138.22 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.124 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -134.61 156.09 49.32 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.63 146.74 47.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.486 HD13 HD11 ' A' ' 37' ' ' LEU . 3.8 mp -134.39 146.9 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -134.1 119.77 19.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.148 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.11 131.96 54.59 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.091 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.34 98.49 5.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.49 -49.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.055 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -161.31 -176.55 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.11 -58.56 0.41 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.68 56.5 4.08 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.547 2.164 . . . . 0.0 112.749 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.84 126.33 30.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 p -78.67 151.17 32.37 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.24 -32.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.672 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -27.13 57.33 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.724 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -41.57 68.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.734 0.302 . . . . 0.0 110.385 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.566 ' CD1' HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -53.6 -52.22 60.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.189 179.02 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.478 ' HA ' HD12 ' A' ' 41' ' ' ILE . 34.1 mm -62.37 -38.82 82.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.615 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -62.39 -46.0 90.59 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.039 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -57.85 -42.22 84.03 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.045 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.566 HD11 ' CD1' ' A' ' 37' ' ' LEU . 14.7 mt -65.64 -31.76 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.792 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.861 HG13 HG11 ' A' ' 52' ' ' VAL . 43.8 t -92.45 -2.9 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.901 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -74.83 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.529 0.204 . . . . 0.0 111.462 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -95.7 -42.73 8.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.294 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.91 -42.77 76.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.631 ' CG2' HG22 ' A' ' 52' ' ' VAL . 35.0 mt -131.73 131.56 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -162.24 74.96 0.44 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.018 0.437 . . . . 0.0 110.87 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.03 121.03 1.42 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.611 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.67 79.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.44 2.093 . . . . 0.0 112.046 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -172.88 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.871 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.529 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.7 p30 -87.4 -41.79 13.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.602 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.861 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -77.63 -35.52 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 t -53.83 -31.56 49.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.333 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.4 mt -90.6 -44.53 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.501 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.654 ' CD1' HD21 ' A' ' 12' ' ' LEU . 35.2 t80 -72.86 -53.75 10.6 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 111.477 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.656 ' HB ' HG12 ' A' ' 52' ' ' VAL . 37.8 mm -99.87 114.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.305 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -71.85 -162.97 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.542 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -64.43 86.93 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.899 0.381 . . . . 0.0 111.046 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 60.38 43.55 13.29 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.93 176.5 3.55 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.07 149.82 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.713 0.292 . . . . 0.0 110.799 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HG2' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -96.11 148.89 35.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.79 159.06 47.42 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.633 2.222 . . . . 0.0 112.275 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.489 ' HA3' HD13 ' A' ' 96' ' ' LEU . . . 98.26 -23.66 35.19 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.798 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.691 HD12 HD11 ' A' ' 12' ' ' LEU . 33.8 mm -83.25 102.62 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.0 124.19 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.198 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 91' ' ' SER . 8.6 m -120.18 141.25 50.07 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.4 mt -135.95 115.06 12.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 111.289 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 27.2 mt -97.71 105.2 16.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.638 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 57.63 52.5 8.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 59.61 32.79 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.216 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.32 169.31 18.15 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.417 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.92 171.52 15.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.847 0.356 . . . . 0.0 111.093 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -100.98 -48.19 4.52 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.993 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -27.04 58.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.144 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.99 -27.63 53.67 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.269 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -120.96 -50.9 2.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.406 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.11 93.22 0.1 Allowed Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.726 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -43.5 73.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -124.58 -40.21 2.24 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.954 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.81 56.52 1.54 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.944 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -128.19 108.25 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.807 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mt -59.86 128.17 20.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.834 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.46 175.07 1.46 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.88 100.96 0.66 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.481 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -48.02 115.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.858 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.17 6.58 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.691 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.49 169.16 9.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.744 0.307 . . . . 0.0 111.064 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.5 mm -115.43 128.07 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.856 ' HB ' HG12 ' A' ' 6' ' ' VAL . 32.7 mt -136.24 145.66 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.842 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 67' ' ' THR . 0.7 OUTLIER -128.65 155.55 44.83 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.748 0.309 . . . . 0.0 111.348 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 41.8 m-85 -143.6 82.2 1.72 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 m -86.75 140.82 29.37 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.126 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.3 t -102.61 103.24 13.52 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.71 88.4 1.69 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.355 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.489 HD13 ' HA3' ' A' ' 64' ' ' GLY . 4.5 mm? -62.99 133.0 53.91 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.225 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -134.42 131.17 37.85 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.011 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.64 -95.65 0.54 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.377 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.828 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.585 0.231 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.7 136.06 62.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.28 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -97.94 140.49 32.21 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.432 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.934 HG21 HD21 ' A' ' 37' ' ' LEU . 35.7 m -136.01 146.11 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.63 113.33 17.24 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.744 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.886 HG12 ' HB ' ' A' ' 90' ' ' ILE . 31.2 m -115.78 151.49 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.479 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.7 tt0 -122.11 110.12 15.37 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.441 ' HD1' HD22 ' A' ' 12' ' ' LEU . 79.3 m-85 -91.21 138.28 31.71 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.09 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.725 ' HB2' HG23 ' A' ' 93' ' ' THR . 3.9 mp -141.84 163.37 33.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.8 -107.87 3.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.402 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.08 26.73 5.25 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.047 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 65' ' ' ILE . 1.9 mp -96.38 -41.79 8.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.89 0.345 . . . . 0.0 110.983 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.29 -28.95 65.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.357 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.28 -35.05 78.7 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.727 0.299 . . . . 0.0 111.047 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 24.7 mt -79.78 -43.75 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.509 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.6 m-85 -58.61 -70.4 0.15 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.735 0.302 . . . . 0.0 111.455 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.7 44.08 0.07 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.395 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 54.59 32.96 18.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.505 0.322 . . . . 0.0 111.402 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -119.38 113.76 21.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.389 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -58.8 -62.56 1.78 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 14.9 p -94.87 143.34 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.153 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -129.06 161.29 30.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -145.31 133.41 21.49 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 4' ' ' VAL . 2.1 pt -147.2 178.76 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.326 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 132.09 15.1 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.38 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.25 108.07 19.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.475 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -91.93 48.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.04 -45.06 6.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.985 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG3' HG22 ' A' ' 32' ' ' VAL . 10.1 pt-20 -166.7 -178.24 4.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.32 -59.13 0.3 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.773 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.8 58.93 6.66 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.363 2.042 . . . . 0.0 112.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.492 ' HB ' HD12 ' A' ' 84' ' ' LEU . 17.9 t -77.01 149.37 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.1 p -98.86 161.6 13.55 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' HD21 ' A' ' 84' ' ' LEU . 10.5 p -60.74 -39.85 83.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.711 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.8 -30.51 69.54 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.945 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -40.44 86.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.769 0.319 . . . . 0.0 110.314 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.934 HD21 HG21 ' A' ' 4' ' ' VAL . 2.6 tm? -56.64 -44.9 81.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.128 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.465 ' HA ' HD12 ' A' ' 41' ' ' ILE . 35.8 mm -59.89 -45.26 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.38 -37.97 82.45 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -60.07 -43.71 95.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.488 HG23 ' SD ' ' A' ' 45' ' ' MET . 14.6 mt -64.63 -30.21 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.153 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.739 HG21 HG13 ' A' ' 56' ' ' ILE . 28.8 t -95.99 -2.46 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -95.33 -64.59 1.05 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.3 p -98.03 -46.98 5.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.722 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.488 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -57.58 -56.8 17.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.24 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 52' ' ' VAL . 19.4 mt -115.61 149.08 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.862 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -173.87 72.51 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -163.76 133.46 3.11 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.148 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.98 65.52 3.32 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.441 2.094 . . . . 0.0 111.823 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -158.85 -49.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.028 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -89.52 -42.51 11.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.456 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.692 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -72.9 -36.28 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.223 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.7 -28.69 15.67 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.42 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -89.28 -34.41 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.722 ' HE1' HG21 ' A' ' 65' ' ' ILE . 51.2 t80 -86.95 -57.63 2.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.515 0.198 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.739 HG13 HG21 ' A' ' 42' ' ' VAL . 35.8 mm -98.53 139.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -148.86 129.6 14.16 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 59.96 42.98 15.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 t0 59.2 38.99 23.34 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.51 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.9 t -166.91 162.31 15.7 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.908 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mt -66.0 148.88 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -78.48 147.7 72.3 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.057 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -73.22 75.69 2.8 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.616 2.211 . . . . 0.0 111.842 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.03 -45.13 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.541 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.722 HG21 ' HE1' ' A' ' 55' ' ' PHE . 28.5 mm -67.17 137.21 25.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.857 0.36 . . . . 0.0 110.829 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.4 mt -110.73 132.41 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -126.32 138.64 53.61 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.5 mt -125.48 109.87 13.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 74' ' ' TRP . 7.2 mt -86.73 105.74 15.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.8 t30 56.92 45.9 20.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.693 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 61.68 41.87 11.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.177 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.76 156.82 43.85 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.578 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -79.98 129.63 34.64 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.949 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.482 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.5 p-90 -57.65 -35.32 70.38 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.645 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.13 -1.94 58.26 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.636 HD12 ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -76.88 -16.08 59.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -137.31 -58.53 0.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.507 0.194 . . . . 0.0 111.26 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.92 112.57 0.53 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.673 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -49.61 -71.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.537 0.208 . . . . 0.0 111.248 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -107.65 -28.23 9.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.931 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.71 -31.37 37.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.226 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.435 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 38.2 t80 -48.26 118.95 2.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 110.838 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.5 mt -80.17 141.25 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD12 ' HB ' ' A' ' 32' ' ' VAL . 19.2 mt -62.74 178.23 0.47 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.955 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -162.74 99.71 1.0 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.824 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -43.5 105.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.828 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.13 5.4 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.035 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.83 170.19 8.31 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.714 0.292 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.3 123.27 68.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.402 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.886 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.8 mp -126.24 107.39 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.774 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -81.72 157.99 24.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 111.597 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -146.82 82.41 1.57 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -91.45 164.13 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.11 132.94 50.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.277 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.19 -63.98 1.22 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.638 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 97' ' ' HIS . 4.4 pp -131.01 165.56 22.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.319 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.623 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.9 OUTLIER 73.08 114.27 0.06 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.082 179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.53 93.02 1.75 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.27 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.553 -1.137 . . . . 0.0 112.863 -179.873 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 86' ' ' ASP . 10.6 p -118.62 111.24 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 111.258 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -105.53 125.1 50.6 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 90' ' ' ILE . 38.9 t -125.09 110.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.271 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 112.98 20.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.526 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.76 HG12 ' HB ' ' A' ' 90' ' ' ILE . 7.2 m -113.35 139.79 36.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.336 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.7 115.46 29.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.54 ' C ' HD12 ' A' ' 9' ' ' LEU . 82.2 m-85 -96.46 124.03 40.31 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.405 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.54 HD12 ' C ' ' A' ' 8' ' ' PHE . 11.0 mp -125.47 159.69 31.33 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.299 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.37 -109.26 3.57 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.414 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.08 35.49 2.84 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.589 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 mt -104.15 -43.13 5.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.637 0.218 . . . . 0.0 111.178 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -59.38 -28.47 66.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.33 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.23 78.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.77 0.319 . . . . 0.0 111.032 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 41.9 mt -73.96 -37.99 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.219 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -69.65 -70.44 0.28 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.74 44.72 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 56.1 33.54 22.14 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.621 0.248 . . . . 0.0 111.401 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -122.57 129.1 51.55 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.603 0.24 . . . . 0.0 110.959 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -83.44 -64.13 1.22 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.5 t -79.65 105.87 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.404 ' CE1' ' HB3' ' A' ' 19' ' ' GLN . 1.0 OUTLIER -111.2 173.7 6.22 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.19 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.61 136.26 47.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.309 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 37' ' ' LEU . 17.6 mm -117.87 152.11 19.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.446 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -150.0 99.52 2.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.127 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -73.52 -53.77 9.79 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.049 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.59 76.13 0.32 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -136.67 -67.57 0.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.335 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -140.97 -175.73 4.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.72 -59.59 0.43 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.086 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.37 60.37 6.39 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.469 2.112 . . . . 0.0 112.598 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.661 ' CG1' HD12 ' A' ' 84' ' ' LEU . 26.7 t -77.8 142.27 14.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 155.24 18.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -57.74 -35.88 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.803 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.63 -27.74 66.71 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.978 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.25 -39.13 65.69 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.15 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.551 ' HB2' HD11 ' A' ' 84' ' ' LEU . 1.3 tm? -54.97 -51.43 66.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.382 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.7 -43.15 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -56.18 -43.66 78.64 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.432 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 55.4 t60 -59.63 -46.52 88.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.31 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.9 mt -59.48 -31.59 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.891 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.706 HG13 ' CG2' ' A' ' 52' ' ' VAL . 36.7 t -97.4 -4.13 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -92.7 -68.81 0.78 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.28 -41.48 7.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.614 0.245 . . . . 0.0 111.351 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -39.78 69.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.286 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.826 HG21 HG23 ' A' ' 52' ' ' VAL . 44.1 mt -131.65 129.79 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.664 0.269 . . . . 0.0 111.047 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -143.91 51.41 1.32 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -142.92 121.52 7.37 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.32 74.41 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.99 2.46 . . . . 0.0 112.238 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.63 -58.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.364 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.8 p30 -79.9 -36.49 36.38 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.706 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.826 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -88.77 -35.33 7.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.945 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -54.23 -36.24 63.31 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.121 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.2 -37.93 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.219 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -67.11 -39.93 86.77 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.006 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.31 116.22 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -115.01 130.89 57.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.64 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 58.81 43.78 17.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.966 0.413 . . . . 0.0 110.464 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 56.39 33.31 22.18 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.489 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.61 149.66 26.87 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.911 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.62 151.58 10.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.061 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.8 ttt180 -93.1 130.25 36.67 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.999 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 50.9 Cg_exo -54.42 118.66 5.3 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.79 2.327 . . . . 0.0 112.325 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.94 -37.88 0.93 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.555 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 mt -74.11 127.89 36.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.69 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.8 mm -103.04 127.54 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.059 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -121.92 134.8 54.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.235 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.685 HD13 ' O ' ' A' ' 72' ' ' THR . 2.4 mm? -110.58 98.54 7.71 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.681 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.665 HD11 ' CD1' ' A' ' 74' ' ' TRP . 24.1 mt -81.13 102.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 57.63 48.4 14.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.628 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 62.13 32.26 17.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.289 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.685 ' O ' HD13 ' A' ' 68' ' ' LEU . 1.3 m -128.58 162.97 26.04 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.49 134.64 36.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.665 ' CD1' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -57.48 -53.37 58.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.888 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -66.44 -36.54 83.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.306 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 76' ' ' LEU . 5.1 tt -56.4 -52.48 64.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.597 0.237 . . . . 0.0 110.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.56 -35.73 81.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.983 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 34.08 0.8 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.185 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.76 -78.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.628 0.371 . . . . 0.0 111.432 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -109.2 16.73 22.25 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 47.52 1.25 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.993 0.425 . . . . 0.0 110.786 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 69' ' ' ILE . 24.1 t80 -144.23 138.23 27.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 83' ' ' ILE . 4.3 mp -92.91 129.96 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.995 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.661 HD12 ' CG1' ' A' ' 32' ' ' VAL . 18.7 mt -59.75 173.78 0.54 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.0 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.65 100.5 1.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.029 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.634 ' HA ' HG23 ' A' ' 2' ' ' VAL . 12.7 p-10 -43.07 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.53 26.96 5.43 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.482 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.584 ' OD1' HG13 ' A' ' 4' ' ' VAL . 3.3 p30 -95.4 174.76 6.86 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.64 0.257 . . . . 0.0 111.086 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.2 mm -119.46 130.43 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.481 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.76 ' HB ' HG12 ' A' ' 6' ' ' VAL . 43.3 mt -133.39 153.17 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.385 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -127.55 156.45 42.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.05 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -143.88 105.76 4.34 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.229 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -109.6 142.19 41.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.032 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.3 t -116.63 97.56 6.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.567 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 68.0 p -73.65 -66.9 0.64 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.986 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.49 102.19 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.9 m80 65.36 17.17 10.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.275 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.89 69.71 1.18 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.385 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.385 -1.231 . . . . 0.0 112.643 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 m -108.63 129.62 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -111.02 139.68 46.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.051 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.572 HG21 ' HG ' ' A' ' 37' ' ' LEU . 9.7 m -140.88 136.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.541 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.25 115.54 27.59 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.362 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.663 HG12 ' HB ' ' A' ' 90' ' ' ILE . 2.9 m -113.27 143.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.461 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.35 154.95 20.54 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.527 ' HD1' HD13 ' A' ' 12' ' ' LEU . 52.9 m-85 -142.82 111.75 6.46 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.4 mm? -123.32 145.41 48.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.012 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.25 -111.16 3.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.524 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.87 28.43 6.41 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.929 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.683 HD21 ' CZ ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -100.17 -48.75 4.51 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.81 0.305 . . . . 0.0 110.767 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.74 -27.0 68.6 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.621 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.78 -34.19 76.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.647 0.261 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 51' ' ' ASP . 19.4 mt -74.91 -37.4 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.227 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.63 -61.33 1.83 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.33 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.62 46.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.503 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp 57.35 33.87 23.91 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -112.24 103.93 12.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.713 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.3 mtt-85 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.604 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 p -97.85 130.32 46.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.88 0.371 . . . . 0.0 111.003 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -128.61 164.67 22.37 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.259 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -128.68 133.48 48.22 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.305 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HB ' HD11 ' A' ' 37' ' ' LEU . 22.6 mm -117.19 145.96 22.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.23 89.72 3.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.1 148.56 51.63 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.175 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -123.59 101.76 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.386 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -166.29 -53.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -174.07 -166.59 0.3 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.78 -59.53 0.33 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.06 59.26 5.83 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.486 2.124 . . . . 0.0 112.548 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.66 131.24 34.23 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -66.69 146.38 54.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.755 0.312 . . . . 0.0 110.766 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.492 HG21 ' HE1' ' A' ' 74' ' ' TRP . 13.9 p -54.62 -33.37 27.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.473 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.57 59.17 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.043 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -39.88 61.64 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 110.3 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 ' HG ' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -55.85 -56.57 19.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.304 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 41' ' ' ILE . 12.9 pt -59.12 -35.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.623 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -63.27 -43.86 96.75 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.662 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -58.07 -39.55 78.8 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 38' ' ' ILE . 16.5 mt -68.6 -30.23 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.038 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.698 HG13 HG21 ' A' ' 52' ' ' VAL . 29.8 t -97.01 -6.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.1 t -100.72 -64.33 1.05 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 m -87.77 -51.27 5.95 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.38 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -51.9 67.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.148 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.869 HG21 HG23 ' A' ' 52' ' ' VAL . 26.1 mt -116.2 143.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-O 120.759 0.314 . . . . 0.0 111.191 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -162.56 41.22 0.12 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.587 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 50' ' ' ASN . 5.4 t30 -134.03 118.54 14.2 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.708 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.37 75.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.908 2.405 . . . . 0.0 112.711 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' ASN . 9.5 m-20 -165.72 -61.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.354 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB2' HG22 ' A' ' 15' ' ' ILE . 29.8 p-10 -79.84 -33.25 40.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.33 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.869 HG23 HG21 ' A' ' 46' ' ' ILE . 1.4 t -93.83 -41.15 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.636 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -35.49 68.49 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.197 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.6 mt -89.0 -33.97 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.33 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 12' ' ' LEU . 19.3 t80 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.495 0.188 . . . . 0.0 111.004 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 42' ' ' VAL . 17.4 mt -131.84 141.8 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 111.446 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.18 -170.27 3.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.534 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -63.16 93.04 0.06 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.956 0.407 . . . . 0.0 110.419 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 56.09 43.65 26.6 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.486 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.88 128.63 1.69 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.184 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.432 ' HA ' HG23 ' A' ' 56' ' ' ILE . 2.1 mp -71.97 153.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.293 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' N ' HG22 ' A' ' 61' ' ' ILE . 8.6 mtp-105 -88.48 139.48 29.92 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.016 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.21 125.1 17.95 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.811 2.341 . . . . 0.0 112.389 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.15 -46.97 1.02 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.866 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.43 112.92 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.45 146.77 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.561 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' SER . 2.0 m -141.52 138.19 32.57 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.633 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -145.87 128.05 15.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.058 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.642 HD11 ' HD1' ' A' ' 74' ' ' TRP . 21.6 mt -90.33 90.27 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.434 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.01 65.88 1.34 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.955 0.407 . . . . 0.0 111.253 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.2 24.29 14.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.595 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 m -130.17 164.6 24.12 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.317 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -79.71 165.87 22.39 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.898 0.38 . . . . 0.0 111.474 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.642 ' HD1' HD11 ' A' ' 69' ' ' ILE . 4.6 t90 -94.22 -41.14 9.63 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.796 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.24 -27.48 35.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.618 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER -54.69 -27.45 40.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG3' ' CD1' ' A' ' 82' ' ' TYR . 1.4 pt-20 -128.41 27.33 5.59 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.68 102.75 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.743 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -54.14 -34.36 60.16 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -122.18 -40.51 2.49 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.448 0.166 . . . . 0.0 110.626 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -55.16 -29.19 57.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.369 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 77' ' ' GLU . 72.3 t80 -55.13 118.91 4.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.22 139.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.565 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.5 ' CD1' HD23 ' A' ' 37' ' ' LEU . 22.9 mt -64.07 175.25 1.28 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.778 0.323 . . . . 0.0 110.942 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -167.11 100.84 0.53 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.595 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -44.35 114.31 0.66 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.99 18.98 6.58 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.866 -0.606 . . . . 0.0 113.017 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.17 177.54 4.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.746 0.273 . . . . 0.0 110.961 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 90' ' ' ILE . 27.4 mt -128.12 150.32 33.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.962 0.41 . . . . 0.0 111.71 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.663 ' HB ' HG12 ' A' ' 6' ' ' VAL . 5.3 mp -142.55 100.26 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.11 142.99 34.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.695 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -136.23 82.9 1.97 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 9' ' ' LEU . 4.2 m -94.02 150.05 20.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.675 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.594 ' OG ' HD12 ' A' ' 12' ' ' LEU . 20.4 m -133.98 99.31 4.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.59 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.3 p -78.14 -51.23 10.56 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 94' ' ' SER . 1.8 mp 65.43 -68.22 0.12 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.4 0.438 . . . . 0.0 111.656 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -77.1 119.99 21.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.751 0.31 . . . . 0.0 110.847 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -120.4 128.02 7.3 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.343 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.454 -179.787 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m -145.9 172.78 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.604 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -141.95 114.28 8.27 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 37' ' ' LEU . 15.0 m -117.75 132.76 66.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.113 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -106.41 105.26 15.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.725 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.708 HG12 ' HB ' ' A' ' 90' ' ' ILE . 15.3 m -105.53 144.37 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.371 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -107.32 135.56 48.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.542 ' C ' HD22 ' A' ' 9' ' ' LEU . 60.7 m-85 -119.01 115.42 24.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.746 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.542 HD22 ' C ' ' A' ' 8' ' ' PHE . 4.5 mm? -122.5 132.53 54.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.088 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 -109.27 1.82 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.386 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.03 -23.84 5.97 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.242 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.717 HD21 ' CD1' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -55.46 -48.24 74.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.994 0.397 . . . . 0.0 111.468 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -57.9 -36.01 71.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.129 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 12' ' ' LEU . 7.5 mt -75.19 -39.22 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.363 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.5 m-85 -67.38 -75.09 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.321 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.21 41.71 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.602 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.35 34.4 20.61 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.705 0.288 . . . . 0.0 111.159 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -110.16 117.5 33.87 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.721 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -28.98 69.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.67 142.28 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -122.73 170.35 10.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.244 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -135.24 121.71 20.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 24' ' ' ILE . 4.2 mp -116.1 143.93 24.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.065 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.96 91.79 2.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.442 ' HE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.3 156.73 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.052 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -143.92 113.91 7.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.034 0.445 . . . . 0.0 111.586 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.68 -48.28 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.94 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -156.13 -177.7 6.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.26 -59.83 0.37 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.984 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.09 58.28 6.51 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.534 2.156 . . . . 0.0 112.409 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -75.14 121.06 25.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.657 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.6 p -68.75 153.47 43.73 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.876 0.369 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.554 HG11 ' HE1' ' A' ' 74' ' ' TRP . 9.1 p -57.68 -31.95 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.579 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.08 -28.04 57.99 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.693 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.33 -38.07 71.7 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.776 0.322 . . . . 0.0 110.324 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -56.28 -47.1 79.29 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.054 178.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.691 HD11 ' CH2' ' A' ' 74' ' ' TRP . 49.7 mt -61.39 -41.88 91.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.449 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.17 -39.68 87.3 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.442 ' HB2' ' HE2' ' A' ' 26' ' ' MET . 47.5 t60 -63.12 -46.1 88.9 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.163 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 45' ' ' MET . 57.2 mt -61.24 -31.41 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.825 HG13 HG11 ' A' ' 52' ' ' VAL . 42.1 t -97.57 -3.36 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.4 t -93.43 -74.87 0.51 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.388 -0.195 . . . . 0.0 111.494 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 t -96.58 -39.99 9.25 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.556 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.8 tpt -57.1 -38.56 73.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.024 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.717 HG22 HG22 ' A' ' 52' ' ' VAL . 15.0 mt -137.62 136.16 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.693 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -159.81 71.72 0.49 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.813 0.34 . . . . 0.0 111.365 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.5 t30 -162.88 134.64 3.9 Favored Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.38 64.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.21 1.94 . . . . 0.0 111.702 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.73 -45.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -91.24 -41.92 10.7 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.641 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.825 HG11 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -72.01 -34.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.29 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.29 -30.67 12.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.5 -65.07 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.466 0.174 . . . . 0.0 111.371 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.717 ' CD1' HD21 ' A' ' 12' ' ' LEU . 41.0 t80 -64.05 -36.53 84.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.324 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.604 ' HB ' HG12 ' A' ' 52' ' ' VAL . 29.6 mm -125.37 93.84 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.89 119.22 38.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.57 64.65 1.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.069 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p30 43.23 33.81 0.62 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.247 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 t -157.36 149.07 22.2 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.661 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.519 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.2 mp -65.07 152.91 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.891 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.687 ' HD3' HD22 ' A' ' 96' ' ' LEU . 3.2 ttt85 -79.73 115.68 55.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.631 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.76 101.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.649 2.233 . . . . 0.0 111.959 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.05 -30.64 0.6 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.584 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.622 HD13 ' CD1' ' A' ' 55' ' ' PHE . 49.1 mt -64.22 136.42 26.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.819 0.343 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.3 mt -103.82 144.79 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.413 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 91' ' ' SER . 25.1 m -143.63 140.93 30.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.7 mt -141.04 121.13 13.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.264 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.726 HD11 ' CD1' ' A' ' 74' ' ' TRP . 35.2 mt -93.7 102.76 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.53 55.42 3.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t0 57.01 31.89 20.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.206 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 m -136.25 166.6 23.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -79.77 149.23 31.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 111.467 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.726 ' CD1' HD11 ' A' ' 69' ' ' ILE . 1.6 t90 -69.05 -54.1 16.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -75.73 -7.77 55.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.042 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 ' HB2' ' A' ' 73' ' ' ASP . 0.6 OUTLIER -56.65 -31.45 64.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.597 0.237 . . . . 0.0 111.366 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.26 -52.06 1.52 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.96 109.15 0.35 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.926 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.46 -48.9 77.96 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.53 0.205 . . . . 0.0 110.847 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -121.19 -42.82 2.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.865 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.76 -24.54 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.948 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -52.84 119.79 5.02 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.883 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 mp -75.56 132.59 32.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.17 174.99 1.78 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.726 0.298 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -169.6 101.85 0.33 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.421 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -44.05 115.43 0.82 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 119.17 3.95 12.7 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.984 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.94 164.25 23.66 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.082 0.441 . . . . 0.0 111.155 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mm -123.05 93.22 2.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.708 ' HB ' HG12 ' A' ' 6' ' ' VAL . 41.6 mt -91.83 152.1 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 67' ' ' THR . 0.9 OUTLIER -128.12 146.62 50.65 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.228 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -138.32 94.75 2.9 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.54 132.91 45.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.04 96.56 5.39 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.223 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.29 -28.14 66.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.129 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.687 HD22 ' HD3' ' A' ' 62' ' ' ARG . 1.6 mp -60.85 117.25 5.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.765 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -109.1 138.86 44.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.291 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.61 81.32 0.52 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.423 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.605 -179.87 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.62 0.248 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m -144.25 127.41 11.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.176 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -104.41 131.88 51.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 37' ' ' LEU . 19.9 m -133.26 147.48 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 21' ' ' VAL . 3.2 tttp -103.66 100.64 10.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.727 HG12 ' HB ' ' A' ' 90' ' ' ILE . 7.5 m -106.01 151.88 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.543 ' OE1' HD11 ' A' ' 9' ' ' LEU . 7.7 pt-20 -125.2 159.09 32.4 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.182 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' C ' HD12 ' A' ' 9' ' ' LEU . 99.5 m-85 -130.17 143.13 50.61 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.395 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.621 ' HB2' HG22 ' A' ' 93' ' ' THR . 4.2 mp -140.65 171.02 14.69 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.503 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.67 -111.42 3.28 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.353 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.84 27.44 5.42 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.829 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.49 HD11 HG23 ' A' ' 65' ' ' ILE . 15.4 mt -90.36 -51.52 5.38 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.763 0.281 . . . . 0.0 110.863 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.0 -27.06 61.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.519 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.28 80.56 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.729 0.3 . . . . 0.0 111.18 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.609 HD13 HD11 ' A' ' 54' ' ' ILE . 40.8 mt -78.62 -43.21 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.82 -69.2 0.24 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.367 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.01 42.33 0.04 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.778 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.64 57.5 6.33 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 111.406 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -143.81 119.42 10.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 14.0 mtm-85 -72.52 -72.02 0.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.955 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.407 HG11 ' HE3' ' A' ' 5' ' ' LYS . 21.8 t -78.59 138.76 19.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 111.362 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -145.55 143.81 30.15 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -108.57 125.42 51.81 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mm -113.59 145.61 19.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.56 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.61 95.56 4.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.234 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.445 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -62.78 -64.51 0.9 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.636 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 58.66 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.851 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.6 -45.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.089 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -150.6 -179.85 7.58 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.825 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.89 -58.67 0.41 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.756 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.0 57.76 6.25 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.481 2.121 . . . . 0.0 112.602 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.5 116.21 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.495 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.492 HG22 HD13 ' A' ' 83' ' ' ILE . 70.8 p -75.01 156.13 36.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.888 0.375 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.65 -31.88 40.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.396 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.86 -25.59 59.37 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.932 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB3' ' HG3' ' A' ' 26' ' ' MET . 1.0 OUTLIER -75.36 -39.49 59.2 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.773 0.321 . . . . 0.0 110.282 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -54.82 -55.41 30.55 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.417 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.809 ' HA ' HD12 ' A' ' 41' ' ' ILE . 11.9 pt -61.07 -36.0 69.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.625 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -39.47 94.27 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.764 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.445 ' CD2' ' HA ' ' A' ' 26' ' ' MET . 18.4 t-80 -61.22 -40.09 92.7 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 38' ' ' ILE . 5.0 mt -67.86 -30.88 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.551 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.68 HG21 HG13 ' A' ' 56' ' ' ILE . 47.7 t -92.6 -4.99 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.811 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.3 p -100.21 -60.83 1.45 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 m -100.22 -50.99 3.78 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.81 -42.39 65.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.273 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.674 ' CG2' HG23 ' A' ' 52' ' ' VAL . 7.9 mt -130.87 129.63 63.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.88 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 64.87 1.15 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.786 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.24 131.14 6.86 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.93 74.41 2.35 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.617 2.211 . . . . 0.0 112.196 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -168.17 -47.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.53 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.85 -38.96 10.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.852 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.674 HG23 ' CG2' ' A' ' 46' ' ' ILE . 1.9 t -82.97 -37.44 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.409 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -53.24 -42.62 66.6 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.663 0.268 . . . . 0.0 111.098 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.609 HD11 HD13 ' A' ' 15' ' ' ILE . 1.2 pt -80.01 -34.15 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.583 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.03 -48.59 62.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.674 0.273 . . . . 0.0 110.649 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.68 HG13 HG21 ' A' ' 42' ' ' VAL . 28.2 mm -124.56 124.02 67.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 -163.24 0.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.481 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.97 84.94 0.08 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.9 40.29 12.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.57 126.32 1.07 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.654 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -65.57 153.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.2 143.26 52.18 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.142 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.94 125.61 11.71 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.523 2.149 . . . . 0.0 112.084 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.54 -35.16 2.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.597 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 12' ' ' LEU . 9.2 mt -73.29 114.51 12.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.706 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 17.1 mt -96.31 149.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.057 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.514 HG22 ' CE3' ' A' ' 74' ' ' TRP . 9.3 t -143.73 128.26 18.04 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.861 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.8 mt -108.53 126.98 53.53 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 pt -106.31 109.2 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.099 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.32 44.74 21.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.2 41.62 16.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.0 167.67 21.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.489 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 125.32 29.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.514 ' CE3' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -59.16 -26.83 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.732 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -97.66 -1.34 43.86 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -61.73 -32.37 72.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.482 0.182 . . . . 0.0 111.423 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 -68.63 0.66 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -145.22 110.15 0.54 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.033 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -72.68 0.05 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.115 0.166 . . . . 0.0 111.287 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.05 -31.03 16.44 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.555 0.217 . . . . 0.0 110.749 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.43 -28.18 28.58 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.487 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -57.39 113.67 1.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 110.551 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 33' ' ' THR . 31.7 mm -77.62 141.53 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.57 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.462 ' CD1' HD23 ' A' ' 37' ' ' LEU . 31.8 mt -62.93 173.65 1.3 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.969 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.59 101.32 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.641 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -43.65 110.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.764 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.39 26.84 4.98 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.874 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.26 168.74 9.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -117.32 129.57 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.612 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.727 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.8 mp -135.51 101.84 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -80.61 152.0 28.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -134.23 93.15 3.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 9' ' ' LEU . 14.4 p -95.97 162.31 13.62 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.3 t -151.72 102.01 2.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.3 p -123.16 -45.6 2.11 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.415 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 tt 64.04 74.32 0.41 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.868 0.366 . . . . 0.0 111.449 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -164.11 40.47 0.09 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -120.69 -70.58 0.3 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.686 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.519 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 86' ' ' ASP . 18.7 m -97.59 164.5 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.698 0.285 . . . . 0.0 111.516 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -132.08 110.43 10.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 24' ' ' ILE . 13.1 m -117.44 135.0 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.304 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -104.55 99.18 8.86 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.612 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.622 HG12 ' HB ' ' A' ' 90' ' ' ILE . 26.2 m -93.31 144.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.236 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -116.61 103.06 10.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.995 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 9' ' ' LEU . 66.1 m-85 -88.74 119.54 29.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.762 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 8' ' ' PHE . 11.2 mp -126.0 161.88 26.54 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.224 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.6 -104.65 2.94 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.338 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.8 -12.82 8.3 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.228 -0.51 . . . . 0.0 113.397 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD21 ' CE2' ' A' ' 55' ' ' PHE . 0.6 OUTLIER -62.83 -44.13 96.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.246 0.523 . . . . 0.0 111.294 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.89 -32.88 71.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.085 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.9 69.45 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.534 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 30.1 mt -74.43 -47.41 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.732 0.301 . . . . 0.0 111.412 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -60.42 -61.15 2.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.357 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.63 0.02 OUTLIER Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.588 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp 59.09 65.01 1.27 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 111.97 8.57 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -34.05 77.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.002 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.8 122.99 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.49 174.73 5.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.066 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -137.94 129.14 27.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.067 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 4' ' ' VAL . 3.6 mp -122.42 140.3 46.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.78 86.41 2.31 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 128.84 37.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.842 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -112.01 82.53 1.64 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.595 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.3 -66.33 0.7 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -148.28 -173.33 4.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -87.71 -54.42 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.975 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.2 Cg_exo -78.47 53.96 4.8 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.872 2.381 . . . . 0.0 112.621 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 36' ' ' ASP . 17.6 t -80.08 129.78 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.709 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -81.99 156.6 24.6 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 110.743 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.653 ' O ' HD12 ' A' ' 38' ' ' ILE . 9.1 p -53.69 -37.7 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.748 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.02 59.19 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.413 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HB2' HG12 ' A' ' 32' ' ' VAL . 64.9 m-20 -69.91 -41.02 75.24 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.709 0.29 . . . . 0.0 110.385 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 HD13 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -54.81 -54.34 43.5 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.204 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.754 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.6 mp -61.89 -35.27 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.455 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -46.0 90.93 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.173 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -59.36 -40.62 87.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.649 0.262 . . . . 0.0 110.694 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 38' ' ' ILE . 14.2 mt -64.32 -33.22 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.713 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.693 HG13 ' CG2' ' A' ' 52' ' ' VAL . 40.9 t -90.76 -6.37 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.846 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.3 -74.95 0.44 Allowed 'General case' 0 N--CA 1.462 0.167 0 O-C-N 122.384 -0.197 . . . . 0.0 111.444 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.5 m -99.19 -41.5 7.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.45 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.526 ' SD ' HG23 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -53.46 -38.31 63.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.118 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 52' ' ' VAL . 21.4 mt -133.42 103.59 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.726 0.298 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.23 71.22 1.19 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.07 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.2 130.16 2.79 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.185 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.48 75.18 2.01 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.599 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -168.5 -44.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.857 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -92.67 -38.71 11.69 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.663 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.748 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -89.17 -36.06 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.223 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -54.75 -39.07 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 111.029 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.9 mt -76.03 -35.04 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.167 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.725 ' CZ ' HG21 ' A' ' 65' ' ' ILE . 6.7 t80 -72.48 -52.94 13.6 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.669 0.271 . . . . 0.0 110.912 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.607 HD12 HG11 ' A' ' 42' ' ' VAL . 30.6 mt -118.0 110.12 29.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.085 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.5 130.46 55.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 59.4 40.95 20.28 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.04 29.61 19.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.46 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.03 144.78 32.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 62' ' ' ARG . 2.1 mp -65.44 153.96 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.277 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.0 mtt180 -88.66 146.1 36.49 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.201 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.71 88.73 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.623 2.215 . . . . 0.0 111.957 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.12 -34.76 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.773 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.725 HG21 ' CZ ' ' A' ' 55' ' ' PHE . 28.6 mm -68.33 119.53 14.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.4 mt -96.72 147.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.944 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.557 HG22 ' CE2' ' A' ' 92' ' ' PHE . 64.2 p -136.83 112.61 9.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.5 mt -105.27 108.17 19.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.754 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.549 HG21 ' CE1' ' A' ' 82' ' ' TYR . 21.2 mt -89.3 100.87 11.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.747 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 t30 58.81 53.2 5.97 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.29 32.93 20.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.235 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 154.14 49.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.449 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 129.07 34.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.653 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -54.58 -33.24 59.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.648 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -80.17 -32.47 38.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.923 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -56.75 -30.99 64.14 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.44 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -121.38 26.26 8.97 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.534 0.207 . . . . 0.0 111.432 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.29 -101.54 0.64 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.838 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.8 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.575 0.35 . . . . 0.0 110.509 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -109.94 -25.15 10.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.219 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -53.48 -25.71 17.54 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.666 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CE1' HG21 ' A' ' 69' ' ' ILE . 48.5 t80 -52.75 115.56 1.88 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.678 0.275 . . . . 0.0 110.718 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.77 142.04 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.68 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -63.22 174.94 1.04 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.936 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -160.53 97.33 1.2 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.784 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.465 ' HB2' HG12 ' A' ' 2' ' ' VAL . 41.1 t0 -45.85 110.95 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.83 26.18 4.83 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.678 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.85 176.57 5.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.649 0.262 . . . . 0.0 111.027 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 90' ' ' ILE . 19.8 mt -123.3 152.69 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.963 0.411 . . . . 0.0 111.554 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.622 ' HB ' HG12 ' A' ' 6' ' ' VAL . 5.2 mp -141.5 153.12 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.72 139.39 48.99 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.093 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.557 ' CE2' HG22 ' A' ' 67' ' ' THR . 30.2 m-85 -127.99 91.07 3.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.72 162.13 14.06 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -155.22 103.9 2.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.005 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -104.07 -82.57 0.5 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt 51.19 86.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.821 0.343 . . . . 0.0 111.553 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -127.67 40.89 3.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.134 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.27 177.06 14.68 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.778 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.571 -1.127 . . . . 0.0 112.804 179.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mmt . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 2' ' ' VAL . 11.3 m -147.2 103.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.765 0.317 . . . . 0.0 111.149 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -83.91 110.11 18.13 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 37' ' ' LEU . 12.5 m -117.06 138.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.95 116.74 33.52 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.777 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 21' ' ' VAL . 18.1 t -109.82 144.98 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HB3' HD11 ' A' ' 9' ' ' LEU . 3.7 mt-10 -127.49 101.27 6.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.92 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -87.7 123.89 33.0 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.826 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 7' ' ' GLU . 4.9 mp -143.6 167.81 21.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.07 -20.73 38.16 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.509 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.36 -34.85 0.39 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.746 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -37.24 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.65 0.225 . . . . 0.0 111.577 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.83 -36.7 72.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.56 0.219 . . . . 0.0 111.017 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.76 -30.91 68.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.479 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 35.2 mt -73.56 -42.09 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.203 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -68.94 -71.66 0.21 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.36 41.58 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.57 44.81 27.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.65 -31.6 15.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.302 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 72.63 -67.44 0.26 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.853 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 6' ' ' VAL . 8.3 p -117.72 124.15 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 152.73 46.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.284 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -112.2 145.22 40.28 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 37' ' ' LEU . 29.9 mt -138.29 148.57 24.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 108.27 8.05 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.95 159.08 32.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.81 93.36 3.4 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.106 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -162.54 -67.91 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.243 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.28 -175.63 5.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.788 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -58.44 0.46 Allowed Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.902 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.37 59.22 6.01 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.485 2.123 . . . . 0.0 112.708 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.15 142.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.83 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.02 151.39 25.84 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.745 0.307 . . . . 0.0 110.562 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 80' ' ' LYS . 11.4 p -55.5 -32.34 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.681 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' HE3' ' A' ' 80' ' ' LYS . . . -60.84 -25.96 64.57 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.063 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.29 75.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.738 0.304 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.793 HD21 HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -60.35 -47.84 84.34 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.312 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.565 ' HA ' HD12 ' A' ' 41' ' ' ILE . 34.2 mm -59.81 -38.52 76.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.406 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -61.36 -41.89 97.81 Favored 'General case' 0 C--N 1.335 -0.032 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -60.22 -38.32 83.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.022 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 38' ' ' ILE . 20.0 mt -67.83 -31.8 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.502 HG13 HG21 ' A' ' 52' ' ' VAL . 22.5 t -98.12 -2.9 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -94.46 -75.79 0.5 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.9 p -91.6 -45.19 8.62 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.658 0.265 . . . . 0.0 111.293 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.2 ttt -54.57 -44.34 72.88 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.816 HG21 HG23 ' A' ' 52' ' ' VAL . 17.5 mt -131.94 145.66 34.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.703 0.287 . . . . 0.0 111.237 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 47.28 0.09 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -138.84 126.28 13.27 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.073 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 32.2 Cg_exo -62.41 77.03 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.938 2.425 . . . . 0.0 112.23 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -170.83 -58.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.411 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.6 p30 -82.42 -36.9 26.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.816 HG23 HG21 ' A' ' 46' ' ' ILE . 1.7 t -93.92 -35.48 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 t -53.75 -38.67 64.61 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.037 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.5 mt -85.87 -34.37 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.083 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.64 ' HE1' HG21 ' A' ' 65' ' ' ILE . 15.9 t80 -67.48 -53.31 29.87 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.074 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.429 HG13 HG21 ' A' ' 42' ' ' VAL . 28.7 mm -104.77 131.1 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.916 0.388 . . . . 0.0 111.397 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -124.37 100.32 6.62 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.767 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 57.62 77.27 0.28 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.067 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 41.6 35.34 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.447 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -161.32 137.38 8.12 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.751 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.29 151.94 4.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.889 0.376 . . . . 0.0 111.391 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -81.87 140.52 46.96 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.996 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 52.4 Cg_exo -54.89 118.1 4.75 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 112.31 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.05 -37.08 1.94 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.504 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.64 HG21 ' HE1' ' A' ' 55' ' ' PHE . 28.0 mm -74.5 139.5 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.966 0.412 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.709 HD11 HG23 ' A' ' 95' ' ' THR . 77.8 mt -105.4 145.29 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.971 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -139.86 84.51 1.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.654 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.05 124.41 28.71 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.332 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 74' ' ' TRP . 17.3 mt -105.63 105.44 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m120 59.87 54.43 4.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.191 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 59.01 30.51 20.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.503 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 169.9 16.81 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.424 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -82.01 162.03 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.833 0.349 . . . . 0.0 111.029 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.477 ' HA ' HD12 ' A' ' 69' ' ' ILE . 45.1 p90 -77.88 -44.2 27.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.228 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -78.25 -24.97 46.67 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.368 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -53.49 -36.44 61.69 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.962 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.34 -32.15 10.16 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.835 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.83 -86.19 0.07 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.06 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.573 0.349 . . . . 0.0 110.396 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' VAL . 2.6 ttmp? -114.67 -27.1 7.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.45 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.79 -22.58 25.22 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -45.24 117.7 1.47 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.42 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.927 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -69.19 177.36 2.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.731 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.86 103.89 0.11 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.954 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -38.67 106.35 0.05 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.942 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.45 -8.88 5.9 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.741 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -80.06 164.33 23.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.166 0.483 . . . . 0.0 111.21 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.8 mm -125.0 117.33 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.137 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.12 142.48 22.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.034 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.7 m -121.68 139.46 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.317 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -119.57 79.98 1.51 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -83.93 172.68 11.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.45 118.17 9.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.103 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.709 HG23 HD11 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -97.2 39.64 1.18 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.045 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.19 -39.36 11.6 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.834 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -152.95 -45.65 0.1 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.576 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.3 -176.76 33.09 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.723 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.399 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.615 0.245 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 86' ' ' ASP . 29.4 m -100.3 157.07 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.621 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -130.68 126.66 37.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG11 HG12 ' A' ' 90' ' ' ILE . 17.9 t -128.75 138.31 54.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.47 103.28 15.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.658 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.2 t -92.63 143.47 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.937 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.34 105.92 9.13 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 110.896 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 9' ' ' LEU . 96.4 m-85 -92.62 127.76 38.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.069 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 8' ' ' PHE . 6.7 mp -132.94 168.12 19.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.743 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.19 -109.46 3.45 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.299 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.79 24.69 7.86 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.014 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 55' ' ' PHE . 13.0 mt -100.55 -37.1 8.94 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.939 0.37 . . . . 0.0 111.273 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.78 -17.31 62.94 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.33 -30.02 22.55 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.774 0.321 . . . . 0.0 111.05 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 1.1 mt -93.55 -27.21 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.692 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.699 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 3.0 m-85 -69.84 -74.66 0.13 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.63 0.252 . . . . 0.0 111.203 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 40.27 0.1 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.807 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt 50.67 37.29 16.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.45 0.3 . . . . 0.0 111.731 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.57 102.96 3.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.736 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.552 ' HG3' HG23 ' A' ' 21' ' ' VAL . 23.7 ptt180 -66.9 -49.03 66.89 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.947 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.552 HG23 ' HG3' ' A' ' 20' ' ' ARG . 24.6 t -81.21 93.61 2.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.885 0.374 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.36 154.48 29.09 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.288 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 24' ' ' ILE . 8.8 mtmp? -109.07 152.4 25.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.485 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.585 HG13 HD11 ' A' ' 37' ' ' LEU . 22.1 mm -128.28 147.17 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.55 123.19 15.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.989 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.8 mmt -118.71 132.87 56.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.136 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -97.21 47.76 1.04 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.72 -164.73 1.02 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.778 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HG3' ' HD2' ' A' ' 31' ' ' PRO . 5.9 pt-20 -68.32 -171.27 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.021 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.15 -57.56 1.1 Allowed Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.36 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' ' HG3' ' A' ' 29' ' ' GLU . 65.1 Cg_endo -72.54 61.49 3.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.284 1.99 . . . . 0.0 113.067 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.15 125.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.598 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.74 152.23 35.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.806 0.336 . . . . 0.0 110.888 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.65 -34.5 47.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.807 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.52 -27.95 59.04 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.805 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -40.85 75.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.649 0.261 . . . . 0.0 110.49 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.585 HD11 HG13 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.15 -50.23 71.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.089 178.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mt -58.91 -38.86 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.589 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.11 -42.24 85.28 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -62.04 -39.57 92.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.867 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' MET . 42.7 mt -62.74 -32.13 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.794 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.863 HG13 HG11 ' A' ' 52' ' ' VAL . 32.2 t -96.46 -3.64 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.8 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.3 t -100.22 -62.68 1.21 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.556 0.217 . . . . 0.0 111.56 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.7 p -98.1 -50.2 4.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.515 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -55.74 -38.0 69.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.169 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.699 HD11 ' CZ ' ' A' ' 16' ' ' PHE . 23.4 mt -136.25 145.26 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.988 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -171.23 72.88 0.05 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.926 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -165.48 126.2 1.32 Allowed Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.078 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.81 77.02 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.895 2.397 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.36 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.402 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.7 OUTLIER -78.48 -42.14 30.6 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.187 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.863 HG11 HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.6 -36.46 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.164 179.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 -31.1 26.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.493 0.187 . . . . 0.0 111.345 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.0 mt -94.2 -30.81 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.654 ' CE1' HD13 ' A' ' 65' ' ' ILE . 51.9 t80 -85.67 -52.17 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.381 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.534 ' HB ' HG12 ' A' ' 52' ' ' VAL . 43.0 mm -103.74 145.78 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.174 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -118.48 61.83 0.78 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 57.97 84.78 0.1 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 58.12 38.67 26.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.646 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.4 t -170.1 118.99 0.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.7 HG22 HD12 ' A' ' 65' ' ' ILE . 2.2 mp -63.65 151.94 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -76.44 147.62 79.19 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.44 128.08 14.93 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.773 2.315 . . . . 0.0 112.577 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.559 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . 122.62 -25.86 6.42 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.945 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 61' ' ' ILE . 20.0 mt -72.97 130.21 35.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 120.897 0.379 . . . . 0.0 110.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.68 121.79 45.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 91' ' ' SER . 91.1 m -125.66 111.18 14.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.834 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.7 mt -108.1 140.59 41.06 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.373 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.679 HG23 ' CD1' ' A' ' 90' ' ' ILE . 20.5 mt -119.18 111.54 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.704 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.71 46.92 8.58 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.78 33.44 17.81 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -141.3 178.46 7.4 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.38 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -80.18 -178.4 6.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.968 0.414 . . . . 0.0 111.325 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -104.45 -47.07 4.21 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.017 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -82.31 -30.2 30.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -26.68 62.2 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.533 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.7 -64.91 1.24 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.522 0.201 . . . . 0.0 111.25 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.66 105.31 0.27 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.679 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -53.24 -65.74 0.51 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.409 0.147 . . . . 0.0 111.318 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -117.56 -39.52 3.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.25 -25.52 48.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.74 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' CE2' HG21 ' A' ' 69' ' ' ILE . 75.9 t80 -48.32 116.38 1.54 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.824 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mt -72.87 132.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.1 173.85 3.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.651 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.07 100.57 0.97 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.419 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' HB3' HG12 ' A' ' 2' ' ' VAL . 9.4 p-10 -46.33 118.13 1.83 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.08 15.99 9.45 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.384 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.33 171.29 9.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mm -126.94 101.16 7.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.757 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.679 ' CD1' HG23 ' A' ' 69' ' ' ILE . 8.0 mm -98.28 142.62 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.043 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -119.87 138.46 53.39 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.31 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.497 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 59.7 m-85 -130.34 82.39 2.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.471 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.417 HG23 ' HB2' ' A' ' 9' ' ' LEU . 16.2 m -97.73 138.25 35.39 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.3 m -108.03 112.12 24.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t -118.13 72.5 0.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.311 0.577 . . . . 0.0 110.458 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.559 HD23 ' HA3' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -135.12 118.63 16.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.89 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -112.84 -42.99 3.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.014 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.33 97.63 1.27 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.353 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.651 -179.73 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.552 0.215 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 m -123.4 131.64 72.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.222 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -91.0 117.18 29.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.714 ' CG1' HD13 ' A' ' 90' ' ' ILE . 18.5 t -115.66 134.73 57.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -103.06 104.68 14.87 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.585 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 90' ' ' ILE . 3.5 m -111.71 155.96 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.525 ' HG2' HG22 ' A' ' 21' ' ' VAL . 18.9 mt-10 -119.15 154.2 33.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.684 ' C ' HD22 ' A' ' 9' ' ' LEU . 42.4 m-85 -136.29 104.75 5.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.062 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.684 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.6 mm? -129.82 121.0 25.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.957 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 46.56 0.45 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.833 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.63 -35.68 4.27 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.795 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.838 HD21 ' CE1' ' A' ' 55' ' ' PHE . 3.3 mt -54.95 -42.76 72.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.653 0.227 . . . . 0.0 111.415 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.23 -37.33 82.65 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.02 -33.58 75.86 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.291 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mt -79.77 -42.12 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.522 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.524 ' CE1' HD11 ' A' ' 41' ' ' ILE . 3.4 m-85 -63.72 -73.8 0.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.392 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.55 40.38 0.07 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.758 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.3 mttm 54.51 59.71 3.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.947 0.403 . . . . 0.0 111.26 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.29 113.04 7.02 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -61.42 -32.84 72.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.734 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 7' ' ' GLU . 21.1 t -125.52 119.28 54.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -113.63 146.03 40.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.959 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' O ' HD13 ' A' ' 24' ' ' ILE . 5.2 mtpm? -108.84 146.48 33.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.27 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.939 HD11 HD12 ' A' ' 41' ' ' ILE . 17.8 mm -128.57 146.61 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.679 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -128.2 87.38 2.59 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.302 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -72.87 135.83 45.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.534 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.77 90.29 2.96 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.44 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.71 -67.6 0.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.396 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.94 -171.59 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -59.18 0.5 Allowed Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.99 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -73.73 61.46 4.54 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.369 2.046 . . . . 0.0 112.547 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.5 ' CG1' HD12 ' A' ' 84' ' ' LEU . 23.6 t -73.85 131.14 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.6 p -97.8 161.16 13.88 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.628 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.76 -33.03 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.594 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.96 -27.38 62.1 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.044 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -41.37 71.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.692 HD21 ' HB ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -54.82 -44.84 74.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.907 178.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.609 HD11 ' HZ ' ' A' ' 92' ' ' PHE . 24.4 mm -68.92 -33.34 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.788 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -50.33 36.13 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.7 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 26' ' ' MET . 26.0 t-80 -60.48 -48.07 83.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.939 HD12 HD11 ' A' ' 24' ' ' ILE . 7.1 tt -62.72 -30.96 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.633 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.674 HG13 ' CG2' ' A' ' 52' ' ' VAL . 89.0 t -94.88 -11.24 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.9 m -100.99 -69.57 0.77 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 p -76.75 -56.91 4.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.52 -55.62 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.938 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.821 HG21 HG23 ' A' ' 52' ' ' VAL . 41.5 mt -109.93 129.43 64.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -149.03 59.17 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.028 0.442 . . . . 0.0 110.703 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -150.12 131.8 7.63 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.183 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 60.7 Cg_endo -72.03 66.12 3.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.573 2.182 . . . . 0.0 112.327 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.11 -49.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.46 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.93 -39.08 15.04 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.679 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.821 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -93.57 -35.59 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.121 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.4 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 13.3 t -52.93 -36.19 59.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.642 0.258 . . . . 0.0 111.12 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.99 -34.19 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.391 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.838 ' CE1' HD21 ' A' ' 12' ' ' LEU . 38.0 t80 -73.28 -52.71 12.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.325 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.571 HG13 HG21 ' A' ' 42' ' ' VAL . 32.3 mm -111.87 136.32 48.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -132.14 134.52 45.52 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.018 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.65 38.77 25.06 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.775 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 33.44 21.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.68 152.67 35.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.062 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 62' ' ' ARG . 2.1 mp -65.57 154.5 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.256 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 61' ' ' ILE . 2.7 mtt-85 -101.04 138.94 20.12 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' ARG . 51.9 Cg_exo -55.22 133.32 57.41 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.797 2.331 . . . . 0.0 112.426 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.35 -35.57 2.56 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.681 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.52 HD13 ' CE1' ' A' ' 55' ' ' PHE . 3.1 mt -83.37 111.84 20.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.962 0.411 . . . . 0.0 110.97 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.99 146.26 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 m -129.43 136.64 50.18 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.105 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.3 mt -130.04 113.78 14.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.003 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.47 109.53 25.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.598 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.34 49.05 9.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.637 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 58.54 31.7 21.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.274 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 73' ' ' ASP . 1.5 m -135.06 170.56 15.72 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.385 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.63 ' HB2' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -79.68 172.0 14.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.886 0.374 . . . . 0.0 111.262 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.424 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 23.0 p-90 -103.86 -33.99 8.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.953 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -88.24 -26.76 22.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.468 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' A' ' 73' ' ' ASP . 6.1 mt -60.62 -21.66 62.93 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.32 -71.55 0.72 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.525 0.203 . . . . 0.0 111.114 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.1 108.8 0.4 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.654 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 16.4 mt-10 -54.92 -72.54 0.06 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.457 0.17 . . . . 0.0 111.074 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -104.39 -33.89 8.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.952 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.21 -23.75 23.85 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.453 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -56.38 106.13 0.26 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.81 141.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.5 HD12 ' CG1' ' A' ' 32' ' ' VAL . 17.7 mt -63.8 175.79 1.07 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.36 97.83 1.25 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -47.8 104.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.802 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.79 27.94 4.43 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.693 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.97 170.48 7.89 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.602 0.239 . . . . 0.0 111.014 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 mm -118.31 130.35 73.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.615 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.714 HD13 ' CG1' ' A' ' 4' ' ' VAL . 5.2 mp -136.15 150.64 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.064 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.03 146.83 50.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.388 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.609 ' HZ ' HD11 ' A' ' 38' ' ' ILE . 18.1 m-85 -133.02 82.11 1.98 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.723 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.05 141.61 28.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 t -119.89 97.34 5.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.429 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.6 p -87.73 52.83 2.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.022 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.27 28.98 0.29 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 62.56 178.46 0.14 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.75 0.309 . . . . 0.0 111.09 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.92 83.87 0.06 OUTLIER Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.843 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.604 179.846 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtm . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.668 0.271 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.33 99.5 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.072 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -82.26 112.05 18.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.996 0.427 . . . . 0.0 111.075 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 m -110.26 129.2 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.326 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 118.16 24.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' HB ' ' A' ' 90' ' ' ILE . 2.7 m -122.75 147.39 26.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.503 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -119.38 107.27 13.16 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.499 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.655 ' C ' HD12 ' A' ' 9' ' ' LEU . 52.8 m-85 -85.25 128.71 34.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.293 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.655 HD12 ' C ' ' A' ' 8' ' ' PHE . 7.0 mp -135.98 149.62 48.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.956 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.72 -102.28 1.96 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.508 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.58 26.46 3.66 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.015 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.72 -41.58 8.02 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.868 0.334 . . . . 0.0 110.828 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.54 -33.05 74.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.455 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.04 73.3 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -74.52 -44.95 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.35 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.435 ' CZ ' HD11 ' A' ' 46' ' ' ILE . 14.7 m-85 -65.02 -71.46 0.18 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.227 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.63 45.64 0.1 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.542 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.2 mttt 56.87 54.35 7.22 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.31 106.95 8.23 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.019 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -9.02 50.46 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.928 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.47 138.69 39.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.64 0.257 . . . . 0.0 110.507 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.69 168.82 19.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.354 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -138.97 143.5 38.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 41' ' ' ILE . 2.9 mp -136.28 150.77 27.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.358 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.62 101.66 5.03 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.842 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG2' ' CG ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -77.67 124.45 27.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.742 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -88.15 68.68 9.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.93 -159.12 0.94 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.509 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.45 -170.78 0.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.225 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -59.7 0.77 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.99 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 83' ' ' ILE . 86.8 Cg_endo -77.42 58.98 6.52 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.39 2.06 . . . . 0.0 112.733 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -72.6 132.23 33.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.842 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.8 p -73.91 149.26 41.56 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.64 -36.49 54.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.575 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.88 -27.79 59.81 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.64 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.93 -42.77 69.42 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.735 0.302 . . . . 0.0 110.424 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -53.5 -53.15 55.62 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.533 ' O ' HG23 ' A' ' 42' ' ' VAL . 3.5 mt -61.01 -37.25 76.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.357 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -41.55 97.26 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG2' ' A' ' 26' ' ' MET . 1.3 t60 -62.16 -36.88 83.19 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 24' ' ' ILE . 33.1 mt -72.09 -27.65 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.296 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG21 ' CD1' ' A' ' 56' ' ' ILE . 28.8 t -94.53 -5.49 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.8 p -100.25 -72.41 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.1 p -87.32 -49.3 7.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.502 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.1 ttt -53.36 -54.74 32.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.918 HG21 HG23 ' A' ' 52' ' ' VAL . 26.0 mt -110.43 125.87 67.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.611 0.243 . . . . 0.0 110.829 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.46 74.69 1.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.188 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.78 119.93 0.42 Allowed Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.63 76.85 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.774 2.316 . . . . 0.0 112.067 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -166.14 -57.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.513 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -82.16 -36.13 27.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.758 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.918 HG23 HG21 ' A' ' 46' ' ' ILE . 1.8 t -89.43 -35.67 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.984 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 m -58.07 -34.35 70.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.38 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.0 mt -83.15 -39.12 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.573 0.225 . . . . 0.0 111.0 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -68.44 -38.1 80.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.077 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.726 ' CD1' HG21 ' A' ' 42' ' ' VAL . 29.5 mt -132.08 129.55 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.288 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -114.0 122.79 48.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.769 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 55.25 52.72 11.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.76 26.61 11.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.72 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.573 ' C ' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -137.71 125.64 22.67 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 110.66 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -56.81 151.7 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.499 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -87.16 143.57 34.92 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.069 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.67 123.81 9.73 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.654 2.236 . . . . 0.0 112.208 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.15 -37.38 1.16 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.627 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 62' ' ' ARG . 1.9 mp -70.78 130.07 34.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 110.921 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.0 mm -110.31 152.76 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.963 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 t -146.33 142.56 28.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.692 0.282 . . . . 0.0 111.254 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 mt -131.12 108.16 9.55 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.562 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 32.3 mt -88.22 109.32 19.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.428 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.6 m120 58.67 43.34 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.96 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.59 30.62 18.73 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.023 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 163.99 25.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.59 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -79.91 117.2 20.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -50.53 -38.65 45.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.909 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.07 -43.87 94.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.655 0.264 . . . . 0.0 110.833 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.83 -26.14 65.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.288 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -111.02 30.43 6.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 111.192 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.66 96.22 0.53 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.487 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.58 -52.73 6.11 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.407 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -112.97 -36.45 5.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.773 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.67 56.61 2.28 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.971 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.562 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 33.1 t80 -119.08 114.98 23.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.859 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' A' ' 31' ' ' PRO . 2.9 mp -65.19 119.51 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 37' ' ' LEU . 27.3 mt -65.63 176.35 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 1.2 mt-10 -167.01 101.12 0.54 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.356 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -45.73 122.29 3.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.965 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.89 25.21 9.88 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.2 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.8 t70 -100.99 169.51 8.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 111.127 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -113.87 104.95 17.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.573 ' HB ' HG12 ' A' ' 6' ' ' VAL . 67.8 mt -118.79 100.22 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.15 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.089 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -134.62 103.22 5.57 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 159.48 15.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.593 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -142.22 110.47 6.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.779 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.1 t -90.98 52.73 2.21 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 110.803 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.69 -55.8 2.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.688 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -100.05 -41.98 6.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.171 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 128.23 -66.7 0.56 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.508 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.49 179.842 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.867 0.365 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.694 HG23 ' HA ' ' A' ' 86' ' ' ASP . 9.0 p -141.86 128.3 19.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.94 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -105.07 89.78 3.24 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 37' ' ' LEU . 30.7 m -83.36 150.07 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.582 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -111.32 110.65 21.22 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 t -104.86 144.98 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -121.36 101.4 7.61 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.562 ' CD2' HD13 ' A' ' 12' ' ' LEU . 86.1 m-85 -89.74 128.81 36.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.39 118.45 13.45 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.302 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.06 -102.03 0.34 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.275 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.21 -33.39 3.2 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.208 -0.52 . . . . 0.0 112.961 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.656 HD11 ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -54.91 -39.23 68.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.34 -37.8 75.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.055 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.94 -43.45 68.14 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.997 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 45.5 mt -66.96 -34.07 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.263 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -71.89 -61.92 1.61 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.648 0.261 . . . . 0.0 111.301 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.58 48.0 0.01 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.318 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mttt 57.22 34.43 24.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 111.255 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -118.37 103.52 9.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.627 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -65.57 0.67 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.549 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -90.23 135.7 25.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.242 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.6 136.97 29.7 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.01 142.05 30.2 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.467 HD13 HG12 ' A' ' 41' ' ' ILE . 12.4 mt -132.78 143.64 39.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.94 123.89 45.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.54 120.09 31.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.943 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -127.57 48.16 2.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.085 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -36.79 23.24 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.017 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -157.47 -178.74 7.56 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -85.62 -54.04 0.43 Allowed Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.949 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 3.1 Cg_exo -79.53 53.8 4.89 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.949 2.433 . . . . 0.0 112.333 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.8 t -74.44 139.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.645 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.21 163.87 13.2 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.531 ' O ' HD12 ' A' ' 38' ' ' ILE . 7.2 p -54.68 -40.44 51.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.995 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -29.28 58.86 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.192 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.76 -42.55 73.71 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -51.74 -53.37 40.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.091 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 34' ' ' VAL . 2.3 mp -59.08 -38.78 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.405 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.6 -41.42 94.72 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -60.49 -39.89 89.34 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.674 0.273 . . . . 0.0 110.611 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.56 HG22 HD12 ' A' ' 46' ' ' ILE . 42.3 mt -64.87 -32.19 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.644 HG13 ' CG2' ' A' ' 52' ' ' VAL . 29.7 t -96.39 -1.41 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.92 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -100.29 -72.73 0.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 t -87.97 -40.56 13.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.478 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -59.56 4.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.054 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.75 HG21 HG23 ' A' ' 52' ' ' VAL . 4.4 mt -117.53 148.43 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 120.706 0.289 . . . . 0.0 111.272 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -165.2 41.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.94 139.75 36.56 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.86 73.45 3.63 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.705 2.27 . . . . 0.0 112.463 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -169.38 -47.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.622 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -93.39 -35.9 12.78 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.75 HG23 HG21 ' A' ' 46' ' ' ILE . 2.1 t -91.22 -35.4 7.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 p -54.4 -33.22 58.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.4 mt -84.51 -33.05 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.309 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.656 ' CE1' HD11 ' A' ' 12' ' ' LEU . 10.5 t80 -77.82 -35.57 51.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.525 0.202 . . . . 0.0 111.03 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.03 133.26 69.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.393 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.1 -156.28 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.56 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -70.57 85.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.06 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.1 t0 60.7 40.75 15.95 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.163 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.1 t -178.57 138.92 0.17 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mt -65.78 142.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.42 ' O ' HD12 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -89.55 155.85 48.19 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.35 146.33 68.59 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.7 2.267 . . . . 0.0 112.467 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.67 -42.54 1.46 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.578 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.522 HG21 ' HE1' ' A' ' 55' ' ' PHE . 1.9 mp -73.1 122.44 25.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-O 120.937 0.399 . . . . 0.0 110.982 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 mt -94.68 131.45 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.419 ' HB ' ' CG ' ' A' ' 74' ' ' TRP . 0.3 OUTLIER -122.33 114.56 20.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 68' ' ' LEU . 24.7 mt -112.76 109.19 18.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.0 mt -88.16 98.58 7.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.55 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.1 m120 57.37 55.25 5.93 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.736 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 31.58 20.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.536 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.97 159.74 40.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.462 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.806 ' HB2' HD12 ' A' ' 76' ' ' LEU . 2.7 m-20 -79.79 120.4 24.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.814 0.34 . . . . 0.0 110.789 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.419 ' CG ' ' HB ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -57.12 -30.68 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.639 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.05 -30.58 44.13 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.584 0.23 . . . . 0.0 111.129 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' HB2' ' A' ' 73' ' ' ASP . 4.8 mt -65.55 -18.11 65.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.575 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -133.59 38.66 3.24 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 111.384 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.59 103.54 0.25 Allowed Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.068 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' O ' HG11 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -47.77 -61.88 1.73 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.101 0.16 . . . . 0.0 111.267 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -103.15 -28.78 11.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.19 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.76 -29.45 18.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.453 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -58.87 114.4 2.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.807 0.337 . . . . 0.0 110.605 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mp -76.82 144.84 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 84' ' ' LEU . 20.1 mt -64.46 171.69 3.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.203 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -171.04 104.25 0.23 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.471 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.694 ' HA ' HG23 ' A' ' 2' ' ' VAL . 27.1 t70 -46.11 115.81 1.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.995 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 20.06 6.67 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.779 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.05 169.98 8.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.779 0.324 . . . . 0.0 111.403 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.452 ' O ' HD13 ' A' ' 90' ' ' ILE . 15.3 mt -127.53 152.34 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.753 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 89' ' ' ILE . 21.2 mm -135.5 150.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.222 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -130.11 138.92 50.94 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.019 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.85 90.76 2.95 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.019 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.19 104.24 16.12 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 80.98 1.37 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.761 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 m -135.11 80.74 1.86 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.75 135.92 45.4 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.121 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -86.01 -45.17 11.7 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.982 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -171.21 -175.46 39.69 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.688 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.613 -1.104 . . . . 0.0 112.819 -179.765 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 m -142.53 165.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -155.85 96.03 1.7 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.74 153.85 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.448 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HG2' HG13 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -115.34 107.77 15.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.581 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.863 HG12 ' HB ' ' A' ' 90' ' ' ILE . 27.5 m -111.91 155.41 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.379 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 21' ' ' VAL . 2.2 mt-10 -124.88 152.64 43.76 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.222 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.592 ' O ' HD12 ' A' ' 9' ' ' LEU . 50.8 m-85 -128.92 114.12 16.07 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.352 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 8' ' ' PHE . 10.9 mp -128.66 108.39 10.45 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.701 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.8 -101.71 0.35 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.528 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.0 28.28 4.15 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.103 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 55' ' ' PHE . 0.9 OUTLIER -106.57 -45.34 4.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.737 0.269 . . . . 0.0 110.844 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.25 -33.57 71.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.08 86.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -72.01 -41.89 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.198 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -66.8 -71.59 0.19 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.62 43.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.626 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 54.7 34.51 21.79 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.545 0.338 . . . . 0.0 111.524 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.24 112.38 24.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.462 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -61.48 -67.05 0.44 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.905 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' A' ' 7' ' ' GLU . 36.3 t -90.83 117.89 34.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.986 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 148.32 38.19 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.052 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -115.84 137.67 51.88 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -134.37 139.84 47.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 123.4 21.55 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -38.29 54.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.576 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.08 43.48 26.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.92 0.39 . . . . 0.0 111.085 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.05 -74.13 0.62 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.591 ' HG2' HG22 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -133.72 -174.28 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.979 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -59.64 0.36 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.097 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.12 57.93 6.37 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.318 2.012 . . . . 0.0 112.573 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG22 ' HG2' ' A' ' 29' ' ' GLU . 21.7 t -74.85 118.9 21.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.458 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 p -66.21 147.01 53.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.792 0.33 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.37 -34.65 23.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.556 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.87 -26.77 58.44 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.117 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.5 -42.07 62.28 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.663 0.268 . . . . 0.0 110.615 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -54.04 -53.05 58.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.198 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.491 ' HA ' HD12 ' A' ' 41' ' ' ILE . 16.4 mt -62.36 -40.03 86.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.386 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.75 -42.71 99.32 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -58.94 -43.29 91.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.957 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 38' ' ' ILE . 15.2 mt -64.52 -32.21 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.141 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG13 ' CG2' ' A' ' 52' ' ' VAL . 21.9 t -97.14 -3.51 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -92.92 -75.44 0.49 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.507 0.194 . . . . 0.0 111.357 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -94.62 -43.02 8.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.187 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -38.45 67.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.776 HG21 HG23 ' A' ' 52' ' ' VAL . 47.0 mt -136.92 136.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.301 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -159.1 38.44 0.21 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 23.0 t30 -128.54 127.45 23.6 Favored Pre-proline 0 C--N 1.334 -0.088 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.866 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 24.9 Cg_exo -64.44 76.58 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.692 2.261 . . . . 0.0 112.254 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -168.25 -45.7 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.43 -31.54 12.31 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.135 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.776 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -102.57 -35.52 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.206 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -36.46 61.28 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.571 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.625 HD12 ' N ' ' A' ' 55' ' ' PHE . 1.4 pp -94.93 -22.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' N ' HD12 ' A' ' 54' ' ' ILE . 46.4 t80 -77.25 -49.07 15.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.594 0.235 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.1 mm -106.5 150.28 9.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -115.07 85.12 2.2 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.235 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 57.06 67.25 1.01 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.401 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 76.28 -42.87 0.45 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.336 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -82.04 129.93 34.94 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.724 0.297 . . . . 0.0 110.985 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -62.48 153.38 6.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.348 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -82.66 135.95 45.61 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.174 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.18 106.54 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.65 2.234 . . . . 0.0 111.965 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.13 -35.52 0.24 Allowed Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.75 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 mt -67.21 121.57 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.836 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -90.01 97.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.8 t -104.75 136.28 44.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.9 mt -126.1 118.53 25.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.445 HG23 HG12 ' A' ' 90' ' ' ILE . 33.6 mt -102.01 109.5 26.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.492 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 58.03 48.14 13.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.61 38.77 21.97 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.362 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.62 161.95 38.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.721 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.72 124.77 29.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.403 ' CG ' HG23 ' A' ' 67' ' ' THR . 1.0 OUTLIER -55.84 -33.59 64.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.506 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -80.11 -33.4 38.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.669 0.271 . . . . 0.0 111.146 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.74 -24.87 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.411 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -103.52 -58.21 1.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.513 0.197 . . . . 0.0 111.181 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.3 98.22 0.11 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.626 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -47.04 -56.81 5.83 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.127 0.171 . . . . 0.0 111.368 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -117.34 -30.64 5.52 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.937 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.92 56.62 2.38 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.168 0.509 . . . . 0.0 110.977 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -137.65 112.52 8.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.019 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mp -61.76 127.87 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 37' ' ' LEU . 15.6 mt -65.31 177.7 1.06 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 110.741 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -163.45 100.03 0.93 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.143 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -49.07 108.91 0.21 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.819 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.03 26.31 5.55 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.16 176.15 5.84 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.662 0.268 . . . . 0.0 111.041 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -116.77 111.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.362 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.863 ' HB ' HG12 ' A' ' 6' ' ' VAL . 62.6 mt -126.41 97.61 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.652 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.4 m -79.91 158.54 26.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.501 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -145.05 85.24 1.74 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -91.92 162.67 14.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.623 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.44 93.96 2.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.865 0.364 . . . . 0.0 110.823 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.76 39.23 2.06 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.918 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.93 121.89 17.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.629 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.86 77.92 3.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.705 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.98 -116.88 2.66 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.654 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.446 -1.197 . . . . 0.0 112.489 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 86' ' ' ASP . 9.1 p -121.84 142.31 38.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.661 0.267 . . . . 0.0 111.145 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -112.93 93.16 4.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.871 HG21 HD21 ' A' ' 37' ' ' LEU . 25.2 m -93.3 144.16 10.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -116.37 97.31 5.96 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.665 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 t -92.79 146.76 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -116.98 97.65 6.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' HD12 ' A' ' 9' ' ' LEU . 72.0 m-85 -87.23 117.92 26.3 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 8' ' ' PHE . 10.3 mp -127.23 176.47 7.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.467 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.94 -112.22 3.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.354 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.81 23.17 12.03 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.784 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD21 ' CE1' ' A' ' 55' ' ' PHE . 1.1 mt -100.27 -43.31 6.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.805 0.303 . . . . 0.0 111.212 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.12 -34.03 67.96 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.39 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -33.74 76.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.703 0.287 . . . . 0.0 111.097 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.7 mt -80.28 -41.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.326 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -61.96 -73.3 0.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.267 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.78 41.63 0.09 OUTLIER Glycine 0 C--N 1.335 0.472 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.588 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt 53.59 41.56 32.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.717 0.294 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -121.78 121.83 38.13 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.655 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -46.06 91.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.384 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 10.1 p -121.34 126.93 75.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.85 135.75 54.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.492 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 24' ' ' ILE . 11.8 pttt -102.46 146.35 28.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.361 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 23' ' ' LYS . 19.0 mm -132.22 147.12 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -121.52 98.14 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.774 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.457 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -96.18 139.55 32.18 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -138.16 81.51 1.86 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.861 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -120.62 -63.07 1.39 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -148.4 -175.51 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.797 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.26 -60.14 0.3 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.052 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.49 58.02 6.8 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.489 2.126 . . . . 0.0 112.297 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.59 ' HB ' HD12 ' A' ' 84' ' ' LEU . 22.5 t -81.17 152.67 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.339 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -103.36 163.8 12.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.327 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.472 ' HA ' HD21 ' A' ' 84' ' ' LEU . 7.5 p -58.55 -34.46 51.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.028 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -27.71 62.61 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.11 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -71.36 -41.86 69.2 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.641 0.258 . . . . 0.0 110.42 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -54.96 -51.79 65.05 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.328 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mt -59.18 -39.67 79.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.336 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.25 -41.94 89.96 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -60.76 -45.02 95.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.204 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.609 HG22 HD12 ' A' ' 46' ' ' ILE . 28.2 mt -62.68 -28.41 44.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.395 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 56' ' ' ILE . 32.8 t -100.52 -9.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -76.21 -75.62 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.58 0.228 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.3 m -100.33 -36.33 9.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.294 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.4 mmm -56.64 -53.49 57.01 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.431 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.613 ' CG2' HG23 ' A' ' 52' ' ' VAL . 9.6 mt -124.61 88.03 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 120.938 0.399 . . . . 0.0 111.082 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -104.2 51.17 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.48 116.54 6.47 Favored Pre-proline 0 N--CA 1.457 -0.105 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.67 -30.92 30.4 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.77 2.313 . . . . 0.0 112.739 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -55.96 -48.91 74.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.319 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.14 31.48 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.755 HG21 HG13 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -150.56 -49.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 p -56.68 -27.54 59.03 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.474 0.178 . . . . 0.0 111.447 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.2 mt -84.04 -33.87 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.666 0.27 . . . . 0.0 110.625 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.574 ' CE1' HD21 ' A' ' 12' ' ' LEU . 52.0 t80 -74.34 -44.21 53.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.085 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 42' ' ' VAL . 42.1 mt -111.57 148.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.899 0.381 . . . . 0.0 111.38 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.15 -158.33 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.851 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.28 92.63 0.06 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.947 0.403 . . . . 0.0 111.109 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t0 53.35 37.0 24.35 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.874 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.45 141.04 1.48 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.557 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.498 HG22 HD12 ' A' ' 65' ' ' ILE . 2.6 mt -58.06 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 120.705 0.288 . . . . 0.0 111.334 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.99 120.2 58.91 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.72 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.57 101.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.676 2.251 . . . . 0.0 112.166 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.67 -42.65 0.63 Allowed Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.694 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.498 HD12 HG22 ' A' ' 61' ' ' ILE . 4.6 mt -59.12 140.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.937 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -108.3 137.71 38.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.118 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' SER . 8.9 t -137.63 125.9 23.19 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.931 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 41.0 mt -108.66 111.09 22.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.54 111.73 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.615 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 58.85 47.5 12.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.96 34.1 23.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.963 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.1 m -140.88 161.7 37.21 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.617 ' HB2' HD23 ' A' ' 76' ' ' LEU . 1.5 m-20 -79.89 150.79 30.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.377 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -62.44 -42.33 99.39 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.43 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.17 -9.07 58.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -63.26 -35.85 81.72 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.343 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.54 29.3 6.65 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 111.503 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 75' ' ' GLU . . . 121.51 -102.72 0.83 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.442 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 179.72 -81.13 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 122.546 0.338 . . . . 0.0 110.303 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -104.82 -24.55 12.87 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.273 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -52.98 -25.48 12.19 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -45.15 107.7 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 110.489 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 mt -68.26 138.41 22.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.015 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.59 HD12 ' HB ' ' A' ' 32' ' ' VAL . 18.4 mt -66.52 174.07 3.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -170.85 104.22 0.24 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.504 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 2' ' ' VAL . 6.1 t0 -42.06 109.17 0.12 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.007 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 111.02 27.05 4.42 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.777 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.44 165.77 12.19 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 mm -126.02 116.64 46.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.804 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 90' ' ' ILE . 4.0 mp -115.92 150.49 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.727 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 67' ' ' THR . 40.3 m -130.26 142.33 50.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.708 0.29 . . . . 0.0 111.413 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB3' HD13 ' A' ' 12' ' ' LEU . 11.1 m-85 -130.99 95.27 3.77 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 156.86 16.82 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.084 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 t -153.92 79.94 1.14 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p -69.59 -35.03 74.96 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 97' ' ' HIS . 4.3 pp -61.79 -25.21 67.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.745 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.421 ' N ' HD12 ' A' ' 96' ' ' LEU . 15.7 t-160 75.86 122.79 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.587 0.355 . . . . 0.0 111.232 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.66 -58.4 12.36 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.887 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.516 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.716 0.293 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 m -138.46 168.76 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.2 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -157.64 94.23 1.34 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.884 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.7 m -105.19 135.38 43.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -89.23 115.56 26.82 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.709 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 7.7 t -110.4 148.48 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.244 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -119.29 99.18 6.54 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CE1' HD22 ' A' ' 12' ' ' LEU . 93.8 m-85 -84.55 133.45 34.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.552 HD13 HG23 ' A' ' 93' ' ' THR . 5.4 mp -140.64 152.13 45.16 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -101.53 2.76 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.222 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.75 -28.74 4.66 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.181 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 8' ' ' PHE . 1.4 mt -56.65 -40.0 74.69 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.897 0.349 . . . . 0.0 111.734 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -66.04 -33.48 75.9 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.419 0.152 . . . . 0.0 111.12 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.75 80.87 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.401 HG21 ' CB ' ' A' ' 51' ' ' ASP . 4.7 mt -81.69 -34.11 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.521 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.8 -73.22 0.14 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.58 0.228 . . . . 0.0 111.187 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.8 41.75 0.09 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.591 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 53.19 34.78 18.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.484 0.313 . . . . 0.0 111.705 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -121.61 123.55 42.2 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.613 0.244 . . . . 0.0 110.872 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -26.87 68.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.598 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' GLU . 7.5 p -132.46 135.27 58.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.838 0.352 . . . . 0.0 110.934 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.16 142.23 28.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -85.42 142.22 29.41 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.991 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.1 mm -123.9 140.75 46.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.135 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.3 115.62 9.42 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 40' ' ' HIS . 15.1 ttt -88.98 -42.36 11.83 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.141 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.3 86.25 0.1 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -66.09 0.37 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.58 -169.26 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.456 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -86.83 -54.2 0.39 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.082 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 4.8 Cg_exo -74.08 55.86 3.55 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.834 2.356 . . . . 0.0 112.588 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.59 124.78 49.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.619 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.73 153.98 30.42 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 111.14 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -56.19 -33.66 37.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.71 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.5 -27.64 54.45 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.82 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -40.74 68.1 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 120.677 0.275 . . . . 0.0 110.496 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.88 -52.89 61.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.344 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.445 HG23 ' CE2' ' A' ' 55' ' ' PHE . 16.3 mt -60.17 -41.29 86.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.107 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -61.23 -40.01 92.39 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' CG ' ' HG3' ' A' ' 26' ' ' MET . 72.6 t60 -58.52 -46.72 86.18 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 46' ' ' ILE . 17.9 mt -63.29 -30.01 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.279 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 56' ' ' ILE . 39.5 t -97.15 -4.9 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.76 -73.92 0.62 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.3 m -87.34 -45.14 10.84 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.465 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.428 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -54.77 -51.67 64.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.042 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.822 ' CG2' HG23 ' A' ' 52' ' ' VAL . 7.6 mt -121.79 150.96 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.106 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -160.81 65.53 0.3 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.42 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . 8.9 t30 -170.88 138.51 1.22 Allowed Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 120.601 0.239 . . . . 0.0 111.572 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.88 75.17 3.23 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.735 2.29 . . . . 0.0 112.6 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 48' ' ' ASN . 20.3 p-10 -166.13 -41.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.401 ' CB ' HG21 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -100.98 -37.31 8.69 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.822 HG23 ' CG2' ' A' ' 46' ' ' ILE . 2.1 t -82.5 -34.45 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.412 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 m -50.88 -31.94 18.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.677 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.95 -46.31 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.755 0.312 . . . . 0.0 111.018 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.481 ' O ' HD13 ' A' ' 56' ' ' ILE . 17.8 t80 -66.59 -47.87 71.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.335 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.848 HG13 HG21 ' A' ' 42' ' ' VAL . 28.2 mm -129.57 143.55 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.813 0.34 . . . . 0.0 111.294 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.5 127.89 26.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 58.33 45.43 16.98 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.449 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 53.99 33.5 17.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.374 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.4 m -150.53 145.66 26.1 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.915 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.87 152.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.191 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -92.64 137.73 24.12 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 99.59 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.582 2.188 . . . . 0.0 111.89 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.17 -35.28 0.44 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.558 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -66.27 134.48 29.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.886 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.43 118.62 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 91' ' ' SER . 4.5 t -121.5 92.09 3.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.945 0.402 . . . . 0.0 111.016 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.4 mt -101.23 122.0 42.88 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.207 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mt -100.66 107.73 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 59.02 52.64 6.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.036 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.33 30.64 19.85 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.117 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -133.28 164.99 25.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.35 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -79.77 177.6 8.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.921 0.391 . . . . 0.0 111.18 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -102.88 -39.94 6.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.677 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.92 -27.62 28.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.763 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -54.27 -30.6 51.16 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -115.69 -62.15 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.522 0.201 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.75 103.86 0.24 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.686 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.44 -57.5 6.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.59 0.234 . . . . 0.0 111.184 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -117.4 -44.3 2.77 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.1 -27.0 5.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.018 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -48.99 109.53 0.27 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.617 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 83' ' ' ILE . 3.4 mp -68.95 133.33 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.138 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -67.63 172.44 5.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.804 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.16 102.6 0.29 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.395 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -48.91 114.51 1.01 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.71 -9.56 6.81 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.814 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.538 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -80.04 157.23 26.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.045 0.422 . . . . 0.0 111.163 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 89' ' ' ILE . 1.5 mp -107.69 125.45 64.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.764 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 6.5 mt -125.99 141.89 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.27 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -116.57 142.21 47.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.76 90.98 3.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.794 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.552 HG23 HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -108.04 95.52 5.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.874 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.9 t -88.04 89.4 7.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.504 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.406 ' O ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -115.52 -83.56 0.62 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.707 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER 176.67 -49.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.58 0.229 . . . . 0.0 110.858 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.28 -69.44 0.19 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.24 -86.77 0.4 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.123 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.688 -179.895 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.522 0.201 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 86' ' ' ASP . 7.7 p -126.69 108.96 19.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.02 0.438 . . . . 0.0 111.227 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -87.63 117.19 26.27 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.413 ' HB ' HD13 ' A' ' 90' ' ' ILE . 18.2 m -114.98 139.5 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.25 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.94 105.88 16.13 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.655 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.816 HG12 ' HB ' ' A' ' 90' ' ' ILE . 8.4 m -98.68 146.13 8.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.329 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -126.0 98.43 5.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.64 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.449 ' C ' HD12 ' A' ' 9' ' ' LEU . 98.0 m-85 -82.95 142.48 31.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' ' 8' ' ' PHE . 5.4 mp -146.04 172.45 13.38 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.213 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.75 -107.96 2.59 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.219 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.44 -6.04 13.76 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.664 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -65.72 -45.13 83.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.398 0.599 . . . . 0.0 111.284 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.56 -30.22 69.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.256 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -38.66 88.21 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.658 0.266 . . . . 0.0 111.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 11.0 mt -70.43 -40.14 77.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.601 ' CE1' HD11 ' A' ' 46' ' ' ILE . 19.5 m-85 -66.44 -70.16 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.245 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.45 48.04 0.04 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.366 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt 56.77 33.81 23.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.382 0.273 . . . . 0.0 111.344 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -104.16 110.65 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.755 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -66.45 -62.39 1.49 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.45 144.14 20.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.808 0.337 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -180.0 6.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -147.9 141.79 25.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.2 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 23' ' ' LYS . 20.0 mm -135.16 146.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.17 84.0 2.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.699 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.04 127.25 30.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.177 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -106.38 92.86 4.31 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.97 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -144.38 -66.04 0.34 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.43 -178.03 6.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.197 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.73 -59.78 0.35 Allowed Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.002 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.94 58.78 6.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.558 2.172 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -92.38 132.86 35.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.2 p -75.37 153.02 37.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.859 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.14 -32.13 33.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.707 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.93 -26.52 55.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.086 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.01 -45.71 69.84 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.584 0.231 . . . . 0.0 110.56 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -54.28 -46.82 72.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.221 178.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.3 mt -58.13 -41.12 79.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.322 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.09 -37.63 80.53 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.835 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.6 -40.48 97.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.866 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.492 HD11 HG13 ' A' ' 24' ' ' ILE . 22.1 mm -65.75 -31.22 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.676 HG21 HG13 ' A' ' 56' ' ' ILE . 24.0 t -97.46 -2.9 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.3 t -99.54 -75.74 0.56 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -87.42 -48.07 8.26 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.359 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.17 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.746 HG21 HG23 ' A' ' 52' ' ' VAL . 16.1 mt -126.48 136.39 60.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.806 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -153.0 44.01 0.64 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.133 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -130.64 129.56 22.74 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.193 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.55 73.85 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 0.0 112.262 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.39 -52.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.575 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.456 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.3 p30 -83.91 -35.64 23.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.746 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -89.74 -35.67 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.946 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 t -58.43 -38.98 78.57 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.312 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.27 -36.86 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.316 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.06 -51.43 38.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.062 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.676 HG13 HG21 ' A' ' 42' ' ' VAL . 28.4 mm -111.71 125.35 69.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.134 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -114.5 122.77 47.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.766 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 57.11 45.14 21.3 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.73 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.29 32.33 21.58 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.362 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -143.89 147.87 34.62 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.853 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -61.58 152.32 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -93.64 148.44 35.42 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.92 122.16 9.26 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.752 2.301 . . . . 0.0 112.468 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.47 -46.26 1.08 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.768 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mt -64.64 117.81 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.5 mm -80.55 147.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.524 HG23 ' CG ' ' A' ' 74' ' ' TRP . 7.4 t -147.49 99.86 3.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.19 143.11 32.41 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.306 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 89' ' ' ILE . 17.1 mt -126.09 112.22 29.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.37 44.74 11.87 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.984 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.31 39.09 25.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -142.93 166.36 24.84 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.42 28.54 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.533 ' CZ3' ' HG2' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -51.87 -36.01 46.99 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.906 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -39.54 32.02 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.406 0.146 . . . . 0.0 111.358 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -25.22 62.54 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -106.56 -35.75 6.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.238 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.4 98.53 0.14 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.533 ' HG2' ' CZ3' ' A' ' 74' ' ' TRP . 2.9 tt0 -42.06 -69.61 0.13 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.258 0.223 . . . . 0.0 111.552 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -116.66 -36.81 3.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.971 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.77 -24.94 24.77 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.494 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -52.12 110.94 0.54 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.837 0.351 . . . . 0.0 110.728 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.0 mt -68.49 141.0 18.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.568 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.12 176.43 0.75 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.04 103.52 0.3 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.41 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.569 ' HA ' HG23 ' A' ' 2' ' ' VAL . 17.3 t0 -43.01 108.29 0.1 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.819 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 29.91 3.4 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.66 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.636 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -103.81 165.06 11.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.636 HD12 ' C ' ' A' ' 88' ' ' ASP . 1.6 mp -115.92 141.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.78 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.816 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.7 mp -138.43 90.12 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -81.41 132.73 35.34 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.114 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -118.95 110.09 16.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.34 100.94 8.24 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.0 t -92.4 88.05 6.25 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 m -119.35 -1.78 10.72 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.911 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 97' ' ' HIS . 13.5 mt 65.74 103.18 0.04 OUTLIER 'General case' 0 C--N 1.344 0.367 0 C-N-CA 122.447 0.299 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 24.4 m80 67.45 160.12 0.16 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.661 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.14 35.24 1.07 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.2 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.43 -1.205 . . . . 0.0 112.444 179.718 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.2 mtp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.6 0.238 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.9 m -135.51 163.16 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.312 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.04 112.13 10.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.16 134.49 49.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.0 116.74 33.33 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.764 HG12 ' HB ' ' A' ' 90' ' ' ILE . 6.6 m -122.47 143.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.403 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -110.95 153.79 25.02 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' C ' HD22 ' A' ' 9' ' ' LEU . 44.9 m-85 -128.57 118.23 22.63 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.048 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.628 ' CB ' HG23 ' A' ' 93' ' ' THR . 4.5 mm? -122.78 171.59 9.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.18 -103.14 1.54 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.436 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.05 27.27 3.32 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.948 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.586 HD21 ' CE1' ' A' ' 55' ' ' PHE . 3.4 mt -87.64 -41.41 13.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.825 0.313 . . . . 0.0 110.896 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.2 -33.93 71.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.165 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.77 -31.99 73.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.229 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 31.6 mt -74.3 -46.89 42.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.216 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -62.76 -65.58 0.67 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.319 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.48 46.74 0.03 OUTLIER Glycine 0 C--N 1.33 0.209 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.444 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.9 mttt 57.44 51.72 9.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -125.82 122.33 35.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.992 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -68.86 -64.31 0.89 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -113.93 137.32 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.783 0.325 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -126.93 156.67 41.11 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.059 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -123.89 132.2 53.7 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.811 HG13 HD11 ' A' ' 41' ' ' ILE . 23.3 mm -116.69 144.07 25.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.338 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.45 108.31 10.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.643 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -100.11 110.12 22.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.993 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -102.39 63.83 0.89 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 110.904 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -112.44 -44.98 3.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.012 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' CG ' HG22 ' A' ' 32' ' ' VAL . 9.5 pt-20 -169.95 -176.66 2.38 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -86.29 -51.93 0.46 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.964 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.5 Cg_exo -78.67 54.09 4.91 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.961 2.44 . . . . 0.0 112.165 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG22 ' CG ' ' A' ' 29' ' ' GLU . 26.8 t -85.65 122.48 38.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.026 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.8 p -74.4 150.45 40.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.234 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -52.59 -30.77 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.583 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.56 -25.71 61.27 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.279 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.4 -43.48 73.37 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -55.67 -47.06 77.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.775 178.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.68 -39.15 78.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.014 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.77 -41.07 94.76 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.829 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -59.89 -41.87 92.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.807 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.811 HD11 HG13 ' A' ' 24' ' ' ILE . 33.9 mm -63.81 -33.18 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.047 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.646 HG13 ' CG2' ' A' ' 52' ' ' VAL . 38.2 t -98.06 -3.89 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 m -95.54 -75.22 0.53 Allowed 'General case' 0 C--O 1.232 0.183 0 O-C-N 122.382 -0.199 . . . . 0.0 111.463 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 t -93.15 -38.78 11.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.458 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -46.81 88.62 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.079 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.717 HG21 HG23 ' A' ' 52' ' ' VAL . 20.1 mt -129.77 150.98 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.25 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -166.06 40.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.106 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 3.2 t-20 -128.58 128.44 23.56 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.484 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 25.0 Cg_exo -63.67 74.37 0.15 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.84 2.36 . . . . 0.0 112.191 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -172.07 -58.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.457 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 2.2 p30 -81.29 -34.56 31.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.758 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.717 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -91.78 -36.0 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.065 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -34.86 72.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.432 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.4 mt -86.63 -36.84 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.73 -0.213 . . . . 0.0 111.025 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.586 ' CE1' HD21 ' A' ' 12' ' ' LEU . 31.9 t80 -69.09 -37.04 78.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.088 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.461 HG13 HG21 ' A' ' 42' ' ' VAL . 35.1 mm -127.3 130.13 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.795 0.331 . . . . 0.0 111.353 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.41 -158.32 0.6 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.591 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.55 85.99 0.11 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.895 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 60.75 46.75 8.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.39 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.39 175.94 2.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.4 mt -97.07 153.4 3.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.832 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 125.31 79.04 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.85 105.33 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.62 2.213 . . . . 0.0 112.065 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 151.88 -31.25 0.9 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.557 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.522 HD12 ' CG2' ' A' ' 61' ' ' ILE . 31.2 mt -70.38 127.59 32.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mt -100.77 134.69 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.958 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 91' ' ' SER . 1.5 m -138.24 143.81 40.28 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.234 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.3 mt -139.4 126.21 20.82 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.447 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 77' ' ' GLU . 9.6 mt -100.73 102.35 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.0 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 59.99 59.75 2.33 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.304 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 57.83 26.02 12.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.209 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.58 173.27 11.04 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.036 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 2.3 m-20 -79.38 157.95 27.51 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -59.99 2.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.712 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.24 -37.42 77.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.185 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -60.36 -29.98 69.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.923 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.441 ' HB3' HD12 ' A' ' 69' ' ' ILE . 2.8 tp10 -93.57 28.4 2.31 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.069 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.95 -6.55 82.73 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.59 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 67.85 -72.41 0.09 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.027 0.414 . . . . 0.0 111.021 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -116.78 -29.71 5.97 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -79.03 54.88 1.68 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.227 0.537 . . . . 0.0 110.922 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -124.58 113.62 18.31 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.615 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.6 mt -61.45 128.5 22.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.8 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 84' ' ' LEU . 18.4 mt -64.2 174.5 1.57 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.858 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.39 103.65 0.21 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.248 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -46.68 113.71 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.026 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.85 23.98 5.69 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.7 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.02 177.65 4.83 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 111.337 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 mm -121.74 132.23 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.764 ' HB ' HG12 ' A' ' 6' ' ' VAL . 62.1 mt -143.06 92.55 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.631 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 67' ' ' THR . 12.9 m -79.88 149.11 31.05 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.711 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -134.46 86.87 2.3 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.776 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.628 HG23 ' CB ' ' A' ' 9' ' ' LEU . 1.2 m -91.23 144.72 25.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.604 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 m -148.66 79.98 1.44 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.004 0.43 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.44 -54.81 4.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.201 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.0 28.65 17.98 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.27 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -175.23 -63.59 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.24 166.64 46.32 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.812 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.482 -1.177 . . . . 0.0 112.522 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 27' ' ' ASP . 1.8 mtp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.593 0.235 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.432 HG13 ' CA ' ' A' ' 86' ' ' ASP . 5.1 t -101.9 102.2 13.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.876 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -80.18 125.28 29.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.551 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.911 HG21 HD21 ' A' ' 37' ' ' LEU . 31.2 m -128.47 139.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.79 118.28 36.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.889 HG12 ' HB ' ' A' ' 90' ' ' ILE . 35.0 m -119.0 153.25 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.376 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.498 ' CD ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -125.77 158.86 33.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.676 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.809 ' C ' HD22 ' A' ' 9' ' ' LEU . 8.2 p90 -160.24 148.03 16.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.809 HD22 ' C ' ' A' ' 8' ' ' PHE . 3.0 mm? -137.96 178.22 7.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.112 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.59 -109.97 3.04 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.83 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.19 -24.22 17.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.943 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 55' ' ' PHE . 4.3 mm? -55.03 -46.41 75.29 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.721 0.261 . . . . 0.0 111.362 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.89 -30.73 71.07 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.134 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.0 -38.2 45.4 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.271 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ASP . 22.3 mt -75.63 -44.59 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.71 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.451 ' HE2' HD12 ' A' ' 12' ' ' LEU . 3.0 m-85 -59.27 -69.78 0.19 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.521 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.74 46.85 0.03 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.452 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.74 44.89 22.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -121.3 -176.66 3.34 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 -56.44 0.56 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.731 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.498 HG22 ' CD ' ' A' ' 7' ' ' GLU . 20.8 t -99.91 117.67 45.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.31 153.57 28.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.21 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -124.47 119.08 28.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -99.45 143.07 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -116.22 80.42 1.45 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.293 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -88.97 106.75 18.62 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.509 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 2.5 p30 -93.92 43.83 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HB3' HG21 ' A' ' 32' ' ' VAL . 1.3 tttp -90.11 -162.28 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.6 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -65.07 -172.19 0.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.904 0.383 . . . . 0.0 111.365 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' CB ' ' HD3' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -83.47 -54.01 0.54 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.036 179.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.455 ' HD3' ' CB ' ' A' ' 30' ' ' ASP . 5.7 Cg_exo -78.66 50.22 3.35 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.858 2.372 . . . . 0.0 112.713 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.578 HG21 ' HB3' ' A' ' 28' ' ' LYS . 35.4 t -81.84 126.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 1.3 p -73.34 157.47 36.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.914 0.387 . . . . 0.0 111.2 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.54 -34.98 48.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.471 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 38' ' ' ILE . . . -56.33 -28.33 54.79 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.875 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -68.91 -43.39 75.31 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.911 HD21 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -53.04 -51.93 60.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.482 HD12 ' HA2' ' A' ' 35' ' ' GLY . 4.6 mt -59.97 -36.84 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.171 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -63.75 -37.85 88.89 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.766 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -60.85 -39.64 89.86 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.627 0.251 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.418 ' CG1' HG12 ' A' ' 24' ' ' ILE . 17.8 mt -72.74 -25.76 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.842 HG13 HG21 ' A' ' 52' ' ' VAL . 30.8 t -100.09 -1.44 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -93.72 -77.87 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.381 -0.199 . . . . 0.0 111.234 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.29 -40.87 14.11 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.656 0.265 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -56.88 16.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.148 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.903 HG21 HG23 ' A' ' 52' ' ' VAL . 22.2 mt -116.24 123.01 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 120.629 0.252 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.6 39.34 1.69 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.139 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -131.84 129.24 21.87 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.72 70.18 2.11 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.519 2.146 . . . . 0.0 112.044 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.9 -50.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.448 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 1.4 p30 -88.68 -36.88 15.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.947 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.903 HG23 HG21 ' A' ' 46' ' ' ILE . 2.0 t -94.08 -35.11 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.342 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 m -56.11 -32.1 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.447 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 62' ' ' ARG . 33.2 mt -92.08 -32.03 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.56 0.219 . . . . 0.0 111.127 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CE1' HD11 ' A' ' 12' ' ' LEU . 58.3 t80 -73.37 -37.4 66.05 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.01 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CD1' HG21 ' A' ' 42' ' ' VAL . 27.1 mt -127.93 150.32 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.17 -163.98 1.02 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.695 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.62 92.41 0.07 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.735 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.5 33.66 22.97 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.471 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.1 p -165.93 122.55 1.37 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.867 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.82 151.61 9.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 20.1 mtt180 -74.5 142.36 77.71 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.16 97.14 0.91 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.689 2.26 . . . . 0.0 112.203 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.9 -39.2 0.09 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.49 132.92 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.5 mt -108.18 93.49 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.539 HG23 ' CG ' ' A' ' 74' ' ' TRP . 3.5 t -93.61 138.66 31.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.2 mt -125.03 122.27 36.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.54 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 mt -92.24 101.65 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 60.25 59.9 2.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.356 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 58.29 24.56 11.69 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.582 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -129.38 178.85 6.15 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.173 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -80.02 -177.07 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.889 0.376 . . . . 0.0 111.009 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.539 ' CG ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -104.61 -39.8 6.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.94 -24.59 19.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.017 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.435 ' HB2' ' CB ' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -54.42 -29.76 50.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.22 -69.32 0.86 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.563 0.221 . . . . 0.0 111.167 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.71 106.81 0.3 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.434 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.11 -71.01 0.08 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.504 0.192 . . . . 0.0 111.067 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -107.83 -36.65 6.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.947 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.37 -29.15 22.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.783 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -49.53 121.25 4.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.677 0.275 . . . . 0.0 110.856 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.97 138.36 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.05 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.438 HD13 HD23 ' A' ' 37' ' ' LEU . 20.6 mt -66.52 177.9 1.41 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.856 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.85 103.28 0.11 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.909 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' CA ' HG13 ' A' ' 2' ' ' VAL . 12.4 t0 -35.22 111.91 0.14 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.44 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.4 6.27 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.946 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -95.26 164.33 12.89 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.823 0.344 . . . . 0.0 111.082 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm -119.49 134.5 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.172 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.889 ' HB ' HG12 ' A' ' 6' ' ' VAL . 4.4 mp -139.0 154.04 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.045 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 67' ' ' THR . 16.3 m -134.75 161.6 34.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.14 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.405 ' CD1' ' HB ' ' A' ' 67' ' ' THR . 94.1 m-85 -150.39 79.98 1.35 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -87.38 130.56 34.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.437 ' HB2' HD23 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -114.54 101.18 8.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.074 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.24 -43.63 14.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.628 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 97' ' ' HIS . 1.0 OUTLIER -92.86 139.51 30.46 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 96' ' ' LEU . 3.2 m80 61.3 32.36 19.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.213 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.34 -77.94 1.25 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.359 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.604 179.759 . . . . . . . . 0 0 . 1 stop_ save_